Skip to content

Instantly share code, notes, and snippets.

@tternquist

tternquist/faers_slim.jsonl

Created April 21, 2026 15:24
Show Gist options

  • Select an option

    Learn more about clone URLs
  • Save tternquist/f20c2b5630164bfa1eea0b2cb681ac28 to your computer and use it in GitHub Desktop.

Select an option

Learn more about clone URLs
Save tternquist/f20c2b5630164bfa1eea0b2cb681ac28 to your computer and use it in GitHub Desktop.
Download ZIP
Lilly FAERS + labels slim
Raw
faers_slim.jsonl
This file has been truncated, but you can view the full file.
{"safetyreportid": "10003319", "receiveDate": "20140312", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "46", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "BENLYSTA", "drugcharacterization": "1", "drugindication": "SYSTEMIC LUPUS ERYTHEMATOSUS", "manufacturer": "GlaxoSmithKline LLC", "genericName": "BELIMUMAB", "brandName": "BENLYSTA", "pharmClass_epc": "B Lymphocyte Stimulator-specific Inhibitor [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "PLAQUENIL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Advanz Pharma (US) Corp.", "genericName": "HYDROXYCHLOROQUINE SULFATE", "brandName": "PLAQUENIL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "FOLTX", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "XANAX", "drugcharacterization": "2", "drugindication": null, "manufacturer": "PHARMACIA & UPJOHN COMPANY LLC", "genericName": "ALPRAZOLAM", "brandName": "XANAX", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "ORAL"}, {"medicinalproduct": "PERCOCET", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Endo USA, Inc.", "genericName": "OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN", "brandName": "PERCOCET", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "NEXIUM", "drugcharacterization": "2", "drugindication": null, "manufacturer": "AstraZeneca Pharmaceuticals LP", "genericName": "ESOMEPRAZOLE MAGNESIUM", "brandName": "NEXIUM", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "SUMATRIPTAN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Rising Pharma Holdings, Inc.", "genericName": "SUMATRIPTAN", "brandName": "SUMATRIPTAN", "pharmClass_epc": "Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "METHOTREXATE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Chartwell RX, LLC", "genericName": "METHOTREXATE", "brandName": "METHOTREXATE", "pharmClass_epc": "Folate Analog Metabolic Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "IBUPROFEN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "DOLGENCORP INC", "genericName": "IBUPROFEN", "brandName": "IBUPROFEN", "pharmClass_epc": "Nonsteroidal Anti-inflammatory Drug [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Cholecystectomy", "outcome": "1"}, {"pt": "Nephrolithiasis", "outcome": "1"}, {"pt": "Biliary tract disorder", "outcome": "1"}, {"pt": "Malaise", "outcome": "6"}], "classifyText": "BENLYSTA PLAQUENIL FOLTX CYMBALTA XANAX PERCOCET NEXIUM SUMATRIPTAN METHOTREXATE IBUPROFEN BELIMUMAB HYDROXYCHLOROQUINE SULFATE DULOXETINE HYDROCHLORIDE ALPRAZOLAM OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN ESOMEPRAZOLE MAGNESIUM SUMATRIPTAN METHOTREXATE IBUPROFEN SYSTEMIC LUPUS ERYTHEMATOSUS Cholecystectomy Nephrolithiasis Biliary tract disorder Malaise"}
{"safetyreportid": "10003397", "receiveDate": "20140312", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "IT", "reportType": "1", "patientSex": "1", "patientAge": "25", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "CITALOPRAM ORAL SOLUTION", "drugcharacterization": "1", "drugindication": "INTENTIONAL SELF-INJURY", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "1", "drugindication": "INTENTIONAL SELF-INJURY", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Sopor", "outcome": "1"}, {"pt": "Drug abuse", "outcome": "1"}, {"pt": "Overdose", "outcome": "1"}], "classifyText": "CITALOPRAM ORAL SOLUTION CYMBALTA DULOXETINE HYDROCHLORIDE INTENTIONAL SELF-INJURY INTENTIONAL SELF-INJURY Sopor Drug abuse Overdose"}
{"safetyreportid": "10003512", "receiveDate": "20140312", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "JP", "reportType": "1", "patientSex": "1", "patientAge": "75", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "FORTEO", "drugcharacterization": "1", "drugindication": "OSTEOPOROSIS", "manufacturer": "Eli Lilly and Company", "genericName": "TERIPARATIDE", "brandName": "FORTEO", "pharmClass_epc": "Parathyroid Hormone Analog [EPC]", "route": "SUBCUTANEOUS"}], "reactions": [{"pt": "Femur fracture", "outcome": "3"}, {"pt": "Fall", "outcome": "1"}], "classifyText": "FORTEO TERIPARATIDE OSTEOPOROSIS Femur fracture Fall"}
{"safetyreportid": "10003584", "receiveDate": "20140312", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "CA", "reportType": "2", "patientSex": "2", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "ACLASTA/ZOLEDRONATE", "drugcharacterization": "1", "drugindication": "OSTEOPOROSIS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "DIDROCAL", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "EVISTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "RALOXIFENE HYDROCHLORIDE", "brandName": "EVISTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "FORTEO", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "TERIPARATIDE", "brandName": "FORTEO", "pharmClass_epc": "Parathyroid Hormone Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "MIACALCIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Mylan Institutional LLC", "genericName": "CALCITONIN SALMON", "brandName": "MIACALCIN", "pharmClass_epc": "Calcitonin [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "VITAMIN D", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Strides Pharma Science Limited", "genericName": "ERGOCALCIFEROL", "brandName": "VITAMIN D", "pharmClass_epc": "Provitamin D2 Compound [EPC]", "route": "ORAL"}, {"medicinalproduct": "CALCIUM", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Apexel Co., Ltd", "genericName": "CALCIUM", "brandName": "7030 CALCIUM PREMIUM", "pharmClass_epc": "Calcium [EPC]", "route": "ORAL"}, {"medicinalproduct": "BISPHOSPHONATES", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "HORMONES NOS", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Bone density decreased", "outcome": "6"}], "classifyText": "ACLASTA/ZOLEDRONATE DIDROCAL EVISTA FORTEO MIACALCIN VITAMIN D 7030 CALCIUM PREMIUM BISPHOSPHONATES HORMONES NOS RALOXIFENE HYDROCHLORIDE TERIPARATIDE CALCITONIN SALMON ERGOCALCIFEROL CALCIUM OSTEOPOROSIS Bone density decreased"}
{"safetyreportid": "10003654", "receiveDate": "20140312", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "57", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "DEPAKOTE", "drugcharacterization": "1", "drugindication": "CONVULSION", "manufacturer": "AbbVie Inc.", "genericName": "DIVALPROEX SODIUM", "brandName": "DEPAKOTE ER", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "DEPAKOTE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "AbbVie Inc.", "genericName": "DIVALPROEX SODIUM", "brandName": "DEPAKOTE ER", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "KEPPRA", "drugcharacterization": "2", "drugindication": "CONVULSION", "manufacturer": "UCB, Inc.", "genericName": "LEVETIRACETAM", "brandName": "KEPPRA", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "LANTUS", "drugcharacterization": "2", "drugindication": "DIABETES MELLITUS", "manufacturer": "sanofi-aventis U.S. LLC", "genericName": "INSULIN GLARGINE", "brandName": "LANTUS", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "2", "drugindication": "DIABETES MELLITUS", "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "ATENOLOL", "drugcharacterization": "2", "drugindication": "HYPERTENSION", "manufacturer": "Almatica Pharma LLC", "genericName": "ATENOLOL", "brandName": "TENORMIN", "pharmClass_epc": "beta-Adrenergic Blocker [EPC]", "route": "ORAL"}, {"medicinalproduct": "SIMVASTATIN", "drugcharacterization": "2", "drugindication": "BLOOD CHOLESTEROL INCREASED", "manufacturer": "Accord Healthcare, Inc.", "genericName": "SIMVASTATIN", "brandName": "SIMVASTATIN", "pharmClass_epc": "HMG-CoA Reductase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "LISINOPRIL", "drugcharacterization": "2", "drugindication": "HYPERTENSION", "manufacturer": "Chartwell RX, LLC", "genericName": "LISINOPRIL", "brandName": "LISINOPRIL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "VITAMIN D NOS", "drugcharacterization": "2", "drugindication": "VITAMIN SUPPLEMENTATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Hair growth abnormal", "outcome": "2"}, {"pt": "Skin disorder", "outcome": "3"}, {"pt": "Alopecia", "outcome": "3"}], "classifyText": "DEPAKOTE ER DEPAKOTE ER KEPPRA LANTUS HUMALOG MIX75/25 TENORMIN SIMVASTATIN LISINOPRIL VITAMIN D NOS DIVALPROEX SODIUM DIVALPROEX SODIUM LEVETIRACETAM INSULIN GLARGINE INSULIN LISPRO ATENOLOL SIMVASTATIN LISINOPRIL CONVULSION CONVULSION DIABETES MELLITUS DIABETES MELLITUS HYPERTENSION BLOOD CHOLESTEROL INCREASED HYPERTENSION VITAMIN SUPPLEMENTATION Hair growth abnormal Skin disorder Alopecia"}
{"safetyreportid": "10003749", "receiveDate": "20140312", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "NL", "reportType": "2", "patientSex": "2", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "ACLASTA", "drugcharacterization": "1", "drugindication": "OSTEOPOROSIS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ACLASTA", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "PANTOZOLE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "FUROSEMIDE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Ipca Laboratories Limited", "genericName": "FUROSEMIDE", "brandName": "FUROSEMIDE", "pharmClass_epc": "Loop Diuretic [EPC]", "route": "ORAL"}, {"medicinalproduct": "CALCIUM", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Apexel Co., Ltd", "genericName": "CALCIUM", "brandName": "7030 CALCIUM PREMIUM", "pharmClass_epc": "Calcium [EPC]", "route": "ORAL"}, {"medicinalproduct": "VITAMIN D3", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Strides Pharma Science Limited", "genericName": "ERGOCALCIFEROL", "brandName": "VITAMIN D", "pharmClass_epc": "Provitamin D2 Compound [EPC]", "route": "ORAL"}, {"medicinalproduct": "MOVICOLON", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ZYPREXA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "OLANZAPINE", "brandName": "ZYPREXA INTRAMUSCULAR", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "SPIRONOLACTON", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "IPRAMOL", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "THEOPHYLLINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Alembic Pharmaceuticals Limited", "genericName": "THEOPHYLLINE", "brandName": "THEOPHYLLINE", "pharmClass_epc": "Methylxanthine [EPC]", "route": "ORAL"}, {"medicinalproduct": "FLIXOTIDE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Chronic obstructive pulmonary disease", "outcome": "6"}], "classifyText": "ACLASTA ACLASTA PANTOZOLE FUROSEMIDE 7030 CALCIUM PREMIUM VITAMIN D MOVICOLON ZYPREXA INTRAMUSCULAR SPIRONOLACTON IPRAMOL THEOPHYLLINE FLIXOTIDE FUROSEMIDE CALCIUM ERGOCALCIFEROL OLANZAPINE THEOPHYLLINE OSTEOPOROSIS Chronic obstructive pulmonary disease"}
{"safetyreportid": "10003756", "receiveDate": "20140312", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "43", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "DEPAKOTE", "drugcharacterization": "1", "drugindication": "AGORAPHOBIA", "manufacturer": "AbbVie Inc.", "genericName": "DIVALPROEX SODIUM", "brandName": "DEPAKOTE ER", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LITHIUM", "drugcharacterization": "1", "drugindication": "AGORAPHOBIA", "manufacturer": "Advagen Pharma Ltd", "genericName": "LITHIUM", "brandName": "LITHIUM", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LEXAPRO FILM-COATED TABLETS", "drugcharacterization": "1", "drugindication": "AGORAPHOBIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LUVOX", "drugcharacterization": "1", "drugindication": "AGORAPHOBIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "PRISTIQ", "drugcharacterization": "1", "drugindication": "AGORAPHOBIA", "manufacturer": "Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.", "genericName": "DESVENLAFAXINE SUCCINATE", "brandName": "PRISTIQ EXTENDED-RELEASE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "PRISTIQ", "drugcharacterization": "1", "drugindication": "DEPRESSION", "manufacturer": "Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.", "genericName": "DESVENLAFAXINE SUCCINATE", "brandName": "PRISTIQ EXTENDED-RELEASE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "PRISTIQ", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.", "genericName": "DESVENLAFAXINE SUCCINATE", "brandName": "PRISTIQ EXTENDED-RELEASE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "PRISTIQ", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.", "genericName": "DESVENLAFAXINE SUCCINATE", "brandName": "PRISTIQ EXTENDED-RELEASE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ZOLOFT", "drugcharacterization": "1", "drugindication": "AGORAPHOBIA", "manufacturer": "ROERIG", "genericName": "SERTRALINE HYDROCHLORIDE", "brandName": "ZOLOFT", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "PROZAC", "drugcharacterization": "1", "drugindication": "AGORAPHOBIA", "manufacturer": "Dista Products Company", "genericName": "FLUOXETINE HYDROCHLORIDE", "brandName": "PROZAC", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LAMICTAL", "drugcharacterization": "1", "drugindication": "AGORAPHOBIA", "manufacturer": "GlaxoSmithKline LLC", "genericName": "LAMOTRIGINE", "brandName": "LAMICTAL", "pharmClass_epc": "Anti-epileptic Agent [EPC]", "route": "ORAL"}, {"medicinalproduct": "PAXIL", "drugcharacterization": "1", "drugindication": "AGORAPHOBIA", "manufacturer": "Apotex Corp", "genericName": "PAROXETINE HYDROCHLORIDE", "brandName": "PAXIL CR", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "VALIUM", "drugcharacterization": "1", "drugindication": "AGORAPHOBIA", "manufacturer": "Roche Laboratories Inc.", "genericName": "DIAZEPAM", "brandName": "VALIUM", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "ORAL"}, {"medicinalproduct": "KLONOPIN", "drugcharacterization": "1", "drugindication": "AGORAPHOBIA", "manufacturer": "H2-Pharma, LLC", "genericName": "CLONAZEPAM", "brandName": "KLONOPIN", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "ORAL"}, {"medicinalproduct": "TOPAMAX", "drugcharacterization": "1", "drugindication": "AGORAPHOBIA", "manufacturer": "Janssen Pharmaceuticals, Inc.", "genericName": "TOPIRAMATE", "brandName": "TOPAMAX", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ABILIFY", "drugcharacterization": "1", "drugindication": "AGORAPHOBIA", "manufacturer": "Otsuka America Pharmaceutical, Inc.", "genericName": "ARIPIPRAZOLE", "brandName": "ABILIFY", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "WELLBUTRIN", "drugcharacterization": "1", "drugindication": "AGORAPHOBIA", "manufacturer": "Bausch Health US LLC", "genericName": "BUPROPION HYDROCHLORIDE", "brandName": "WELLBUTRIN XL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CELEXA", "drugcharacterization": "1", "drugindication": "AGORAPHOBIA", "manufacturer": "Allergan, Inc.", "genericName": "CITALOPRAM", "brandName": "CELEXA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "1", "drugindication": "AGORAPHOBIA", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ANAFRANIL", "drugcharacterization": "1", "drugindication": "AGORAPHOBIA", "manufacturer": "SpecGx LLC", "genericName": "CLOMIPRAMINE HYDROCHLORIDE", "brandName": "ANAFRANIL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "IMIPRAMINE", "drugcharacterization": "1", "drugindication": "AGORAPHOBIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "TEGRETOL", "drugcharacterization": "1", "drugindication": "AGORAPHOBIA", "manufacturer": "Novartis Pharmaceuticals Corporation", "genericName": "CARBAMAZEPINE", "brandName": "TEGRETOL", "pharmClass_epc": "Mood Stabilizer [EPC]", "route": "ORAL"}, {"medicinalproduct": "SEROQUEL", "drugcharacterization": "1", "drugindication": "AGORAPHOBIA", "manufacturer": "AstraZeneca Pharmaceuticals LP", "genericName": "QUETIAPINE", "brandName": "SEROQUEL XR", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "SEROQUEL XR", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "AstraZeneca Pharmaceuticals LP", "genericName": "QUETIAPINE", "brandName": "SEROQUEL XR", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "XANAX", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "PHARMACIA & UPJOHN COMPANY LLC", "genericName": "ALPRAZOLAM", "brandName": "XANAX", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "ORAL"}, {"medicinalproduct": "ADDERALL", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Teva Pharmaceuticals USA, Inc.", "genericName": "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE", "brandName": "ADDERALL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "UNSPECIFIED MEDICATION", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Activities of daily living impaired", "outcome": "6"}, {"pt": "Crying", "outcome": "6"}, {"pt": "Drug ineffective", "outcome": "6"}, {"pt": "Depression", "outcome": "6"}], "classifyText": "DEPAKOTE ER LITHIUM LEXAPRO FILM-COATED TABLETS LUVOX PRISTIQ EXTENDED-RELEASE PRISTIQ EXTENDED-RELEASE PRISTIQ EXTENDED-RELEASE PRISTIQ EXTENDED-RELEASE ZOLOFT PROZAC LAMICTAL PAXIL CR VALIUM KLONOPIN TOPAMAX ABILIFY WELLBUTRIN XL CELEXA CYMBALTA ANAFRANIL IMIPRAMINE TEGRETOL SEROQUEL XR SEROQUEL XR XANAX ADDERALL UNSPECIFIED MEDICATION DIVALPROEX SODIUM LITHIUM DESVENLAFAXINE SUCCINATE DESVENLAFAXINE SUCCINATE DESVENLAFAXINE SUCCINATE DESVENLAFAXINE SUCCINATE SERTRALINE HYDROCHLORIDE FLUOXETINE HYDROCHLORIDE LAMOTRIGINE PAROXETINE HYDROCHLORIDE DIAZEPAM CLONAZEPAM TOPIRAMATE ARIPIPRAZOLE BUPROPION HYDROCHLORIDE CITALOPRAM DULOXETINE HYDROCHLORIDE CLOMIPRAMINE HYDROCHLORIDE CARBAMAZEPINE QUETIAPINE QUETIAPINE ALPRAZOLAM DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE AGORAPHOBIA AGORAPHOBIA AGORAPHOBIA AGORAPHOBIA AGORAPHOBIA DEPRESSION AGORAPHOBIA AGORAPHOBIA AGORAPHOBIA AGORAPHOBIA AGORAPHOBIA AGORAPHOBIA AGORAPHOBIA AGORAPHOBIA AGORAPHOBIA AGORAPHOBIA AGORAPHOBIA AGORAPHOBIA AGORAPHOBIA AGORAPHOBIA AGORAPHOBIA PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Activities of daily living impaired Crying Drug ineffective Depression"}
{"safetyreportid": "10003771", "receiveDate": "20140312", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "2", "patientSex": "2", "patientAge": "53", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "HUMIRA", "drugcharacterization": "1", "drugindication": "RHEUMATOID ARTHRITIS", "manufacturer": "Cordavis Limited", "genericName": "ADALIMUMAB", "brandName": "HUMIRA", "pharmClass_epc": null, "route": null}, {"medicinalproduct": "METHOTREXATE", "drugcharacterization": "2", "drugindication": "RHEUMATOID ARTHRITIS", "manufacturer": "Chartwell RX, LLC", "genericName": "METHOTREXATE", "brandName": "METHOTREXATE", "pharmClass_epc": "Folate Analog Metabolic Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "METHOTREXATE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Chartwell RX, LLC", "genericName": "METHOTREXATE", "brandName": "METHOTREXATE", "pharmClass_epc": "Folate Analog Metabolic Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "APRISO", "drugcharacterization": "2", "drugindication": "CROHN^S DISEASE", "manufacturer": "Salix Pharmaceuticals, Inc.", "genericName": "MESALAMINE", "brandName": "APRISO", "pharmClass_epc": "Aminosalicylate [EPC]", "route": "ORAL"}, {"medicinalproduct": "PENTASSA", "drugcharacterization": "2", "drugindication": "CROHN^S DISEASE", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ABILIFY", "drugcharacterization": "2", "drugindication": "BIPOLAR DISORDER", "manufacturer": "Otsuka America Pharmaceutical, Inc.", "genericName": "ARIPIPRAZOLE", "brandName": "ABILIFY", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": "BIPOLAR DISORDER", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "VALIUM", "drugcharacterization": "2", "drugindication": "ANXIETY", "manufacturer": "Roche Laboratories Inc.", "genericName": "DIAZEPAM", "brandName": "VALIUM", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "ORAL"}, {"medicinalproduct": "FENTANYL PATCHES", "drugcharacterization": "2", "drugindication": "PANCREATITIS CHRONIC", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "REGLAN", "drugcharacterization": "2", "drugindication": "GASTROOESOPHAGEAL REFLUX DISEASE", "manufacturer": "ANI Pharmaceuticals, Inc.", "genericName": "METOCLOPRAMIDE HYDROCHLORIDE", "brandName": "REGLAN", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "AMBIEN", "drugcharacterization": "2", "drugindication": "INSOMNIA", "manufacturer": "Cosette Pharmaceuticals, Inc.", "genericName": "ZOLPIDEM TARTRATE", "brandName": "AMBIEN", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "OXYCODONE", "drugcharacterization": "2", "drugindication": "PAIN", "manufacturer": "Amneal Pharmaceuticals LLC", "genericName": "OXYCODONE", "brandName": "OXYCODONE HYDROCHLORIDE", "pharmClass_epc": "Opioid Agonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "OMEPRAZOLE", "drugcharacterization": "2", "drugindication": "GASTROOESOPHAGEAL REFLUX DISEASE", "manufacturer": "Amerisource Bergen", "genericName": "OMEPRAZOLE", "brandName": "GOOD NEIGHBOR PHARMACY OMEPRAZOLE", "pharmClass_epc": "Proton Pump Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "ZOFRAN", "drugcharacterization": "2", "drugindication": "NAUSEA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "TOVIAZ", "drugcharacterization": "2", "drugindication": "URINARY INCONTINENCE", "manufacturer": "Pfizer Laboratories Div Pfizer Inc", "genericName": "FESOTERODINE FUMARATE", "brandName": "TOVIAZ", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ENALAPRIL MALEATE", "drugcharacterization": "2", "drugindication": "HYPERTENSION", "manufacturer": "NorthStar RxLLC", "genericName": "ENALAPRIL MALEATE", "brandName": "ENALAPRIL MALEATE ORAL SOLUTION", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "FOLIC ACID", "drugcharacterization": "2", "drugindication": "VITAMIN SUPPLEMENTATION", "manufacturer": "PureTek Corporation", "genericName": "FOLIC ACID", "brandName": "VENTRIXYL", "pharmClass_epc": "Vitamin C [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Hyponatraemia", "outcome": "1"}, {"pt": "Dyspnoea", "outcome": "1"}, {"pt": "Pyrexia", "outcome": "1"}, {"pt": "Pancreatitis", "outcome": "1"}, {"pt": "Influenza", "outcome": "1"}, {"pt": "Pneumonia", "outcome": "1"}, {"pt": "Sepsis", "outcome": "1"}], "classifyText": "HUMIRA METHOTREXATE METHOTREXATE APRISO PENTASSA ABILIFY CYMBALTA VALIUM FENTANYL PATCHES REGLAN AMBIEN OXYCODONE HYDROCHLORIDE GOOD NEIGHBOR PHARMACY OMEPRAZOLE ZOFRAN TOVIAZ ENALAPRIL MALEATE ORAL SOLUTION VENTRIXYL ADALIMUMAB METHOTREXATE METHOTREXATE MESALAMINE ARIPIPRAZOLE DULOXETINE HYDROCHLORIDE DIAZEPAM METOCLOPRAMIDE HYDROCHLORIDE ZOLPIDEM TARTRATE OXYCODONE OMEPRAZOLE FESOTERODINE FUMARATE ENALAPRIL MALEATE FOLIC ACID RHEUMATOID ARTHRITIS RHEUMATOID ARTHRITIS CROHN^S DISEASE CROHN^S DISEASE BIPOLAR DISORDER BIPOLAR DISORDER ANXIETY PANCREATITIS CHRONIC GASTROOESOPHAGEAL REFLUX DISEASE INSOMNIA PAIN GASTROOESOPHAGEAL REFLUX DISEASE NAUSEA URINARY INCONTINENCE HYPERTENSION VITAMIN SUPPLEMENTATION Hyponatraemia Dyspnoea Pyrexia Pancreatitis Influenza Pneumonia Sepsis"}
{"safetyreportid": "10003810", "receiveDate": "20140312", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "1", "patientAge": "28", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "VALPROATE SEMISODIUM", "drugcharacterization": "1", "drugindication": "AFFECTIVE DISORDER", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "VALPROATE SEMISODIUM", "drugcharacterization": "1", "drugindication": "ATTENTION DEFICIT/HYPERACTIVITY DISORDER", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "OLANZAPINE", "drugcharacterization": "2", "drugindication": "CARNITINE DEFICIENCY", "manufacturer": "Hisun Pharmaceuticals USA, Inc.", "genericName": "OLANZAPINE", "brandName": "OLANZAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "OLANZAPINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Hisun Pharmaceuticals USA, Inc.", "genericName": "OLANZAPINE", "brandName": "OLANZAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "LORAZEPAM", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "International Medication Systems, Limited", "genericName": "LORAZEPAM", "brandName": "LORAZEPAM", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "CITALOPRAM", "drugcharacterization": "2", "drugindication": "CARNITINE DEFICIENCY", "manufacturer": "Chartwell Governmental & Specialty RX, LLC.", "genericName": "CITALOPRAM", "brandName": "CITALOPRAM", "pharmClass_epc": "Serotonin Reuptake Inhibitor [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Carnitine deficiency", "outcome": "2"}, {"pt": "Hyperammonaemia", "outcome": "1"}, {"pt": "Irritability", "outcome": "2"}, {"pt": "Affective disorder", "outcome": "2"}, {"pt": "Condition aggravated", "outcome": "2"}], "classifyText": "VALPROATE SEMISODIUM VALPROATE SEMISODIUM OLANZAPINE OLANZAPINE LORAZEPAM CITALOPRAM OLANZAPINE OLANZAPINE LORAZEPAM CITALOPRAM AFFECTIVE DISORDER ATTENTION DEFICIT/HYPERACTIVITY DISORDER CARNITINE DEFICIENCY PRODUCT USED FOR UNKNOWN INDICATION CARNITINE DEFICIENCY Carnitine deficiency Hyperammonaemia Irritability Affective disorder Condition aggravated"}
{"safetyreportid": "10003911", "receiveDate": "20140312", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "1", "patientAge": "8", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "DEPAKOTE", "drugcharacterization": "1", "drugindication": "AGGRESSION", "manufacturer": "AbbVie Inc.", "genericName": "DIVALPROEX SODIUM", "brandName": "DEPAKOTE ER", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LEVOTHYROXINE SODIUM", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Lupin Pharmaceuticals, Inc.", "genericName": "LEVOTHYROXINE SODIUM", "brandName": "LEVOTHYROXINE SODIUM", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ZYPREXA", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "OLANZAPINE", "brandName": "ZYPREXA INTRAMUSCULAR", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "GUANFACINE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Apotex Corp.", "genericName": "GUANFACINE", "brandName": "GUANFACINE EXTENDED-RELEASE", "pharmClass_epc": "Central alpha-2 Adrenergic Agonist [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Drug ineffective", "outcome": "3"}, {"pt": "Somnolence", "outcome": "3"}], "classifyText": "DEPAKOTE ER LEVOTHYROXINE SODIUM ZYPREXA INTRAMUSCULAR GUANFACINE EXTENDED-RELEASE DIVALPROEX SODIUM LEVOTHYROXINE SODIUM OLANZAPINE GUANFACINE AGGRESSION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Drug ineffective Somnolence"}
{"safetyreportid": "10003973", "receiveDate": "20140312", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "DEPAKOTE", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "AbbVie Inc.", "genericName": "DIVALPROEX SODIUM", "brandName": "DEPAKOTE ER", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ZYPREXA", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "OLANZAPINE", "brandName": "ZYPREXA INTRAMUSCULAR", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "INTRAMUSCULAR"}], "reactions": [{"pt": "Blood glucose increased", "outcome": "2"}, {"pt": "Blood cholesterol increased", "outcome": "2"}, {"pt": "Alopecia", "outcome": "3"}, {"pt": "Insomnia", "outcome": "3"}, {"pt": "Weight increased", "outcome": "3"}], "classifyText": "DEPAKOTE ER ZYPREXA INTRAMUSCULAR DIVALPROEX SODIUM OLANZAPINE PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Blood glucose increased Blood cholesterol increased Alopecia Insomnia Weight increased"}
{"safetyreportid": "10003998", "receiveDate": "20140312", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "AMITRIPTYLINE", "drugcharacterization": "2", "drugindication": "DIABETIC NEUROPATHY", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": "DEPRESSION", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "XIFAXAN", "drugcharacterization": "2", "drugindication": "HEPATIC CIRRHOSIS", "manufacturer": "Salix Pharmaceuticals, Inc.", "genericName": "RIFAXIMIN", "brandName": "XIFAXAN", "pharmClass_epc": "Rifamycin Antibacterial [EPC]", "route": "ORAL"}, {"medicinalproduct": "DILTIAZEM", "drugcharacterization": "2", "drugindication": "HYPERTENSION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LANTUS", "drugcharacterization": "2", "drugindication": "DIABETES MELLITUS", "manufacturer": "sanofi-aventis U.S. LLC", "genericName": "INSULIN GLARGINE", "brandName": "LANTUS", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "B12", "drugcharacterization": "2", "drugindication": "VITAMIN B12 DEFICIENCY", "manufacturer": "Apex Energetics Inc.", "genericName": "ADRENALINUM, ARGENTUM NITRICUM, BOS TAURUS PITUITARUM POSTERIUM, GLYCERINUM, GLYCYRRHIZA GLABRA, KALI CARBONICUM, LACTICUM ACIDUM, MAGNESIA SULPHURICA, NICCOLUM METALLICUM, PANCREATINUM, PHOSPHORICUM ACIDUM, SACCHARINUM, SACCHARUM LACTIS, SACCHARUM OFFICINALE, SARCOLACTICUM ACIDUM, SELENIUM METALLICUM, SYZYGIUM JAMBOLANUM, THYROIDINUM, ZINCUM METALLICUM", "brandName": "B05 GLUCO BALANCE", "pharmClass_epc": "alpha-Adrenergic Agonist [EPC]", "route": "SUBLINGUAL"}, {"medicinalproduct": "B12", "drugcharacterization": "2", "drugindication": "PERNICIOUS ANAEMIA", "manufacturer": "Apex Energetics Inc.", "genericName": "ADRENALINUM, ARGENTUM NITRICUM, BOS TAURUS PITUITARUM POSTERIUM, GLYCERINUM, GLYCYRRHIZA GLABRA, KALI CARBONICUM, LACTICUM ACIDUM, MAGNESIA SULPHURICA, NICCOLUM METALLICUM, PANCREATINUM, PHOSPHORICUM ACIDUM, SACCHARINUM, SACCHARUM LACTIS, SACCHARUM OFFICINALE, SARCOLACTICUM ACIDUM, SELENIUM METALLICUM, SYZYGIUM JAMBOLANUM, THYROIDINUM, ZINCUM METALLICUM", "brandName": "B05 GLUCO BALANCE", "pharmClass_epc": "alpha-Adrenergic Agonist [EPC]", "route": "SUBLINGUAL"}, {"medicinalproduct": "METFORMIN", "drugcharacterization": "2", "drugindication": "DIABETES MELLITUS", "manufacturer": "Mylan Pharmaceuticals Inc.", "genericName": "METFORMIN", "brandName": "METFORMIN HYDROCHLORIDE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "KCL", "drugcharacterization": "2", "drugindication": "BLOOD POTASSIUM DECREASED", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "2", "drugindication": "DIABETES MELLITUS", "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "OMEPRAZOLE", "drugcharacterization": "2", "drugindication": "GASTROOESOPHAGEAL REFLUX DISEASE", "manufacturer": "Amerisource Bergen", "genericName": "OMEPRAZOLE", "brandName": "GOOD NEIGHBOR PHARMACY OMEPRAZOLE", "pharmClass_epc": "Proton Pump Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "DEPAKOTE", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "AbbVie Inc.", "genericName": "DIVALPROEX SODIUM", "brandName": "DEPAKOTE ER", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "GABAPENTIN", "drugcharacterization": "1", "drugindication": "DIABETIC NEUROPATHY", "manufacturer": "Rising Pharma Holdings, Inc.", "genericName": "GABAPENTIN", "brandName": "GABAPENTIN", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LASIX", "drugcharacterization": "2", "drugindication": "OEDEMA", "manufacturer": "Validus Pharmaceuticals LLC", "genericName": "FUROSEMIDE", "brandName": "LASIX", "pharmClass_epc": "Loop Diuretic [EPC]", "route": "ORAL"}, {"medicinalproduct": "SYNTHROID", "drugcharacterization": "2", "drugindication": "HYPOTHYROIDISM", "manufacturer": "AbbVie Inc.", "genericName": "LEVOTHYROXINE SODIUM", "brandName": "SYNTHROID", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Feeling abnormal", "outcome": "6"}, {"pt": "Pneumonia", "outcome": "6"}, {"pt": "Suicidal ideation", "outcome": "6"}, {"pt": "Psychotic disorder", "outcome": "6"}, {"pt": "Unevaluable event", "outcome": "6"}, {"pt": "Unevaluable event", "outcome": "6"}, {"pt": "Malaise", "outcome": "6"}, {"pt": "Drug level increased", "outcome": "6"}, {"pt": "Asthenia", "outcome": "6"}, {"pt": "Apathy", "outcome": "6"}, {"pt": "Pain", "outcome": "6"}], "classifyText": "AMITRIPTYLINE CYMBALTA XIFAXAN DILTIAZEM LANTUS B05 GLUCO BALANCE B05 GLUCO BALANCE METFORMIN HYDROCHLORIDE KCL HUMALOG MIX75/25 GOOD NEIGHBOR PHARMACY OMEPRAZOLE DEPAKOTE ER GABAPENTIN LASIX SYNTHROID DULOXETINE HYDROCHLORIDE RIFAXIMIN INSULIN GLARGINE ADRENALINUM, ARGENTUM NITRICUM, BOS TAURUS PITUITARUM POSTERIUM, GLYCERINUM, GLYCYRRHIZA GLABRA, KALI CARBONICUM, LACTICUM ACIDUM, MAGNESIA SULPHURICA, NICCOLUM METALLICUM, PANCREATINUM, PHOSPHORICUM ACIDUM, SACCHARINUM, SACCHARUM LACTIS, SACCHARUM OFFICINALE, SARCOLACTICUM ACIDUM, SELENIUM METALLICUM, SYZYGIUM JAMBOLANUM, THYROIDINUM, ZINCUM METALLICUM ADRENALINUM, ARGENTUM NITRICUM, BOS TAURUS PITUITARUM POSTERIUM, GLYCERINUM, GLYCYRRHIZA GLABRA, KALI CARBONICUM, LACTICUM ACIDUM, MAGNESIA SULPHURICA, NICCOLUM METALLICUM, PANCREATINUM, PHOSPHORICUM ACIDUM, SACCHARINUM, SACCHARUM LACTIS, SACCHARUM OFFICINALE, SARCOLACTICUM ACIDUM, SELENIUM METALLICUM, SYZYGIUM JAMBOLANUM, THYROIDINUM, ZINCUM METALLICUM METFORMIN INSULIN LISPRO OMEPRAZOLE DIVALPROEX SODIUM GABAPENTIN FUROSEMIDE LEVOTHYROXINE SODIUM DIABETIC NEUROPATHY DEPRESSION HEPATIC CIRRHOSIS HYPERTENSION DIABETES MELLITUS VITAMIN B12 DEFICIENCY PERNICIOUS ANAEMIA DIABETES MELLITUS BLOOD POTASSIUM DECREASED DIABETES MELLITUS GASTROOESOPHAGEAL REFLUX DISEASE PRODUCT USED FOR UNKNOWN INDICATION DIABETIC NEUROPATHY OEDEMA HYPOTHYROIDISM Feeling abnormal Pneumonia Suicidal ideation Psychotic disorder Unevaluable event Unevaluable event Malaise Drug level increased Asthenia Apathy Pain"}
{"safetyreportid": "10004213", "receiveDate": "20140312", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "SE", "reportType": "1", "patientSex": "2", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "OMEPRAZOLE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Amerisource Bergen", "genericName": "OMEPRAZOLE", "brandName": "GOOD NEIGHBOR PHARMACY OMEPRAZOLE", "pharmClass_epc": "Proton Pump Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "SEROQUEL", "drugcharacterization": "1", "drugindication": null, "manufacturer": "AstraZeneca Pharmaceuticals LP", "genericName": "QUETIAPINE", "brandName": "SEROQUEL XR", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "STESOLID", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ZYPREXA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "OLANZAPINE", "brandName": "ZYPREXA INTRAMUSCULAR", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "OXASCAND", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CISORDINOL", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "FLUOXETINE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "QUALLENT PHARMACEUTICALS HEALTH LLC", "genericName": "FLUOXETINE HYDROCHLORIDE", "brandName": "FLUOXETINE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LITHIONIT", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "HEMINEVRIN", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "AKINETON", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "THERALEN", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "IMOVANE", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "PROPAVAN", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SOBRIL", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ERGENYL", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "INVEGA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Janssen Pharmaceuticals, Inc.", "genericName": "PALIPERIDONE", "brandName": "INVEGA", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "NOZINAN", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "PARGITAN", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ATARAX", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CETIRIZINE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "GERI-CARE PHARMACEUTICAL CORP", "genericName": "CETIRIZINE", "brandName": "CETIRIZINE HCL", "pharmClass_epc": "Histamine-1 Receptor Antagonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "TOPIRAMATE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Camber Pharmaceuticals, Inc.", "genericName": "TOPIRAMATE", "brandName": "TOPIRAMATE", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Ovarian germ cell cancer stage II", "outcome": "6"}, {"pt": "Amenorrhoea", "outcome": "6"}, {"pt": "Weight increased", "outcome": "6"}, {"pt": "Tremor", "outcome": "6"}, {"pt": "Galactorrhoea", "outcome": "6"}, {"pt": "Dyspnoea", "outcome": "6"}, {"pt": "Blood prolactin increased", "outcome": "6"}, {"pt": "Palpitations", "outcome": "6"}, {"pt": "Dyskinesia", "outcome": "6"}, {"pt": "Dysuria", "outcome": "6"}, {"pt": "Swelling", "outcome": "6"}, {"pt": "Muscle spasms", "outcome": "6"}, {"pt": "Breast enlargement", "outcome": "6"}, {"pt": "Fatigue", "outcome": "6"}, {"pt": "Muscular weakness", "outcome": "6"}, {"pt": "Agitation", "outcome": "6"}, {"pt": "Aggression", "outcome": "6"}, {"pt": "Hyperhidrosis", "outcome": "6"}, {"pt": "Abdominal pain", "outcome": "6"}], "classifyText": "GOOD NEIGHBOR PHARMACY OMEPRAZOLE SEROQUEL XR STESOLID ZYPREXA INTRAMUSCULAR OXASCAND CISORDINOL FLUOXETINE LITHIONIT HEMINEVRIN AKINETON THERALEN IMOVANE PROPAVAN SOBRIL ERGENYL INVEGA NOZINAN PARGITAN ATARAX CETIRIZINE HCL TOPIRAMATE OMEPRAZOLE QUETIAPINE OLANZAPINE FLUOXETINE HYDROCHLORIDE PALIPERIDONE CETIRIZINE TOPIRAMATE Ovarian germ cell cancer stage II Amenorrhoea Weight increased Tremor Galactorrhoea Dyspnoea Blood prolactin increased Palpitations Dyskinesia Dysuria Swelling Muscle spasms Breast enlargement Fatigue Muscular weakness Agitation Aggression Hyperhidrosis Abdominal pain"}
{"safetyreportid": "10004231", "receiveDate": "20140312", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "1", "patientAge": "42", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "NODOZ", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LITHIUM", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Advagen Pharma Ltd", "genericName": "LITHIUM", "brandName": "LITHIUM", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "OLANZAPINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Hisun Pharmaceuticals USA, Inc.", "genericName": "OLANZAPINE", "brandName": "OLANZAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Renal failure acute", "outcome": "1"}, {"pt": "Rhabdomyolysis", "outcome": "1"}, {"pt": "Traumatic liver injury", "outcome": "1"}, {"pt": "Pneumonia aspiration", "outcome": "1"}, {"pt": "Intentional overdose", "outcome": "1"}, {"pt": "Suicide attempt", "outcome": "1"}, {"pt": "Loss of consciousness", "outcome": "1"}, {"pt": "Diarrhoea", "outcome": "1"}, {"pt": "Vomiting", "outcome": "1"}, {"pt": "Nausea", "outcome": "1"}, {"pt": "Restlessness", "outcome": "1"}], "classifyText": "NODOZ LITHIUM OLANZAPINE LITHIUM OLANZAPINE Renal failure acute Rhabdomyolysis Traumatic liver injury Pneumonia aspiration Intentional overdose Suicide attempt Loss of consciousness Diarrhoea Vomiting Nausea Restlessness"}
{"safetyreportid": "10004292", "receiveDate": "20140312", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "IT", "reportType": "1", "patientSex": "1", "patientAge": "83", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "CARDIOASPIRIN", "drugcharacterization": "1", "drugindication": "PROPHYLAXIS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CITALOPRAM (UNKNOWN)", "drugcharacterization": "1", "drugindication": "DEPRESSION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ENAPREN", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LASIX", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Validus Pharmaceuticals LLC", "genericName": "FUROSEMIDE", "brandName": "LASIX", "pharmClass_epc": "Loop Diuretic [EPC]", "route": "ORAL"}, {"medicinalproduct": "SIVASTIN", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "OLANZAPINE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Hisun Pharmaceuticals USA, Inc.", "genericName": "OLANZAPINE", "brandName": "OLANZAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "MIRTAZAPINE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Aurolife Pharma LLC", "genericName": "MIRTAZAPINE", "brandName": "MIRTAZAPINE", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Subarachnoid haemorrhage", "outcome": "2"}], "classifyText": "CARDIOASPIRIN CITALOPRAM (UNKNOWN) ENAPREN LASIX SIVASTIN OLANZAPINE MIRTAZAPINE FUROSEMIDE OLANZAPINE MIRTAZAPINE PROPHYLAXIS DEPRESSION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Subarachnoid haemorrhage"}
{"safetyreportid": "10004454", "receiveDate": "20140312", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "IT", "reportType": "1", "patientSex": "1", "patientAge": "23", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "PEGASYS", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "pharmaand GmbH", "genericName": "PEGINTERFERON ALFA-2A", "brandName": "PEGASYS", "pharmClass_epc": "Interferon alpha [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "INCIVO", "drugcharacterization": "3", "drugindication": "CHRONIC HEPATITIS C", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "COPEGUS", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SUBOXONE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "INDIVIOR INC.", "genericName": "BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE", "brandName": "SUBOXONE", "pharmClass_epc": null, "route": "BUCCAL"}, {"medicinalproduct": "DEPAKINE CHRONO", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ZYPREXA", "drugcharacterization": "3", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "OLANZAPINE", "brandName": "ZYPREXA INTRAMUSCULAR", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "INTRAMUSCULAR"}], "reactions": [{"pt": "Drug interaction", "outcome": "1"}, {"pt": "Oedematous pancreatitis", "outcome": "1"}, {"pt": "Amylase increased", "outcome": "1"}, {"pt": "Lipase increased", "outcome": "1"}], "classifyText": "PEGASYS INCIVO COPEGUS SUBOXONE DEPAKINE CHRONO ZYPREXA INTRAMUSCULAR PEGINTERFERON ALFA-2A BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE OLANZAPINE PRODUCT USED FOR UNKNOWN INDICATION CHRONIC HEPATITIS C PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Drug interaction Oedematous pancreatitis Amylase increased Lipase increased"}
{"safetyreportid": "10004519", "receiveDate": "20140312", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "OXYCONTIN (NDA 22-272)", "drugcharacterization": "1", "drugindication": "OSTEOARTHRITIS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "FORTEO", "drugcharacterization": "2", "drugindication": "OSTEOPOROSIS", "manufacturer": "Eli Lilly and Company", "genericName": "TERIPARATIDE", "brandName": "FORTEO", "pharmClass_epc": "Parathyroid Hormone Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "FORTEO", "drugcharacterization": "2", "drugindication": "OSTEOPENIA", "manufacturer": "Eli Lilly and Company", "genericName": "TERIPARATIDE", "brandName": "FORTEO", "pharmClass_epc": "Parathyroid Hormone Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "CALCIUM", "drugcharacterization": "2", "drugindication": "OSTEOPOROSIS", "manufacturer": "Apexel Co., Ltd", "genericName": "CALCIUM", "brandName": "7030 CALCIUM PREMIUM", "pharmClass_epc": "Calcium [EPC]", "route": "ORAL"}, {"medicinalproduct": "CALCIUM", "drugcharacterization": "2", "drugindication": "OSTEOPENIA", "manufacturer": "Apexel Co., Ltd", "genericName": "CALCIUM", "brandName": "7030 CALCIUM PREMIUM", "pharmClass_epc": "Calcium [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Osteopenia", "outcome": "6"}, {"pt": "Osteoporosis", "outcome": "6"}], "classifyText": "OXYCONTIN (NDA 22-272) FORTEO FORTEO 7030 CALCIUM PREMIUM 7030 CALCIUM PREMIUM TERIPARATIDE TERIPARATIDE CALCIUM CALCIUM OSTEOARTHRITIS OSTEOPOROSIS OSTEOPENIA OSTEOPOROSIS OSTEOPENIA Osteopenia Osteoporosis"}
{"safetyreportid": "10004723", "receiveDate": "20140312", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "IT", "reportType": "1", "patientSex": "2", "patientAge": "73", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "RAMIPRIL", "drugcharacterization": "1", "drugindication": "HYPERTENSION", "manufacturer": "Lupin Pharmaceuticals, Inc.", "genericName": "RAMIPRIL", "brandName": "RAMIPRIL", "pharmClass_epc": "Angiotensin Converting Enzyme Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "COUMADIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CONGESCOR", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "LASIX", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Validus Pharmaceuticals LLC", "genericName": "FUROSEMIDE", "brandName": "LASIX", "pharmClass_epc": "Loop Diuretic [EPC]", "route": "ORAL"}, {"medicinalproduct": "TORVAST", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "DIAMOX", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SODIUM BICARBONATE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Advanced Rx LLC", "genericName": "SODIUM BICARBONATE", "brandName": "SODIUM BICARBONATE 10 GR (650 MG)", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CALCIUM CARBONATE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "WINCO FOODS, LLC", "genericName": "CALCIUM CARBONATE", "brandName": "WINCO FOODS ANTACID ULTRA STRENGTH", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Angioedema", "outcome": "1"}, {"pt": "Metabolic acidosis", "outcome": "1"}, {"pt": "Dyspnoea", "outcome": "1"}, {"pt": "Drug ineffective", "outcome": "1"}], "classifyText": "RAMIPRIL COUMADIN CONGESCOR HUMALOG MIX75/25 LASIX TORVAST DIAMOX SODIUM BICARBONATE 10 GR (650 MG) WINCO FOODS ANTACID ULTRA STRENGTH RAMIPRIL INSULIN LISPRO FUROSEMIDE SODIUM BICARBONATE CALCIUM CARBONATE HYPERTENSION Angioedema Metabolic acidosis Dyspnoea Drug ineffective"}
{"safetyreportid": "10004909", "receiveDate": "20140312", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "JP", "reportType": "1", "patientSex": "1", "patientAge": "36", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "CLOZARIL (CLOZAPINE)", "drugcharacterization": "1", "drugindication": "SCHIZOPHRENIA, PARANOID TYPE", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CLOZARIL (CLOZAPINE)", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CLOZARIL (CLOZAPINE)", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CLOZARIL (CLOZAPINE)", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CLOZARIL (CLOZAPINE)", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CLOZARIL (CLOZAPINE)", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CLOZARIL (CLOZAPINE)", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CLOZARIL (CLOZAPINE)", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CLOZARIL (CLOZAPINE)", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CLOZARIL (CLOZAPINE)", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CLOZARIL (CLOZAPINE)", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CLOZARIL (CLOZAPINE)", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CLOZARIL (CLOZAPINE)", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CLOZARIL (CLOZAPINE)", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CLOZARIL (CLOZAPINE)", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CLOZARIL (CLOZAPINE)", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CLOZARIL (CLOZAPINE)", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CLOZARIL (CLOZAPINE)", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CLOZARIL (CLOZAPINE)", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CLOZARIL (CLOZAPINE)", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CLOZARIL (CLOZAPINE)", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "RISPERIDONE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Amneal Pharmaceuticals LLC", "genericName": "RISPERIDONE", "brandName": "RISPERIDONE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "ARIPIPRAZOLE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Dr. Reddy's Laboratories Inc", "genericName": "ARIPIPRAZOLE ORALLY DISINTEGRATING", "brandName": "ARIPIPRAZOLE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "OLANZAPINE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Hisun Pharmaceuticals USA, Inc.", "genericName": "OLANZAPINE", "brandName": "OLANZAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "ACINON", "drugcharacterization": "2", "drugindication": "SCHIZOPHRENIA, PARANOID TYPE", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "MEILAX", "drugcharacterization": "2", "drugindication": "SCHIZOPHRENIA, PARANOID TYPE", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "MEILAX", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ROHYPNOL", "drugcharacterization": "2", "drugindication": "SCHIZOPHRENIA, PARANOID TYPE", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "OLMETEC", "drugcharacterization": "2", "drugindication": "HYPERTENSION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Weight decreased", "outcome": "3"}, {"pt": "Subileus", "outcome": "2"}, {"pt": "Sedation", "outcome": "1"}, {"pt": "Somnolence", "outcome": "6"}, {"pt": "Constipation", "outcome": "6"}, {"pt": "Akathisia", "outcome": "6"}, {"pt": "Abnormal behaviour", "outcome": "6"}, {"pt": "Drug ineffective", "outcome": "6"}], "classifyText": "CLOZARIL (CLOZAPINE) CLOZARIL (CLOZAPINE) CLOZARIL (CLOZAPINE) CLOZARIL (CLOZAPINE) CLOZARIL (CLOZAPINE) CLOZARIL (CLOZAPINE) CLOZARIL (CLOZAPINE) CLOZARIL (CLOZAPINE) CLOZARIL (CLOZAPINE) CLOZARIL (CLOZAPINE) CLOZARIL (CLOZAPINE) CLOZARIL (CLOZAPINE) CLOZARIL (CLOZAPINE) CLOZARIL (CLOZAPINE) CLOZARIL (CLOZAPINE) CLOZARIL (CLOZAPINE) CLOZARIL (CLOZAPINE) CLOZARIL (CLOZAPINE) CLOZARIL (CLOZAPINE) CLOZARIL (CLOZAPINE) CLOZARIL (CLOZAPINE) RISPERIDONE ARIPIPRAZOLE OLANZAPINE ACINON MEILAX MEILAX ROHYPNOL OLMETEC RISPERIDONE ARIPIPRAZOLE ORALLY DISINTEGRATING OLANZAPINE SCHIZOPHRENIA, PARANOID TYPE SCHIZOPHRENIA, PARANOID TYPE SCHIZOPHRENIA, PARANOID TYPE SCHIZOPHRENIA, PARANOID TYPE HYPERTENSION Weight decreased Subileus Sedation Somnolence Constipation Akathisia Abnormal behaviour Drug ineffective"}
{"safetyreportid": "10005078", "receiveDate": "20140312", "serious": 1, "seriousnessdeath": 1, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "68", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "REVLIMID", "drugcharacterization": "1", "drugindication": "MYELODYSPLASTIC SYNDROME", "manufacturer": "Celgene Corporation", "genericName": "LENALIDOMIDE", "brandName": "REVLIMID", "pharmClass_epc": "Thalidomide Analog [EPC]", "route": "ORAL"}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "AMLODIPINE BESYLATE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Zydus Pharmaceuticals USA Inc.", "genericName": "AMLODIPINE BESYLATE", "brandName": "AMLODIPINE BESYLATE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "FLUTICASONE PROPIONATE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Selder, S.A. de C.V.", "genericName": "FLUTICASONE PROPIONATE", "brandName": "FLUTICASONE PROPIONATE", "pharmClass_epc": null, "route": "NASAL"}, {"medicinalproduct": "DEXAMETHASONE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Zydus Lifesciences Limited", "genericName": "DEXAMETHASONE", "brandName": "DEXAMETHASONE", "pharmClass_epc": "Corticosteroid [EPC]", "route": "ORAL"}, {"medicinalproduct": "LIPITOR", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Viatris Specialty LLC", "genericName": "ATORVASTATIN CALCIUM", "brandName": "LIPITOR", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "POTASSIUM CL ER", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CLONAZEPAM", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Advagen Pharma Ltd", "genericName": "CLONAZEPAM", "brandName": "CLONAZEPAM", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "ORAL"}, {"medicinalproduct": "GABAPENTIN", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Rising Pharma Holdings, Inc.", "genericName": "GABAPENTIN", "brandName": "GABAPENTIN", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Myelodysplastic syndrome", "outcome": "5"}, {"pt": "Abasia", "outcome": "6"}, {"pt": "Chronic obstructive pulmonary disease", "outcome": "6"}, {"pt": "Diabetes mellitus", "outcome": "6"}, {"pt": "Pancytopenia", "outcome": "6"}, {"pt": "Asthenia", "outcome": "6"}], "classifyText": "REVLIMID HUMALOG MIX75/25 AMLODIPINE BESYLATE FLUTICASONE PROPIONATE DEXAMETHASONE LIPITOR POTASSIUM CL ER CLONAZEPAM GABAPENTIN LENALIDOMIDE INSULIN LISPRO AMLODIPINE BESYLATE FLUTICASONE PROPIONATE DEXAMETHASONE ATORVASTATIN CALCIUM CLONAZEPAM GABAPENTIN MYELODYSPLASTIC SYNDROME PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Myelodysplastic syndrome Abasia Chronic obstructive pulmonary disease Diabetes mellitus Pancytopenia Asthenia"}
{"safetyreportid": "10005204", "receiveDate": "20140312", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "76", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "JAKAFI", "drugcharacterization": "1", "drugindication": "MYELOFIBROSIS", "manufacturer": "Incyte Corporation", "genericName": "RUXOLITINIB", "brandName": "JAKAFI", "pharmClass_epc": "Kinase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "JAKAFI", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Incyte Corporation", "genericName": "RUXOLITINIB", "brandName": "JAKAFI", "pharmClass_epc": "Kinase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "EVISTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "RALOXIFENE HYDROCHLORIDE", "brandName": "EVISTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CELEBREX", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Viatris Specialty LLC", "genericName": "CELECOXIB", "brandName": "CELEBREX", "pharmClass_epc": "Nonsteroidal Anti-inflammatory Drug [EPC]", "route": "ORAL"}, {"medicinalproduct": "NORVASC", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Viatris Specialty LLC", "genericName": "AMLODIPINE BESYLATE", "brandName": "NORVASC", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "HYDROCHLOROTHIAZIDE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Aurobindo Pharma Limited", "genericName": "HYDROCHLOROTHIAZIDE", "brandName": "HYDROCHLOROTHIAZIDE", "pharmClass_epc": "Thiazide Diuretic [EPC]", "route": "ORAL"}, {"medicinalproduct": "LISINOPRIL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Chartwell RX, LLC", "genericName": "LISINOPRIL", "brandName": "LISINOPRIL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "SODIUM CHLORIDE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Hospira, Inc.", "genericName": "SODIUM CHLORIDE", "brandName": "SODIUM CHLORIDE", "pharmClass_epc": "Osmotic Laxative [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "ASPIRIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Unifirst First Aid Corporation", "genericName": "ASPIRIN", "brandName": "BAYER GENUINE ASPIRIN", "pharmClass_epc": "Nonsteroidal Anti-inflammatory Drug [EPC]", "route": "ORAL"}, {"medicinalproduct": "BIOTIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Guangdong Aimu Biological Technology Co., Ltd", "genericName": "BIOTIN", "brandName": "AVEYA BIOTIN HAIR GROWTH", "pharmClass_epc": "Arteriolar Vasodilator [EPC]", "route": "TOPICAL"}, {"medicinalproduct": "CALCIUM", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Apexel Co., Ltd", "genericName": "CALCIUM", "brandName": "7030 CALCIUM PREMIUM", "pharmClass_epc": "Calcium [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Nasal congestion", "outcome": "1"}, {"pt": "Constipation", "outcome": "1"}, {"pt": "Spondylitis", "outcome": "1"}, {"pt": "Weight increased", "outcome": "6"}], "classifyText": "JAKAFI JAKAFI EVISTA CELEBREX NORVASC HYDROCHLOROTHIAZIDE LISINOPRIL SODIUM CHLORIDE BAYER GENUINE ASPIRIN AVEYA BIOTIN HAIR GROWTH 7030 CALCIUM PREMIUM RUXOLITINIB RUXOLITINIB RALOXIFENE HYDROCHLORIDE CELECOXIB AMLODIPINE BESYLATE HYDROCHLOROTHIAZIDE LISINOPRIL SODIUM CHLORIDE ASPIRIN BIOTIN CALCIUM MYELOFIBROSIS Nasal congestion Constipation Spondylitis Weight increased"}
{"safetyreportid": "10005223", "receiveDate": "20140312", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "2", "patientSex": "2", "patientAge": "60", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "BYSTOLIC", "drugcharacterization": "2", "drugindication": "HYPERTENSION", "manufacturer": "Allergan, Inc.", "genericName": "NEBIVOLOL HYDROCHLORIDE", "brandName": "BYSTOLIC", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": "PAIN", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "DICLOFENAC", "drugcharacterization": "2", "drugindication": "PAIN", "manufacturer": "Amneal Pharmaceuticals LLC", "genericName": "DICLOFENAC", "brandName": "DICLOFENAC SODIUM", "pharmClass_epc": "Nonsteroidal Anti-inflammatory Drug [EPC]", "route": "TOPICAL"}, {"medicinalproduct": "XANAX", "drugcharacterization": "2", "drugindication": "ANXIETY", "manufacturer": "PHARMACIA & UPJOHN COMPANY LLC", "genericName": "ALPRAZOLAM", "brandName": "XANAX", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "ORAL"}, {"medicinalproduct": "XANAX", "drugcharacterization": "2", "drugindication": null, "manufacturer": "PHARMACIA & UPJOHN COMPANY LLC", "genericName": "ALPRAZOLAM", "brandName": "XANAX", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "ORAL"}, {"medicinalproduct": "TIZANIDINE (TIZANIDINE)", "drugcharacterization": "2", "drugindication": "MUSCLE SPASMS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "IRON", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "True Botanica, LLC", "genericName": "IRON", "brandName": "FERRUM METALLICUM 6X", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "GABAPENTIN.", "drugcharacterization": "2", "drugindication": "PAIN", "manufacturer": "Rising Pharma Holdings, Inc.", "genericName": "GABAPENTIN", "brandName": "GABAPENTIN", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "HUMIRA", "drugcharacterization": "1", "drugindication": "CROHN^S DISEASE", "manufacturer": "Cordavis Limited", "genericName": "ADALIMUMAB", "brandName": "HUMIRA", "pharmClass_epc": null, "route": null}, {"medicinalproduct": "METFORMIN", "drugcharacterization": "2", "drugindication": "DIABETES MELLITUS", "manufacturer": "Mylan Pharmaceuticals Inc.", "genericName": "METFORMIN", "brandName": "METFORMIN HYDROCHLORIDE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "NOVOLOG", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Novo Nordisk", "genericName": "INSULIN ASPART", "brandName": "NOVOLOG", "pharmClass_epc": "Insulin Analog [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "GABAPENTIN.", "drugcharacterization": "2", "drugindication": "MUSCLE SPASMS", "manufacturer": "Rising Pharma Holdings, Inc.", "genericName": "GABAPENTIN", "brandName": "GABAPENTIN", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "PREDNISONE.", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "ANI Pharmaceuticals, Inc.", "genericName": "PREDNISONE", "brandName": "PREDNISONE", "pharmClass_epc": "Corticosteroid [EPC]", "route": "ORAL"}, {"medicinalproduct": "LEVEMIR", "drugcharacterization": "2", "drugindication": "DIABETES MELLITUS", "manufacturer": "Novo Nordisk", "genericName": "INSULIN DETEMIR", "brandName": "LEVEMIR", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}], "reactions": [{"pt": "Faecal incontinence", "outcome": "1"}, {"pt": "Neck surgery", "outcome": "1"}, {"pt": "Drug effect decreased", "outcome": "3"}, {"pt": "Abdominal pain", "outcome": "1"}, {"pt": "Diarrhoea", "outcome": "1"}, {"pt": "Cellulitis", "outcome": "1"}], "classifyText": "BYSTOLIC CYMBALTA DICLOFENAC SODIUM XANAX XANAX TIZANIDINE (TIZANIDINE) FERRUM METALLICUM 6X GABAPENTIN HUMIRA METFORMIN HYDROCHLORIDE NOVOLOG GABAPENTIN PREDNISONE LEVEMIR NEBIVOLOL HYDROCHLORIDE DULOXETINE HYDROCHLORIDE DICLOFENAC ALPRAZOLAM ALPRAZOLAM IRON GABAPENTIN ADALIMUMAB METFORMIN INSULIN ASPART GABAPENTIN PREDNISONE INSULIN DETEMIR HYPERTENSION PAIN PAIN ANXIETY MUSCLE SPASMS PRODUCT USED FOR UNKNOWN INDICATION PAIN CROHN^S DISEASE DIABETES MELLITUS PRODUCT USED FOR UNKNOWN INDICATION MUSCLE SPASMS PRODUCT USED FOR UNKNOWN INDICATION DIABETES MELLITUS Faecal incontinence Neck surgery Drug effect decreased Abdominal pain Diarrhoea Cellulitis"}
{"safetyreportid": "10005268", "receiveDate": "20140312", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "FR", "reportType": "1", "patientSex": "2", "patientAge": "85", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "OMNIPAQUE", "drugcharacterization": "1", "drugindication": "ABDOMINAL PAIN UPPER", "manufacturer": "GE Healthcare", "genericName": "IOHEXOL", "brandName": "OMNIPAQUE", "pharmClass_epc": "Radiographic Contrast Agent [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "OMNIPAQUE", "drugcharacterization": "1", "drugindication": "DIAGNOSTIC PROCEDURE", "manufacturer": "GE Healthcare", "genericName": "IOHEXOL", "brandName": "OMNIPAQUE", "pharmClass_epc": "Radiographic Contrast Agent [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "LASILIX /00032601/", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LEVOTHYROX", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ALDACTONE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Pfizer Laboratories Div Pfizer Inc", "genericName": "SPIRONOLACTONE", "brandName": "ALDACTONE", "pharmClass_epc": "Aldosterone Antagonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "DIFFU K", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "SINGULAIR", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Organon LLC", "genericName": "MONTELUKAST SODIUM", "brandName": "SINGULAIR", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "MYSOLINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Bausch Health US, LLC", "genericName": "PRIMIDONE", "brandName": "MYSOLINE", "pharmClass_epc": "Anti-epileptic Agent [EPC]", "route": "ORAL"}, {"medicinalproduct": "PROCORALAN", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Acute generalised exanthematous pustulosis", "outcome": "1"}, {"pt": "Pyrexia", "outcome": "1"}, {"pt": "Tremor", "outcome": "1"}], "classifyText": "OMNIPAQUE OMNIPAQUE LASILIX /00032601/ LEVOTHYROX ALDACTONE DIFFU K CYMBALTA SINGULAIR MYSOLINE PROCORALAN IOHEXOL IOHEXOL SPIRONOLACTONE DULOXETINE HYDROCHLORIDE MONTELUKAST SODIUM PRIMIDONE ABDOMINAL PAIN UPPER DIAGNOSTIC PROCEDURE Acute generalised exanthematous pustulosis Pyrexia Tremor"}
{"safetyreportid": "10005416", "receiveDate": "20140313", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "40", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "PROZAC", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Dista Products Company", "genericName": "FLUOXETINE HYDROCHLORIDE", "brandName": "PROZAC", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "SAVELLA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Allergan, Inc.", "genericName": "MILNACIPRAN HYDROCHLORIDE", "brandName": "SAVELLA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "TYLENOL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Kenvue Brands LLC", "genericName": "ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE", "brandName": "TYLENOL COLD PLUS HEAD CONGESTION SEVERE", "pharmClass_epc": "Expectorant [EPC]", "route": "ORAL"}, {"medicinalproduct": "ZYPREXA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "OLANZAPINE", "brandName": "ZYPREXA INTRAMUSCULAR", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "AVONEX", "drugcharacterization": "1", "drugindication": "MULTIPLE SCLEROSIS", "manufacturer": "Biogen Inc.", "genericName": "INTERFERON BETA-1A", "brandName": "AVONEX", "pharmClass_epc": "Interferon beta [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "ASPIRIN LOW DOSE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "L.N.K. International, Inc.", "genericName": "ASPIRIN", "brandName": "ASPIRIN LOW DOSE", "pharmClass_epc": "Nonsteroidal Anti-inflammatory Drug [EPC]", "route": "ORAL"}, {"medicinalproduct": "BUSPIRONE HCL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Advagen Pharma Ltd", "genericName": "BUSPIRONE HYDROCHLORIDE", "brandName": "BUSPIRONE HCL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "IBUPROFEN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "DOLGENCORP INC", "genericName": "IBUPROFEN", "brandName": "IBUPROFEN", "pharmClass_epc": "Nonsteroidal Anti-inflammatory Drug [EPC]", "route": "ORAL"}, {"medicinalproduct": "INDERAL LA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "ANI Pharmaceuticals, Inc.", "genericName": "PROPRANOLOL HYDROCHLORIDE", "brandName": "INDERAL LA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "PROVIL", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Adverse event", "outcome": "6"}, {"pt": "Influenza like illness", "outcome": "6"}], "classifyText": "PROZAC SAVELLA TYLENOL COLD PLUS HEAD CONGESTION SEVERE ZYPREXA INTRAMUSCULAR AVONEX ASPIRIN LOW DOSE BUSPIRONE HCL IBUPROFEN INDERAL LA PROVIL FLUOXETINE HYDROCHLORIDE MILNACIPRAN HYDROCHLORIDE ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE OLANZAPINE INTERFERON BETA-1A ASPIRIN BUSPIRONE HYDROCHLORIDE IBUPROFEN PROPRANOLOL HYDROCHLORIDE MULTIPLE SCLEROSIS Adverse event Influenza like illness"}
{"safetyreportid": "10005450", "receiveDate": "20140312", "serious": 1, "seriousnessdeath": 1, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "JP", "reportType": "1", "patientSex": null, "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "HUMALOG", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "1", "drugindication": "DIABETES MELLITUS", "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "1", "drugindication": "DIABETES MELLITUS", "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "ALDOMET /00637902/", "drugcharacterization": "2", "drugindication": "GESTATIONAL HYPERTENSION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "INAVIR /07146202/", "drugcharacterization": "2", "drugindication": "INFLUENZA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "INAVIR /07146202/", "drugcharacterization": "2", "drugindication": "INFLUENZA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CALONAL", "drugcharacterization": "2", "drugindication": "INFLUENZA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "ALDOMET /00637902/", "drugcharacterization": "2", "drugindication": "GESTATIONAL HYPERTENSION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "CALONAL", "drugcharacterization": "2", "drugindication": "INFLUENZA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Foetal exposure during pregnancy", "outcome": "3"}, {"pt": "Foetal death", "outcome": "5"}], "classifyText": "HUMALOG MIX75/25 HUMALOG MIX75/25 HUMALOG MIX75/25 HUMALOG MIX75/25 HUMALOG MIX75/25 HUMALOG MIX75/25 ALDOMET /00637902/ INAVIR /07146202/ INAVIR /07146202/ CALONAL HUMALOG MIX75/25 HUMALOG MIX75/25 ALDOMET /00637902/ HUMALOG MIX75/25 HUMALOG MIX75/25 HUMALOG MIX75/25 HUMALOG MIX75/25 HUMALOG MIX75/25 HUMALOG MIX75/25 CALONAL INSULIN LISPRO INSULIN LISPRO INSULIN LISPRO INSULIN LISPRO INSULIN LISPRO INSULIN LISPRO INSULIN LISPRO INSULIN LISPRO INSULIN LISPRO INSULIN LISPRO INSULIN LISPRO INSULIN LISPRO INSULIN LISPRO INSULIN LISPRO DIABETES MELLITUS DIABETES MELLITUS GESTATIONAL HYPERTENSION INFLUENZA INFLUENZA INFLUENZA GESTATIONAL HYPERTENSION INFLUENZA Foetal exposure during pregnancy Foetal death"}
{"safetyreportid": "10005459", "receiveDate": "20140312", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "FR", "reportType": "1", "patientSex": "1", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "CIALIS", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "TADALAFIL", "brandName": "CIALIS", "pharmClass_epc": "Phosphodiesterase 5 Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "FLUDARABINE", "drugcharacterization": "2", "drugindication": "CHRONIC LYMPHOCYTIC LEUKAEMIA", "manufacturer": "Fresenius Kabi USA, LLC", "genericName": "FLUDARABINE PHOSPHATE", "brandName": "FLUDARABINE", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "CYCLOPHOSPHAMIDE", "drugcharacterization": "2", "drugindication": "CHRONIC LYMPHOCYTIC LEUKAEMIA", "manufacturer": "Slate Run Pharmaceuticals, LLC", "genericName": "CYCLOPHOSPHAMIDE FOR INJECTION", "brandName": "CYCLOPHOSPHAMIDE", "pharmClass_epc": "Alkylating Drug [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "DEXAMETHASONE", "drugcharacterization": "2", "drugindication": "CHRONIC LYMPHOCYTIC LEUKAEMIA", "manufacturer": "Zydus Lifesciences Limited", "genericName": "DEXAMETHASONE", "brandName": "DEXAMETHASONE", "pharmClass_epc": "Corticosteroid [EPC]", "route": "ORAL"}, {"medicinalproduct": "ZELITREX", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "BACTRIM", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Sun Pharmaceutical Industries, Inc", "genericName": "SULFAMETHOXAZOLE AND TRIMETHOPRIM", "brandName": "BACTRIM", "pharmClass_epc": "Sulfonamide Antimicrobial [EPC]", "route": "ORAL"}, {"medicinalproduct": "INEXIUM /01479302/", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Visual acuity reduced", "outcome": "6"}, {"pt": "Temporal arteritis", "outcome": "6"}, {"pt": "Papilloedema", "outcome": "6"}], "classifyText": "CIALIS FLUDARABINE CYCLOPHOSPHAMIDE DEXAMETHASONE ZELITREX BACTRIM INEXIUM /01479302/ TADALAFIL FLUDARABINE PHOSPHATE CYCLOPHOSPHAMIDE FOR INJECTION DEXAMETHASONE SULFAMETHOXAZOLE AND TRIMETHOPRIM PRODUCT USED FOR UNKNOWN INDICATION CHRONIC LYMPHOCYTIC LEUKAEMIA CHRONIC LYMPHOCYTIC LEUKAEMIA CHRONIC LYMPHOCYTIC LEUKAEMIA Visual acuity reduced Temporal arteritis Papilloedema"}
{"safetyreportid": "10005474", "receiveDate": "20140312", "serious": 1, "seriousnessdeath": 1, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "JP", "reportType": "1", "patientSex": "2", "patientAge": "77", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "FORTEO", "drugcharacterization": "1", "drugindication": "OSTEOPOROSIS", "manufacturer": "Eli Lilly and Company", "genericName": "TERIPARATIDE", "brandName": "FORTEO", "pharmClass_epc": "Parathyroid Hormone Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "PLAVIX", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Sanofi-Aventis U.S. LLC", "genericName": "CLOPIDOGREL", "brandName": "PLAVIX", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "NIVADIL", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "DEPAS", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "MINZAIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "REMODELLIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "MENATETRENONE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "IPRIFLAVONE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "BIOFERMIN /00275501/", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "MAGNESIUM OXIDE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Westminster Pharmaceuticals, LLC", "genericName": "MAGNESIUM OXIDE", "brandName": "MAGNESIUM OXIDE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "YODEL", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Acute myeloid leukaemia", "outcome": "5"}, {"pt": "Hypothyroidism", "outcome": "6"}, {"pt": "Inflammation", "outcome": "1"}, {"pt": "Bronchitis", "outcome": "1"}, {"pt": "Hepatic enzyme increased", "outcome": "6"}], "classifyText": "FORTEO PLAVIX NIVADIL DEPAS MINZAIN REMODELLIN MENATETRENONE IPRIFLAVONE BIOFERMIN /00275501/ MAGNESIUM OXIDE YODEL TERIPARATIDE CLOPIDOGREL MAGNESIUM OXIDE OSTEOPOROSIS Acute myeloid leukaemia Hypothyroidism Inflammation Bronchitis Hepatic enzyme increased"}
{"safetyreportid": "10005491", "receiveDate": "20140312", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "FORTEO", "drugcharacterization": "1", "drugindication": "OSTEOPOROSIS", "manufacturer": "Eli Lilly and Company", "genericName": "TERIPARATIDE", "brandName": "FORTEO", "pharmClass_epc": "Parathyroid Hormone Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "CALCIUM", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Apexel Co., Ltd", "genericName": "CALCIUM", "brandName": "7030 CALCIUM PREMIUM", "pharmClass_epc": "Calcium [EPC]", "route": "ORAL"}, {"medicinalproduct": "NIFEDIPINE ER", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SERTRALINE HCL", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Biocon Pharma Inc.", "genericName": "SERTRALINE HYDROCHLORIDE", "brandName": "SERTRALINE HCL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "SPIRONOLACTONE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Amneal Pharmaceuticals LLC", "genericName": "SPIRONOLACTONE", "brandName": "SPIRONOLACTONE", "pharmClass_epc": "Aldosterone Antagonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "VITAMIN D /00107901/", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "B12", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Apex Energetics Inc.", "genericName": "ADRENALINUM, ARGENTUM NITRICUM, BOS TAURUS PITUITARUM POSTERIUM, GLYCERINUM, GLYCYRRHIZA GLABRA, KALI CARBONICUM, LACTICUM ACIDUM, MAGNESIA SULPHURICA, NICCOLUM METALLICUM, PANCREATINUM, PHOSPHORICUM ACIDUM, SACCHARINUM, SACCHARUM LACTIS, SACCHARUM OFFICINALE, SARCOLACTICUM ACIDUM, SELENIUM METALLICUM, SYZYGIUM JAMBOLANUM, THYROIDINUM, ZINCUM METALLICUM", "brandName": "B05 GLUCO BALANCE", "pharmClass_epc": "alpha-Adrenergic Agonist [EPC]", "route": "SUBLINGUAL"}, {"medicinalproduct": "IBUPROFEN", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "DOLGENCORP INC", "genericName": "IBUPROFEN", "brandName": "IBUPROFEN", "pharmClass_epc": "Nonsteroidal Anti-inflammatory Drug [EPC]", "route": "ORAL"}, {"medicinalproduct": "LEVOTHYROXINE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Arthralgia", "outcome": "3"}, {"pt": "Pain in extremity", "outcome": "3"}, {"pt": "Gait disturbance", "outcome": "3"}, {"pt": "Mobility decreased", "outcome": "3"}, {"pt": "Fatigue", "outcome": "3"}, {"pt": "Asthenia", "outcome": "3"}, {"pt": "Depressed mood", "outcome": "3"}, {"pt": "Vision blurred", "outcome": "6"}, {"pt": "Dry mouth", "outcome": "6"}], "classifyText": "FORTEO 7030 CALCIUM PREMIUM NIFEDIPINE ER SERTRALINE HCL SPIRONOLACTONE VITAMIN D /00107901/ B05 GLUCO BALANCE IBUPROFEN LEVOTHYROXINE TERIPARATIDE CALCIUM SERTRALINE HYDROCHLORIDE SPIRONOLACTONE ADRENALINUM, ARGENTUM NITRICUM, BOS TAURUS PITUITARUM POSTERIUM, GLYCERINUM, GLYCYRRHIZA GLABRA, KALI CARBONICUM, LACTICUM ACIDUM, MAGNESIA SULPHURICA, NICCOLUM METALLICUM, PANCREATINUM, PHOSPHORICUM ACIDUM, SACCHARINUM, SACCHARUM LACTIS, SACCHARUM OFFICINALE, SARCOLACTICUM ACIDUM, SELENIUM METALLICUM, SYZYGIUM JAMBOLANUM, THYROIDINUM, ZINCUM METALLICUM IBUPROFEN OSTEOPOROSIS PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Arthralgia Pain in extremity Gait disturbance Mobility decreased Fatigue Asthenia Depressed mood Vision blurred Dry mouth"}
{"safetyreportid": "10005544", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "2", "patientSex": "2", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "ACTEMRA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Genentech, Inc.", "genericName": "TOCILIZUMAB", "brandName": "ACTEMRA", "pharmClass_epc": "Interleukin-6 Receptor Antagonist [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ACTEMRA", "drugcharacterization": "1", "drugindication": "RHEUMATOID ARTHRITIS", "manufacturer": "Genentech, Inc.", "genericName": "TOCILIZUMAB", "brandName": "ACTEMRA", "pharmClass_epc": "Interleukin-6 Receptor Antagonist [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "METHOTREXATE", "drugcharacterization": "2", "drugindication": "RHEUMATOID ARTHRITIS", "manufacturer": "Chartwell RX, LLC", "genericName": "METHOTREXATE", "brandName": "METHOTREXATE", "pharmClass_epc": "Folate Analog Metabolic Inhibitor [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Pain in extremity", "outcome": "3"}, {"pt": "Oedema peripheral", "outcome": "6"}, {"pt": "Arthralgia", "outcome": "3"}, {"pt": "Oedema peripheral", "outcome": "3"}, {"pt": "Skin warm", "outcome": "6"}], "classifyText": "ACTEMRA CYMBALTA ACTEMRA METHOTREXATE TOCILIZUMAB DULOXETINE HYDROCHLORIDE TOCILIZUMAB METHOTREXATE RHEUMATOID ARTHRITIS RHEUMATOID ARTHRITIS Pain in extremity Oedema peripheral Arthralgia Oedema peripheral Skin warm"}
{"safetyreportid": "10005765", "receiveDate": "20140313", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "TECFIDERA", "drugcharacterization": "1", "drugindication": "MULTIPLE SCLEROSIS", "manufacturer": "Biogen Inc.", "genericName": "DIMETHYL FUMARATE", "brandName": "TECFIDERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "DETROL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Viatris Specialty LLC", "genericName": "TOLTERODINE TARTRATE", "brandName": "DETROL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "BACLOFEN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Northstar RxLLC", "genericName": "BACLOFEN", "brandName": "BACLOFEN", "pharmClass_epc": "gamma-Aminobutyric Acid-ergic Agonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "CIPROFLOXACIN ER", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "AMPRYA", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Depression", "outcome": "6"}], "classifyText": "TECFIDERA CYMBALTA DETROL BACLOFEN CIPROFLOXACIN ER AMPRYA DIMETHYL FUMARATE DULOXETINE HYDROCHLORIDE TOLTERODINE TARTRATE BACLOFEN MULTIPLE SCLEROSIS Depression"}
{"safetyreportid": "10005771", "receiveDate": "20140313", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "32", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "TECFIDERA", "drugcharacterization": "1", "drugindication": "MULTIPLE SCLEROSIS", "manufacturer": "Biogen Inc.", "genericName": "DIMETHYL FUMARATE", "brandName": "TECFIDERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LIPITOR", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Viatris Specialty LLC", "genericName": "ATORVASTATIN CALCIUM", "brandName": "LIPITOR", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Urticaria", "outcome": "6"}, {"pt": "Flushing", "outcome": "6"}], "classifyText": "TECFIDERA CYMBALTA LIPITOR DIMETHYL FUMARATE DULOXETINE HYDROCHLORIDE ATORVASTATIN CALCIUM MULTIPLE SCLEROSIS Urticaria Flushing"}
{"safetyreportid": "10005825", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 1, "occurcountry": "GB", "reportType": "1", "patientSex": "2", "patientAge": "66", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "OLANZAPINE", "drugcharacterization": "1", "drugindication": "AGITATION", "manufacturer": "Hisun Pharmaceuticals USA, Inc.", "genericName": "OLANZAPINE", "brandName": "OLANZAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "OLANZAPINE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Hisun Pharmaceuticals USA, Inc.", "genericName": "OLANZAPINE", "brandName": "OLANZAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "AMITRIPTYLINE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ATENOLOL", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Almatica Pharma LLC", "genericName": "ATENOLOL", "brandName": "TENORMIN", "pharmClass_epc": "beta-Adrenergic Blocker [EPC]", "route": "ORAL"}, {"medicinalproduct": "FOLIC ACID", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "PureTek Corporation", "genericName": "FOLIC ACID", "brandName": "VENTRIXYL", "pharmClass_epc": "Vitamin C [EPC]", "route": "ORAL"}, {"medicinalproduct": "LEVOTHYROXINE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "QUETIAPINE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Solco Healthcare U.S., LLC", "genericName": "QUETIAPINE", "brandName": "QUETIAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "SIMVASTATIN", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Accord Healthcare, Inc.", "genericName": "SIMVASTATIN", "brandName": "SIMVASTATIN", "pharmClass_epc": "HMG-CoA Reductase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "ZOPICLONE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Sepsis", "outcome": "1"}, {"pt": "Body temperature increased", "outcome": "6"}, {"pt": "Hypotension", "outcome": "6"}, {"pt": "Tachycardia", "outcome": "6"}, {"pt": "Neutropenia", "outcome": "2"}, {"pt": "Thrombocytopenia", "outcome": "2"}], "classifyText": "OLANZAPINE OLANZAPINE AMITRIPTYLINE TENORMIN VENTRIXYL LEVOTHYROXINE QUETIAPINE SIMVASTATIN ZOPICLONE OLANZAPINE OLANZAPINE ATENOLOL FOLIC ACID QUETIAPINE SIMVASTATIN AGITATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Sepsis Body temperature increased Hypotension Tachycardia Neutropenia Thrombocytopenia"}
{"safetyreportid": "10005888", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 1, "occurcountry": "US", "reportType": "1", "patientSex": "1", "patientAge": "54", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "CRESTOR", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "AstraZeneca Pharmaceuticals LP", "genericName": "ROSUVASTATIN", "brandName": "CRESTOR", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ASPIRIN USA", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "IRON", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "True Botanica, LLC", "genericName": "IRON", "brandName": "FERRUM METALLICUM 6X", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "NITROSTAT", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Viatris Specialty LLC", "genericName": "NITROGLYCERIN", "brandName": "NITROSTAT", "pharmClass_epc": "Nitrate Vasodilator [EPC]", "route": "SUBLINGUAL"}, {"medicinalproduct": "ATENOLOL.", "drugcharacterization": "1", "drugindication": "VENTRICULAR EXTRASYSTOLES", "manufacturer": "Almatica Pharma LLC", "genericName": "ATENOLOL", "brandName": "TENORMIN", "pharmClass_epc": "beta-Adrenergic Blocker [EPC]", "route": "ORAL"}, {"medicinalproduct": "LASIX", "drugcharacterization": "1", "drugindication": "CARDIAC FAILURE", "manufacturer": "Validus Pharmaceuticals LLC", "genericName": "FUROSEMIDE", "brandName": "LASIX", "pharmClass_epc": "Loop Diuretic [EPC]", "route": "ORAL"}, {"medicinalproduct": "AXIRON", "drugcharacterization": "1", "drugindication": "ANDROGEN DEFICIENCY", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "AXIRON", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "NORPACE", "drugcharacterization": "2", "drugindication": "VENTRICULAR EXTRASYSTOLES", "manufacturer": "Pfizer Laboratories Div Pfizer Inc", "genericName": "DISOPYRAMIDE PHOSPHATE", "brandName": "NORPACE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "NIASPAN", "drugcharacterization": "2", "drugindication": "HYPERLIPIDAEMIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "PRADAXA", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Boehringer Ingelheim Pharmaceuticals Inc.", "genericName": "DABIGATRAN ETEXILATE MESYLATE", "brandName": "PRADAXA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "PLAVIX", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Sanofi-Aventis U.S. LLC", "genericName": "CLOPIDOGREL", "brandName": "PLAVIX", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LASIX", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Validus Pharmaceuticals LLC", "genericName": "FUROSEMIDE", "brandName": "LASIX", "pharmClass_epc": "Loop Diuretic [EPC]", "route": "ORAL"}, {"medicinalproduct": "CIALIS", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "TADALAFIL", "brandName": "CIALIS", "pharmClass_epc": "Phosphodiesterase 5 Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "VITAMIN D /00107901/", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "AMIODARONE", "drugcharacterization": "1", "drugindication": "VENTRICULAR TACHYCARDIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "AXIRON", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ANDROGEL", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "ASCEND Therapeutics U.S., LLC", "genericName": "TESTOSTERONE", "brandName": "ANDROGEL", "pharmClass_epc": "Androgen [EPC]", "route": "TRANSDERMAL"}, {"medicinalproduct": "ATENOLOL.", "drugcharacterization": "1", "drugindication": "PRESYNCOPE", "manufacturer": "Almatica Pharma LLC", "genericName": "ATENOLOL", "brandName": "TENORMIN", "pharmClass_epc": "beta-Adrenergic Blocker [EPC]", "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": "DEPRESSION", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "WELLBUTRIN", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Bausch Health US LLC", "genericName": "BUPROPION HYDROCHLORIDE", "brandName": "WELLBUTRIN XL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "SYNTHROID", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "AbbVie Inc.", "genericName": "LEVOTHYROXINE SODIUM", "brandName": "SYNTHROID", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "MULTAQ", "drugcharacterization": "2", "drugindication": "ATRIAL FIBRILLATION", "manufacturer": "Sanofi-Aventis U.S. LLC", "genericName": "DRONEDARONE", "brandName": "MULTAQ", "pharmClass_epc": "Antiarrhythmic [EPC]", "route": "ORAL"}, {"medicinalproduct": "COREG", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Waylis Therapeutics LLC", "genericName": "CARVEDILOL", "brandName": "COREG", "pharmClass_epc": "alpha-Adrenergic Blocker [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Cardiac arrest", "outcome": "1"}, {"pt": "Acute myocardial infarction", "outcome": "3"}, {"pt": "Left atrial dilatation", "outcome": "6"}, {"pt": "Hyponatraemia", "outcome": "6"}, {"pt": "Hypertension", "outcome": "6"}, {"pt": "Coronary artery disease", "outcome": "6"}, {"pt": "Ischaemic cardiomyopathy", "outcome": "3"}, {"pt": "Fatigue", "outcome": "3"}, {"pt": "Ventricular tachycardia", "outcome": "6"}, {"pt": "Ventricular fibrillation", "outcome": "6"}, {"pt": "Heart rate increased", "outcome": "6"}, {"pt": "Cardiac failure acute", "outcome": "6"}, {"pt": "Atrial fibrillation", "outcome": "6"}, {"pt": "Hypogonadism", "outcome": "6"}, {"pt": "Respiratory failure", "outcome": "1"}, {"pt": "Ejection fraction decreased", "outcome": "3"}, {"pt": "Cardiac failure congestive", "outcome": "3"}, {"pt": "Sinus bradycardia", "outcome": "6"}, {"pt": "Coronary artery occlusion", "outcome": "6"}, {"pt": "Sleep apnoea syndrome", "outcome": "6"}], "classifyText": "CRESTOR ASPIRIN USA FERRUM METALLICUM 6X NITROSTAT TENORMIN LASIX AXIRON AXIRON NORPACE NIASPAN PRADAXA PLAVIX LASIX CIALIS VITAMIN D /00107901/ AMIODARONE AXIRON ANDROGEL TENORMIN CYMBALTA WELLBUTRIN XL SYNTHROID MULTAQ COREG ROSUVASTATIN IRON NITROGLYCERIN ATENOLOL FUROSEMIDE DISOPYRAMIDE PHOSPHATE DABIGATRAN ETEXILATE MESYLATE CLOPIDOGREL FUROSEMIDE TADALAFIL TESTOSTERONE ATENOLOL DULOXETINE HYDROCHLORIDE BUPROPION HYDROCHLORIDE LEVOTHYROXINE SODIUM DRONEDARONE CARVEDILOL PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION VENTRICULAR EXTRASYSTOLES CARDIAC FAILURE ANDROGEN DEFICIENCY VENTRICULAR EXTRASYSTOLES HYPERLIPIDAEMIA PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION VENTRICULAR TACHYCARDIA PRODUCT USED FOR UNKNOWN INDICATION PRESYNCOPE DEPRESSION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION ATRIAL FIBRILLATION PRODUCT USED FOR UNKNOWN INDICATION Cardiac arrest Acute myocardial infarction Left atrial dilatation Hyponatraemia Hypertension Coronary artery disease Ischaemic cardiomyopathy Fatigue Ventricular tachycardia Ventricular fibrillation Heart rate increased Cardiac failure acute Atrial fibrillation Hypogonadism Respiratory failure Ejection fraction decreased Cardiac failure congestive Sinus bradycardia Coronary artery occlusion Sleep apnoea syndrome"}
{"safetyreportid": "10005889", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "JP", "reportType": "1", "patientSex": "2", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "FORTEO", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "TERIPARATIDE", "brandName": "FORTEO", "pharmClass_epc": "Parathyroid Hormone Analog [EPC]", "route": "SUBCUTANEOUS"}], "reactions": [{"pt": "Compression fracture", "outcome": "6"}, {"pt": "Decreased appetite", "outcome": "3"}, {"pt": "Vomiting", "outcome": "6"}, {"pt": "Nausea", "outcome": "3"}], "classifyText": "FORTEO TERIPARATIDE PRODUCT USED FOR UNKNOWN INDICATION Compression fracture Decreased appetite Vomiting Nausea"}
{"safetyreportid": "10005891", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "81", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "FORTEO", "drugcharacterization": "1", "drugindication": "OSTEOPOROSIS", "manufacturer": "Eli Lilly and Company", "genericName": "TERIPARATIDE", "brandName": "FORTEO", "pharmClass_epc": "Parathyroid Hormone Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "FORTEO", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "TERIPARATIDE", "brandName": "FORTEO", "pharmClass_epc": "Parathyroid Hormone Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "FORTEO", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "TERIPARATIDE", "brandName": "FORTEO", "pharmClass_epc": "Parathyroid Hormone Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "HUMIRA", "drugcharacterization": "2", "drugindication": "IMMUNOSUPPRESSION", "manufacturer": "Cordavis Limited", "genericName": "ADALIMUMAB", "brandName": "HUMIRA", "pharmClass_epc": null, "route": null}, {"medicinalproduct": "METHOTREXATE", "drugcharacterization": "2", "drugindication": "IMMUNOSUPPRESSION", "manufacturer": "Chartwell RX, LLC", "genericName": "METHOTREXATE", "brandName": "METHOTREXATE", "pharmClass_epc": "Folate Analog Metabolic Inhibitor [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Pneumonia", "outcome": "1"}, {"pt": "Fall", "outcome": "1"}, {"pt": "Face injury", "outcome": "1"}, {"pt": "Loss of consciousness", "outcome": "1"}, {"pt": "Asthenia", "outcome": "1"}, {"pt": "Contusion", "outcome": "1"}, {"pt": "Fall", "outcome": "1"}, {"pt": "Head injury", "outcome": "1"}, {"pt": "Asthenia", "outcome": "1"}], "classifyText": "FORTEO FORTEO FORTEO HUMIRA METHOTREXATE TERIPARATIDE TERIPARATIDE TERIPARATIDE ADALIMUMAB METHOTREXATE OSTEOPOROSIS IMMUNOSUPPRESSION IMMUNOSUPPRESSION Pneumonia Fall Face injury Loss of consciousness Asthenia Contusion Fall Head injury Asthenia"}
{"safetyreportid": "10005892", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "FORTEO", "drugcharacterization": "1", "drugindication": "OSTEOPOROSIS", "manufacturer": "Eli Lilly and Company", "genericName": "TERIPARATIDE", "brandName": "FORTEO", "pharmClass_epc": "Parathyroid Hormone Analog [EPC]", "route": "SUBCUTANEOUS"}], "reactions": [{"pt": "Pancreatic carcinoma", "outcome": "6"}, {"pt": "Nephrolithiasis", "outcome": "6"}], "classifyText": "FORTEO TERIPARATIDE OSTEOPOROSIS Pancreatic carcinoma Nephrolithiasis"}
{"safetyreportid": "10005893", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "BR", "reportType": "1", "patientSex": "1", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "HUMALOG", "drugcharacterization": "1", "drugindication": "TYPE 2 DIABETES MELLITUS", "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "HUMULIN R", "drugcharacterization": "1", "drugindication": "TYPE 2 DIABETES MELLITUS", "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN HUMAN", "brandName": "HUMULIN R", "pharmClass_epc": "Insulin [EPC]", "route": "PARENTERAL"}, {"medicinalproduct": "NOVOLIN NPH", "drugcharacterization": "1", "drugindication": "TYPE 2 DIABETES MELLITUS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "NOVOLIN NPH", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "NOVOLIN R", "drugcharacterization": "2", "drugindication": "TYPE 2 DIABETES MELLITUS", "manufacturer": "Novo Nordisk", "genericName": "HUMAN INSULIN", "brandName": "NOVOLIN R", "pharmClass_epc": "Insulin [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "LANTUS", "drugcharacterization": "2", "drugindication": "TYPE 2 DIABETES MELLITUS", "manufacturer": "sanofi-aventis U.S. LLC", "genericName": "INSULIN GLARGINE", "brandName": "LANTUS", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "MILGAMMA /01146701/", "drugcharacterization": "2", "drugindication": "DIABETIC NEUROPATHY", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LYRICA", "drugcharacterization": "2", "drugindication": "SPINAL PAIN", "manufacturer": "Parke-Davis Div of Pfizer Inc", "genericName": "PREGABALIN", "brandName": "LYRICA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LYRICA", "drugcharacterization": "2", "drugindication": "RELAXATION THERAPY", "manufacturer": "Parke-Davis Div of Pfizer Inc", "genericName": "PREGABALIN", "brandName": "LYRICA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ARADOIS", "drugcharacterization": "2", "drugindication": "BLOOD PRESSURE", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "THIOCTACID /00213801/", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SINVASTATINA", "drugcharacterization": "2", "drugindication": "BLOOD CHOLESTEROL", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "GABAPENTINA", "drugcharacterization": "2", "drugindication": "SPINAL PAIN", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "GABAPENTINA", "drugcharacterization": "2", "drugindication": "RELAXATION THERAPY", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "FUROSEMIDA /00032601/", "drugcharacterization": "2", "drugindication": "OEDEMA PERIPHERAL", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Visual acuity reduced", "outcome": "6"}, {"pt": "Intervertebral disc protrusion", "outcome": "6"}, {"pt": "Fall", "outcome": "6"}, {"pt": "Diarrhoea", "outcome": "1"}, {"pt": "Gastrooesophageal reflux disease", "outcome": "2"}, {"pt": "Hypertension", "outcome": "6"}, {"pt": "Local swelling", "outcome": "6"}, {"pt": "Hypoglycaemia", "outcome": "1"}, {"pt": "Drug hypersensitivity", "outcome": "6"}, {"pt": "Drug ineffective", "outcome": "6"}, {"pt": "Hyperglycaemia", "outcome": "6"}, {"pt": "Nail injury", "outcome": "6"}, {"pt": "Nail growth abnormal", "outcome": "6"}, {"pt": "Aphonia", "outcome": "6"}, {"pt": "Dysphonia", "outcome": "6"}, {"pt": "Blood glucose increased", "outcome": "3"}, {"pt": "Therapeutic response delayed", "outcome": "6"}, {"pt": "Abdominal pain", "outcome": "1"}, {"pt": "Pain in extremity", "outcome": "6"}, {"pt": "Angiopathy", "outcome": "6"}, {"pt": "Back pain", "outcome": "6"}, {"pt": "Burning sensation", "outcome": "6"}, {"pt": "Dengue fever", "outcome": "6"}, {"pt": "Hyperkeratosis", "outcome": "6"}, {"pt": "Induration", "outcome": "6"}, {"pt": "Gait disturbance", "outcome": "3"}], "classifyText": "HUMALOG MIX75/25 HUMALOG MIX75/25 HUMULIN R NOVOLIN NPH NOVOLIN NPH NOVOLIN R LANTUS MILGAMMA /01146701/ LYRICA LYRICA ARADOIS THIOCTACID /00213801/ SINVASTATINA GABAPENTINA GABAPENTINA FUROSEMIDA /00032601/ INSULIN LISPRO INSULIN LISPRO INSULIN HUMAN HUMAN INSULIN INSULIN GLARGINE PREGABALIN PREGABALIN TYPE 2 DIABETES MELLITUS TYPE 2 DIABETES MELLITUS TYPE 2 DIABETES MELLITUS TYPE 2 DIABETES MELLITUS TYPE 2 DIABETES MELLITUS DIABETIC NEUROPATHY SPINAL PAIN RELAXATION THERAPY BLOOD PRESSURE PRODUCT USED FOR UNKNOWN INDICATION BLOOD CHOLESTEROL SPINAL PAIN RELAXATION THERAPY OEDEMA PERIPHERAL Visual acuity reduced Intervertebral disc protrusion Fall Diarrhoea Gastrooesophageal reflux disease Hypertension Local swelling Hypoglycaemia Drug hypersensitivity Drug ineffective Hyperglycaemia Nail injury Nail growth abnormal Aphonia Dysphonia Blood glucose increased Therapeutic response delayed Abdominal pain Pain in extremity Angiopathy Back pain Burning sensation Dengue fever Hyperkeratosis Induration Gait disturbance"}
{"safetyreportid": "10005897", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "GB", "reportType": "1", "patientSex": "2", "patientAge": "21", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "QUETIAPINE", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Solco Healthcare U.S., LLC", "genericName": "QUETIAPINE", "brandName": "QUETIAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "RISPERIDONE", "drugcharacterization": "1", "drugindication": "AGITATION", "manufacturer": "Amneal Pharmaceuticals LLC", "genericName": "RISPERIDONE", "brandName": "RISPERIDONE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "CIRCADIN", "drugcharacterization": "2", "drugindication": "INSOMNIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SERTRALINE", "drugcharacterization": "2", "drugindication": "AGITATION", "manufacturer": "Exelan Pharmaceuticals, Inc.", "genericName": "SERTRALINE", "brandName": "SERTRALINE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CITALOPRAM", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Chartwell Governmental & Specialty RX, LLC.", "genericName": "CITALOPRAM", "brandName": "CITALOPRAM", "pharmClass_epc": "Serotonin Reuptake Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": "ATTENTION DEFICIT/HYPERACTIVITY DISORDER", "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Depression", "outcome": "3"}, {"pt": "Merycism", "outcome": "3"}, {"pt": "Major depression", "outcome": "3"}, {"pt": "Attention deficit/hyperactivity disorder", "outcome": "3"}, {"pt": "Somnolence", "outcome": "3"}, {"pt": "Sedation", "outcome": "3"}, {"pt": "Agitation", "outcome": "3"}, {"pt": "Bipolar I disorder", "outcome": "3"}], "classifyText": "QUETIAPINE RISPERIDONE CIRCADIN SERTRALINE CITALOPRAM STRATTERA QUETIAPINE RISPERIDONE SERTRALINE CITALOPRAM ATOMOXETINE HYDROCHLORIDE PRODUCT USED FOR UNKNOWN INDICATION AGITATION INSOMNIA AGITATION PRODUCT USED FOR UNKNOWN INDICATION ATTENTION DEFICIT/HYPERACTIVITY DISORDER Depression Merycism Major depression Attention deficit/hyperactivity disorder Somnolence Sedation Agitation Bipolar I disorder"}
{"safetyreportid": "10005908", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "DE", "reportType": "1", "patientSex": "2", "patientAge": "52", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "VICTOZA", "drugcharacterization": "1", "drugindication": "TYPE 2 DIABETES MELLITUS", "manufacturer": "Novo Nordisk", "genericName": "LIRAGLUTIDE", "brandName": "VICTOZA", "pharmClass_epc": "GLP-1 Receptor Agonist [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "VICTOZA", "drugcharacterization": "3", "drugindication": null, "manufacturer": "Novo Nordisk", "genericName": "LIRAGLUTIDE", "brandName": "VICTOZA", "pharmClass_epc": "GLP-1 Receptor Agonist [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "METFORMIN", "drugcharacterization": "3", "drugindication": "TYPE 2 DIABETES MELLITUS", "manufacturer": "Mylan Pharmaceuticals Inc.", "genericName": "METFORMIN", "brandName": "METFORMIN HYDROCHLORIDE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "METFORMIN", "drugcharacterization": "3", "drugindication": null, "manufacturer": "Mylan Pharmaceuticals Inc.", "genericName": "METFORMIN", "brandName": "METFORMIN HYDROCHLORIDE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LEVEMIR", "drugcharacterization": "2", "drugindication": "TYPE 2 DIABETES MELLITUS", "manufacturer": "Novo Nordisk", "genericName": "INSULIN DETEMIR", "brandName": "LEVEMIR", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "VALSARTAN", "drugcharacterization": "2", "drugindication": "HYPERTENSION", "manufacturer": "Aurobindo Pharma Limited", "genericName": "VALSARTAN", "brandName": "VALSARTAN", "pharmClass_epc": "Angiotensin 2 Receptor Blocker [EPC]", "route": "ORAL"}, {"medicinalproduct": "AMLODIPIN /00972401/", "drugcharacterization": "2", "drugindication": "HYPERTENSION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "METOPROLOL", "drugcharacterization": "2", "drugindication": "HYPERTENSION", "manufacturer": "Baxter Healthcare Corporation", "genericName": "METOPROLOL TARTRATE", "brandName": "METOPROLOL", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": "DEPRESSION", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Drug interaction", "outcome": "1"}, {"pt": "Headache", "outcome": "1"}], "classifyText": "VICTOZA VICTOZA METFORMIN HYDROCHLORIDE METFORMIN HYDROCHLORIDE LEVEMIR VALSARTAN AMLODIPIN /00972401/ METOPROLOL CYMBALTA LIRAGLUTIDE LIRAGLUTIDE METFORMIN METFORMIN INSULIN DETEMIR VALSARTAN METOPROLOL TARTRATE DULOXETINE HYDROCHLORIDE TYPE 2 DIABETES MELLITUS TYPE 2 DIABETES MELLITUS TYPE 2 DIABETES MELLITUS HYPERTENSION HYPERTENSION HYPERTENSION DEPRESSION Drug interaction Headache"}
{"safetyreportid": "10005918", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "JP", "reportType": "1", "patientSex": "2", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "EVISTA", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "RALOXIFENE HYDROCHLORIDE", "brandName": "EVISTA", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Breast cancer female", "outcome": "3"}], "classifyText": "EVISTA RALOXIFENE HYDROCHLORIDE PRODUCT USED FOR UNKNOWN INDICATION Breast cancer female"}
{"safetyreportid": "10005948", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "AU", "reportType": "2", "patientSex": "2", "patientAge": "53", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "CLOZARIL", "drugcharacterization": "1", "drugindication": null, "manufacturer": "HLS Therapeutics (USA), Inc.", "genericName": "CLOZAPINE", "brandName": "CLOZARIL", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "SODIUM VALPROATE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "RISPERIDONE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Amneal Pharmaceuticals LLC", "genericName": "RISPERIDONE", "brandName": "RISPERIDONE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "RISPERIDONE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Amneal Pharmaceuticals LLC", "genericName": "RISPERIDONE", "brandName": "RISPERIDONE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "CITALOPRAM", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Chartwell Governmental & Specialty RX, LLC.", "genericName": "CITALOPRAM", "brandName": "CITALOPRAM", "pharmClass_epc": "Serotonin Reuptake Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "CITALOPRAM", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Chartwell Governmental & Specialty RX, LLC.", "genericName": "CITALOPRAM", "brandName": "CITALOPRAM", "pharmClass_epc": "Serotonin Reuptake Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "LORAZEPAM", "drugcharacterization": "2", "drugindication": null, "manufacturer": "International Medication Systems, Limited", "genericName": "LORAZEPAM", "brandName": "LORAZEPAM", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "LORAZEPAM", "drugcharacterization": "2", "drugindication": null, "manufacturer": "International Medication Systems, Limited", "genericName": "LORAZEPAM", "brandName": "LORAZEPAM", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "SPIRIVA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Boehringer Ingelheim Pharmaceuticals, Inc.", "genericName": "TIOTROPIUM BROMIDE", "brandName": "SPIRIVA HANDIHALER", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "IPRATROPIUM", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "NICOTINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "McKesson Corporation dba SKY Packaging", "genericName": "NICOTINE POLACRILEX", "brandName": "NICOTINE", "pharmClass_epc": "Cholinergic Nicotinic Agonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "SODIBIC", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ENOXAPARIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "MEROPENEM", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Xellia Pharmaceuticals USA LLC", "genericName": "MEROPENEM", "brandName": "MEROPENEM", "pharmClass_epc": "Penem Antibacterial [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "DIAZEPAM", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Hospira, Inc.", "genericName": "DIAZEPAM", "brandName": "DIAZEPAM", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "OXAZEPAM", "drugcharacterization": "2", "drugindication": null, "manufacturer": "TruPharma, LLC", "genericName": "OXAZEPAM", "brandName": "OXAZEPAM", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "ORAL"}, {"medicinalproduct": "OXAZEPAM", "drugcharacterization": "2", "drugindication": null, "manufacturer": "TruPharma, LLC", "genericName": "OXAZEPAM", "brandName": "OXAZEPAM", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "ORAL"}, {"medicinalproduct": "RISPERIDONE CONSTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "PROMETHAZINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "OLANZAPINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Hisun Pharmaceuticals USA, Inc.", "genericName": "OLANZAPINE", "brandName": "OLANZAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "SALBUTAMOL", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "PARACETAMOL", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ONDANSETRON", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Dr. Reddy's Laboratories Limited", "genericName": "ONDANSETRON HYDROCHLORIDE", "brandName": "ONDANSETRON", "pharmClass_epc": "Serotonin-3 Receptor Antagonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "ONDANSETRON", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Dr. Reddy's Laboratories Limited", "genericName": "ONDANSETRON HYDROCHLORIDE", "brandName": "ONDANSETRON", "pharmClass_epc": "Serotonin-3 Receptor Antagonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "METOCLOPRAMIDE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Teva Parenteral Medicines, Inc.", "genericName": "METOCLOPRAMIDE", "brandName": "METOCLOPRAMIDE", "pharmClass_epc": null, "route": "INTRAMUSCULAR"}, {"medicinalproduct": "METOCLOPRAMIDE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Teva Parenteral Medicines, Inc.", "genericName": "METOCLOPRAMIDE", "brandName": "METOCLOPRAMIDE", "pharmClass_epc": null, "route": "INTRAMUSCULAR"}, {"medicinalproduct": "MIDAZOLAM", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Hikma Pharmaceuticals USA Inc.", "genericName": "MIDAZOLAM", "brandName": "MIDAZOLAM", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "FENTANYL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Aveva Drug Delivery Systems Inc.", "genericName": "FENTANYL", "brandName": "FENTANYL", "pharmClass_epc": "Opioid Agonist [EPC]", "route": "TRANSDERMAL"}, {"medicinalproduct": "FENTANYL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Aveva Drug Delivery Systems Inc.", "genericName": "FENTANYL", "brandName": "FENTANYL", "pharmClass_epc": "Opioid Agonist [EPC]", "route": "TRANSDERMAL"}], "reactions": [{"pt": "Agranulocytosis", "outcome": "6"}, {"pt": "Leukopenia", "outcome": "2"}, {"pt": "Neutropenia", "outcome": "2"}, {"pt": "White blood cell count increased", "outcome": "1"}, {"pt": "Neutrophil count increased", "outcome": "1"}, {"pt": "Bacterial infection", "outcome": "6"}, {"pt": "Schizoaffective disorder", "outcome": "6"}, {"pt": "Granuloma", "outcome": "6"}, {"pt": "Dyspnoea", "outcome": "6"}, {"pt": "Haematocrit decreased", "outcome": "1"}, {"pt": "Obstructive airways disorder", "outcome": "6"}, {"pt": "Neutrophil toxic granulation present", "outcome": "6"}, {"pt": "Shift to the left", "outcome": "6"}, {"pt": "Poor venous access", "outcome": "6"}, {"pt": "Vitamin B12 abnormal", "outcome": "6"}, {"pt": "Blood folate abnormal", "outcome": "6"}, {"pt": "Red blood cell count decreased", "outcome": "1"}, {"pt": "Metamyelocyte count increased", "outcome": "6"}, {"pt": "Myelocyte count increased", "outcome": "6"}, {"pt": "Promyelocyte count increased", "outcome": "6"}, {"pt": "Blast cell count increased", "outcome": "6"}, {"pt": "Blood creatinine abnormal", "outcome": "6"}, {"pt": "Blood pressure increased", "outcome": "6"}, {"pt": "Platelet count abnormal", "outcome": "6"}, {"pt": "Basophil count increased", "outcome": "1"}, {"pt": "Liver function test abnormal", "outcome": "6"}, {"pt": "Eosinophil count increased", "outcome": "1"}, {"pt": "Monocyte count increased", "outcome": "1"}, {"pt": "Blood creatine phosphokinase decreased", "outcome": "6"}, {"pt": "Lymphocyte count decreased", "outcome": "1"}, {"pt": "Haemoglobin decreased", "outcome": "1"}, {"pt": "Heart rate increased", "outcome": "6"}, {"pt": "Pyrexia", "outcome": "6"}, {"pt": "Lymphocyte count increased", "outcome": "1"}], "classifyText": "CLOZARIL SODIUM VALPROATE RISPERIDONE RISPERIDONE CITALOPRAM CITALOPRAM LORAZEPAM LORAZEPAM SPIRIVA HANDIHALER IPRATROPIUM NICOTINE SODIBIC ENOXAPARIN MEROPENEM DIAZEPAM OXAZEPAM OXAZEPAM RISPERIDONE CONSTA PROMETHAZINE OLANZAPINE SALBUTAMOL PARACETAMOL ONDANSETRON ONDANSETRON METOCLOPRAMIDE METOCLOPRAMIDE MIDAZOLAM FENTANYL FENTANYL CLOZAPINE RISPERIDONE RISPERIDONE CITALOPRAM CITALOPRAM LORAZEPAM LORAZEPAM TIOTROPIUM BROMIDE NICOTINE POLACRILEX MEROPENEM DIAZEPAM OXAZEPAM OXAZEPAM OLANZAPINE ONDANSETRON HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE METOCLOPRAMIDE METOCLOPRAMIDE MIDAZOLAM FENTANYL FENTANYL Agranulocytosis Leukopenia Neutropenia White blood cell count increased Neutrophil count increased Bacterial infection Schizoaffective disorder Granuloma Dyspnoea Haematocrit decreased Obstructive airways disorder Neutrophil toxic granulation present Shift to the left Poor venous access Vitamin B12 abnormal Blood folate abnormal Red blood cell count decreased Metamyelocyte count increased Myelocyte count increased Promyelocyte count increased Blast cell count increased Blood creatinine abnormal Blood pressure increased Platelet count abnormal Basophil count increased Liver function test abnormal Eosinophil count increased Monocyte count increased Blood creatine phosphokinase decreased Lymphocyte count decreased Haemoglobin decreased Heart rate increased Pyrexia Lymphocyte count increased"}
{"safetyreportid": "10005956", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "IT", "reportType": "1", "patientSex": "2", "patientAge": "28", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "HALDOL", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "DEPAKIN CHRONO", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "TEGRETOL", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Novartis Pharmaceuticals Corporation", "genericName": "CARBAMAZEPINE", "brandName": "TEGRETOL", "pharmClass_epc": "Mood Stabilizer [EPC]", "route": "ORAL"}, {"medicinalproduct": "ZYPREXA", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "OLANZAPINE", "brandName": "ZYPREXA INTRAMUSCULAR", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "INTRAMUSCULAR"}], "reactions": [{"pt": "Self injurious behaviour", "outcome": "6"}, {"pt": "Sopor", "outcome": "6"}], "classifyText": "HALDOL DEPAKIN CHRONO TEGRETOL ZYPREXA INTRAMUSCULAR CARBAMAZEPINE OLANZAPINE PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Self injurious behaviour Sopor"}
{"safetyreportid": "10006156", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 1, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "2", "patientSex": "1", "patientAge": "73", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "ERLOTINIB TABLET", "drugcharacterization": "1", "drugindication": "LUNG NEOPLASM MALIGNANT", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ZYPREXA", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "OLANZAPINE", "brandName": "ZYPREXA INTRAMUSCULAR", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "MEGACE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LIPITOR", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Viatris Specialty LLC", "genericName": "ATORVASTATIN CALCIUM", "brandName": "LIPITOR", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "DEPAKOTE ER", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "AbbVie Inc.", "genericName": "DIVALPROEX SODIUM", "brandName": "DEPAKOTE ER", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "TRICOR /00499301/", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CLONAZEPAM", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Advagen Pharma Ltd", "genericName": "CLONAZEPAM", "brandName": "CLONAZEPAM", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "ORAL"}, {"medicinalproduct": "MILK OF MAGNESIA", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "RITE AID PHARMACY", "genericName": "MAGNESIUM HYDROXIDE", "brandName": "MILK OF MAGNESIA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "NEXIUM /01479302/", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CELEXA /00582602/", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "FLOMAX /01280302/", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "MIRALAX /06344701/", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "AMITIZA", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Takeda Pharmaceuticals America, Inc.", "genericName": "LUBIPROSTONE", "brandName": "AMITIZA", "pharmClass_epc": "Chloride Channel Activator [EPC]", "route": "ORAL"}, {"medicinalproduct": "TRAMADOL HCL", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ASPIRIN", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Unifirst First Aid Corporation", "genericName": "ASPIRIN", "brandName": "BAYER GENUINE ASPIRIN", "pharmClass_epc": "Nonsteroidal Anti-inflammatory Drug [EPC]", "route": "ORAL"}, {"medicinalproduct": "D3", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "DNA Labs, Inc.", "genericName": "BLACK COHOSH, BRYONIA ALBA WHOLE, TOXICODENDRON PUBESCENS WHOLE, ARNICA MONTANA, CAUSTICUM, FERROSOFERRIC PHOSPHATE, SODIUM SULFATE ANHYDROUS, STRYCHNOS NUX-VOMICA SEED, RHODODENDRON AUREUM WHOLE, CITRULLUS COLOCYNTHIS WHOLE, SOLANUM DULCAMARA WHOLE, KALMIA LATIFOLIA WHOLE, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, ARSENIC TRIOXIDE, AND TRIBASIC CALCIUM PHOSPHATE", "brandName": "D134", "pharmClass_epc": "Non-Standardized Plant Allergenic Extract [EPC]", "route": "SUBLINGUAL"}], "reactions": [{"pt": "Death", "outcome": "5"}], "classifyText": "ERLOTINIB TABLET ZYPREXA INTRAMUSCULAR MEGACE LIPITOR DEPAKOTE ER TRICOR /00499301/ CLONAZEPAM MILK OF MAGNESIA NEXIUM /01479302/ CELEXA /00582602/ FLOMAX /01280302/ MIRALAX /06344701/ AMITIZA TRAMADOL HCL BAYER GENUINE ASPIRIN D134 OLANZAPINE ATORVASTATIN CALCIUM DIVALPROEX SODIUM CLONAZEPAM MAGNESIUM HYDROXIDE LUBIPROSTONE ASPIRIN BLACK COHOSH, BRYONIA ALBA WHOLE, TOXICODENDRON PUBESCENS WHOLE, ARNICA MONTANA, CAUSTICUM, FERROSOFERRIC PHOSPHATE, SODIUM SULFATE ANHYDROUS, STRYCHNOS NUX-VOMICA SEED, RHODODENDRON AUREUM WHOLE, CITRULLUS COLOCYNTHIS WHOLE, SOLANUM DULCAMARA WHOLE, KALMIA LATIFOLIA WHOLE, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, ARSENIC TRIOXIDE, AND TRIBASIC CALCIUM PHOSPHATE LUNG NEOPLASM MALIGNANT PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Death"}
{"safetyreportid": "10006341", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "CH", "reportType": "1", "patientSex": "2", "patientAge": "37", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "REMERON", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Organon LLC", "genericName": "MIRTAZAPINE", "brandName": "REMERON", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "REMERON SOLTAB", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "DIAZEPAM", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Hospira, Inc.", "genericName": "DIAZEPAM", "brandName": "DIAZEPAM", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "LISINOPRIL", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Chartwell RX, LLC", "genericName": "LISINOPRIL", "brandName": "LISINOPRIL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CLORAZEPATE DIPOTASSIUM", "drugcharacterization": "1", "drugindication": null, "manufacturer": "NORTHSTAR RX LLC", "genericName": "CLORAZEPATE DIPOTASSIUM", "brandName": "CLORAZEPATE DIPOTASSIUM", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CLORAZEPATE DIPOTASSIUM", "drugcharacterization": "1", "drugindication": null, "manufacturer": "NORTHSTAR RX LLC", "genericName": "CLORAZEPATE DIPOTASSIUM", "brandName": "CLORAZEPATE DIPOTASSIUM", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "AGOMELATINE", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "AGOMELATINE", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "OLANZAPINE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Hisun Pharmaceuticals USA, Inc.", "genericName": "OLANZAPINE", "brandName": "OLANZAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "LEVOMEPROMAZINE", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ALPRAZOLAM", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Actavis Pharma, Inc.", "genericName": "ALPRAZOLAM", "brandName": "ALPRAZOLAM", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "ORAL"}, {"medicinalproduct": "FLURAZEPAM", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Coma", "outcome": "1"}, {"pt": "Suicide attempt", "outcome": "1"}, {"pt": "Suicide attempt", "outcome": "1"}, {"pt": "Tachycardia", "outcome": "1"}, {"pt": "Oxygen saturation decreased", "outcome": "1"}, {"pt": "Electrocardiogram QT prolonged", "outcome": "1"}, {"pt": "Hypotension", "outcome": "1"}, {"pt": "Endotracheal intubation", "outcome": "1"}, {"pt": "Poisoning", "outcome": "1"}, {"pt": "Overdose", "outcome": "6"}, {"pt": "Overdose", "outcome": "6"}], "classifyText": "REMERON REMERON SOLTAB DIAZEPAM LISINOPRIL CLORAZEPATE DIPOTASSIUM CLORAZEPATE DIPOTASSIUM AGOMELATINE AGOMELATINE OLANZAPINE LEVOMEPROMAZINE ALPRAZOLAM FLURAZEPAM MIRTAZAPINE DIAZEPAM LISINOPRIL CLORAZEPATE DIPOTASSIUM CLORAZEPATE DIPOTASSIUM OLANZAPINE ALPRAZOLAM Coma Suicide attempt Suicide attempt Tachycardia Oxygen saturation decreased Electrocardiogram QT prolonged Hypotension Endotracheal intubation Poisoning Overdose Overdose"}
{"safetyreportid": "10006416", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "23", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "LETAIRIS", "drugcharacterization": "1", "drugindication": "PULMONARY HYPERTENSION", "manufacturer": "Gilead Sciences, Inc.", "genericName": "AMBRISENTAN", "brandName": "LETAIRIS", "pharmClass_epc": "Endothelin Receptor Antagonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "ALDACTONE /00006201/", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "RIOCIGUAT", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Bayer HealthCare Pharmaceuticals Inc.", "genericName": "RIOCIGUAT", "brandName": "ADEMPAS", "pharmClass_epc": "Soluble Guanylate Cyclase Stimulator [EPC]", "route": "ORAL"}, {"medicinalproduct": "COUMADIN /00014802/", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "REMODULIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "United Therapeutics Corporation", "genericName": "TREPROSTINIL", "brandName": "REMODULIN", "pharmClass_epc": "Prostacycline Vasodilator [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "TADALAFIL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "AvKARE", "genericName": "TADALAFIL", "brandName": "TADALAFIL", "pharmClass_epc": "Phosphodiesterase 5 Inhibitor [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Fluid retention", "outcome": "1"}], "classifyText": "LETAIRIS ALDACTONE /00006201/ ADEMPAS COUMADIN /00014802/ REMODULIN TADALAFIL AMBRISENTAN RIOCIGUAT TREPROSTINIL TADALAFIL PULMONARY HYPERTENSION Fluid retention"}
{"safetyreportid": "10006496", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "GB", "reportType": "1", "patientSex": "2", "patientAge": "60", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "CISPLATIN", "drugcharacterization": "1", "drugindication": "NEOADJUVANT THERAPY", "manufacturer": "Teva Parenteral Medicines, Inc.", "genericName": "CISPLATIN", "brandName": "CISPLATIN", "pharmClass_epc": "Platinum-based Drug [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "CISPLATIN", "drugcharacterization": "1", "drugindication": "LUNG ADENOCARCINOMA", "manufacturer": "Teva Parenteral Medicines, Inc.", "genericName": "CISPLATIN", "brandName": "CISPLATIN", "pharmClass_epc": "Platinum-based Drug [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "VITAMIN B12 SUBSTANCES", "drugcharacterization": "1", "drugindication": "NON-SMALL CELL LUNG CANCER", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ALIMTA", "drugcharacterization": "1", "drugindication": "NEOADJUVANT THERAPY", "manufacturer": "Eli Lilly and Company", "genericName": "PEMETREXED DISODIUM", "brandName": "ALIMTA", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "APREPITANT", "drugcharacterization": "2", "drugindication": "NON-SMALL CELL LUNG CANCER", "manufacturer": "Merck Sharp & Dohme LLC", "genericName": "APREPITANT", "brandName": "EMEND", "pharmClass_epc": "Substance P/Neurokinin-1 Receptor Antagonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "CYCLIZINE", "drugcharacterization": "2", "drugindication": "NON-SMALL CELL LUNG CANCER", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "DEXAMETHASONE", "drugcharacterization": "2", "drugindication": "NON-SMALL CELL LUNG CANCER", "manufacturer": "Zydus Lifesciences Limited", "genericName": "DEXAMETHASONE", "brandName": "DEXAMETHASONE", "pharmClass_epc": "Corticosteroid [EPC]", "route": "ORAL"}, {"medicinalproduct": "FOLINIC ACID", "drugcharacterization": "2", "drugindication": "NON-SMALL CELL LUNG CANCER", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ONDANSETRON", "drugcharacterization": "2", "drugindication": "NON-SMALL CELL LUNG CANCER", "manufacturer": "Dr. Reddy's Laboratories Limited", "genericName": "ONDANSETRON HYDROCHLORIDE", "brandName": "ONDANSETRON", "pharmClass_epc": "Serotonin-3 Receptor Antagonist [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Rash generalised", "outcome": "1"}, {"pt": "Capillary leak syndrome", "outcome": "1"}, {"pt": "Swelling face", "outcome": "1"}, {"pt": "Vomiting", "outcome": "1"}, {"pt": "Rash", "outcome": "6"}, {"pt": "Peripheral swelling", "outcome": "1"}, {"pt": "Nausea", "outcome": "1"}], "classifyText": "CISPLATIN CISPLATIN VITAMIN B12 SUBSTANCES ALIMTA EMEND CYCLIZINE DEXAMETHASONE FOLINIC ACID ONDANSETRON CISPLATIN CISPLATIN PEMETREXED DISODIUM APREPITANT DEXAMETHASONE ONDANSETRON HYDROCHLORIDE NEOADJUVANT THERAPY LUNG ADENOCARCINOMA NON-SMALL CELL LUNG CANCER NEOADJUVANT THERAPY NON-SMALL CELL LUNG CANCER NON-SMALL CELL LUNG CANCER NON-SMALL CELL LUNG CANCER NON-SMALL CELL LUNG CANCER NON-SMALL CELL LUNG CANCER Rash generalised Capillary leak syndrome Swelling face Vomiting Rash Peripheral swelling Nausea"}
{"safetyreportid": "10006523", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 1, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "2", "patientSex": "1", "patientAge": "57", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "BOCEPREVIR", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "BOCEPREVIR", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "RIBAVIRIN.", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Bausch Health US, LLC", "genericName": "RIBAVIRIN", "brandName": "VIRAZOLE", "pharmClass_epc": "Nucleoside Analog Antiviral [EPC]", "route": "RESPIRATORY (INHALATION)"}, {"medicinalproduct": "RIBAVIRIN.", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Bausch Health US, LLC", "genericName": "RIBAVIRIN", "brandName": "VIRAZOLE", "pharmClass_epc": "Nucleoside Analog Antiviral [EPC]", "route": "RESPIRATORY (INHALATION)"}, {"medicinalproduct": "SINGULAIR", "drugcharacterization": "2", "drugindication": "ASTHMA", "manufacturer": "Organon LLC", "genericName": "MONTELUKAST SODIUM", "brandName": "SINGULAIR", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "RIBAVIRIN.", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Bausch Health US, LLC", "genericName": "RIBAVIRIN", "brandName": "VIRAZOLE", "pharmClass_epc": "Nucleoside Analog Antiviral [EPC]", "route": "RESPIRATORY (INHALATION)"}, {"medicinalproduct": "PEGASYS", "drugcharacterization": "1", "drugindication": null, "manufacturer": "pharmaand GmbH", "genericName": "PEGINTERFERON ALFA-2A", "brandName": "PEGASYS", "pharmClass_epc": "Interferon alpha [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "RIBAVIRIN.", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Bausch Health US, LLC", "genericName": "RIBAVIRIN", "brandName": "VIRAZOLE", "pharmClass_epc": "Nucleoside Analog Antiviral [EPC]", "route": "RESPIRATORY (INHALATION)"}, {"medicinalproduct": "RIBAVIRIN.", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Bausch Health US, LLC", "genericName": "RIBAVIRIN", "brandName": "VIRAZOLE", "pharmClass_epc": "Nucleoside Analog Antiviral [EPC]", "route": "RESPIRATORY (INHALATION)"}, {"medicinalproduct": "PEGASYS", "drugcharacterization": "1", "drugindication": "CHRONIC HEPATITIS C", "manufacturer": "pharmaand GmbH", "genericName": "PEGINTERFERON ALFA-2A", "brandName": "PEGASYS", "pharmClass_epc": "Interferon alpha [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "PEGASYS", "drugcharacterization": "1", "drugindication": null, "manufacturer": "pharmaand GmbH", "genericName": "PEGINTERFERON ALFA-2A", "brandName": "PEGASYS", "pharmClass_epc": "Interferon alpha [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "CARAFATE", "drugcharacterization": "2", "drugindication": "GASTROOESOPHAGEAL REFLUX DISEASE", "manufacturer": "Allergan, Inc.", "genericName": "SUCRALFATE", "brandName": "CARAFATE", "pharmClass_epc": "Aluminum Complex [EPC]", "route": "ORAL"}, {"medicinalproduct": "BOCEPREVIR", "drugcharacterization": "1", "drugindication": "CHRONIC HEPATITIS C", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "RIBAVIRIN.", "drugcharacterization": "1", "drugindication": "CHRONIC HEPATITIS C", "manufacturer": "Bausch Health US, LLC", "genericName": "RIBAVIRIN", "brandName": "VIRAZOLE", "pharmClass_epc": "Nucleoside Analog Antiviral [EPC]", "route": "RESPIRATORY (INHALATION)"}, {"medicinalproduct": "RIBAVIRIN.", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Bausch Health US, LLC", "genericName": "RIBAVIRIN", "brandName": "VIRAZOLE", "pharmClass_epc": "Nucleoside Analog Antiviral [EPC]", "route": "RESPIRATORY (INHALATION)"}, {"medicinalproduct": "PROSCAR", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Organon LLC", "genericName": "FINASTERIDE", "brandName": "PROSCAR", "pharmClass_epc": "5-alpha Reductase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "KEFLEX", "drugcharacterization": "2", "drugindication": "BRONCHITIS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "DEXILANT", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Takeda Pharmaceuticals America, Inc.", "genericName": "DEXLANSOPRAZOLE", "brandName": "DEXILANT", "pharmClass_epc": "Proton Pump Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "GLIMEPIRIDE.", "drugcharacterization": "2", "drugindication": "TYPE 2 DIABETES MELLITUS", "manufacturer": "Carlsbad Technology, Inc.", "genericName": "GLIMEPIRIDE", "brandName": "GLIMEPIRIDE", "pharmClass_epc": "Sulfonylurea [EPC]", "route": "ORAL"}, {"medicinalproduct": "BOCEPREVIR", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "BOCEPREVIR", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CIALIS", "drugcharacterization": "2", "drugindication": "ERECTILE DYSFUNCTION", "manufacturer": "Eli Lilly and Company", "genericName": "TADALAFIL", "brandName": "CIALIS", "pharmClass_epc": "Phosphodiesterase 5 Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "SYMBICORT", "drugcharacterization": "2", "drugindication": "ASTHMA", "manufacturer": "AstraZeneca Pharmaceuticals LP", "genericName": "BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE", "brandName": "SYMBICORT", "pharmClass_epc": "Corticosteroid [EPC]", "route": "RESPIRATORY (INHALATION)"}, {"medicinalproduct": "TERAZOSIN HYDROCHLORIDE.", "drugcharacterization": "2", "drugindication": "BENIGN PROSTATIC HYPERPLASIA", "manufacturer": "Apnar Pharma LP", "genericName": "TERAZOSIN HYDROCHLORIDE", "brandName": "TERAZOSIN HYDROCHLORIDE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "OXYCONTIN", "drugcharacterization": "2", "drugindication": "BACK PAIN", "manufacturer": "Purdue Pharma LP", "genericName": "OXYCODONE HYDROCHLORIDE", "brandName": "OXYCONTIN", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "INVOKANA", "drugcharacterization": "2", "drugindication": "TYPE 2 DIABETES MELLITUS", "manufacturer": "Janssen Pharmaceuticals, Inc.", "genericName": "CANAGLIFLOZIN", "brandName": "INVOKANA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "XANAX", "drugcharacterization": "2", "drugindication": "ANXIETY", "manufacturer": "PHARMACIA & UPJOHN COMPANY LLC", "genericName": "ALPRAZOLAM", "brandName": "XANAX", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Death", "outcome": "5"}], "classifyText": "BOCEPREVIR BOCEPREVIR VIRAZOLE VIRAZOLE SINGULAIR VIRAZOLE PEGASYS VIRAZOLE VIRAZOLE PEGASYS PEGASYS CARAFATE BOCEPREVIR VIRAZOLE VIRAZOLE PROSCAR KEFLEX DEXILANT GLIMEPIRIDE BOCEPREVIR BOCEPREVIR CIALIS SYMBICORT TERAZOSIN HYDROCHLORIDE OXYCONTIN INVOKANA XANAX RIBAVIRIN RIBAVIRIN MONTELUKAST SODIUM RIBAVIRIN PEGINTERFERON ALFA-2A RIBAVIRIN RIBAVIRIN PEGINTERFERON ALFA-2A PEGINTERFERON ALFA-2A SUCRALFATE RIBAVIRIN RIBAVIRIN FINASTERIDE DEXLANSOPRAZOLE GLIMEPIRIDE TADALAFIL BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE TERAZOSIN HYDROCHLORIDE OXYCODONE HYDROCHLORIDE CANAGLIFLOZIN ALPRAZOLAM ASTHMA CHRONIC HEPATITIS C GASTROOESOPHAGEAL REFLUX DISEASE CHRONIC HEPATITIS C CHRONIC HEPATITIS C BRONCHITIS TYPE 2 DIABETES MELLITUS ERECTILE DYSFUNCTION ASTHMA BENIGN PROSTATIC HYPERPLASIA BACK PAIN TYPE 2 DIABETES MELLITUS ANXIETY Death"}
{"safetyreportid": "10006537", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "67", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "LISINOPRIL", "drugcharacterization": "1", "drugindication": "BLOOD PRESSURE ABNORMAL", "manufacturer": "Chartwell RX, LLC", "genericName": "LISINOPRIL", "brandName": "LISINOPRIL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LISINOPRIL", "drugcharacterization": "1", "drugindication": "BLOOD PRESSURE ABNORMAL", "manufacturer": "Chartwell RX, LLC", "genericName": "LISINOPRIL", "brandName": "LISINOPRIL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "BRILINTA", "drugcharacterization": "1", "drugindication": "STENT PLACEMENT", "manufacturer": "AstraZeneca Pharmaceuticals LP", "genericName": "TICAGRELOR", "brandName": "BRILINTA", "pharmClass_epc": "P2Y12 Platelet Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "PLAVIX", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Sanofi-Aventis U.S. LLC", "genericName": "CLOPIDOGREL", "brandName": "PLAVIX", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "PLAVIX", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Sanofi-Aventis U.S. LLC", "genericName": "CLOPIDOGREL", "brandName": "PLAVIX", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ASPRIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "HUMILIN", "drugcharacterization": "2", "drugindication": "DIABETES MELLITUS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "2", "drugindication": "DIABETES MELLITUS", "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "DOCUSATE", "drugcharacterization": "2", "drugindication": "FAECES HARD", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Coronary artery occlusion", "outcome": "1"}, {"pt": "Eye haemorrhage", "outcome": "1"}, {"pt": "Blood pressure increased", "outcome": "1"}, {"pt": "Sleep apnoea syndrome", "outcome": "3"}, {"pt": "Dyspnoea", "outcome": "6"}, {"pt": "Dyspnoea", "outcome": "6"}, {"pt": "Rash maculo-papular", "outcome": "1"}, {"pt": "Nervousness", "outcome": "1"}], "classifyText": "LISINOPRIL LISINOPRIL BRILINTA PLAVIX PLAVIX ASPRIN HUMILIN HUMALOG MIX75/25 DOCUSATE LISINOPRIL LISINOPRIL TICAGRELOR CLOPIDOGREL CLOPIDOGREL INSULIN LISPRO BLOOD PRESSURE ABNORMAL BLOOD PRESSURE ABNORMAL STENT PLACEMENT DIABETES MELLITUS DIABETES MELLITUS FAECES HARD Coronary artery occlusion Eye haemorrhage Blood pressure increased Sleep apnoea syndrome Dyspnoea Dyspnoea Rash maculo-papular Nervousness"}
{"safetyreportid": "10006572", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "57", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "LIPITOR", "drugcharacterization": "1", "drugindication": "LOW DENSITY LIPOPROTEIN INCREASED", "manufacturer": "Viatris Specialty LLC", "genericName": "ATORVASTATIN CALCIUM", "brandName": "LIPITOR", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": "ANXIETY", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "VESICARE", "drugcharacterization": "2", "drugindication": "HYPERTONIC BLADDER", "manufacturer": "Astellas Pharma US, Inc.", "genericName": "SOLIFENACIN SUCCINATE", "brandName": "VESICARE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": "DEPRESSION", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ATENOLOL.", "drugcharacterization": "2", "drugindication": "CHEST PAIN", "manufacturer": "Almatica Pharma LLC", "genericName": "ATENOLOL", "brandName": "TENORMIN", "pharmClass_epc": "beta-Adrenergic Blocker [EPC]", "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": "PAIN", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LIPITOR", "drugcharacterization": "1", "drugindication": "BLOOD TRIGLYCERIDES INCREASED", "manufacturer": "Viatris Specialty LLC", "genericName": "ATORVASTATIN CALCIUM", "brandName": "LIPITOR", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "AMLODIPINE BESYLATE.", "drugcharacterization": "2", "drugindication": "HYPERTENSION", "manufacturer": "Zydus Pharmaceuticals USA Inc.", "genericName": "AMLODIPINE BESYLATE", "brandName": "AMLODIPINE BESYLATE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LIPITOR", "drugcharacterization": "1", "drugindication": "BLOOD CHOLESTEROL INCREASED", "manufacturer": "Viatris Specialty LLC", "genericName": "ATORVASTATIN CALCIUM", "brandName": "LIPITOR", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": "FIBROMYALGIA", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LIPITOR", "drugcharacterization": "1", "drugindication": "CARDIOVASCULAR EVENT PROPHYLAXIS", "manufacturer": "Viatris Specialty LLC", "genericName": "ATORVASTATIN CALCIUM", "brandName": "LIPITOR", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "DIOVAN", "drugcharacterization": "2", "drugindication": "HYPERTENSION", "manufacturer": "Novartis Pharmaceuticals Corporation", "genericName": "VALSARTAN", "brandName": "DIOVAN", "pharmClass_epc": "Angiotensin 2 Receptor Blocker [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Type 2 diabetes mellitus", "outcome": "3"}], "classifyText": "LIPITOR CYMBALTA VESICARE CYMBALTA TENORMIN CYMBALTA LIPITOR AMLODIPINE BESYLATE LIPITOR CYMBALTA LIPITOR DIOVAN ATORVASTATIN CALCIUM DULOXETINE HYDROCHLORIDE SOLIFENACIN SUCCINATE DULOXETINE HYDROCHLORIDE ATENOLOL DULOXETINE HYDROCHLORIDE ATORVASTATIN CALCIUM AMLODIPINE BESYLATE ATORVASTATIN CALCIUM DULOXETINE HYDROCHLORIDE ATORVASTATIN CALCIUM VALSARTAN LOW DENSITY LIPOPROTEIN INCREASED ANXIETY HYPERTONIC BLADDER DEPRESSION CHEST PAIN PAIN BLOOD TRIGLYCERIDES INCREASED HYPERTENSION BLOOD CHOLESTEROL INCREASED FIBROMYALGIA CARDIOVASCULAR EVENT PROPHYLAXIS HYPERTENSION Type 2 diabetes mellitus"}
{"safetyreportid": "10006721", "receiveDate": "20140313", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "0", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "ARTHROTEC", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Pfizer Laboratories Div Pfizer Inc", "genericName": "DICLOFENAC SODIUM AND MISOPROSTOL", "brandName": "ARTHROTEC", "pharmClass_epc": "Prostaglandin E1 Analog [EPC]", "route": "ORAL"}, {"medicinalproduct": "VALTREX", "drugcharacterization": "1", "drugindication": null, "manufacturer": "GlaxoSmithKline LLC", "genericName": "VALACYCLOVIR HYDROCHLORIDE", "brandName": "VALTREX", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ALEVE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Bayer HealthCare LLC.", "genericName": "NAPROXEN SODIUM", "brandName": "ALEVE GELCAPS", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "DISALCID", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "MOTRIN", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Kenvue Brands LLC", "genericName": "IBUPROFEN", "brandName": "MOTRIN INFANTS", "pharmClass_epc": "Nonsteroidal Anti-inflammatory Drug [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Drug hypersensitivity", "outcome": "6"}], "classifyText": "ARTHROTEC VALTREX ALEVE GELCAPS DISALCID CYMBALTA MOTRIN INFANTS DICLOFENAC SODIUM AND MISOPROSTOL VALACYCLOVIR HYDROCHLORIDE NAPROXEN SODIUM DULOXETINE HYDROCHLORIDE IBUPROFEN Drug hypersensitivity"}
{"safetyreportid": "10006768", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "83", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "GLIMEPIRIDE.", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Carlsbad Technology, Inc.", "genericName": "GLIMEPIRIDE", "brandName": "GLIMEPIRIDE", "pharmClass_epc": "Sulfonylurea [EPC]", "route": "ORAL"}, {"medicinalproduct": "TRAZODONE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "WARFARIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Exelan Pharmaceuticals Inc.", "genericName": "WARFARIN", "brandName": "WARFARIN SODIUM", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "PREDNISONE.", "drugcharacterization": "2", "drugindication": null, "manufacturer": "ANI Pharmaceuticals, Inc.", "genericName": "PREDNISONE", "brandName": "PREDNISONE", "pharmClass_epc": "Corticosteroid [EPC]", "route": "ORAL"}, {"medicinalproduct": "CRESTOR", "drugcharacterization": "2", "drugindication": null, "manufacturer": "AstraZeneca Pharmaceuticals LP", "genericName": "ROSUVASTATIN", "brandName": "CRESTOR", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "LEVOXYL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Pfizer Laboratories Div Pfizer Inc", "genericName": "LEVOTHYROXINE SODIUM", "brandName": "LEVOXYL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "NEXIUM", "drugcharacterization": "2", "drugindication": null, "manufacturer": "AstraZeneca Pharmaceuticals LP", "genericName": "ESOMEPRAZOLE MAGNESIUM", "brandName": "NEXIUM", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "COREG", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Waylis Therapeutics LLC", "genericName": "CARVEDILOL", "brandName": "COREG", "pharmClass_epc": "alpha-Adrenergic Blocker [EPC]", "route": "ORAL"}, {"medicinalproduct": "LETAIRIS", "drugcharacterization": "1", "drugindication": "SCLERODERMA", "manufacturer": "Gilead Sciences, Inc.", "genericName": "AMBRISENTAN", "brandName": "LETAIRIS", "pharmClass_epc": "Endothelin Receptor Antagonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "LETAIRIS", "drugcharacterization": "1", "drugindication": "PULMONARY HYPERTENSION", "manufacturer": "Gilead Sciences, Inc.", "genericName": "AMBRISENTAN", "brandName": "LETAIRIS", "pharmClass_epc": "Endothelin Receptor Antagonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "TORSEMIDE.", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Chartwell RX, LLC", "genericName": "TORSEMIDE", "brandName": "TORSEMIDE", "pharmClass_epc": "Loop Diuretic [EPC]", "route": "ORAL"}, {"medicinalproduct": "ACTOS", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Takeda Pharmaceuticals America, Inc.", "genericName": "PIOGLITAZONE", "brandName": "ACTOS", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Fluid retention", "outcome": "6"}, {"pt": "Cardiac failure", "outcome": "6"}], "classifyText": "GLIMEPIRIDE TRAZODONE WARFARIN SODIUM PREDNISONE CRESTOR HUMALOG MIX75/25 LEVOXYL NEXIUM COREG LETAIRIS LETAIRIS TORSEMIDE ACTOS GLIMEPIRIDE WARFARIN PREDNISONE ROSUVASTATIN INSULIN LISPRO LEVOTHYROXINE SODIUM ESOMEPRAZOLE MAGNESIUM CARVEDILOL AMBRISENTAN AMBRISENTAN TORSEMIDE PIOGLITAZONE SCLERODERMA PULMONARY HYPERTENSION Fluid retention Cardiac failure"}
{"safetyreportid": "10006882", "receiveDate": "20140313", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "73", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "TADALAFIL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "AvKARE", "genericName": "TADALAFIL", "brandName": "TADALAFIL", "pharmClass_epc": "Phosphodiesterase 5 Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "LETAIRIS", "drugcharacterization": "1", "drugindication": "SCLERODERMA", "manufacturer": "Gilead Sciences, Inc.", "genericName": "AMBRISENTAN", "brandName": "LETAIRIS", "pharmClass_epc": "Endothelin Receptor Antagonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "LETAIRIS", "drugcharacterization": "1", "drugindication": "SYSTEMIC SCLEROSIS", "manufacturer": "Gilead Sciences, Inc.", "genericName": "AMBRISENTAN", "brandName": "LETAIRIS", "pharmClass_epc": "Endothelin Receptor Antagonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "LETAIRIS", "drugcharacterization": "1", "drugindication": "PULMONARY ARTERIAL HYPERTENSION", "manufacturer": "Gilead Sciences, Inc.", "genericName": "AMBRISENTAN", "brandName": "LETAIRIS", "pharmClass_epc": "Endothelin Receptor Antagonist [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Nasal congestion", "outcome": "6"}, {"pt": "Dyspnoea", "outcome": "6"}], "classifyText": "TADALAFIL LETAIRIS LETAIRIS LETAIRIS TADALAFIL AMBRISENTAN AMBRISENTAN AMBRISENTAN SCLERODERMA SYSTEMIC SCLEROSIS PULMONARY ARTERIAL HYPERTENSION Nasal congestion Dyspnoea"}
{"safetyreportid": "10007107", "receiveDate": "20140313", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "62", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "LETAIRIS", "drugcharacterization": "1", "drugindication": "PULMONARY ARTERIAL HYPERTENSION", "manufacturer": "Gilead Sciences, Inc.", "genericName": "AMBRISENTAN", "brandName": "LETAIRIS", "pharmClass_epc": "Endothelin Receptor Antagonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "PLAVIX", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Sanofi-Aventis U.S. LLC", "genericName": "CLOPIDOGREL", "brandName": "PLAVIX", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "APLENZIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Bausch Health US, LLC", "genericName": "BUPROPION HYDROBROMIDE", "brandName": "APLENZIN", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ATORVASTATIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "PREVACID", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Takeda Pharmaceuticals America, Inc.", "genericName": "LANSOPRAZOLE", "brandName": "PREVACID", "pharmClass_epc": "Proton Pump Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "SPIRONOLACTONE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Amneal Pharmaceuticals LLC", "genericName": "SPIRONOLACTONE", "brandName": "SPIRONOLACTONE", "pharmClass_epc": "Aldosterone Antagonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "AMLODIPINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Pangea Pharmaceuticals, LLC", "genericName": "AMLODIPINE", "brandName": "SDAMLO", "pharmClass_epc": "Dihydropyridine Calcium Channel Blocker [EPC]", "route": "ORAL"}, {"medicinalproduct": "BYSTOLIC", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Allergan, Inc.", "genericName": "NEBIVOLOL HYDROCHLORIDE", "brandName": "BYSTOLIC", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Oedema peripheral", "outcome": "6"}, {"pt": "Fluid retention", "outcome": "6"}], "classifyText": "LETAIRIS PLAVIX APLENZIN ATORVASTATIN CYMBALTA PREVACID SPIRONOLACTONE SDAMLO BYSTOLIC AMBRISENTAN CLOPIDOGREL BUPROPION HYDROBROMIDE DULOXETINE HYDROCHLORIDE LANSOPRAZOLE SPIRONOLACTONE AMLODIPINE NEBIVOLOL HYDROCHLORIDE PULMONARY ARTERIAL HYPERTENSION Oedema peripheral Fluid retention"}
{"safetyreportid": "10007136", "receiveDate": "20140313", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "66", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "LYRICA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Parke-Davis Div of Pfizer Inc", "genericName": "PREGABALIN", "brandName": "LYRICA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "SAVELLA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Allergan, Inc.", "genericName": "MILNACIPRAN HYDROCHLORIDE", "brandName": "SAVELLA", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Drug ineffective", "outcome": "6"}, {"pt": "Pain", "outcome": "6"}], "classifyText": "LYRICA CYMBALTA SAVELLA PREGABALIN DULOXETINE HYDROCHLORIDE MILNACIPRAN HYDROCHLORIDE Drug ineffective Pain"}
{"safetyreportid": "10007197", "receiveDate": "20140311", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": null, "reportType": "1", "patientSex": "2", "patientAge": "15", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "FERRIPROX", "drugcharacterization": "1", "drugindication": "SIDEROBLASTIC ANAEMIA", "manufacturer": "Chiesi USA, Inc.", "genericName": "DEFERIPRONE", "brandName": "FERRIPROX", "pharmClass_epc": "Iron Chelator [EPC]", "route": "ORAL"}, {"medicinalproduct": "FERRIPROX", "drugcharacterization": "1", "drugindication": "HAEMOCHROMATOSIS", "manufacturer": "Chiesi USA, Inc.", "genericName": "DEFERIPRONE", "brandName": "FERRIPROX", "pharmClass_epc": "Iron Chelator [EPC]", "route": "ORAL"}, {"medicinalproduct": "CARVEDILOL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Advagen Pharma Limited", "genericName": "CARVEDILOL", "brandName": "CARVEDILOL", "pharmClass_epc": "alpha-Adrenergic Blocker [EPC]", "route": "ORAL"}, {"medicinalproduct": "LEVEMIR", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Novo Nordisk", "genericName": "INSULIN DETEMIR", "brandName": "LEVEMIR", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "WARFARIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Exelan Pharmaceuticals Inc.", "genericName": "WARFARIN", "brandName": "WARFARIN SODIUM", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ASA", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "VITAMIN D", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Strides Pharma Science Limited", "genericName": "ERGOCALCIFEROL", "brandName": "VITAMIN D", "pharmClass_epc": "Provitamin D2 Compound [EPC]", "route": "ORAL"}, {"medicinalproduct": "TUMS", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Haleon US Holdings LLC", "genericName": "CALCIUM CARBONATE", "brandName": "TUMS EXTRA STRENGTH, SMOOTHIES", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "PENICILLIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "FAMOTIDINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "LEADER/ Cardinal Health 110, Inc.", "genericName": "FAMOTIDINE", "brandName": "FAMOTIDINE", "pharmClass_epc": "Histamine-2 Receptor Antagonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "EXJADE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Novartis Pharmaceuticals Corporation", "genericName": "DEFERASIROX", "brandName": "EXJADE", "pharmClass_epc": "Iron Chelator [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Agranulocytosis", "outcome": null}, {"pt": "Influenza", "outcome": null}], "classifyText": "FERRIPROX FERRIPROX CARVEDILOL LEVEMIR HUMALOG MIX75/25 WARFARIN SODIUM ASA VITAMIN D TUMS EXTRA STRENGTH, SMOOTHIES PENICILLIN FAMOTIDINE EXJADE DEFERIPRONE DEFERIPRONE CARVEDILOL INSULIN DETEMIR INSULIN LISPRO WARFARIN ERGOCALCIFEROL CALCIUM CARBONATE FAMOTIDINE DEFERASIROX SIDEROBLASTIC ANAEMIA HAEMOCHROMATOSIS Agranulocytosis Influenza"}
{"safetyreportid": "10007230", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "30", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "MIRENA", "drugcharacterization": "1", "drugindication": "CONTRACEPTION", "manufacturer": "Bayer HealthCare Pharmaceuticals Inc.", "genericName": "LEVONORGESTREL", "brandName": "MIRENA", "pharmClass_epc": "Progestin [EPC]", "route": "INTRAUTERINE"}], "reactions": [{"pt": "Device dislocation", "outcome": null}, {"pt": "Vomiting", "outcome": "3"}, {"pt": "Pregnancy with contraceptive device", "outcome": "3"}, {"pt": "Nausea", "outcome": "3"}, {"pt": "Drug ineffective", "outcome": null}], "classifyText": "CYMBALTA MIRENA DULOXETINE HYDROCHLORIDE LEVONORGESTREL CONTRACEPTION Device dislocation Vomiting Pregnancy with contraceptive device Nausea Drug ineffective"}
{"safetyreportid": "10007534", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "2", "patientSex": "2", "patientAge": "65", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "DRONEDARONE", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Sanofi-Aventis U.S. LLC", "genericName": "DRONEDARONE", "brandName": "MULTAQ", "pharmClass_epc": "Antiarrhythmic [EPC]", "route": "ORAL"}, {"medicinalproduct": "DABIGATRAN", "drugcharacterization": "3", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Novadoz Pharmaceuticals LLC", "genericName": "DABIGATRAN ETEXILATE", "brandName": "DABIGATRAN", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "NEBIVOLOL HYDROCHLORIDE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "AvKARE", "genericName": "NEBIVOLOL HYDROCHLORIDE", "brandName": "NEBIVOLOL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "FLUTICASONE PROPIONATE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Selder, S.A. de C.V.", "genericName": "FLUTICASONE PROPIONATE", "brandName": "FLUTICASONE PROPIONATE", "pharmClass_epc": null, "route": "NASAL"}, {"medicinalproduct": "ESTRADIOL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Sandoz Inc", "genericName": "ESTRADIOL", "brandName": "VIVELLE-DOT", "pharmClass_epc": "Estrogen [EPC]", "route": "TRANSDERMAL"}, {"medicinalproduct": "KLONOPIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "H2-Pharma, LLC", "genericName": "CLONAZEPAM", "brandName": "KLONOPIN", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "ORAL"}, {"medicinalproduct": "PEPCID", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Bausch Health US LLC", "genericName": "FAMOTIDINE", "brandName": "PEPCID", "pharmClass_epc": "Histamine-2 Receptor Antagonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "OXYBUTYNIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Zydus Pharmaceuticals USA Inc.", "genericName": "OXYBUTYNIN", "brandName": "OXYBUTYNIN", "pharmClass_epc": "Cholinergic Muscarinic Antagonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "MECLIZINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Advanced Rx LLC", "genericName": "MECLIZINE HCL 12.5 MG", "brandName": "MECLIZINE", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Rectal haemorrhage", "outcome": "6"}, {"pt": "Drug interaction", "outcome": "6"}], "classifyText": "MULTAQ DABIGATRAN NEBIVOLOL FLUTICASONE PROPIONATE VIVELLE-DOT KLONOPIN PEPCID CYMBALTA OXYBUTYNIN MECLIZINE DRONEDARONE DABIGATRAN ETEXILATE NEBIVOLOL HYDROCHLORIDE FLUTICASONE PROPIONATE ESTRADIOL CLONAZEPAM FAMOTIDINE DULOXETINE HYDROCHLORIDE OXYBUTYNIN MECLIZINE HCL 12.5 MG PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Rectal haemorrhage Drug interaction"}
{"safetyreportid": "10007639", "receiveDate": "20140313", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "66", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "CIALIS", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "TADALAFIL", "brandName": "CIALIS", "pharmClass_epc": "Phosphodiesterase 5 Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "LETAIRIS", "drugcharacterization": "1", "drugindication": "PULMONARY ARTERIAL HYPERTENSION", "manufacturer": "Gilead Sciences, Inc.", "genericName": "AMBRISENTAN", "brandName": "LETAIRIS", "pharmClass_epc": "Endothelin Receptor Antagonist [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Nasal congestion", "outcome": "6"}, {"pt": "Upper respiratory tract congestion", "outcome": "6"}, {"pt": "Headache", "outcome": "6"}], "classifyText": "CIALIS LETAIRIS TADALAFIL AMBRISENTAN PULMONARY ARTERIAL HYPERTENSION Nasal congestion Upper respiratory tract congestion Headache"}
{"safetyreportid": "10007970", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 1, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "1", "patientAge": "71", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "MONOPRIL", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "FERROUS SULFATE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Boiron", "genericName": "FERROUS SULFATE", "brandName": "FERRUM SULPHURICUM", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "BYETTA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "AstraZeneca Pharmaceuticals LP", "genericName": "EXENATIDE", "brandName": "BYETTA", "pharmClass_epc": "GLP-1 Receptor Agonist [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "CARDURA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Viatris Specialty LLC", "genericName": "DOXAZOSIN MESYLATE", "brandName": "CARDURA XL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "BENADRYL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Lil' Drug Store Products, Inc.", "genericName": "DIPHENHYDRAMINE HYDROCHLORIDE", "brandName": "BENADRYL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "GERITOL", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LATANOPROST.", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Micro Labs Limited", "genericName": "LATANOPROST", "brandName": "LATANOPROST", "pharmClass_epc": "Prostaglandin Analog [EPC]", "route": "OPHTHALMIC"}, {"medicinalproduct": "PHENIRAMINE+NAPHAZOLINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "BECONASE AQ", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "IRON", "drugcharacterization": "2", "drugindication": null, "manufacturer": "True Botanica, LLC", "genericName": "IRON", "brandName": "FERRUM METALLICUM 6X", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "MEGACE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "HYDROXYZINE HCL", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "PRILOSEC", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Covis Pharma US, Inc", "genericName": "OMEPRAZOLE MAGNESIUM", "brandName": "PRILOSEC", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "FLONASE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Haleon US Holdings LLC", "genericName": "FLUTICASONE PROPIONATE", "brandName": "FLONASE ALLERGY RELIEF", "pharmClass_epc": null, "route": "NASAL"}, {"medicinalproduct": "ZOCOR", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Organon LLC", "genericName": "SIMVASTATIN", "brandName": "ZOCOR", "pharmClass_epc": "HMG-CoA Reductase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "FLOMAX", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "LANTUS", "drugcharacterization": "2", "drugindication": null, "manufacturer": "sanofi-aventis U.S. LLC", "genericName": "INSULIN GLARGINE", "brandName": "LANTUS", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "METFORMIN HCL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Ascend Laboratories, LLC", "genericName": "METFORMIN HCL", "brandName": "METFORMIN HCL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "GLUCERNA", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "COLACE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Atlantis Consumer Healthcare, Inc.", "genericName": "DOCUSATE SODIUM", "brandName": "COLACE", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Pancreatic carcinoma", "outcome": "5"}], "classifyText": "MONOPRIL FERRUM SULPHURICUM BYETTA CARDURA XL BENADRYL GERITOL LATANOPROST PHENIRAMINE+NAPHAZOLINE BECONASE AQ FERRUM METALLICUM 6X MEGACE HYDROXYZINE HCL PRILOSEC FLONASE ALLERGY RELIEF ZOCOR FLOMAX HUMALOG MIX75/25 LANTUS METFORMIN HCL GLUCERNA COLACE FERROUS SULFATE EXENATIDE DOXAZOSIN MESYLATE DIPHENHYDRAMINE HYDROCHLORIDE LATANOPROST IRON OMEPRAZOLE MAGNESIUM FLUTICASONE PROPIONATE SIMVASTATIN INSULIN LISPRO INSULIN GLARGINE METFORMIN HCL DOCUSATE SODIUM Pancreatic carcinoma"}
{"safetyreportid": "10007977", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "EVISTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "RALOXIFENE HYDROCHLORIDE", "brandName": "EVISTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "FOLIC ACID", "drugcharacterization": "2", "drugindication": null, "manufacturer": "PureTek Corporation", "genericName": "FOLIC ACID", "brandName": "VENTRIXYL", "pharmClass_epc": "Vitamin C [EPC]", "route": "ORAL"}, {"medicinalproduct": "VITAMIN B12", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ALIMTA", "drugcharacterization": "1", "drugindication": "LUNG NEOPLASM MALIGNANT", "manufacturer": "Eli Lilly and Company", "genericName": "PEMETREXED DISODIUM", "brandName": "ALIMTA", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "CISPLATIN", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Teva Parenteral Medicines, Inc.", "genericName": "CISPLATIN", "brandName": "CISPLATIN", "pharmClass_epc": "Platinum-based Drug [EPC]", "route": "INTRAVENOUS"}], "reactions": [{"pt": "Rectal haemorrhage", "outcome": "6"}, {"pt": "Neuropathy peripheral", "outcome": "6"}, {"pt": "Oropharyngeal pain", "outcome": "6"}, {"pt": "Stomatitis", "outcome": "6"}, {"pt": "Pyrexia", "outcome": "6"}], "classifyText": "EVISTA VENTRIXYL VITAMIN B12 ALIMTA CISPLATIN RALOXIFENE HYDROCHLORIDE FOLIC ACID PEMETREXED DISODIUM CISPLATIN LUNG NEOPLASM MALIGNANT Rectal haemorrhage Neuropathy peripheral Oropharyngeal pain Stomatitis Pyrexia"}
{"safetyreportid": "10008087", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 1, "occurcountry": "GB", "reportType": "1", "patientSex": "2", "patientAge": "5", "patientAgeUnit": "800", "drugs": [{"medicinalproduct": "VENLAFAXINE HCL", "drugcharacterization": "1", "drugindication": "DEPRESSION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "OLANZAPINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Hisun Pharmaceuticals USA, Inc.", "genericName": "OLANZAPINE", "brandName": "OLANZAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Ventricular tachycardia", "outcome": "4"}, {"pt": "Acute hepatic failure", "outcome": "4"}, {"pt": "Renal failure acute", "outcome": "4"}, {"pt": "Convulsion", "outcome": "4"}, {"pt": "Toxicity to various agents", "outcome": "6"}, {"pt": "Intentional overdose", "outcome": "6"}, {"pt": "Dyspnoea", "outcome": "6"}, {"pt": "Acidosis", "outcome": "6"}], "classifyText": "VENLAFAXINE HCL OLANZAPINE OLANZAPINE DEPRESSION Ventricular tachycardia Acute hepatic failure Renal failure acute Convulsion Toxicity to various agents Intentional overdose Dyspnoea Acidosis"}
{"safetyreportid": "10008102", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "SE", "reportType": "1", "patientSex": "2", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "FLUOXETINE (UNKNOWN)", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "STESOLID", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "OMEPRAZOLE (UNKNOWN)", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CETIRIZINE (UNKNOWN)", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "TOPIRAMATE (UNKNOWN)", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ZYPREXA", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "OLANZAPINE", "brandName": "ZYPREXA INTRAMUSCULAR", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "SEROQUEL", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "AstraZeneca Pharmaceuticals LP", "genericName": "QUETIAPINE", "brandName": "SEROQUEL XR", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LITHIONIT", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "OXASCAND", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CISORDINOL /00876702/", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "HEMINEVRIN", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "AKINETON /00079501/", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "THERALEN", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "IMOVANE", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "PROPAVAN", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SOBRIL", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ERGENYL", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "INVEGA", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Janssen Pharmaceuticals, Inc.", "genericName": "PALIPERIDONE", "brandName": "INVEGA", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "NOZINAN /00038601/", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "PARGITAN", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "QUETIAPINE", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Solco Healthcare U.S., LLC", "genericName": "QUETIAPINE", "brandName": "QUETIAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "ATARAX /00058401/", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Ovarian germ cell cancer stage II", "outcome": "6"}, {"pt": "Amenorrhoea", "outcome": "6"}, {"pt": "Weight increased", "outcome": "6"}, {"pt": "Galactorrhoea", "outcome": "6"}, {"pt": "Tremor", "outcome": "6"}, {"pt": "Muscular weakness", "outcome": "6"}, {"pt": "Agitation", "outcome": "6"}, {"pt": "Dyspnoea", "outcome": "6"}, {"pt": "Blood prolactin increased", "outcome": "6"}, {"pt": "Palpitations", "outcome": "6"}, {"pt": "Aggression", "outcome": "6"}, {"pt": "Dyskinesia", "outcome": "6"}, {"pt": "Hyperhidrosis", "outcome": "6"}, {"pt": "Abdominal pain", "outcome": "6"}, {"pt": "Dysuria", "outcome": "6"}, {"pt": "Swelling", "outcome": "6"}, {"pt": "Muscle spasms", "outcome": "6"}, {"pt": "Breast enlargement", "outcome": "6"}, {"pt": "Fatigue", "outcome": "6"}], "classifyText": "FLUOXETINE (UNKNOWN) STESOLID OMEPRAZOLE (UNKNOWN) CETIRIZINE (UNKNOWN) TOPIRAMATE (UNKNOWN) ZYPREXA INTRAMUSCULAR SEROQUEL XR LITHIONIT OXASCAND CISORDINOL /00876702/ HEMINEVRIN AKINETON /00079501/ THERALEN IMOVANE PROPAVAN SOBRIL ERGENYL INVEGA NOZINAN /00038601/ PARGITAN QUETIAPINE ATARAX /00058401/ OLANZAPINE QUETIAPINE PALIPERIDONE QUETIAPINE PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Ovarian germ cell cancer stage II Amenorrhoea Weight increased Galactorrhoea Tremor Muscular weakness Agitation Dyspnoea Blood prolactin increased Palpitations Aggression Dyskinesia Hyperhidrosis Abdominal pain Dysuria Swelling Muscle spasms Breast enlargement Fatigue"}
{"safetyreportid": "10008153", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "IT", "reportType": "1", "patientSex": "1", "patientAge": "25", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "CITALOPRAM HYDROCHLORIDE", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Drug abuse", "outcome": "1"}, {"pt": "Intentional self-injury", "outcome": "1"}, {"pt": "Sopor", "outcome": "1"}, {"pt": "Overdose", "outcome": "1"}], "classifyText": "CITALOPRAM HYDROCHLORIDE CYMBALTA DULOXETINE HYDROCHLORIDE PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Drug abuse Intentional self-injury Sopor Overdose"}
{"safetyreportid": "10008541", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 1, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "1", "patientAge": "51", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "ALIMTA", "drugcharacterization": "1", "drugindication": "NON-SMALL CELL LUNG CANCER", "manufacturer": "Eli Lilly and Company", "genericName": "PEMETREXED DISODIUM", "brandName": "ALIMTA", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "AVASTIN /01555201/", "drugcharacterization": "1", "drugindication": "NON-SMALL CELL LUNG CANCER", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CARBOPLATIN", "drugcharacterization": "1", "drugindication": "NON-SMALL CELL LUNG CANCER", "manufacturer": "Apotex Corp.", "genericName": "CARBOPLATIN", "brandName": "CARBOPLATIN", "pharmClass_epc": "Platinum-based Drug [EPC]", "route": "INTRAVENOUS"}], "reactions": [{"pt": "Death", "outcome": "5"}, {"pt": "Malignant neoplasm progression", "outcome": "6"}, {"pt": "Off label use", "outcome": "6"}], "classifyText": "ALIMTA AVASTIN /01555201/ CARBOPLATIN PEMETREXED DISODIUM CARBOPLATIN NON-SMALL CELL LUNG CANCER NON-SMALL CELL LUNG CANCER NON-SMALL CELL LUNG CANCER Death Malignant neoplasm progression Off label use"}
{"safetyreportid": "10008553", "receiveDate": "20140312", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "57", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "JAKAFI", "drugcharacterization": "1", "drugindication": "MYELOFIBROSIS", "manufacturer": "Incyte Corporation", "genericName": "RUXOLITINIB", "brandName": "JAKAFI", "pharmClass_epc": "Kinase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "POTASSIUM", "drugcharacterization": "2", "drugindication": "SUPPLEMENTATION THERAPY", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "PERCOCET", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Endo USA, Inc.", "genericName": "OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN", "brandName": "PERCOCET", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "VALIUM", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Roche Laboratories Inc.", "genericName": "DIAZEPAM", "brandName": "VALIUM", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "ORAL"}, {"medicinalproduct": "LISINOPRIL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Chartwell RX, LLC", "genericName": "LISINOPRIL", "brandName": "LISINOPRIL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "METOPROLOL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Baxter Healthcare Corporation", "genericName": "METOPROLOL TARTRATE", "brandName": "METOPROLOL", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "LASIX", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Validus Pharmaceuticals LLC", "genericName": "FUROSEMIDE", "brandName": "LASIX", "pharmClass_epc": "Loop Diuretic [EPC]", "route": "ORAL"}, {"medicinalproduct": "XANAX", "drugcharacterization": "2", "drugindication": null, "manufacturer": "PHARMACIA & UPJOHN COMPANY LLC", "genericName": "ALPRAZOLAM", "brandName": "XANAX", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "ORAL"}, {"medicinalproduct": "ASPIRIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Unifirst First Aid Corporation", "genericName": "ASPIRIN", "brandName": "BAYER GENUINE ASPIRIN", "pharmClass_epc": "Nonsteroidal Anti-inflammatory Drug [EPC]", "route": "ORAL"}, {"medicinalproduct": "VITAMIN D", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Strides Pharma Science Limited", "genericName": "ERGOCALCIFEROL", "brandName": "VITAMIN D", "pharmClass_epc": "Provitamin D2 Compound [EPC]", "route": "ORAL"}, {"medicinalproduct": "MAGNESIUM", "drugcharacterization": "2", "drugindication": "SUPPLEMENTATION THERAPY", "manufacturer": "Korea Life Science", "genericName": "MAGNESIUM", "brandName": "BYE ZERO", "pharmClass_epc": null, "route": "TOPICAL"}, {"medicinalproduct": "PRILOSEC", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Covis Pharma US, Inc", "genericName": "OMEPRAZOLE MAGNESIUM", "brandName": "PRILOSEC", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ZOFRAN", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "NORTRIPTYLINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Malaise", "outcome": null}, {"pt": "Decreased appetite", "outcome": null}, {"pt": "Diarrhoea", "outcome": null}, {"pt": "Hypoaesthesia", "outcome": null}, {"pt": "Vision blurred", "outcome": null}, {"pt": "Insomnia", "outcome": null}, {"pt": "Dizziness", "outcome": null}, {"pt": "Headache", "outcome": null}], "classifyText": "JAKAFI POTASSIUM PERCOCET VALIUM LISINOPRIL METOPROLOL LASIX XANAX BAYER GENUINE ASPIRIN VITAMIN D BYE ZERO PRILOSEC CYMBALTA ZOFRAN NORTRIPTYLINE RUXOLITINIB OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN DIAZEPAM LISINOPRIL METOPROLOL TARTRATE FUROSEMIDE ALPRAZOLAM ASPIRIN ERGOCALCIFEROL MAGNESIUM OMEPRAZOLE MAGNESIUM DULOXETINE HYDROCHLORIDE MYELOFIBROSIS SUPPLEMENTATION THERAPY SUPPLEMENTATION THERAPY Malaise Decreased appetite Diarrhoea Hypoaesthesia Vision blurred Insomnia Dizziness Headache"}
{"safetyreportid": "10008589", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 1, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "FR", "reportType": "1", "patientSex": "1", "patientAge": "74", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "DIAMICRON", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "INSPRA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Viatris Specialty LLC", "genericName": "EPLERENONE", "brandName": "INSPRA", "pharmClass_epc": "Aldosterone Antagonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "PRAVADUAL", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "JANUMET", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Merck Sharp & Dohme LLC", "genericName": "SITAGLIPTIN AND METFORMIN HYDROCHLORIDE", "brandName": "JANUMET", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CAJUPUT OIL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Boiron", "genericName": "CAJUPUT OIL", "brandName": "CAJUPUTUM", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CISPLATINE", "drugcharacterization": "2", "drugindication": "LUNG ADENOCARCINOMA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "METFORMINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LASILIX", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ALIMTA", "drugcharacterization": "1", "drugindication": "LUNG ADENOCARCINOMA", "manufacturer": "Eli Lilly and Company", "genericName": "PEMETREXED DISODIUM", "brandName": "ALIMTA", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "LANTUS", "drugcharacterization": "2", "drugindication": null, "manufacturer": "sanofi-aventis U.S. LLC", "genericName": "INSULIN GLARGINE", "brandName": "LANTUS", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "EPINITRIL", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CARDENSIEL", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "BIPRETERAX", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Abdominal pain", "outcome": "3"}, {"pt": "Acute kidney injury", "outcome": "5"}, {"pt": "Bone marrow failure", "outcome": "3"}], "classifyText": "DIAMICRON INSPRA PRAVADUAL JANUMET CAJUPUTUM CISPLATINE METFORMINE LASILIX ALIMTA LANTUS EPINITRIL CARDENSIEL BIPRETERAX EPLERENONE SITAGLIPTIN AND METFORMIN HYDROCHLORIDE CAJUPUT OIL PEMETREXED DISODIUM INSULIN GLARGINE LUNG ADENOCARCINOMA LUNG ADENOCARCINOMA Abdominal pain Acute kidney injury Bone marrow failure"}
{"safetyreportid": "10008619", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "CN", "reportType": "1", "patientSex": "1", "patientAge": "58", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "PIOGLITAZONE HCL", "drugcharacterization": "1", "drugindication": "DIABETES MELLITUS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "NOVORAPID", "drugcharacterization": "1", "drugindication": "DIABETES MELLITUS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "METFORMIN HYDROCHLORIDE.", "drugcharacterization": "1", "drugindication": "DIABETES MELLITUS", "manufacturer": "Granules Pharmaceuticals Inc.", "genericName": "METFORMIN HYDROCHLORIDE", "brandName": "METFORMIN HYDROCHLORIDE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "INSULIN GLARGINE", "drugcharacterization": "1", "drugindication": "DIABETES MELLITUS", "manufacturer": "Biocon Biologics Inc.", "genericName": "INSULIN GLARGINE-YFGN", "brandName": "INSULIN GLARGINE", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}], "reactions": [{"pt": "Demyelination", "outcome": "1"}, {"pt": "Diabetic neuropathy", "outcome": "1"}], "classifyText": "PIOGLITAZONE HCL NOVORAPID METFORMIN HYDROCHLORIDE INSULIN GLARGINE METFORMIN HYDROCHLORIDE INSULIN GLARGINE-YFGN DIABETES MELLITUS DIABETES MELLITUS DIABETES MELLITUS DIABETES MELLITUS Demyelination Diabetic neuropathy"}
{"safetyreportid": "10008621", "receiveDate": "20140312", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "JAKAFI", "drugcharacterization": "1", "drugindication": "MYELOFIBROSIS", "manufacturer": "Incyte Corporation", "genericName": "RUXOLITINIB", "brandName": "JAKAFI", "pharmClass_epc": "Kinase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "TOPROL", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "DIOVAN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Novartis Pharmaceuticals Corporation", "genericName": "VALSARTAN", "brandName": "DIOVAN", "pharmClass_epc": "Angiotensin 2 Receptor Blocker [EPC]", "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "BUPROPION", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Zydus Pharmaceuticals USA Inc.", "genericName": "BUPROPION", "brandName": "BUPROPION", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "SYNTHROID", "drugcharacterization": "2", "drugindication": null, "manufacturer": "AbbVie Inc.", "genericName": "LEVOTHYROXINE SODIUM", "brandName": "SYNTHROID", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "FUROSEMIDE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Ipca Laboratories Limited", "genericName": "FUROSEMIDE", "brandName": "FUROSEMIDE", "pharmClass_epc": "Loop Diuretic [EPC]", "route": "ORAL"}, {"medicinalproduct": "PROTONIX", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.", "genericName": "PANTOPRAZOLE SODIUM", "brandName": "PROTONIX I.V.", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "GABAPENTIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Rising Pharma Holdings, Inc.", "genericName": "GABAPENTIN", "brandName": "GABAPENTIN", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ULORIC", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Takeda Pharmaceuticals America, Inc.", "genericName": "FEBUXOSTAT", "brandName": "ULORIC", "pharmClass_epc": "Xanthine Oxidase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "NAPROXEN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "MARKSANS PHARMA LIMITED", "genericName": "NAPROXEN", "brandName": "NAPROXEN", "pharmClass_epc": "Nonsteroidal Anti-inflammatory Drug [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Abnormal dreams", "outcome": "6"}], "classifyText": "JAKAFI TOPROL DIOVAN CYMBALTA BUPROPION SYNTHROID FUROSEMIDE PROTONIX I.V. GABAPENTIN ULORIC NAPROXEN RUXOLITINIB VALSARTAN DULOXETINE HYDROCHLORIDE BUPROPION LEVOTHYROXINE SODIUM FUROSEMIDE PANTOPRAZOLE SODIUM GABAPENTIN FEBUXOSTAT NAPROXEN MYELOFIBROSIS Abnormal dreams"}
{"safetyreportid": "10008666", "receiveDate": "20140312", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "1", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "JAKAFI", "drugcharacterization": "1", "drugindication": "MYELOFIBROSIS", "manufacturer": "Incyte Corporation", "genericName": "RUXOLITINIB", "brandName": "JAKAFI", "pharmClass_epc": "Kinase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "OMEPRAZOLE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Amerisource Bergen", "genericName": "OMEPRAZOLE", "brandName": "GOOD NEIGHBOR PHARMACY OMEPRAZOLE", "pharmClass_epc": "Proton Pump Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "FLUCONAZOLE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Zydus Lifesciences Limited", "genericName": "FLUCONAZOLE", "brandName": "FLUCONAZOLE", "pharmClass_epc": "Azole Antifungal [EPC]", "route": "ORAL"}, {"medicinalproduct": "BACTRIM DS", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Sun Pharmaceutical Industries, Inc", "genericName": "SULFAMETHOXAZOLE AND TRIMETHOPRIM", "brandName": "BACTRIM DS", "pharmClass_epc": "Sulfonamide Antimicrobial [EPC]", "route": "ORAL"}, {"medicinalproduct": "PREDNISONE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "ANI Pharmaceuticals, Inc.", "genericName": "PREDNISONE", "brandName": "PREDNISONE", "pharmClass_epc": "Corticosteroid [EPC]", "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Malaise", "outcome": "1"}, {"pt": "Drug ineffective", "outcome": "1"}], "classifyText": "JAKAFI GOOD NEIGHBOR PHARMACY OMEPRAZOLE FLUCONAZOLE BACTRIM DS PREDNISONE CYMBALTA RUXOLITINIB OMEPRAZOLE FLUCONAZOLE SULFAMETHOXAZOLE AND TRIMETHOPRIM PREDNISONE DULOXETINE HYDROCHLORIDE MYELOFIBROSIS Malaise Drug ineffective"}
{"safetyreportid": "10008711", "receiveDate": "20140312", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "75", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "JAKAFI", "drugcharacterization": "1", "drugindication": "MYELOFIBROSIS", "manufacturer": "Incyte Corporation", "genericName": "RUXOLITINIB", "brandName": "JAKAFI", "pharmClass_epc": "Kinase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "PRADAXA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Boehringer Ingelheim Pharmaceuticals Inc.", "genericName": "DABIGATRAN ETEXILATE MESYLATE", "brandName": "PRADAXA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LIZINOPRIL", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LEVOTHYROXINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ALLOPURINOL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Accord Healthcare Inc.", "genericName": "ALLOPURINOL", "brandName": "ALLOPURINOL", "pharmClass_epc": "Xanthine Oxidase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "FISH OIL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Fresenius Kabi USA, LLC", "genericName": "FISH OIL", "brandName": "OMEGAVEN", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "VITAMIN D", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Strides Pharma Science Limited", "genericName": "ERGOCALCIFEROL", "brandName": "VITAMIN D", "pharmClass_epc": "Provitamin D2 Compound [EPC]", "route": "ORAL"}, {"medicinalproduct": "COQ10", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "NAPROXEN", "drugcharacterization": "2", "drugindication": "PAIN", "manufacturer": "MARKSANS PHARMA LIMITED", "genericName": "NAPROXEN", "brandName": "NAPROXEN", "pharmClass_epc": "Nonsteroidal Anti-inflammatory Drug [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Bone pain", "outcome": "6"}], "classifyText": "JAKAFI PRADAXA LIZINOPRIL LEVOTHYROXINE CYMBALTA ALLOPURINOL OMEGAVEN VITAMIN D COQ10 NAPROXEN RUXOLITINIB DABIGATRAN ETEXILATE MESYLATE DULOXETINE HYDROCHLORIDE ALLOPURINOL FISH OIL ERGOCALCIFEROL NAPROXEN MYELOFIBROSIS PAIN Bone pain"}
{"safetyreportid": "10008846", "receiveDate": "20140313", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "1", "patientAge": "69", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "JAKAFI", "drugcharacterization": "1", "drugindication": "MYELOFIBROSIS", "manufacturer": "Incyte Corporation", "genericName": "RUXOLITINIB", "brandName": "JAKAFI", "pharmClass_epc": "Kinase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "JAKAFI", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Incyte Corporation", "genericName": "RUXOLITINIB", "brandName": "JAKAFI", "pharmClass_epc": "Kinase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "CLONAZEPAM", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Advagen Pharma Ltd", "genericName": "CLONAZEPAM", "brandName": "CLONAZEPAM", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "ORAL"}, {"medicinalproduct": "CRESTOR", "drugcharacterization": "2", "drugindication": null, "manufacturer": "AstraZeneca Pharmaceuticals LP", "genericName": "ROSUVASTATIN", "brandName": "CRESTOR", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "METOPROLOL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Baxter Healthcare Corporation", "genericName": "METOPROLOL TARTRATE", "brandName": "METOPROLOL", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "TAMSULOSIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ZYPREXA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "OLANZAPINE", "brandName": "ZYPREXA INTRAMUSCULAR", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "VITAMIN D", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Strides Pharma Science Limited", "genericName": "ERGOCALCIFEROL", "brandName": "VITAMIN D", "pharmClass_epc": "Provitamin D2 Compound [EPC]", "route": "ORAL"}, {"medicinalproduct": "FISH OIL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Fresenius Kabi USA, LLC", "genericName": "FISH OIL", "brandName": "OMEGAVEN", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Liver tenderness", "outcome": "6"}, {"pt": "Blood triglycerides increased", "outcome": "6"}, {"pt": "Thrombocytopenia", "outcome": "3"}], "classifyText": "JAKAFI JAKAFI CLONAZEPAM CRESTOR METOPROLOL CYMBALTA TAMSULOSIN ZYPREXA INTRAMUSCULAR VITAMIN D OMEGAVEN CYMBALTA RUXOLITINIB RUXOLITINIB CLONAZEPAM ROSUVASTATIN METOPROLOL TARTRATE DULOXETINE HYDROCHLORIDE OLANZAPINE ERGOCALCIFEROL FISH OIL DULOXETINE HYDROCHLORIDE MYELOFIBROSIS Liver tenderness Blood triglycerides increased Thrombocytopenia"}
{"safetyreportid": "10008893", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 1, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "66", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "WARFARIN", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Exelan Pharmaceuticals Inc.", "genericName": "WARFARIN", "brandName": "WARFARIN SODIUM", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "PREDNISONE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "ANI Pharmaceuticals, Inc.", "genericName": "PREDNISONE", "brandName": "PREDNISONE", "pharmClass_epc": "Corticosteroid [EPC]", "route": "ORAL"}, {"medicinalproduct": "TERIPARATIDE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Teva Pharmaceuticals USA, Inc.", "genericName": "TERIPARATIDE", "brandName": "TERIPARATIDE", "pharmClass_epc": "Parathyroid Hormone Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "LEFLUNOMIDE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Chartwell RX, LLC", "genericName": "LEFLUNOMIDE", "brandName": "LEFLUNOMIDE", "pharmClass_epc": "Antirheumatic Agent [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Death", "outcome": "5"}, {"pt": "Calciphylaxis", "outcome": "6"}, {"pt": "Pain", "outcome": "6"}, {"pt": "Nodule", "outcome": "6"}, {"pt": "Lividity", "outcome": "6"}, {"pt": "Erythema", "outcome": "6"}, {"pt": "Skin induration", "outcome": "6"}, {"pt": "Skin plaque", "outcome": "6"}, {"pt": "Purpura", "outcome": "6"}, {"pt": "Skin lesion", "outcome": "6"}, {"pt": "Hyperplasia", "outcome": "6"}], "classifyText": "WARFARIN SODIUM PREDNISONE TERIPARATIDE LEFLUNOMIDE WARFARIN PREDNISONE TERIPARATIDE LEFLUNOMIDE Death Calciphylaxis Pain Nodule Lividity Erythema Skin induration Skin plaque Purpura Skin lesion Hyperplasia"}
{"safetyreportid": "10008894", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "1", "patientAge": "64", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "JAKAFI", "drugcharacterization": "1", "drugindication": "MYELOFIBROSIS", "manufacturer": "Incyte Corporation", "genericName": "RUXOLITINIB", "brandName": "JAKAFI", "pharmClass_epc": "Kinase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "JANUVIA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Merck Sharp & Dohme LLC", "genericName": "SITAGLIPTIN", "brandName": "JANUVIA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LOSARTAN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Granules Pharmaceuticals Inc.", "genericName": "LOSARTAN", "brandName": "LOSARTAN POTASSIUM", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "METFORMIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Mylan Pharmaceuticals Inc.", "genericName": "METFORMIN", "brandName": "METFORMIN HYDROCHLORIDE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CARVEDILOL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Advagen Pharma Limited", "genericName": "CARVEDILOL", "brandName": "CARVEDILOL", "pharmClass_epc": "alpha-Adrenergic Blocker [EPC]", "route": "ORAL"}, {"medicinalproduct": "MAGNESIUM", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Korea Life Science", "genericName": "MAGNESIUM", "brandName": "BYE ZERO", "pharmClass_epc": null, "route": "TOPICAL"}, {"medicinalproduct": "DICLOFENAC", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Amneal Pharmaceuticals LLC", "genericName": "DICLOFENAC", "brandName": "DICLOFENAC SODIUM", "pharmClass_epc": "Nonsteroidal Anti-inflammatory Drug [EPC]", "route": "TOPICAL"}, {"medicinalproduct": "HYDROCODONE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CARISOPRODOL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Viatris Specialty LLC", "genericName": "CARISOPRODOL", "brandName": "SOMA", "pharmClass_epc": "Muscle Relaxant [EPC]", "route": "ORAL"}, {"medicinalproduct": "VIAGRA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Viatris Specialty LLC", "genericName": "SILDENAFIL CITRATE", "brandName": "VIAGRA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "TYLENOL PM", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Jones Healthcare Group - Packaging Services, Inc", "genericName": "ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE", "brandName": "TYLENOL PM EXTRA STRENGTH", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Haemoglobin decreased", "outcome": "6"}], "classifyText": "JAKAFI HUMALOG MIX75/25 JANUVIA LOSARTAN POTASSIUM METFORMIN HYDROCHLORIDE CARVEDILOL BYE ZERO DICLOFENAC SODIUM HYDROCODONE SOMA VIAGRA TYLENOL PM EXTRA STRENGTH RUXOLITINIB INSULIN LISPRO SITAGLIPTIN LOSARTAN METFORMIN CARVEDILOL MAGNESIUM DICLOFENAC CARISOPRODOL SILDENAFIL CITRATE ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE MYELOFIBROSIS Haemoglobin decreased"}
{"safetyreportid": "10008912", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "86", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "JAKAFI", "drugcharacterization": "1", "drugindication": "BLOOD DISORDER", "manufacturer": "Incyte Corporation", "genericName": "RUXOLITINIB", "brandName": "JAKAFI", "pharmClass_epc": "Kinase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "EVISTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "RALOXIFENE HYDROCHLORIDE", "brandName": "EVISTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "TOPROL XL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Melinta Therapeutics, LLC", "genericName": "METOPROLOL SUCCINATE", "brandName": "TOPROL XL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LISINOPRIL/HCTZ", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SIMVASTATIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Accord Healthcare, Inc.", "genericName": "SIMVASTATIN", "brandName": "SIMVASTATIN", "pharmClass_epc": "HMG-CoA Reductase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "METFORMIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Mylan Pharmaceuticals Inc.", "genericName": "METFORMIN", "brandName": "METFORMIN HYDROCHLORIDE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "B12", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Apex Energetics Inc.", "genericName": "ADRENALINUM, ARGENTUM NITRICUM, BOS TAURUS PITUITARUM POSTERIUM, GLYCERINUM, GLYCYRRHIZA GLABRA, KALI CARBONICUM, LACTICUM ACIDUM, MAGNESIA SULPHURICA, NICCOLUM METALLICUM, PANCREATINUM, PHOSPHORICUM ACIDUM, SACCHARINUM, SACCHARUM LACTIS, SACCHARUM OFFICINALE, SARCOLACTICUM ACIDUM, SELENIUM METALLICUM, SYZYGIUM JAMBOLANUM, THYROIDINUM, ZINCUM METALLICUM", "brandName": "B05 GLUCO BALANCE", "pharmClass_epc": "alpha-Adrenergic Agonist [EPC]", "route": "SUBLINGUAL"}, {"medicinalproduct": "ASPIRIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Unifirst First Aid Corporation", "genericName": "ASPIRIN", "brandName": "BAYER GENUINE ASPIRIN", "pharmClass_epc": "Nonsteroidal Anti-inflammatory Drug [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Blood count abnormal", "outcome": "6"}], "classifyText": "JAKAFI EVISTA TOPROL XL LISINOPRIL/HCTZ SIMVASTATIN METFORMIN HYDROCHLORIDE B05 GLUCO BALANCE BAYER GENUINE ASPIRIN RUXOLITINIB RALOXIFENE HYDROCHLORIDE METOPROLOL SUCCINATE SIMVASTATIN METFORMIN ADRENALINUM, ARGENTUM NITRICUM, BOS TAURUS PITUITARUM POSTERIUM, GLYCERINUM, GLYCYRRHIZA GLABRA, KALI CARBONICUM, LACTICUM ACIDUM, MAGNESIA SULPHURICA, NICCOLUM METALLICUM, PANCREATINUM, PHOSPHORICUM ACIDUM, SACCHARINUM, SACCHARUM LACTIS, SACCHARUM OFFICINALE, SARCOLACTICUM ACIDUM, SELENIUM METALLICUM, SYZYGIUM JAMBOLANUM, THYROIDINUM, ZINCUM METALLICUM ASPIRIN BLOOD DISORDER Blood count abnormal"}
{"safetyreportid": "10008927", "receiveDate": "20140313", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "56", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "JAKAFI", "drugcharacterization": "1", "drugindication": "MYELOFIBROSIS", "manufacturer": "Incyte Corporation", "genericName": "RUXOLITINIB", "brandName": "JAKAFI", "pharmClass_epc": "Kinase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "JAKAFI", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Incyte Corporation", "genericName": "RUXOLITINIB", "brandName": "JAKAFI", "pharmClass_epc": "Kinase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "SYNTHROID", "drugcharacterization": "2", "drugindication": null, "manufacturer": "AbbVie Inc.", "genericName": "LEVOTHYROXINE SODIUM", "brandName": "SYNTHROID", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ZANAFLEX", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Covis Pharma US, Inc", "genericName": "TIZANIDINE HYDROCHLORIDE", "brandName": "ZANAFLEX", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "PRILOSEC", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Covis Pharma US, Inc", "genericName": "OMEPRAZOLE MAGNESIUM", "brandName": "PRILOSEC", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Fatigue", "outcome": "6"}, {"pt": "Haemoglobin increased", "outcome": "6"}], "classifyText": "JAKAFI JAKAFI CYMBALTA SYNTHROID ZANAFLEX PRILOSEC RUXOLITINIB RUXOLITINIB DULOXETINE HYDROCHLORIDE LEVOTHYROXINE SODIUM TIZANIDINE HYDROCHLORIDE OMEPRAZOLE MAGNESIUM MYELOFIBROSIS Fatigue Haemoglobin increased"}
{"safetyreportid": "10008952", "receiveDate": "20140313", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "74", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "JAKAFI", "drugcharacterization": "1", "drugindication": "MYELOFIBROSIS", "manufacturer": "Incyte Corporation", "genericName": "RUXOLITINIB", "brandName": "JAKAFI", "pharmClass_epc": "Kinase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "SYNTHROID", "drugcharacterization": "2", "drugindication": null, "manufacturer": "AbbVie Inc.", "genericName": "LEVOTHYROXINE SODIUM", "brandName": "SYNTHROID", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "COLCHICINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Camber Pharmaceuticals, Inc.", "genericName": "COLCHICINE", "brandName": "COLCHICINE", "pharmClass_epc": "Alkaloid [EPC]", "route": "ORAL"}, {"medicinalproduct": "ZOCOR", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Organon LLC", "genericName": "SIMVASTATIN", "brandName": "ZOCOR", "pharmClass_epc": "HMG-CoA Reductase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "NIASPAN", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LUNESTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Waylis Therapeutics LLC", "genericName": "ESZOPICLONE", "brandName": "LUNESTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Insomnia", "outcome": "6"}], "classifyText": "JAKAFI SYNTHROID COLCHICINE ZOCOR NIASPAN LUNESTA CYMBALTA RUXOLITINIB LEVOTHYROXINE SODIUM COLCHICINE SIMVASTATIN ESZOPICLONE DULOXETINE HYDROCHLORIDE MYELOFIBROSIS Insomnia"}
{"safetyreportid": "10009050", "receiveDate": "20140313", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "51", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "OXYCODONE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Amneal Pharmaceuticals LLC", "genericName": "OXYCODONE", "brandName": "OXYCODONE HYDROCHLORIDE", "pharmClass_epc": "Opioid Agonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "OXCARBAZEPINE.", "drugcharacterization": "2", "drugindication": null, "manufacturer": "NorthStar RxLLC", "genericName": "OXCARBAZEPINE", "brandName": "OXCARBAZEPINE", "pharmClass_epc": "Anti-epileptic Agent [EPC]", "route": "ORAL"}, {"medicinalproduct": "RAMELTEON", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Zydus Pharmaceuticals USA Inc.", "genericName": "RAMELTEON", "brandName": "RAMELTEON", "pharmClass_epc": "Melatonin Receptor Agonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "SPIRONOLACTONE.", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Amneal Pharmaceuticals LLC", "genericName": "SPIRONOLACTONE", "brandName": "SPIRONOLACTONE", "pharmClass_epc": "Aldosterone Antagonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "GABAPENTIN.", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Rising Pharma Holdings, Inc.", "genericName": "GABAPENTIN", "brandName": "GABAPENTIN", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "KETOCONAZOLE.", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Viona Pharmaceuticals Inc", "genericName": "KETOCONAZOLE", "brandName": "KETOCONAZOLE", "pharmClass_epc": "Azole Antifungal [EPC]", "route": "TOPICAL"}, {"medicinalproduct": "FUROSEMIDE.", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Ipca Laboratories Limited", "genericName": "FUROSEMIDE", "brandName": "FUROSEMIDE", "pharmClass_epc": "Loop Diuretic [EPC]", "route": "ORAL"}, {"medicinalproduct": "EPOPROSTENOL.", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Gland Pharma Limited", "genericName": "EPOPROSTENOL", "brandName": "EPOPROSTENOL", "pharmClass_epc": "Prostacycline Vasodilator [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "HALOPERIDOL.", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Lifestar Pharma LLC", "genericName": "HALOPERIDOL", "brandName": "HALOPERIDOL", "pharmClass_epc": "Typical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "OLANZAPINE.", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Hisun Pharmaceuticals USA, Inc.", "genericName": "OLANZAPINE", "brandName": "OLANZAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "BENZTROPINE MESYLATE.", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Chartwell RX, LLC.", "genericName": "BENZTROPINE MESYLATE", "brandName": "BENZTROPINE MESYLATE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LETAIRIS", "drugcharacterization": "1", "drugindication": "PULMONARY HYPERTENSION", "manufacturer": "Gilead Sciences, Inc.", "genericName": "AMBRISENTAN", "brandName": "LETAIRIS", "pharmClass_epc": "Endothelin Receptor Antagonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "LORAZEPAM.", "drugcharacterization": "2", "drugindication": null, "manufacturer": "International Medication Systems, Limited", "genericName": "LORAZEPAM", "brandName": "LORAZEPAM", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "CITALOPRAM", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Chartwell Governmental & Specialty RX, LLC.", "genericName": "CITALOPRAM", "brandName": "CITALOPRAM", "pharmClass_epc": "Serotonin Reuptake Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "PANTOPRAZOLE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "XLCare Pharmaceuticals Inc.", "genericName": "PANTOPRAZOLE", "brandName": "PANTOPRAZOLE SODIUM", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "POTASSIUM CHLORIDE.", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Zydus Lifesciences Limited", "genericName": "POTASSIUM CHLORIDE", "brandName": "POTASSIUM CHLORIDE", "pharmClass_epc": "Potassium Salt [EPC]", "route": "ORAL"}, {"medicinalproduct": "WARFARIN SODIUM.", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Sun Pharmaceutical Industries, Inc.", "genericName": "WARFARIN SODIUM", "brandName": "WARFARIN SODIUM", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "SILDENAFIL.", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eugia US LLC", "genericName": "SILDENAFIL CITRATE", "brandName": "SILDENAFIL", "pharmClass_epc": "Phosphodiesterase 5 Inhibitor [EPC]", "route": "INTRAVENOUS"}], "reactions": [{"pt": "Insomnia", "outcome": "6"}], "classifyText": "OXYCODONE HYDROCHLORIDE OXCARBAZEPINE RAMELTEON SPIRONOLACTONE GABAPENTIN KETOCONAZOLE FUROSEMIDE EPOPROSTENOL HALOPERIDOL OLANZAPINE BENZTROPINE MESYLATE LETAIRIS LORAZEPAM CITALOPRAM PANTOPRAZOLE SODIUM POTASSIUM CHLORIDE WARFARIN SODIUM SILDENAFIL OXYCODONE OXCARBAZEPINE RAMELTEON SPIRONOLACTONE GABAPENTIN KETOCONAZOLE FUROSEMIDE EPOPROSTENOL HALOPERIDOL OLANZAPINE BENZTROPINE MESYLATE AMBRISENTAN LORAZEPAM CITALOPRAM PANTOPRAZOLE POTASSIUM CHLORIDE WARFARIN SODIUM SILDENAFIL CITRATE PULMONARY HYPERTENSION Insomnia"}
{"safetyreportid": "10009054", "receiveDate": "20140313", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "67", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "JAKAFI", "drugcharacterization": "1", "drugindication": "MYELOFIBROSIS", "manufacturer": "Incyte Corporation", "genericName": "RUXOLITINIB", "brandName": "JAKAFI", "pharmClass_epc": "Kinase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "FEMARA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Novartis Pharmaceuticals Corporation", "genericName": "LETROZOLE", "brandName": "FEMARA", "pharmClass_epc": "Aromatase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "GABAPENTIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Rising Pharma Holdings, Inc.", "genericName": "GABAPENTIN", "brandName": "GABAPENTIN", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "VITAMIN D", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Strides Pharma Science Limited", "genericName": "ERGOCALCIFEROL", "brandName": "VITAMIN D", "pharmClass_epc": "Provitamin D2 Compound [EPC]", "route": "ORAL"}, {"medicinalproduct": "VITAMINS", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "FISH OIL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Fresenius Kabi USA, LLC", "genericName": "FISH OIL", "brandName": "OMEGAVEN", "pharmClass_epc": null, "route": "INTRAVENOUS"}], "reactions": [{"pt": "Dyspnoea", "outcome": "6"}, {"pt": "Flatulence", "outcome": "6"}, {"pt": "Fatigue", "outcome": "6"}, {"pt": "Platelet count decreased", "outcome": "6"}], "classifyText": "JAKAFI CYMBALTA FEMARA GABAPENTIN VITAMIN D VITAMINS OMEGAVEN RUXOLITINIB DULOXETINE HYDROCHLORIDE LETROZOLE GABAPENTIN ERGOCALCIFEROL FISH OIL MYELOFIBROSIS Dyspnoea Flatulence Fatigue Platelet count decreased"}
{"safetyreportid": "10009393", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 1, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "GB", "reportType": "1", "patientSex": "1", "patientAge": "63", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "PARACETAMOL", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SALBUTAMOL", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LISINOPRIL", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Chartwell RX, LLC", "genericName": "LISINOPRIL", "brandName": "LISINOPRIL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "NYSTATIN", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Pharmaceutical Associates, Inc.", "genericName": "NYSTATIN", "brandName": "NYSTATIN", "pharmClass_epc": "Polyene Antifungal [EPC]", "route": "ORAL"}, {"medicinalproduct": "TRAMADOL HYDROCHLORIDE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Amneal Pharmaceuticals NY LLC", "genericName": "TRAMADOL HYDROCHLORIDE", "brandName": "TRAMADOL HYDROCHLORIDE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "FOSAMAX", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Organon LLC", "genericName": "ALENDRONATE SODIUM", "brandName": "FOSAMAX", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "HUMULIN", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN HUMAN", "brandName": "HUMULIN R", "pharmClass_epc": "Insulin [EPC]", "route": "PARENTERAL"}, {"medicinalproduct": "SERETIDE", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SINGULAIR", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Organon LLC", "genericName": "MONTELUKAST SODIUM", "brandName": "SINGULAIR", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "SPIRIVA", "drugcharacterization": "1", "drugindication": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "manufacturer": "Boehringer Ingelheim Pharmaceuticals, Inc.", "genericName": "TIOTROPIUM BROMIDE", "brandName": "SPIRIVA HANDIHALER", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "BUMETANIDE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Advagen Pharma Limited", "genericName": "BUMETANIDE", "brandName": "BUMETANIDE", "pharmClass_epc": "Loop Diuretic [EPC]", "route": "ORAL"}, {"medicinalproduct": "INSULIN ISOPHANE", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "INSUMAN COMB", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Lobar pneumonia", "outcome": "5"}], "classifyText": "PARACETAMOL SALBUTAMOL LISINOPRIL NYSTATIN TRAMADOL HYDROCHLORIDE FOSAMAX HUMALOG MIX75/25 HUMULIN R SERETIDE SINGULAIR SPIRIVA HANDIHALER BUMETANIDE INSULIN ISOPHANE INSUMAN COMB LISINOPRIL NYSTATIN TRAMADOL HYDROCHLORIDE ALENDRONATE SODIUM INSULIN LISPRO INSULIN HUMAN MONTELUKAST SODIUM TIOTROPIUM BROMIDE BUMETANIDE CHRONIC OBSTRUCTIVE PULMONARY DISEASE Lobar pneumonia"}
{"safetyreportid": "10009400", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "1", "patientAge": "87", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "JAKAFI", "drugcharacterization": "1", "drugindication": "MYELOFIBROSIS", "manufacturer": "Incyte Corporation", "genericName": "RUXOLITINIB", "brandName": "JAKAFI", "pharmClass_epc": "Kinase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "TRAMADOL", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "TRAMADOL", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ALLOPURINOL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Accord Healthcare Inc.", "genericName": "ALLOPURINOL", "brandName": "ALLOPURINOL", "pharmClass_epc": "Xanthine Oxidase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "VESICARE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Astellas Pharma US, Inc.", "genericName": "SOLIFENACIN SUCCINATE", "brandName": "VESICARE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "NEXIUM", "drugcharacterization": "2", "drugindication": null, "manufacturer": "AstraZeneca Pharmaceuticals LP", "genericName": "ESOMEPRAZOLE MAGNESIUM", "brandName": "NEXIUM", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "TAMSULOSIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "PLAVIX", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Sanofi-Aventis U.S. LLC", "genericName": "CLOPIDOGREL", "brandName": "PLAVIX", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "METOCLOPRAMIDE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Teva Parenteral Medicines, Inc.", "genericName": "METOCLOPRAMIDE", "brandName": "METOCLOPRAMIDE", "pharmClass_epc": null, "route": "INTRAMUSCULAR"}, {"medicinalproduct": "OMEPRAZOLE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Amerisource Bergen", "genericName": "OMEPRAZOLE", "brandName": "GOOD NEIGHBOR PHARMACY OMEPRAZOLE", "pharmClass_epc": "Proton Pump Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "MELOXICAM", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Zydus Pharmaceuticals USA Inc.", "genericName": "MELOXICAM", "brandName": "MELOXICAM", "pharmClass_epc": "Nonsteroidal Anti-inflammatory Drug [EPC]", "route": "ORAL"}, {"medicinalproduct": "HYDROCODONE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "VITAMIN B12", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Haemoglobin decreased", "outcome": "4"}, {"pt": "Haematocrit decreased", "outcome": "6"}], "classifyText": "JAKAFI CYMBALTA TRAMADOL TRAMADOL ALLOPURINOL VESICARE NEXIUM TAMSULOSIN PLAVIX METOCLOPRAMIDE GOOD NEIGHBOR PHARMACY OMEPRAZOLE MELOXICAM HYDROCODONE VITAMIN B12 RUXOLITINIB DULOXETINE HYDROCHLORIDE ALLOPURINOL SOLIFENACIN SUCCINATE ESOMEPRAZOLE MAGNESIUM CLOPIDOGREL METOCLOPRAMIDE OMEPRAZOLE MELOXICAM MYELOFIBROSIS Haemoglobin decreased Haematocrit decreased"}
{"safetyreportid": "10009429", "receiveDate": "20140313", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "49", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "JAKAFI", "drugcharacterization": "1", "drugindication": "MYELOFIBROSIS", "manufacturer": "Incyte Corporation", "genericName": "RUXOLITINIB", "brandName": "JAKAFI", "pharmClass_epc": "Kinase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "JAKAFI", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Incyte Corporation", "genericName": "RUXOLITINIB", "brandName": "JAKAFI", "pharmClass_epc": "Kinase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "PAXIL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Apotex Corp", "genericName": "PAROXETINE HYDROCHLORIDE", "brandName": "PAXIL CR", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "PROGRAF", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Astellas Pharma US, Inc.", "genericName": "TACROLIMUS", "brandName": "PROGRAF", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LANTUS", "drugcharacterization": "2", "drugindication": null, "manufacturer": "sanofi-aventis U.S. LLC", "genericName": "INSULIN GLARGINE", "brandName": "LANTUS", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}], "reactions": [{"pt": "Neuropathy peripheral", "outcome": "1"}], "classifyText": "JAKAFI JAKAFI PAXIL CR PROGRAF LANTUS HUMALOG MIX75/25 RUXOLITINIB RUXOLITINIB PAROXETINE HYDROCHLORIDE TACROLIMUS INSULIN GLARGINE INSULIN LISPRO MYELOFIBROSIS Neuropathy peripheral"}
{"safetyreportid": "10009480", "receiveDate": "20140313", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "1", "patientAge": "70", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "JAKAFI", "drugcharacterization": "1", "drugindication": "MYELOFIBROSIS", "manufacturer": "Incyte Corporation", "genericName": "RUXOLITINIB", "brandName": "JAKAFI", "pharmClass_epc": "Kinase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Feeling abnormal", "outcome": "3"}, {"pt": "Headache", "outcome": "3"}], "classifyText": "JAKAFI CYMBALTA RUXOLITINIB DULOXETINE HYDROCHLORIDE MYELOFIBROSIS Feeling abnormal Headache"}
{"safetyreportid": "10009506", "receiveDate": "20140312", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "1", "patientAge": "58", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "JAKAFI", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Incyte Corporation", "genericName": "RUXOLITINIB", "brandName": "JAKAFI", "pharmClass_epc": "Kinase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "GABAPENTIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Rising Pharma Holdings, Inc.", "genericName": "GABAPENTIN", "brandName": "GABAPENTIN", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ALLOPURINOL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Accord Healthcare Inc.", "genericName": "ALLOPURINOL", "brandName": "ALLOPURINOL", "pharmClass_epc": "Xanthine Oxidase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "TAMSULOSIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LISINOPRIL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Chartwell RX, LLC", "genericName": "LISINOPRIL", "brandName": "LISINOPRIL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "TESTOSTERONE CIPIONATE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "COLCHICINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Camber Pharmaceuticals, Inc.", "genericName": "COLCHICINE", "brandName": "COLCHICINE", "pharmClass_epc": "Alkaloid [EPC]", "route": "ORAL"}, {"medicinalproduct": "HYDROCODONE W/APAP", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "VALIUM", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Roche Laboratories Inc.", "genericName": "DIAZEPAM", "brandName": "VALIUM", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "ORAL"}, {"medicinalproduct": "SOMA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Viatris Specialty LLC", "genericName": "CARISOPRODOL", "brandName": "SOMA", "pharmClass_epc": "Muscle Relaxant [EPC]", "route": "ORAL"}, {"medicinalproduct": "PROMETHAZINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "DIPHENHYDRAMINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Velocity Pharma", "genericName": "DIPHENHYDRAMINE", "brandName": "NIGHTIME SLEEP AID", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Hypersomnia", "outcome": "3"}], "classifyText": "JAKAFI GABAPENTIN ALLOPURINOL TAMSULOSIN CYMBALTA LISINOPRIL TESTOSTERONE CIPIONATE COLCHICINE HYDROCODONE W/APAP VALIUM SOMA PROMETHAZINE NIGHTIME SLEEP AID RUXOLITINIB GABAPENTIN ALLOPURINOL DULOXETINE HYDROCHLORIDE LISINOPRIL COLCHICINE DIAZEPAM CARISOPRODOL DIPHENHYDRAMINE Hypersomnia"}
{"safetyreportid": "10009531", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "2", "patientSex": "2", "patientAge": "63", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "DABIGATRAN", "drugcharacterization": "1", "drugindication": "ATRIAL FIBRILLATION", "manufacturer": "Novadoz Pharmaceuticals LLC", "genericName": "DABIGATRAN ETEXILATE", "brandName": "DABIGATRAN", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "PRINIVIL", "drugcharacterization": "1", "drugindication": "HYPERTENSION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LASIX", "drugcharacterization": "1", "drugindication": "DIURETIC THERAPY", "manufacturer": "Validus Pharmaceuticals LLC", "genericName": "FUROSEMIDE", "brandName": "LASIX", "pharmClass_epc": "Loop Diuretic [EPC]", "route": "ORAL"}, {"medicinalproduct": "ROCALTROL", "drugcharacterization": "2", "drugindication": "PROPHYLAXIS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": "DEPRESSION", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "NEXIUM", "drugcharacterization": "2", "drugindication": "GASTROOESOPHAGEAL REFLUX DISEASE", "manufacturer": "AstraZeneca Pharmaceuticals LP", "genericName": "ESOMEPRAZOLE MAGNESIUM", "brandName": "NEXIUM", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ULORIC", "drugcharacterization": "2", "drugindication": "GOUT", "manufacturer": "Takeda Pharmaceuticals America, Inc.", "genericName": "FEBUXOSTAT", "brandName": "ULORIC", "pharmClass_epc": "Xanthine Oxidase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "FORTEO", "drugcharacterization": "2", "drugindication": "OSTEOPOROSIS", "manufacturer": "Eli Lilly and Company", "genericName": "TERIPARATIDE", "brandName": "FORTEO", "pharmClass_epc": "Parathyroid Hormone Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "PLAQUENIL", "drugcharacterization": "2", "drugindication": "SYSTEMIC LUPUS ERYTHEMATOSUS", "manufacturer": "Advanz Pharma (US) Corp.", "genericName": "HYDROXYCHLOROQUINE SULFATE", "brandName": "PLAQUENIL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LANTUS", "drugcharacterization": "2", "drugindication": "DIABETES MELLITUS", "manufacturer": "sanofi-aventis U.S. LLC", "genericName": "INSULIN GLARGINE", "brandName": "LANTUS", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "ADCIRCA", "drugcharacterization": "2", "drugindication": "HYPERTENSION", "manufacturer": "United Therapeutics Corporation", "genericName": "TADALAFIL", "brandName": "ADCIRCA", "pharmClass_epc": "Phosphodiesterase 5 Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "ADCIRCA", "drugcharacterization": "2", "drugindication": "OSTEONECROSIS", "manufacturer": "United Therapeutics Corporation", "genericName": "TADALAFIL", "brandName": "ADCIRCA", "pharmClass_epc": "Phosphodiesterase 5 Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "AMBIEN", "drugcharacterization": "2", "drugindication": "SLEEP DISORDER", "manufacturer": "Cosette Pharmaceuticals, Inc.", "genericName": "ZOLPIDEM TARTRATE", "brandName": "AMBIEN", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Mouth haemorrhage", "outcome": "1"}, {"pt": "Epistaxis", "outcome": "1"}, {"pt": "Rectal haemorrhage", "outcome": "1"}, {"pt": "Fatigue", "outcome": "1"}, {"pt": "Renal failure acute", "outcome": "3"}, {"pt": "Oesophageal candidiasis", "outcome": "3"}, {"pt": "Hiatus hernia", "outcome": "3"}, {"pt": "Haemorrhoids", "outcome": "3"}], "classifyText": "DABIGATRAN PRINIVIL LASIX ROCALTROL CYMBALTA NEXIUM ULORIC FORTEO PLAQUENIL LANTUS ADCIRCA ADCIRCA AMBIEN DABIGATRAN ETEXILATE FUROSEMIDE DULOXETINE HYDROCHLORIDE ESOMEPRAZOLE MAGNESIUM FEBUXOSTAT TERIPARATIDE HYDROXYCHLOROQUINE SULFATE INSULIN GLARGINE TADALAFIL TADALAFIL ZOLPIDEM TARTRATE ATRIAL FIBRILLATION HYPERTENSION DIURETIC THERAPY PROPHYLAXIS DEPRESSION GASTROOESOPHAGEAL REFLUX DISEASE GOUT OSTEOPOROSIS SYSTEMIC LUPUS ERYTHEMATOSUS DIABETES MELLITUS HYPERTENSION OSTEONECROSIS SLEEP DISORDER Mouth haemorrhage Epistaxis Rectal haemorrhage Fatigue Renal failure acute Oesophageal candidiasis Hiatus hernia Haemorrhoids"}
{"safetyreportid": "10009580", "receiveDate": "20140312", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "1", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "JAKAFI", "drugcharacterization": "1", "drugindication": "MYELOFIBROSIS", "manufacturer": "Incyte Corporation", "genericName": "RUXOLITINIB", "brandName": "JAKAFI", "pharmClass_epc": "Kinase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "LANTUS SOLOSTAR", "drugcharacterization": "2", "drugindication": null, "manufacturer": "sanofi-aventis U.S. LLC", "genericName": "INSULIN GLARGINE", "brandName": "LANTUS SOLOSTAR", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "LOSARTAN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Granules Pharmaceuticals Inc.", "genericName": "LOSARTAN", "brandName": "LOSARTAN POTASSIUM", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CARVEDILOL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Advagen Pharma Limited", "genericName": "CARVEDILOL", "brandName": "CARVEDILOL", "pharmClass_epc": "alpha-Adrenergic Blocker [EPC]", "route": "ORAL"}, {"medicinalproduct": "MAGNESIUM", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Korea Life Science", "genericName": "MAGNESIUM", "brandName": "BYE ZERO", "pharmClass_epc": null, "route": "TOPICAL"}, {"medicinalproduct": "DICLOFENAC", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Amneal Pharmaceuticals LLC", "genericName": "DICLOFENAC", "brandName": "DICLOFENAC SODIUM", "pharmClass_epc": "Nonsteroidal Anti-inflammatory Drug [EPC]", "route": "TOPICAL"}, {"medicinalproduct": "VICODIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SOMA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Viatris Specialty LLC", "genericName": "CARISOPRODOL", "brandName": "SOMA", "pharmClass_epc": "Muscle Relaxant [EPC]", "route": "ORAL"}, {"medicinalproduct": "VIAGRA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Viatris Specialty LLC", "genericName": "SILDENAFIL CITRATE", "brandName": "VIAGRA", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Blood glucose fluctuation", "outcome": "6"}, {"pt": "Dysphonia", "outcome": "6"}, {"pt": "Fatigue", "outcome": "6"}], "classifyText": "JAKAFI HUMALOG MIX75/25 LANTUS SOLOSTAR LOSARTAN POTASSIUM CARVEDILOL BYE ZERO DICLOFENAC SODIUM VICODIN SOMA VIAGRA RUXOLITINIB INSULIN LISPRO INSULIN GLARGINE LOSARTAN CARVEDILOL MAGNESIUM DICLOFENAC CARISOPRODOL SILDENAFIL CITRATE MYELOFIBROSIS Blood glucose fluctuation Dysphonia Fatigue"}
{"safetyreportid": "10009581", "receiveDate": "20140312", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "1", "patientAge": "64", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "JAKAFI", "drugcharacterization": "1", "drugindication": "MYELOFIBROSIS", "manufacturer": "Incyte Corporation", "genericName": "RUXOLITINIB", "brandName": "JAKAFI", "pharmClass_epc": "Kinase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "LANTUS", "drugcharacterization": "2", "drugindication": null, "manufacturer": "sanofi-aventis U.S. LLC", "genericName": "INSULIN GLARGINE", "brandName": "LANTUS", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "LOSARTAN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Granules Pharmaceuticals Inc.", "genericName": "LOSARTAN", "brandName": "LOSARTAN POTASSIUM", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CARVEDILOL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Advagen Pharma Limited", "genericName": "CARVEDILOL", "brandName": "CARVEDILOL", "pharmClass_epc": "alpha-Adrenergic Blocker [EPC]", "route": "ORAL"}, {"medicinalproduct": "MAGNESIUM", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Korea Life Science", "genericName": "MAGNESIUM", "brandName": "BYE ZERO", "pharmClass_epc": null, "route": "TOPICAL"}, {"medicinalproduct": "VOLTAREN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Haleon US Holdings LLC", "genericName": "DICLOFENAC SODIUM", "brandName": "VOLTAREN ARTHRITIS PAIN", "pharmClass_epc": null, "route": "TOPICAL"}, {"medicinalproduct": "VICODIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "VIAGRA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Viatris Specialty LLC", "genericName": "SILDENAFIL CITRATE", "brandName": "VIAGRA", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Musculoskeletal pain", "outcome": "6"}], "classifyText": "JAKAFI HUMALOG MIX75/25 LANTUS LOSARTAN POTASSIUM CARVEDILOL BYE ZERO VOLTAREN ARTHRITIS PAIN VICODIN VIAGRA RUXOLITINIB INSULIN LISPRO INSULIN GLARGINE LOSARTAN CARVEDILOL MAGNESIUM DICLOFENAC SODIUM SILDENAFIL CITRATE MYELOFIBROSIS Musculoskeletal pain"}
{"safetyreportid": "10009588", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "1", "patientAge": "57", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "RANOLAZINE", "drugcharacterization": "1", "drugindication": "ANGINA PECTORIS", "manufacturer": "Ascend Laboratories, LLC", "genericName": "RANOLAZINE", "brandName": "RANOLAZINE", "pharmClass_epc": "Anti-anginal [EPC]", "route": "ORAL"}, {"medicinalproduct": "RANOLAZINE", "drugcharacterization": "3", "drugindication": null, "manufacturer": "Ascend Laboratories, LLC", "genericName": "RANOLAZINE", "brandName": "RANOLAZINE", "pharmClass_epc": "Anti-anginal [EPC]", "route": "ORAL"}, {"medicinalproduct": "SIROLIMUS", "drugcharacterization": "3", "drugindication": "IMMUNOSUPPRESSANT DRUG THERAPY", "manufacturer": "Rising Pharma Holdings, Inc.", "genericName": "SIROLIMUS", "brandName": "SIROLIMUS", "pharmClass_epc": "mTOR Inhibitor Immunosuppressant [EPC]", "route": "ORAL"}, {"medicinalproduct": "SIROLIMUS", "drugcharacterization": "3", "drugindication": null, "manufacturer": "Rising Pharma Holdings, Inc.", "genericName": "SIROLIMUS", "brandName": "SIROLIMUS", "pharmClass_epc": "mTOR Inhibitor Immunosuppressant [EPC]", "route": "ORAL"}, {"medicinalproduct": "SIROLIMUS", "drugcharacterization": "3", "drugindication": null, "manufacturer": "Rising Pharma Holdings, Inc.", "genericName": "SIROLIMUS", "brandName": "SIROLIMUS", "pharmClass_epc": "mTOR Inhibitor Immunosuppressant [EPC]", "route": "ORAL"}, {"medicinalproduct": "SIROLIMUS", "drugcharacterization": "3", "drugindication": null, "manufacturer": "Rising Pharma Holdings, Inc.", "genericName": "SIROLIMUS", "brandName": "SIROLIMUS", "pharmClass_epc": "mTOR Inhibitor Immunosuppressant [EPC]", "route": "ORAL"}, {"medicinalproduct": "SIROLIMUS", "drugcharacterization": "3", "drugindication": null, "manufacturer": "Rising Pharma Holdings, Inc.", "genericName": "SIROLIMUS", "brandName": "SIROLIMUS", "pharmClass_epc": "mTOR Inhibitor Immunosuppressant [EPC]", "route": "ORAL"}, {"medicinalproduct": "SIROLIMUS", "drugcharacterization": "3", "drugindication": null, "manufacturer": "Rising Pharma Holdings, Inc.", "genericName": "SIROLIMUS", "brandName": "SIROLIMUS", "pharmClass_epc": "mTOR Inhibitor Immunosuppressant [EPC]", "route": "ORAL"}, {"medicinalproduct": "SIROLIMUS", "drugcharacterization": "3", "drugindication": null, "manufacturer": "Rising Pharma Holdings, Inc.", "genericName": "SIROLIMUS", "brandName": "SIROLIMUS", "pharmClass_epc": "mTOR Inhibitor Immunosuppressant [EPC]", "route": "ORAL"}, {"medicinalproduct": "PREDNISONE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "ANI Pharmaceuticals, Inc.", "genericName": "PREDNISONE", "brandName": "PREDNISONE", "pharmClass_epc": "Corticosteroid [EPC]", "route": "ORAL"}, {"medicinalproduct": "TACROLIMUS", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Glenmark Pharmaceuticals Inc., USA", "genericName": "TACROLIMUS", "brandName": "TACROLIMUS", "pharmClass_epc": "Calcineurin Inhibitor Immunosuppressant [EPC]", "route": "TOPICAL"}, {"medicinalproduct": "CLOPIDOGREL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "NorthStar RxLLC", "genericName": "CLOPIDOGREL", "brandName": "CLOPIDOGREL", "pharmClass_epc": "P2Y12 Platelet Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "ASPIRIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Unifirst First Aid Corporation", "genericName": "ASPIRIN", "brandName": "BAYER GENUINE ASPIRIN", "pharmClass_epc": "Nonsteroidal Anti-inflammatory Drug [EPC]", "route": "ORAL"}, {"medicinalproduct": "AMLODIPINE BESYLATE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Zydus Pharmaceuticals USA Inc.", "genericName": "AMLODIPINE BESYLATE", "brandName": "AMLODIPINE BESYLATE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LISINOPRIL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Chartwell RX, LLC", "genericName": "LISINOPRIL", "brandName": "LISINOPRIL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "METOPROLOL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Baxter Healthcare Corporation", "genericName": "METOPROLOL TARTRATE", "brandName": "METOPROLOL", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "FUROSEMIDE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Ipca Laboratories Limited", "genericName": "FUROSEMIDE", "brandName": "FUROSEMIDE", "pharmClass_epc": "Loop Diuretic [EPC]", "route": "ORAL"}, {"medicinalproduct": "INSULIN LISPRO", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Sanofi-Aventis U.S. LLC", "genericName": "INSULIN LISPRO", "brandName": "ADMELOG", "pharmClass_epc": "Insulin Analog [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "NITROGLYCERIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Aurobindo Pharma Limited", "genericName": "NITROGLYCERIN", "brandName": "NITROGLYCERIN", "pharmClass_epc": "Nitrate Vasodilator [EPC]", "route": "SUBLINGUAL"}, {"medicinalproduct": "HYDROCODONE HYDROCHLORIDE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "VITAMIN D NOS", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Angina pectoris", "outcome": "6"}, {"pt": "Dehydration", "outcome": "6"}, {"pt": "Malaise", "outcome": "6"}, {"pt": "Pain", "outcome": "6"}, {"pt": "Oral surgery", "outcome": "6"}, {"pt": "Immunosuppressant drug level increased", "outcome": "1"}, {"pt": "Drug interaction", "outcome": "6"}], "classifyText": "RANOLAZINE RANOLAZINE SIROLIMUS SIROLIMUS SIROLIMUS SIROLIMUS SIROLIMUS SIROLIMUS SIROLIMUS PREDNISONE TACROLIMUS CLOPIDOGREL BAYER GENUINE ASPIRIN AMLODIPINE BESYLATE LISINOPRIL METOPROLOL FUROSEMIDE ADMELOG NITROGLYCERIN HYDROCODONE HYDROCHLORIDE VITAMIN D NOS RANOLAZINE RANOLAZINE SIROLIMUS SIROLIMUS SIROLIMUS SIROLIMUS SIROLIMUS SIROLIMUS SIROLIMUS PREDNISONE TACROLIMUS CLOPIDOGREL ASPIRIN AMLODIPINE BESYLATE LISINOPRIL METOPROLOL TARTRATE FUROSEMIDE INSULIN LISPRO NITROGLYCERIN ANGINA PECTORIS IMMUNOSUPPRESSANT DRUG THERAPY Angina pectoris Dehydration Malaise Pain Oral surgery Immunosuppressant drug level increased Drug interaction"}
{"safetyreportid": "10009600", "receiveDate": "20140312", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "74", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "JAKAFI", "drugcharacterization": "1", "drugindication": "MYELOFIBROSIS", "manufacturer": "Incyte Corporation", "genericName": "RUXOLITINIB", "brandName": "JAKAFI", "pharmClass_epc": "Kinase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "JAKAFI", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Incyte Corporation", "genericName": "RUXOLITINIB", "brandName": "JAKAFI", "pharmClass_epc": "Kinase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "METFORMIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Mylan Pharmaceuticals Inc.", "genericName": "METFORMIN", "brandName": "METFORMIN HYDROCHLORIDE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "MODAFINIL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Alembic Pharmaceuticals Limited", "genericName": "MODAFINIL", "brandName": "MODAFINIL", "pharmClass_epc": "Sympathomimetic-like Agent [EPC]", "route": "ORAL"}, {"medicinalproduct": "SYNTHROID", "drugcharacterization": "2", "drugindication": null, "manufacturer": "AbbVie Inc.", "genericName": "LEVOTHYROXINE SODIUM", "brandName": "SYNTHROID", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "PANTOPRAZOLE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "XLCare Pharmaceuticals Inc.", "genericName": "PANTOPRAZOLE", "brandName": "PANTOPRAZOLE SODIUM", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "MELOXICAM", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Zydus Pharmaceuticals USA Inc.", "genericName": "MELOXICAM", "brandName": "MELOXICAM", "pharmClass_epc": "Nonsteroidal Anti-inflammatory Drug [EPC]", "route": "ORAL"}, {"medicinalproduct": "AMLODIPINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Pangea Pharmaceuticals, LLC", "genericName": "AMLODIPINE", "brandName": "SDAMLO", "pharmClass_epc": "Dihydropyridine Calcium Channel Blocker [EPC]", "route": "ORAL"}, {"medicinalproduct": "FUROSEMIDE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Ipca Laboratories Limited", "genericName": "FUROSEMIDE", "brandName": "FUROSEMIDE", "pharmClass_epc": "Loop Diuretic [EPC]", "route": "ORAL"}, {"medicinalproduct": "ESTRADIOL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Sandoz Inc", "genericName": "ESTRADIOL", "brandName": "VIVELLE-DOT", "pharmClass_epc": "Estrogen [EPC]", "route": "TRANSDERMAL"}, {"medicinalproduct": "PROCRIT", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Janssen Products, LP", "genericName": "ERYTHROPOIETIN", "brandName": "PROCRIT", "pharmClass_epc": null, "route": "INTRAVENOUS"}], "reactions": [{"pt": "Insomnia", "outcome": "1"}, {"pt": "Wrong technique in drug usage process", "outcome": "6"}, {"pt": "Dizziness", "outcome": "1"}], "classifyText": "JAKAFI JAKAFI CYMBALTA METFORMIN HYDROCHLORIDE MODAFINIL SYNTHROID PANTOPRAZOLE SODIUM MELOXICAM SDAMLO FUROSEMIDE VIVELLE-DOT PROCRIT RUXOLITINIB RUXOLITINIB DULOXETINE HYDROCHLORIDE METFORMIN MODAFINIL LEVOTHYROXINE SODIUM PANTOPRAZOLE MELOXICAM AMLODIPINE FUROSEMIDE ESTRADIOL ERYTHROPOIETIN MYELOFIBROSIS Insomnia Wrong technique in drug usage process Dizziness"}
{"safetyreportid": "10009698", "receiveDate": "20140312", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "JAKAFI", "drugcharacterization": "1", "drugindication": "POLYCYTHAEMIA VERA", "manufacturer": "Incyte Corporation", "genericName": "RUXOLITINIB", "brandName": "JAKAFI", "pharmClass_epc": "Kinase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Decreased appetite", "outcome": "6"}, {"pt": "Somnolence", "outcome": "6"}, {"pt": "Dizziness", "outcome": "6"}], "classifyText": "JAKAFI CYMBALTA RUXOLITINIB DULOXETINE HYDROCHLORIDE POLYCYTHAEMIA VERA Decreased appetite Somnolence Dizziness"}
{"safetyreportid": "10009855", "receiveDate": "20140312", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "66", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "JAKAFI", "drugcharacterization": "1", "drugindication": "MYELOFIBROSIS", "manufacturer": "Incyte Corporation", "genericName": "RUXOLITINIB", "brandName": "JAKAFI", "pharmClass_epc": "Kinase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "METFORMIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Mylan Pharmaceuticals Inc.", "genericName": "METFORMIN", "brandName": "METFORMIN HYDROCHLORIDE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "JANUVIA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Merck Sharp & Dohme LLC", "genericName": "SITAGLIPTIN", "brandName": "JANUVIA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "HYDROXYUREA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Leading Pharma, LLC", "genericName": "HYDROXYUREA", "brandName": "HYDROXYUREA", "pharmClass_epc": "Antimetabolite [EPC]", "route": "ORAL"}, {"medicinalproduct": "ANAGRELIDE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Torrent Pharmaceuticals Limited", "genericName": "ANAGRELIDE", "brandName": "ANAGRELIDE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LEVEMIR", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Novo Nordisk", "genericName": "INSULIN DETEMIR", "brandName": "LEVEMIR", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}], "reactions": [{"pt": "Breast tenderness", "outcome": "2"}, {"pt": "Urinary tract infection", "outcome": "1"}], "classifyText": "JAKAFI METFORMIN HYDROCHLORIDE JANUVIA HYDROXYUREA ANAGRELIDE LEVEMIR HUMALOG MIX75/25 RUXOLITINIB METFORMIN SITAGLIPTIN HYDROXYUREA ANAGRELIDE INSULIN DETEMIR INSULIN LISPRO MYELOFIBROSIS Breast tenderness Urinary tract infection"}
{"safetyreportid": "10010164", "receiveDate": "20140312", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "JAKAFI", "drugcharacterization": "1", "drugindication": "MYELOFIBROSIS", "manufacturer": "Incyte Corporation", "genericName": "RUXOLITINIB", "brandName": "JAKAFI", "pharmClass_epc": "Kinase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "ASPIRIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Unifirst First Aid Corporation", "genericName": "ASPIRIN", "brandName": "BAYER GENUINE ASPIRIN", "pharmClass_epc": "Nonsteroidal Anti-inflammatory Drug [EPC]", "route": "ORAL"}, {"medicinalproduct": "VITAMIN D3", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Strides Pharma Science Limited", "genericName": "ERGOCALCIFEROL", "brandName": "VITAMIN D", "pharmClass_epc": "Provitamin D2 Compound [EPC]", "route": "ORAL"}, {"medicinalproduct": "FOLIC ACID", "drugcharacterization": "2", "drugindication": null, "manufacturer": "PureTek Corporation", "genericName": "FOLIC ACID", "brandName": "VENTRIXYL", "pharmClass_epc": "Vitamin C [EPC]", "route": "ORAL"}, {"medicinalproduct": "B12 INJECTION", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "FIBERCON", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Foundation Consumer Brands", "genericName": "CALCIUM POLYCARBOPHIL", "brandName": "FIBERCON", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "REQUIP", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Neuropathy peripheral", "outcome": "6"}, {"pt": "Bone pain", "outcome": "6"}, {"pt": "Myalgia", "outcome": "6"}, {"pt": "Cyst", "outcome": "6"}], "classifyText": "JAKAFI BAYER GENUINE ASPIRIN VITAMIN D VENTRIXYL B12 INJECTION CYMBALTA FIBERCON REQUIP RUXOLITINIB ASPIRIN ERGOCALCIFEROL FOLIC ACID DULOXETINE HYDROCHLORIDE CALCIUM POLYCARBOPHIL MYELOFIBROSIS Neuropathy peripheral Bone pain Myalgia Cyst"}
{"safetyreportid": "10010239", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "IT", "reportType": "1", "patientSex": "1", "patientAge": "61", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "CIALIS", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "TADALAFIL", "brandName": "CIALIS", "pharmClass_epc": "Phosphodiesterase 5 Inhibitor [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Arrhythmia", "outcome": "1"}, {"pt": "Palpitations", "outcome": "1"}, {"pt": "Drug abuse", "outcome": "6"}], "classifyText": "CIALIS TADALAFIL PRODUCT USED FOR UNKNOWN INDICATION Arrhythmia Palpitations Drug abuse"}
{"safetyreportid": "10010240", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "EVISTA", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "RALOXIFENE HYDROCHLORIDE", "brandName": "EVISTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "DOXYCYCLINE", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Lupin Pharmaceuticals, Inc.", "genericName": "DOXYCYCLINE", "brandName": "DOXYCYCLINE", "pharmClass_epc": "Tetracycline-class Drug [EPC]", "route": "ORAL"}, {"medicinalproduct": "CALCIUM CARBONATE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "WINCO FOODS, LLC", "genericName": "CALCIUM CARBONATE", "brandName": "WINCO FOODS ANTACID ULTRA STRENGTH", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "MELOXICAM", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Zydus Pharmaceuticals USA Inc.", "genericName": "MELOXICAM", "brandName": "MELOXICAM", "pharmClass_epc": "Nonsteroidal Anti-inflammatory Drug [EPC]", "route": "ORAL"}, {"medicinalproduct": "NIFEDIPINE ER", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SERTRALINE HCL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Biocon Pharma Inc.", "genericName": "SERTRALINE HYDROCHLORIDE", "brandName": "SERTRALINE HCL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "SPIRONOLACTONE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Amneal Pharmaceuticals LLC", "genericName": "SPIRONOLACTONE", "brandName": "SPIRONOLACTONE", "pharmClass_epc": "Aldosterone Antagonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "VITAMIN D NOS", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "B12", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Apex Energetics Inc.", "genericName": "ADRENALINUM, ARGENTUM NITRICUM, BOS TAURUS PITUITARUM POSTERIUM, GLYCERINUM, GLYCYRRHIZA GLABRA, KALI CARBONICUM, LACTICUM ACIDUM, MAGNESIA SULPHURICA, NICCOLUM METALLICUM, PANCREATINUM, PHOSPHORICUM ACIDUM, SACCHARINUM, SACCHARUM LACTIS, SACCHARUM OFFICINALE, SARCOLACTICUM ACIDUM, SELENIUM METALLICUM, SYZYGIUM JAMBOLANUM, THYROIDINUM, ZINCUM METALLICUM", "brandName": "B05 GLUCO BALANCE", "pharmClass_epc": "alpha-Adrenergic Agonist [EPC]", "route": "SUBLINGUAL"}, {"medicinalproduct": "IBUPROFEN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "DOLGENCORP INC", "genericName": "IBUPROFEN", "brandName": "IBUPROFEN", "pharmClass_epc": "Nonsteroidal Anti-inflammatory Drug [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Pulmonary embolism", "outcome": "6"}, {"pt": "Chronic obstructive pulmonary disease", "outcome": "3"}, {"pt": "Respiratory failure", "outcome": "6"}, {"pt": "Stevens-Johnson syndrome", "outcome": "6"}, {"pt": "Osteoporosis", "outcome": "6"}], "classifyText": "EVISTA DOXYCYCLINE WINCO FOODS ANTACID ULTRA STRENGTH MELOXICAM NIFEDIPINE ER SERTRALINE HCL SPIRONOLACTONE VITAMIN D NOS B05 GLUCO BALANCE IBUPROFEN RALOXIFENE HYDROCHLORIDE DOXYCYCLINE CALCIUM CARBONATE MELOXICAM SERTRALINE HYDROCHLORIDE SPIRONOLACTONE ADRENALINUM, ARGENTUM NITRICUM, BOS TAURUS PITUITARUM POSTERIUM, GLYCERINUM, GLYCYRRHIZA GLABRA, KALI CARBONICUM, LACTICUM ACIDUM, MAGNESIA SULPHURICA, NICCOLUM METALLICUM, PANCREATINUM, PHOSPHORICUM ACIDUM, SACCHARINUM, SACCHARUM LACTIS, SACCHARUM OFFICINALE, SARCOLACTICUM ACIDUM, SELENIUM METALLICUM, SYZYGIUM JAMBOLANUM, THYROIDINUM, ZINCUM METALLICUM IBUPROFEN PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Pulmonary embolism Chronic obstructive pulmonary disease Respiratory failure Stevens-Johnson syndrome Osteoporosis"}
{"safetyreportid": "10010242", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 1, "occurcountry": "IE", "reportType": "1", "patientSex": "1", "patientAge": "60", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "CIALIS", "drugcharacterization": "1", "drugindication": "ERECTILE DYSFUNCTION", "manufacturer": "Eli Lilly and Company", "genericName": "TADALAFIL", "brandName": "CIALIS", "pharmClass_epc": "Phosphodiesterase 5 Inhibitor [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Arrhythmia", "outcome": "1"}, {"pt": "Presyncope", "outcome": "1"}], "classifyText": "CIALIS TADALAFIL ERECTILE DYSFUNCTION Arrhythmia Presyncope"}
{"safetyreportid": "10010243", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "BR", "reportType": "1", "patientSex": "1", "patientAge": "52", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "FORTEO", "drugcharacterization": "1", "drugindication": "OSTEOPOROSIS", "manufacturer": "Eli Lilly and Company", "genericName": "TERIPARATIDE", "brandName": "FORTEO", "pharmClass_epc": "Parathyroid Hormone Analog [EPC]", "route": "SUBCUTANEOUS"}], "reactions": [{"pt": "Plasma cell myeloma", "outcome": "6"}], "classifyText": "FORTEO TERIPARATIDE OSTEOPOROSIS Plasma cell myeloma"}
{"safetyreportid": "10010244", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "85", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "FORTEO", "drugcharacterization": "1", "drugindication": "OSTEOPOROSIS", "manufacturer": "Eli Lilly and Company", "genericName": "TERIPARATIDE", "brandName": "FORTEO", "pharmClass_epc": "Parathyroid Hormone Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "FORTEO", "drugcharacterization": "1", "drugindication": "FRACTURE", "manufacturer": "Eli Lilly and Company", "genericName": "TERIPARATIDE", "brandName": "FORTEO", "pharmClass_epc": "Parathyroid Hormone Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "MORPHINE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Edenbridge Pharmaceuticals, LLC", "genericName": "MORPHINE", "brandName": "OPIUM TINCTURE DEODORIZED", "pharmClass_epc": "Opioid Agonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "DEPAKOTE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "AbbVie Inc.", "genericName": "DIVALPROEX SODIUM", "brandName": "DEPAKOTE ER", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "SEROQUEL", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "AstraZeneca Pharmaceuticals LP", "genericName": "QUETIAPINE", "brandName": "SEROQUEL XR", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "POTASSIUM", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "EXOLAN", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "NEXIUM /01479302/", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ZOFRAN /00955301/", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "TYLENOL /00020001/", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LASIX /00032601/", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "VITAMIN B12 /00056201/", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "VITAMIN C /00008001/", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Convulsion", "outcome": "6"}, {"pt": "Urinary tract infection", "outcome": "6"}, {"pt": "Psychiatric symptom", "outcome": "6"}], "classifyText": "FORTEO FORTEO CYMBALTA OPIUM TINCTURE DEODORIZED DEPAKOTE ER SEROQUEL XR POTASSIUM EXOLAN NEXIUM /01479302/ ZOFRAN /00955301/ TYLENOL /00020001/ LASIX /00032601/ VITAMIN B12 /00056201/ VITAMIN C /00008001/ TERIPARATIDE TERIPARATIDE DULOXETINE HYDROCHLORIDE MORPHINE DIVALPROEX SODIUM QUETIAPINE OSTEOPOROSIS FRACTURE PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Convulsion Urinary tract infection Psychiatric symptom"}
{"safetyreportid": "10010246", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 1, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "BR", "reportType": "1", "patientSex": "1", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "HUMULIN R", "drugcharacterization": "1", "drugindication": "TYPE 2 DIABETES MELLITUS", "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN HUMAN", "brandName": "HUMULIN R", "pharmClass_epc": "Insulin [EPC]", "route": "PARENTERAL"}], "reactions": [{"pt": "Oesophageal carcinoma", "outcome": "5"}, {"pt": "Oesophageal oedema", "outcome": "5"}, {"pt": "Asphyxia", "outcome": "5"}, {"pt": "Visual acuity reduced", "outcome": "6"}, {"pt": "Neuropathy peripheral", "outcome": "3"}, {"pt": "Mobility decreased", "outcome": "6"}, {"pt": "Injury", "outcome": "6"}, {"pt": "Fall", "outcome": "6"}, {"pt": "Head injury", "outcome": "6"}, {"pt": "Pain", "outcome": "6"}], "classifyText": "HUMULIN R INSULIN HUMAN TYPE 2 DIABETES MELLITUS Oesophageal carcinoma Oesophageal oedema Asphyxia Visual acuity reduced Neuropathy peripheral Mobility decreased Injury Fall Head injury Pain"}
{"safetyreportid": "10010247", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 1, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "BR", "reportType": "1", "patientSex": "1", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "HUMALOG", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "LANTUS", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "sanofi-aventis U.S. LLC", "genericName": "INSULIN GLARGINE", "brandName": "LANTUS", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}], "reactions": [{"pt": "Cerebrovascular accident", "outcome": "5"}, {"pt": "Hypertension", "outcome": "6"}, {"pt": "Diabetes mellitus", "outcome": "6"}], "classifyText": "HUMALOG MIX75/25 LANTUS INSULIN LISPRO INSULIN GLARGINE PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Cerebrovascular accident Hypertension Diabetes mellitus"}
{"safetyreportid": "10010278", "receiveDate": "20140314", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "61", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "ENBREL", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Immunex Corporation", "genericName": "ETANERCEPT", "brandName": "ENBREL", "pharmClass_epc": "Tumor Necrosis Factor Blocker [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "FOSAMAX", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Organon LLC", "genericName": "ALENDRONATE SODIUM", "brandName": "FOSAMAX", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "PREDNISONE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "ANI Pharmaceuticals, Inc.", "genericName": "PREDNISONE", "brandName": "PREDNISONE", "pharmClass_epc": "Corticosteroid [EPC]", "route": "ORAL"}, {"medicinalproduct": "ARAVA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "sanofi-aventis U.S. LLC", "genericName": "LEFLUNOMIDE", "brandName": "ARAVA", "pharmClass_epc": "Antirheumatic Agent [EPC]", "route": "ORAL"}, {"medicinalproduct": "BACLOFEN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Northstar RxLLC", "genericName": "BACLOFEN", "brandName": "BACLOFEN", "pharmClass_epc": "gamma-Aminobutyric Acid-ergic Agonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "FLONASE /00908302/", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "OXYCODONE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Amneal Pharmaceuticals LLC", "genericName": "OXYCODONE", "brandName": "OXYCODONE HYDROCHLORIDE", "pharmClass_epc": "Opioid Agonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "ZANTAC", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CLARITIN-D", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Bayer HealthCare LLC.", "genericName": "LORATADINE PSEUDOEPHEDRINE SULFATE", "brandName": "CLARITIN-D 24 HOUR", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "OXYCONTIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Purdue Pharma LP", "genericName": "OXYCODONE HYDROCHLORIDE", "brandName": "OXYCONTIN", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Staphylococcal osteomyelitis", "outcome": "6"}], "classifyText": "ENBREL CYMBALTA FOSAMAX PREDNISONE ARAVA BACLOFEN FLONASE /00908302/ OXYCODONE HYDROCHLORIDE ZANTAC CLARITIN-D 24 HOUR OXYCONTIN ETANERCEPT DULOXETINE HYDROCHLORIDE ALENDRONATE SODIUM PREDNISONE LEFLUNOMIDE BACLOFEN OXYCODONE LORATADINE PSEUDOEPHEDRINE SULFATE OXYCODONE HYDROCHLORIDE PRODUCT USED FOR UNKNOWN INDICATION Staphylococcal osteomyelitis"}
{"safetyreportid": "10010299", "receiveDate": "20140314", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "2", "patientSex": "1", "patientAge": "73", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "RIBAVIRIN", "drugcharacterization": "1", "drugindication": "HEPATITIS C", "manufacturer": "Bausch Health US, LLC", "genericName": "RIBAVIRIN", "brandName": "VIRAZOLE", "pharmClass_epc": "Nucleoside Analog Antiviral [EPC]", "route": "RESPIRATORY (INHALATION)"}, {"medicinalproduct": "PEG-INTERFERON ALFA 2A", "drugcharacterization": "1", "drugindication": "HEPATITIS C", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SOFOSBUVIR", "drugcharacterization": "1", "drugindication": "HEPATITIS C", "manufacturer": "Gilead Sciences, Inc.", "genericName": "SOFOSBUVIR", "brandName": "SOVALDI", "pharmClass_epc": "Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "TACROLIMUS", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Glenmark Pharmaceuticals Inc., USA", "genericName": "TACROLIMUS", "brandName": "TACROLIMUS", "pharmClass_epc": "Calcineurin Inhibitor Immunosuppressant [EPC]", "route": "TOPICAL"}, {"medicinalproduct": "SEPTRA", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LIDODERM", "drugcharacterization": "2", "drugindication": null, "manufacturer": "TPU Pharma, Inc.", "genericName": "LIDOCAINE PATCH 5%", "brandName": "LIDODERM", "pharmClass_epc": "Amide Local Anesthetic [EPC]", "route": "TOPICAL"}, {"medicinalproduct": "FLEXERIL (UNITED STATES)", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ROXICODONE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "SpecGx LLC", "genericName": "OXYCODONE HYDROCHLORIDE", "brandName": "ROXICODONE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ACYCLOVIR", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Zydus Pharmaceuticals (USA) Inc.", "genericName": "ACYCLOVIR", "brandName": "ACYCLOVIR", "pharmClass_epc": "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "PENTAMIDINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LABETALOL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Marlex Pharmaceuticals Inc", "genericName": "LABETALOL", "brandName": "LABETALOL HYDROCHLORIDE", "pharmClass_epc": "beta-Adrenergic Blocker [EPC]", "route": "ORAL"}, {"medicinalproduct": "OLANZAPINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Hisun Pharmaceuticals USA, Inc.", "genericName": "OLANZAPINE", "brandName": "OLANZAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "PANTOPRAZOLE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "XLCare Pharmaceuticals Inc.", "genericName": "PANTOPRAZOLE", "brandName": "PANTOPRAZOLE SODIUM", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "FLUDROCORTISONE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "VICODIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "MAGNESIUM OXIDE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Westminster Pharmaceuticals, LLC", "genericName": "MAGNESIUM OXIDE", "brandName": "MAGNESIUM OXIDE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "NYSTATIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Pharmaceutical Associates, Inc.", "genericName": "NYSTATIN", "brandName": "NYSTATIN", "pharmClass_epc": "Polyene Antifungal [EPC]", "route": "ORAL"}, {"medicinalproduct": "PREDNISONE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "ANI Pharmaceuticals, Inc.", "genericName": "PREDNISONE", "brandName": "PREDNISONE", "pharmClass_epc": "Corticosteroid [EPC]", "route": "ORAL"}, {"medicinalproduct": "TORSEMIDE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Chartwell RX, LLC", "genericName": "TORSEMIDE", "brandName": "TORSEMIDE", "pharmClass_epc": "Loop Diuretic [EPC]", "route": "ORAL"}, {"medicinalproduct": "BACTRIM", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Sun Pharmaceutical Industries, Inc", "genericName": "SULFAMETHOXAZOLE AND TRIMETHOPRIM", "brandName": "BACTRIM", "pharmClass_epc": "Sulfonamide Antimicrobial [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Renal failure acute", "outcome": "3"}, {"pt": "Hyponatraemia", "outcome": "1"}], "classifyText": "VIRAZOLE PEG-INTERFERON ALFA 2A SOVALDI TACROLIMUS SEPTRA LIDODERM FLEXERIL (UNITED STATES) ROXICODONE ACYCLOVIR PENTAMIDINE LABETALOL HYDROCHLORIDE OLANZAPINE PANTOPRAZOLE SODIUM FLUDROCORTISONE VICODIN MAGNESIUM OXIDE NYSTATIN PREDNISONE TORSEMIDE BACTRIM RIBAVIRIN SOFOSBUVIR TACROLIMUS LIDOCAINE PATCH 5% OXYCODONE HYDROCHLORIDE ACYCLOVIR LABETALOL OLANZAPINE PANTOPRAZOLE MAGNESIUM OXIDE NYSTATIN PREDNISONE TORSEMIDE SULFAMETHOXAZOLE AND TRIMETHOPRIM HEPATITIS C HEPATITIS C HEPATITIS C Renal failure acute Hyponatraemia"}
{"safetyreportid": "10010342", "receiveDate": "20140314", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "KR", "reportType": "1", "patientSex": "2", "patientAge": "31", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "QUETIAPINE", "drugcharacterization": "1", "drugindication": "MANIA", "manufacturer": "Solco Healthcare U.S., LLC", "genericName": "QUETIAPINE", "brandName": "QUETIAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "OLANZAPINE", "drugcharacterization": "1", "drugindication": "MANIA", "manufacturer": "Hisun Pharmaceuticals USA, Inc.", "genericName": "OLANZAPINE", "brandName": "OLANZAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Oligohydramnios", "outcome": "6"}, {"pt": "Exposure during pregnancy", "outcome": "6"}], "classifyText": "QUETIAPINE OLANZAPINE QUETIAPINE OLANZAPINE MANIA MANIA Oligohydramnios Exposure during pregnancy"}
{"safetyreportid": "10010346", "receiveDate": "20140314", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "2", "patientSex": "1", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "KLOR-CON", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Upsher-Smith Laboratories, LLC", "genericName": "POTASSIUM CHLORIDE", "brandName": "KLOR-CON", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LUCENTIS", "drugcharacterization": "1", "drugindication": "MACULAR DEGENERATION", "manufacturer": "Genentech, Inc.", "genericName": "RANIBIZUMAB", "brandName": "LUCENTIS", "pharmClass_epc": "Vascular Endothelial Growth Factor Inhibitor [EPC]", "route": "INTRAVITREAL"}, {"medicinalproduct": "ATORVASTATIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "MUPIROCIN.", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Alembic Pharmaceuticals Inc.", "genericName": "MUPIROCIN", "brandName": "MUPIROCIN", "pharmClass_epc": "RNA Synthetase Inhibitor Antibacterial [EPC]", "route": "TOPICAL"}, {"medicinalproduct": "FUROSEMIDE.", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Ipca Laboratories Limited", "genericName": "FUROSEMIDE", "brandName": "FUROSEMIDE", "pharmClass_epc": "Loop Diuretic [EPC]", "route": "ORAL"}, {"medicinalproduct": "ASPIRIN.", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Unifirst First Aid Corporation", "genericName": "ASPIRIN", "brandName": "BAYER GENUINE ASPIRIN", "pharmClass_epc": "Nonsteroidal Anti-inflammatory Drug [EPC]", "route": "ORAL"}, {"medicinalproduct": "NORPACE", "drugcharacterization": "2", "drugindication": "VENTRICULAR TACHYCARDIA", "manufacturer": "Pfizer Laboratories Div Pfizer Inc", "genericName": "DISOPYRAMIDE PHOSPHATE", "brandName": "NORPACE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "METOPROLOL TARTRATE.", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Almaject, Inc.", "genericName": "METOPROLOL TARTRATE", "brandName": "METOPROLOL TARTRATE", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "LISINOPRIL.", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Chartwell RX, LLC", "genericName": "LISINOPRIL", "brandName": "LISINOPRIL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ALLOPURINOL.", "drugcharacterization": "2", "drugindication": "NEPHROLITHIASIS", "manufacturer": "Accord Healthcare Inc.", "genericName": "ALLOPURINOL", "brandName": "ALLOPURINOL", "pharmClass_epc": "Xanthine Oxidase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "NITROGLYCERIN.", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Aurobindo Pharma Limited", "genericName": "NITROGLYCERIN", "brandName": "NITROGLYCERIN", "pharmClass_epc": "Nitrate Vasodilator [EPC]", "route": "SUBLINGUAL"}, {"medicinalproduct": "OMEPRAZOLE.", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Amerisource Bergen", "genericName": "OMEPRAZOLE", "brandName": "GOOD NEIGHBOR PHARMACY OMEPRAZOLE", "pharmClass_epc": "Proton Pump Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "LUCENTIS", "drugcharacterization": "1", "drugindication": "NEOVASCULAR AGE-RELATED MACULAR DEGENERATION", "manufacturer": "Genentech, Inc.", "genericName": "RANIBIZUMAB", "brandName": "LUCENTIS", "pharmClass_epc": "Vascular Endothelial Growth Factor Inhibitor [EPC]", "route": "INTRAVITREAL"}, {"medicinalproduct": "SYNTHROID", "drugcharacterization": "2", "drugindication": null, "manufacturer": "AbbVie Inc.", "genericName": "LEVOTHYROXINE SODIUM", "brandName": "SYNTHROID", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LANTUS", "drugcharacterization": "2", "drugindication": "DIABETES MELLITUS", "manufacturer": "sanofi-aventis U.S. LLC", "genericName": "INSULIN GLARGINE", "brandName": "LANTUS", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "2", "drugindication": "DIABETES MELLITUS", "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}], "reactions": [{"pt": "Intestinal obstruction", "outcome": "6"}, {"pt": "Hearing impaired", "outcome": "6"}, {"pt": "Arterial occlusive disease", "outcome": "6"}, {"pt": "Coronary artery occlusion", "outcome": "6"}, {"pt": "Renal impairment", "outcome": "6"}], "classifyText": "KLOR-CON LUCENTIS ATORVASTATIN MUPIROCIN FUROSEMIDE BAYER GENUINE ASPIRIN NORPACE METOPROLOL TARTRATE LISINOPRIL ALLOPURINOL NITROGLYCERIN GOOD NEIGHBOR PHARMACY OMEPRAZOLE LUCENTIS SYNTHROID LANTUS HUMALOG MIX75/25 POTASSIUM CHLORIDE RANIBIZUMAB MUPIROCIN FUROSEMIDE ASPIRIN DISOPYRAMIDE PHOSPHATE METOPROLOL TARTRATE LISINOPRIL ALLOPURINOL NITROGLYCERIN OMEPRAZOLE RANIBIZUMAB LEVOTHYROXINE SODIUM INSULIN GLARGINE INSULIN LISPRO MACULAR DEGENERATION VENTRICULAR TACHYCARDIA NEPHROLITHIASIS NEOVASCULAR AGE-RELATED MACULAR DEGENERATION DIABETES MELLITUS DIABETES MELLITUS Intestinal obstruction Hearing impaired Arterial occlusive disease Coronary artery occlusion Renal impairment"}
{"safetyreportid": "10010361", "receiveDate": "20140314", "serious": 1, "seriousnessdeath": 1, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "57", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "TYSABRI", "drugcharacterization": "1", "drugindication": "MULTIPLE SCLEROSIS", "manufacturer": "Biogen Inc.", "genericName": "NATALIZUMAB", "brandName": "TYSABRI", "pharmClass_epc": "Integrin Receptor Antagonist [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "AVONEX", "drugcharacterization": "2", "drugindication": "MULTIPLE SCLEROSIS", "manufacturer": "Biogen Inc.", "genericName": "INTERFERON BETA-1A", "brandName": "AVONEX", "pharmClass_epc": "Interferon beta [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "OMEPRAZOLE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Amerisource Bergen", "genericName": "OMEPRAZOLE", "brandName": "GOOD NEIGHBOR PHARMACY OMEPRAZOLE", "pharmClass_epc": "Proton Pump Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "AMITRIPTYLINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "MIRTAZAPINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Aurolife Pharma LLC", "genericName": "MIRTAZAPINE", "brandName": "MIRTAZAPINE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ZYPREXA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "OLANZAPINE", "brandName": "ZYPREXA INTRAMUSCULAR", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "LAMICTAL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "GlaxoSmithKline LLC", "genericName": "LAMOTRIGINE", "brandName": "LAMICTAL", "pharmClass_epc": "Anti-epileptic Agent [EPC]", "route": "ORAL"}, {"medicinalproduct": "CILOSTAZOL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Slate Run Pharmaceuticals, LLC", "genericName": "CILOSTAZOL", "brandName": "CILOSTAZOL", "pharmClass_epc": "Phosphodiesterase 3 Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "MOBIC", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "XOPENEX HFA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Lupin Pharmaceuticals, Inc.", "genericName": "LEVALBUTEROL TARTRATE", "brandName": "XOPENEX HFA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "REGLAN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "ANI Pharmaceuticals, Inc.", "genericName": "METOCLOPRAMIDE HYDROCHLORIDE", "brandName": "REGLAN", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ALBUTEROL SULFATE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Chartwell RX, LLC", "genericName": "ALBUTEROL SULFATE", "brandName": "ALBUTEROL SULFATE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "MAGNESIUM", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Korea Life Science", "genericName": "MAGNESIUM", "brandName": "BYE ZERO", "pharmClass_epc": null, "route": "TOPICAL"}, {"medicinalproduct": "ZANTAC", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LYSINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "VITAMIN D3", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Strides Pharma Science Limited", "genericName": "ERGOCALCIFEROL", "brandName": "VITAMIN D", "pharmClass_epc": "Provitamin D2 Compound [EPC]", "route": "ORAL"}, {"medicinalproduct": "TIZANIDINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Sun Pharmaceutical Industries, Inc.", "genericName": "TIZANIDINE", "brandName": "TIZANIDINE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LANOXIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Covis Pharma US, Inc", "genericName": "DIGOXIN", "brandName": "LANOXIN", "pharmClass_epc": "Cardiac Glycoside [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "XANAX", "drugcharacterization": "2", "drugindication": null, "manufacturer": "PHARMACIA & UPJOHN COMPANY LLC", "genericName": "ALPRAZOLAM", "brandName": "XANAX", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "ORAL"}, {"medicinalproduct": "AMBIEN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Cosette Pharmaceuticals, Inc.", "genericName": "ZOLPIDEM TARTRATE", "brandName": "AMBIEN", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "SAVELLA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Allergan, Inc.", "genericName": "MILNACIPRAN HYDROCHLORIDE", "brandName": "SAVELLA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "HYDROCODONE ACETAMINOPHEN", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SALAGEN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Advanz Pharma (US) Corp.", "genericName": "PILOCARPINE HYDROCHLORIDE", "brandName": "SALAGEN", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CALCIUM AND VITAMIN D3", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "OMEGA 3 FATTY ACIDS", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "EFFER-K", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Nomax Inc.", "genericName": "POTASSIUM BICARBONATE", "brandName": "EFFER-K ORANGE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ESTRADIOL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Sandoz Inc", "genericName": "ESTRADIOL", "brandName": "VIVELLE-DOT", "pharmClass_epc": "Estrogen [EPC]", "route": "TRANSDERMAL"}, {"medicinalproduct": "BENADRYL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Lil' Drug Store Products, Inc.", "genericName": "DIPHENHYDRAMINE HYDROCHLORIDE", "brandName": "BENADRYL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "PLAQUENIL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Advanz Pharma (US) Corp.", "genericName": "HYDROXYCHLOROQUINE SULFATE", "brandName": "PLAQUENIL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "GUAIFENESIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "CHAIN DRUG MARKETING ASSOCIATION, INC.", "genericName": "GUAIFENESIN", "brandName": "MUCUS RELIEF", "pharmClass_epc": "Expectorant [EPC]", "route": "ORAL"}, {"medicinalproduct": "PROMETHAZINE-CODEINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Death", "outcome": "5"}, {"pt": "Cervical vertebral fracture", "outcome": "5"}, {"pt": "Fall", "outcome": "5"}], "classifyText": "TYSABRI AVONEX GOOD NEIGHBOR PHARMACY OMEPRAZOLE AMITRIPTYLINE MIRTAZAPINE ZYPREXA INTRAMUSCULAR LAMICTAL CILOSTAZOL MOBIC XOPENEX HFA REGLAN ALBUTEROL SULFATE BYE ZERO ZANTAC LYSINE VITAMIN D TIZANIDINE LANOXIN XANAX AMBIEN SAVELLA HYDROCODONE ACETAMINOPHEN SALAGEN CALCIUM AND VITAMIN D3 OMEGA 3 FATTY ACIDS EFFER-K ORANGE VIVELLE-DOT BENADRYL PLAQUENIL MUCUS RELIEF PROMETHAZINE-CODEINE NATALIZUMAB INTERFERON BETA-1A OMEPRAZOLE MIRTAZAPINE OLANZAPINE LAMOTRIGINE CILOSTAZOL LEVALBUTEROL TARTRATE METOCLOPRAMIDE HYDROCHLORIDE ALBUTEROL SULFATE MAGNESIUM ERGOCALCIFEROL TIZANIDINE DIGOXIN ALPRAZOLAM ZOLPIDEM TARTRATE MILNACIPRAN HYDROCHLORIDE PILOCARPINE HYDROCHLORIDE POTASSIUM BICARBONATE ESTRADIOL DIPHENHYDRAMINE HYDROCHLORIDE HYDROXYCHLOROQUINE SULFATE GUAIFENESIN MULTIPLE SCLEROSIS MULTIPLE SCLEROSIS Death Cervical vertebral fracture Fall"}
{"safetyreportid": "10010475", "receiveDate": "20140314", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "GB", "reportType": "1", "patientSex": "1", "patientAge": "1", "patientAgeUnit": "805", "drugs": [{"medicinalproduct": "QUETIAPINE.", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Solco Healthcare U.S., LLC", "genericName": "QUETIAPINE", "brandName": "QUETIAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "ZYPREXA", "drugcharacterization": "1", "drugindication": "SCHIZOAFFECTIVE DISORDER", "manufacturer": "Eli Lilly and Company", "genericName": "OLANZAPINE", "brandName": "ZYPREXA INTRAMUSCULAR", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "DULOXETINE.", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "MARKSANS PHARMA LIMITED", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "DULOXETINE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ARIPIPRAZOLE.", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Dr. Reddy's Laboratories Inc", "genericName": "ARIPIPRAZOLE ORALLY DISINTEGRATING", "brandName": "ARIPIPRAZOLE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "ZOPICLONE", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Selective eating disorder", "outcome": "1"}, {"pt": "Foetal exposure during pregnancy", "outcome": "6"}, {"pt": "Cleft palate", "outcome": "6"}, {"pt": "High arched palate", "outcome": "6"}, {"pt": "Exposure during breast feeding", "outcome": "6"}], "classifyText": "QUETIAPINE ZYPREXA INTRAMUSCULAR DULOXETINE ARIPIPRAZOLE ZOPICLONE QUETIAPINE OLANZAPINE DULOXETINE HYDROCHLORIDE ARIPIPRAZOLE ORALLY DISINTEGRATING PRODUCT USED FOR UNKNOWN INDICATION SCHIZOAFFECTIVE DISORDER PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Selective eating disorder Foetal exposure during pregnancy Cleft palate High arched palate Exposure during breast feeding"}
{"safetyreportid": "10010494", "receiveDate": "20140314", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "GB", "reportType": "3", "patientSex": "1", "patientAge": "1", "patientAgeUnit": "805", "drugs": [{"medicinalproduct": "QUETIAPINE.", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Solco Healthcare U.S., LLC", "genericName": "QUETIAPINE", "brandName": "QUETIAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "ARIPIPRAZOLE.", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Dr. Reddy's Laboratories Inc", "genericName": "ARIPIPRAZOLE ORALLY DISINTEGRATING", "brandName": "ARIPIPRAZOLE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "ZYPREXA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "OLANZAPINE", "brandName": "ZYPREXA INTRAMUSCULAR", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "DULOXETINE HYDROCHLORIDE.", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "MARKSANS PHARMA LIMITED", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "DULOXETINE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ZYPREXA", "drugcharacterization": "1", "drugindication": "SCHIZOAFFECTIVE DISORDER", "manufacturer": "Eli Lilly and Company", "genericName": "OLANZAPINE", "brandName": "ZYPREXA INTRAMUSCULAR", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "ZOPICLONE", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Cleft palate", "outcome": "6"}, {"pt": "Foetal exposure during pregnancy", "outcome": "6"}, {"pt": "Selective eating disorder", "outcome": "1"}, {"pt": "High arched palate", "outcome": "6"}, {"pt": "Exposure during breast feeding", "outcome": "6"}], "classifyText": "QUETIAPINE ARIPIPRAZOLE ZYPREXA INTRAMUSCULAR DULOXETINE ZYPREXA INTRAMUSCULAR ZOPICLONE QUETIAPINE ARIPIPRAZOLE ORALLY DISINTEGRATING OLANZAPINE DULOXETINE HYDROCHLORIDE OLANZAPINE PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION SCHIZOAFFECTIVE DISORDER PRODUCT USED FOR UNKNOWN INDICATION Cleft palate Foetal exposure during pregnancy Selective eating disorder High arched palate Exposure during breast feeding"}
{"safetyreportid": "10010539", "receiveDate": "20140314", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "IT", "reportType": "1", "patientSex": "1", "patientAge": "75", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "GLUCOPHAGE TABS", "drugcharacterization": "1", "drugindication": "TYPE 2 DIABETES MELLITUS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ENAPREN", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "ANTRA", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CARDIOASPIRIN", "drugcharacterization": "2", "drugindication": "GASTROENTERITIS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "PLAVIX", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Sanofi-Aventis U.S. LLC", "genericName": "CLOPIDOGREL", "brandName": "PLAVIX", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "TORVAST", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "XYZAL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Chattem, Inc.", "genericName": "LEVOCETIRIZINE DIHYDROCHLORIDE", "brandName": "XYZAL", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Renal failure acute", "outcome": "1"}, {"pt": "Metabolic acidosis", "outcome": "1"}], "classifyText": "GLUCOPHAGE TABS ENAPREN HUMALOG MIX75/25 ANTRA CARDIOASPIRIN PLAVIX TORVAST XYZAL INSULIN LISPRO CLOPIDOGREL LEVOCETIRIZINE DIHYDROCHLORIDE TYPE 2 DIABETES MELLITUS GASTROENTERITIS Renal failure acute Metabolic acidosis"}
{"safetyreportid": "10010545", "receiveDate": "20140314", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "FR", "reportType": "1", "patientSex": "2", "patientAge": "33", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "DEPAKOTE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "AbbVie Inc.", "genericName": "DIVALPROEX SODIUM", "brandName": "DEPAKOTE ER", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ZOLOFT", "drugcharacterization": "2", "drugindication": "BIPOLAR DISORDER", "manufacturer": "ROERIG", "genericName": "SERTRALINE HYDROCHLORIDE", "brandName": "ZOLOFT", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ABILIFY", "drugcharacterization": "1", "drugindication": "BIPOLAR DISORDER", "manufacturer": "Otsuka America Pharmaceutical, Inc.", "genericName": "ARIPIPRAZOLE", "brandName": "ABILIFY", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "ZYPREXA", "drugcharacterization": "2", "drugindication": "BIPOLAR DISORDER", "manufacturer": "Eli Lilly and Company", "genericName": "OLANZAPINE", "brandName": "ZYPREXA INTRAMUSCULAR", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "INTRAMUSCULAR"}], "reactions": [{"pt": "Abortion induced", "outcome": "6"}, {"pt": "Maternal exposure during pregnancy", "outcome": "1"}], "classifyText": "DEPAKOTE ER ZOLOFT ABILIFY ZYPREXA INTRAMUSCULAR DIVALPROEX SODIUM SERTRALINE HYDROCHLORIDE ARIPIPRAZOLE OLANZAPINE PRODUCT USED FOR UNKNOWN INDICATION BIPOLAR DISORDER BIPOLAR DISORDER BIPOLAR DISORDER Abortion induced Maternal exposure during pregnancy"}
{"safetyreportid": "10010632", "receiveDate": "20140314", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "GB", "reportType": "3", "patientSex": "2", "patientAge": "21", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "QUETIAPINE", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Solco Healthcare U.S., LLC", "genericName": "QUETIAPINE", "brandName": "QUETIAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "CITALOPRAM", "drugcharacterization": "1", "drugindication": "DEPRESSION", "manufacturer": "Chartwell Governmental & Specialty RX, LLC.", "genericName": "CITALOPRAM", "brandName": "CITALOPRAM", "pharmClass_epc": "Serotonin Reuptake Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "CITALOPRAM", "drugcharacterization": "1", "drugindication": "OBSESSIVE RUMINATION", "manufacturer": "Chartwell Governmental & Specialty RX, LLC.", "genericName": "CITALOPRAM", "brandName": "CITALOPRAM", "pharmClass_epc": "Serotonin Reuptake Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "RISPERIDONE", "drugcharacterization": "1", "drugindication": "AGITATION", "manufacturer": "Amneal Pharmaceuticals LLC", "genericName": "RISPERIDONE", "brandName": "RISPERIDONE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "ATOMOXETINE HYDROCHLORIDE", "drugcharacterization": "1", "drugindication": "ATTENTION DEFICIT/HYPERACTIVITY DISORDER", "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ATOMOXETINE HYDROCHLORIDE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ATOMOXETINE HYDROCHLORIDE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ATOMOXETINE HYDROCHLORIDE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ATOMOXETINE HYDROCHLORIDE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ATOMOXETINE HYDROCHLORIDE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ATOMOXETINE HYDROCHLORIDE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CIRCADIN", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SERTRALINE", "drugcharacterization": "2", "drugindication": "AGITATION", "manufacturer": "Exelan Pharmaceuticals, Inc.", "genericName": "SERTRALINE", "brandName": "SERTRALINE", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Bipolar I disorder", "outcome": "3"}, {"pt": "Sedation", "outcome": "3"}, {"pt": "Paranoia", "outcome": "3"}, {"pt": "Treatment noncompliance", "outcome": "6"}], "classifyText": "QUETIAPINE CITALOPRAM CITALOPRAM RISPERIDONE STRATTERA STRATTERA STRATTERA STRATTERA STRATTERA STRATTERA STRATTERA CIRCADIN SERTRALINE QUETIAPINE CITALOPRAM CITALOPRAM RISPERIDONE ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE SERTRALINE PRODUCT USED FOR UNKNOWN INDICATION DEPRESSION OBSESSIVE RUMINATION AGITATION ATTENTION DEFICIT/HYPERACTIVITY DISORDER PRODUCT USED FOR UNKNOWN INDICATION AGITATION Bipolar I disorder Sedation Paranoia Treatment noncompliance"}
{"safetyreportid": "10010681", "receiveDate": "20140314", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "1", "patientAge": "67", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "AMOXICILLIN.", "drugcharacterization": "1", "drugindication": "ENDOCARDITIS PROPHYLAXIS", "manufacturer": "Hikma Pharmaceuticals USA Inc.", "genericName": "AMOXICILLIN", "brandName": "AMOXICILLIN", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "INSULIN GLARGINE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Biocon Biologics Inc.", "genericName": "INSULIN GLARGINE-YFGN", "brandName": "INSULIN GLARGINE", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "LISINOPRIL.", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Chartwell RX, LLC", "genericName": "LISINOPRIL", "brandName": "LISINOPRIL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "OMEGA 3", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "AMLODIPINE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Pangea Pharmaceuticals, LLC", "genericName": "AMLODIPINE", "brandName": "SDAMLO", "pharmClass_epc": "Dihydropyridine Calcium Channel Blocker [EPC]", "route": "ORAL"}, {"medicinalproduct": "METOPROLOL.", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Baxter Healthcare Corporation", "genericName": "METOPROLOL TARTRATE", "brandName": "METOPROLOL", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "NICOTINIC ACID", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "COLECALCIFEROL", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ACETYLSALICYLIC ACID", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "METFORMIN", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Mylan Pharmaceuticals Inc.", "genericName": "METFORMIN", "brandName": "METFORMIN HYDROCHLORIDE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "GLIPIZIDE.", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Roerig", "genericName": "GLIPIZIDE", "brandName": "GLUCOTROL XL", "pharmClass_epc": "Sulfonylurea [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Angioedema", "outcome": "1"}], "classifyText": "AMOXICILLIN INSULIN GLARGINE LISINOPRIL OMEGA 3 SDAMLO METOPROLOL NICOTINIC ACID COLECALCIFEROL ACETYLSALICYLIC ACID METFORMIN HYDROCHLORIDE GLUCOTROL XL AMOXICILLIN INSULIN GLARGINE-YFGN LISINOPRIL AMLODIPINE METOPROLOL TARTRATE METFORMIN GLIPIZIDE ENDOCARDITIS PROPHYLAXIS PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Angioedema"}
{"safetyreportid": "10010696", "receiveDate": "20140311", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": null, "reportType": "1", "patientSex": "1", "patientAge": "1", "patientAgeUnit": "805", "drugs": [{"medicinalproduct": "QUETIAPINE (QUETIAPINE)", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ARIPIPRAZOLE (ARIPIPRAZOLE)", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "DULOXETINE HYDROCHLORIDE", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "MARKSANS PHARMA LIMITED", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "DULOXETINE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ZOPICLONE (ZOPICLONE)", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ZYPREXA (OLANZAPINE)", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Maternal drugs affecting foetus", "outcome": null}, {"pt": "Cleft palate", "outcome": null}, {"pt": "High arched palate", "outcome": null}, {"pt": "Poor sucking reflex", "outcome": null}, {"pt": "Exposure during breast feeding", "outcome": null}, {"pt": "Congenital anomaly", "outcome": null}], "classifyText": "QUETIAPINE (QUETIAPINE) ARIPIPRAZOLE (ARIPIPRAZOLE) DULOXETINE ZOPICLONE (ZOPICLONE) ZYPREXA (OLANZAPINE) DULOXETINE HYDROCHLORIDE PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Maternal drugs affecting foetus Cleft palate High arched palate Poor sucking reflex Exposure during breast feeding Congenital anomaly"}
{"safetyreportid": "10010735", "receiveDate": "20140314", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "83", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "XARELTO", "drugcharacterization": "1", "drugindication": "ATRIAL FIBRILLATION", "manufacturer": "Janssen Pharmaceuticals, Inc.", "genericName": "RIVAROXABAN", "brandName": "XARELTO", "pharmClass_epc": "Factor Xa Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "XARELTO", "drugcharacterization": "1", "drugindication": "CEREBROVASCULAR ACCIDENT PROPHYLAXIS", "manufacturer": "Janssen Pharmaceuticals, Inc.", "genericName": "RIVAROXABAN", "brandName": "XARELTO", "pharmClass_epc": "Factor Xa Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "POTASSIUM", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ADVAIR", "drugcharacterization": "2", "drugindication": null, "manufacturer": "GlaxoSmithKline LLC", "genericName": "FLUTICASONE PROPIONATE AND SALMETEROL", "brandName": "ADVAIR DISKUS", "pharmClass_epc": null, "route": "RESPIRATORY (INHALATION)"}, {"medicinalproduct": "ALBUTEROL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Nivagen Pharmaceuticals Inc", "genericName": "ALBUTEROL SULFATE", "brandName": "ALBUTEROL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "PREDNISONE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "ANI Pharmaceuticals, Inc.", "genericName": "PREDNISONE", "brandName": "PREDNISONE", "pharmClass_epc": "Corticosteroid [EPC]", "route": "ORAL"}, {"medicinalproduct": "ABILIFY", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Otsuka America Pharmaceutical, Inc.", "genericName": "ARIPIPRAZOLE", "brandName": "ABILIFY", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "FENTANYL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Aveva Drug Delivery Systems Inc.", "genericName": "FENTANYL", "brandName": "FENTANYL", "pharmClass_epc": "Opioid Agonist [EPC]", "route": "TRANSDERMAL"}, {"medicinalproduct": "ZOLOFT", "drugcharacterization": "2", "drugindication": null, "manufacturer": "ROERIG", "genericName": "SERTRALINE HYDROCHLORIDE", "brandName": "ZOLOFT", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "TRAZODONE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "LANTUS", "drugcharacterization": "2", "drugindication": null, "manufacturer": "sanofi-aventis U.S. LLC", "genericName": "INSULIN GLARGINE", "brandName": "LANTUS", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "OMEPRAZOLE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Amerisource Bergen", "genericName": "OMEPRAZOLE", "brandName": "GOOD NEIGHBOR PHARMACY OMEPRAZOLE", "pharmClass_epc": "Proton Pump Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "SIMVASTATIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Accord Healthcare, Inc.", "genericName": "SIMVASTATIN", "brandName": "SIMVASTATIN", "pharmClass_epc": "HMG-CoA Reductase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "AMIODARONE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LOSARTAN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Granules Pharmaceuticals Inc.", "genericName": "LOSARTAN", "brandName": "LOSARTAN POTASSIUM", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "TOPROL", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SYNTHROID", "drugcharacterization": "2", "drugindication": null, "manufacturer": "AbbVie Inc.", "genericName": "LEVOTHYROXINE SODIUM", "brandName": "SYNTHROID", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "AMBIEN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Cosette Pharmaceuticals, Inc.", "genericName": "ZOLPIDEM TARTRATE", "brandName": "AMBIEN", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ACTONEL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Allergan, Inc.", "genericName": "RISEDRONATE SODIUM", "brandName": "ACTONEL", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Deep vein thrombosis", "outcome": "1"}], "classifyText": "XARELTO XARELTO POTASSIUM ADVAIR DISKUS ALBUTEROL PREDNISONE ABILIFY FENTANYL ZOLOFT TRAZODONE HUMALOG MIX75/25 LANTUS GOOD NEIGHBOR PHARMACY OMEPRAZOLE SIMVASTATIN AMIODARONE LOSARTAN POTASSIUM TOPROL SYNTHROID AMBIEN ACTONEL RIVAROXABAN RIVAROXABAN FLUTICASONE PROPIONATE AND SALMETEROL ALBUTEROL SULFATE PREDNISONE ARIPIPRAZOLE FENTANYL SERTRALINE HYDROCHLORIDE INSULIN LISPRO INSULIN GLARGINE OMEPRAZOLE SIMVASTATIN LOSARTAN LEVOTHYROXINE SODIUM ZOLPIDEM TARTRATE RISEDRONATE SODIUM ATRIAL FIBRILLATION CEREBROVASCULAR ACCIDENT PROPHYLAXIS Deep vein thrombosis"}
{"safetyreportid": "10010752", "receiveDate": "20140314", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "GB", "reportType": "1", "patientSex": "1", "patientAge": "49", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "SERTRALINE", "drugcharacterization": "1", "drugindication": "DEPRESSION", "manufacturer": "Exelan Pharmaceuticals, Inc.", "genericName": "SERTRALINE", "brandName": "SERTRALINE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "OLANZAPINE", "drugcharacterization": "2", "drugindication": "MANIA", "manufacturer": "Hisun Pharmaceuticals USA, Inc.", "genericName": "OLANZAPINE", "brandName": "OLANZAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Alopecia", "outcome": "3"}, {"pt": "Hair growth abnormal", "outcome": "3"}, {"pt": "Hair colour changes", "outcome": "3"}], "classifyText": "SERTRALINE OLANZAPINE SERTRALINE OLANZAPINE DEPRESSION MANIA Alopecia Hair growth abnormal Hair colour changes"}
{"safetyreportid": "10010824", "receiveDate": "20140311", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": null, "reportType": "1", "patientSex": "1", "patientAge": "25", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "CITALOPRAM", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Chartwell Governmental & Specialty RX, LLC.", "genericName": "CITALOPRAM", "brandName": "CITALOPRAM", "pharmClass_epc": "Serotonin Reuptake Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Drug abuse", "outcome": null}, {"pt": "Intentional self-injury", "outcome": null}, {"pt": "Sopor", "outcome": null}], "classifyText": "CITALOPRAM CYMBALTA CITALOPRAM DULOXETINE HYDROCHLORIDE PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Drug abuse Intentional self-injury Sopor"}
{"safetyreportid": "10010838", "receiveDate": "20140314", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "GB", "reportType": "1", "patientSex": "2", "patientAge": "60", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "CISPLATIN", "drugcharacterization": "1", "drugindication": "LUNG ADENOCARCINOMA", "manufacturer": "Teva Parenteral Medicines, Inc.", "genericName": "CISPLATIN", "brandName": "CISPLATIN", "pharmClass_epc": "Platinum-based Drug [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "CISPLATIN", "drugcharacterization": "1", "drugindication": "LUNG ADENOCARCINOMA", "manufacturer": "Teva Parenteral Medicines, Inc.", "genericName": "CISPLATIN", "brandName": "CISPLATIN", "pharmClass_epc": "Platinum-based Drug [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "CISPLATIN", "drugcharacterization": "1", "drugindication": "LUNG ADENOCARCINOMA", "manufacturer": "Teva Parenteral Medicines, Inc.", "genericName": "CISPLATIN", "brandName": "CISPLATIN", "pharmClass_epc": "Platinum-based Drug [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "PEMETREXED DISODIUM", "drugcharacterization": "1", "drugindication": "LUNG ADENOCARCINOMA", "manufacturer": "Sagent Pharmaceuticals", "genericName": "PEMETREXED DISODIUM", "brandName": "PEMETREXED", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "PEMETREXED DISODIUM", "drugcharacterization": "1", "drugindication": "LUNG ADENOCARCINOMA", "manufacturer": "Sagent Pharmaceuticals", "genericName": "PEMETREXED DISODIUM", "brandName": "PEMETREXED", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "PEMETREXED DISODIUM", "drugcharacterization": "1", "drugindication": "LUNG ADENOCARCINOMA", "manufacturer": "Sagent Pharmaceuticals", "genericName": "PEMETREXED DISODIUM", "brandName": "PEMETREXED", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "APREPITANT", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Merck Sharp & Dohme LLC", "genericName": "APREPITANT", "brandName": "EMEND", "pharmClass_epc": "Substance P/Neurokinin-1 Receptor Antagonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "CYCLIZINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ONDANSETRON", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Dr. Reddy's Laboratories Limited", "genericName": "ONDANSETRON HYDROCHLORIDE", "brandName": "ONDANSETRON", "pharmClass_epc": "Serotonin-3 Receptor Antagonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "DEXAMETHASONE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Zydus Lifesciences Limited", "genericName": "DEXAMETHASONE", "brandName": "DEXAMETHASONE", "pharmClass_epc": "Corticosteroid [EPC]", "route": "ORAL"}, {"medicinalproduct": "VITAMIN B12", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Rash generalised", "outcome": "1"}, {"pt": "Swelling face", "outcome": "1"}, {"pt": "Local swelling", "outcome": "1"}, {"pt": "Vomiting", "outcome": "1"}, {"pt": "Rash", "outcome": "6"}, {"pt": "Capillary leak syndrome", "outcome": "6"}], "classifyText": "CISPLATIN CISPLATIN CISPLATIN PEMETREXED PEMETREXED PEMETREXED EMEND CYCLIZINE ONDANSETRON DEXAMETHASONE VITAMIN B12 CISPLATIN CISPLATIN CISPLATIN PEMETREXED DISODIUM PEMETREXED DISODIUM PEMETREXED DISODIUM APREPITANT ONDANSETRON HYDROCHLORIDE DEXAMETHASONE LUNG ADENOCARCINOMA LUNG ADENOCARCINOMA LUNG ADENOCARCINOMA LUNG ADENOCARCINOMA LUNG ADENOCARCINOMA LUNG ADENOCARCINOMA Rash generalised Swelling face Local swelling Vomiting Rash Capillary leak syndrome"}
{"safetyreportid": "10010847", "receiveDate": "20140314", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "2", "patientSex": "1", "patientAge": "72", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "FERROUS SULFATE", "drugcharacterization": "2", "drugindication": "ANAEMIA", "manufacturer": "Boiron", "genericName": "FERROUS SULFATE", "brandName": "FERRUM SULPHURICUM", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "HYDROCODONE BITARTRATE AND ACETAMINOPHEN", "drugcharacterization": "2", "drugindication": "BACK PAIN", "manufacturer": "Eywa Pharma Inc", "genericName": "HYDROCODONE BITARTRATE AND ACETAMINOPHEN", "brandName": "HYDROCODONE BITARTRATE AND ACETAMINOPHEN", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ZINC", "drugcharacterization": "2", "drugindication": "MINERAL SUPPLEMENTATION", "manufacturer": "Boiron", "genericName": "ZINC", "brandName": "ZINCUM METALLICUM", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ASPIRIN.", "drugcharacterization": "2", "drugindication": "PROPHYLAXIS", "manufacturer": "Unifirst First Aid Corporation", "genericName": "ASPIRIN", "brandName": "BAYER GENUINE ASPIRIN", "pharmClass_epc": "Nonsteroidal Anti-inflammatory Drug [EPC]", "route": "ORAL"}, {"medicinalproduct": "OMEPRAZOLE.", "drugcharacterization": "2", "drugindication": "GASTROOESOPHAGEAL REFLUX DISEASE", "manufacturer": "Amerisource Bergen", "genericName": "OMEPRAZOLE", "brandName": "GOOD NEIGHBOR PHARMACY OMEPRAZOLE", "pharmClass_epc": "Proton Pump Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "VITAMIN D", "drugcharacterization": "2", "drugindication": "HYPOVITAMINOSIS", "manufacturer": "Strides Pharma Science Limited", "genericName": "ERGOCALCIFEROL", "brandName": "VITAMIN D", "pharmClass_epc": "Provitamin D2 Compound [EPC]", "route": "ORAL"}, {"medicinalproduct": "MAGNESIUM", "drugcharacterization": "2", "drugindication": "MINERAL SUPPLEMENTATION", "manufacturer": "Korea Life Science", "genericName": "MAGNESIUM", "brandName": "BYE ZERO", "pharmClass_epc": null, "route": "TOPICAL"}, {"medicinalproduct": "MULTIVITAMIN", "drugcharacterization": "2", "drugindication": "VITAMIN SUPPLEMENTATION", "manufacturer": "Oncora Pharma, LLC", "genericName": "MULTIVITAMIN", "brandName": "LUMAVEX", "pharmClass_epc": "Vitamin C [EPC]", "route": "ORAL"}, {"medicinalproduct": "TRICOR", "drugcharacterization": "2", "drugindication": "HYPERTRIGLYCERIDAEMIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LOPERAMIDE", "drugcharacterization": "2", "drugindication": "CROHN^S DISEASE", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CERTOLIZUMAB PEGOL CD", "drugcharacterization": "1", "drugindication": "CROHN^S DISEASE", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ANDROGEL", "drugcharacterization": "2", "drugindication": "HYPOGONADISM", "manufacturer": "ASCEND Therapeutics U.S., LLC", "genericName": "TESTOSTERONE", "brandName": "ANDROGEL", "pharmClass_epc": "Androgen [EPC]", "route": "TRANSDERMAL"}, {"medicinalproduct": "CALCIUM CITRATE", "drugcharacterization": "2", "drugindication": "OSTEOPOROSIS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "INSULIN LISPRO", "drugcharacterization": "2", "drugindication": "DIABETES MELLITUS", "manufacturer": "Sanofi-Aventis U.S. LLC", "genericName": "INSULIN LISPRO", "brandName": "ADMELOG", "pharmClass_epc": "Insulin Analog [EPC]", "route": "INTRAVENOUS"}], "reactions": [{"pt": "Malignant melanoma in situ", "outcome": "1"}], "classifyText": "FERRUM SULPHURICUM HYDROCODONE BITARTRATE AND ACETAMINOPHEN ZINCUM METALLICUM BAYER GENUINE ASPIRIN GOOD NEIGHBOR PHARMACY OMEPRAZOLE VITAMIN D BYE ZERO LUMAVEX TRICOR LOPERAMIDE CERTOLIZUMAB PEGOL CD ANDROGEL CALCIUM CITRATE ADMELOG FERROUS SULFATE HYDROCODONE BITARTRATE AND ACETAMINOPHEN ZINC ASPIRIN OMEPRAZOLE ERGOCALCIFEROL MAGNESIUM MULTIVITAMIN TESTOSTERONE INSULIN LISPRO ANAEMIA BACK PAIN MINERAL SUPPLEMENTATION PROPHYLAXIS GASTROOESOPHAGEAL REFLUX DISEASE HYPOVITAMINOSIS MINERAL SUPPLEMENTATION VITAMIN SUPPLEMENTATION HYPERTRIGLYCERIDAEMIA CROHN^S DISEASE CROHN^S DISEASE HYPOGONADISM OSTEOPOROSIS DIABETES MELLITUS Malignant melanoma in situ"}
{"safetyreportid": "10010873", "receiveDate": "20140314", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "1", "patientAge": "68", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "METFORMIN", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Mylan Pharmaceuticals Inc.", "genericName": "METFORMIN", "brandName": "METFORMIN HYDROCHLORIDE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "NEURONTIN", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Parke-Davis Div of Pfizer Inc", "genericName": "GABAPENTIN", "brandName": "NEURONTIN", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "MIRAPEX", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "TESTOSTERONE CYPIONATE USP RX 200 MG/ML 9Z8", "drugcharacterization": "1", "drugindication": "BLOOD TESTOSTERONE DECREASED", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LISINOPRIL.", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Chartwell RX, LLC", "genericName": "LISINOPRIL", "brandName": "LISINOPRIL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LAMISIL /00992602/", "drugcharacterization": "2", "drugindication": "ONYCHOMYCOSIS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "PROVIGIL", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Cephalon, LLC", "genericName": "MODAFINIL", "brandName": "PROVIGIL", "pharmClass_epc": "Sympathomimetic-like Agent [EPC]", "route": "ORAL"}, {"medicinalproduct": "FUNGI-NAIL", "drugcharacterization": "2", "drugindication": "ONYCHOMYCOSIS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "XANAX", "drugcharacterization": "2", "drugindication": "ANXIETY", "manufacturer": "PHARMACIA & UPJOHN COMPANY LLC", "genericName": "ALPRAZOLAM", "brandName": "XANAX", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "ORAL"}, {"medicinalproduct": "HYDROCODONE/APAP", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "EXALGO", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Cerebrovascular accident", "outcome": "1"}, {"pt": "Transient ischaemic attack", "outcome": "1"}, {"pt": "Thrombosis", "outcome": "1"}, {"pt": "Diplopia", "outcome": "3"}, {"pt": "Pulmonary embolism", "outcome": "1"}, {"pt": "Headache", "outcome": "6"}], "classifyText": "METFORMIN HYDROCHLORIDE NEURONTIN MIRAPEX TESTOSTERONE CYPIONATE USP RX 200 MG/ML 9Z8 LISINOPRIL CYMBALTA LAMISIL /00992602/ PROVIGIL FUNGI-NAIL XANAX HYDROCODONE/APAP EXALGO METFORMIN GABAPENTIN LISINOPRIL DULOXETINE HYDROCHLORIDE MODAFINIL ALPRAZOLAM PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION BLOOD TESTOSTERONE DECREASED PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION ONYCHOMYCOSIS PRODUCT USED FOR UNKNOWN INDICATION ONYCHOMYCOSIS ANXIETY PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Cerebrovascular accident Transient ischaemic attack Thrombosis Diplopia Pulmonary embolism Headache"}
{"safetyreportid": "10010941", "receiveDate": "20140314", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "IT", "reportType": "1", "patientSex": "1", "patientAge": "54", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "HALDOL", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "AKINETON", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ZYPREXA", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "OLANZAPINE", "brandName": "ZYPREXA INTRAMUSCULAR", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "ALCOHOL", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Bath & Body Works, Inc.", "genericName": "ALCOHOL", "brandName": "ANTIBACTERIALHANDSPRAY TWISTED PEPPERMINT", "pharmClass_epc": null, "route": "TOPICAL"}], "reactions": [{"pt": "Self injurious behaviour", "outcome": "6"}, {"pt": "Intentional drug misuse", "outcome": "6"}, {"pt": "Sluggishness", "outcome": "6"}], "classifyText": "HALDOL AKINETON ZYPREXA INTRAMUSCULAR ANTIBACTERIALHANDSPRAY TWISTED PEPPERMINT OLANZAPINE ALCOHOL PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Self injurious behaviour Intentional drug misuse Sluggishness"}
{"safetyreportid": "10010953", "receiveDate": "20140311", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": null, "reportType": "2", "patientSex": "2", "patientAge": "68", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "XYREM", "drugcharacterization": "1", "drugindication": "NARCOLEPSY", "manufacturer": "Jazz Pharmaceuticals, Inc.", "genericName": "SODIUM OXYBATE", "brandName": "XYREM", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "XYREM", "drugcharacterization": "1", "drugindication": "CATAPLEXY", "manufacturer": "Jazz Pharmaceuticals, Inc.", "genericName": "SODIUM OXYBATE", "brandName": "XYREM", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ATENOLOL (ATENOLOL)", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SIMVASTATIN (SIMVASTATIN)", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LISIHEXAL", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ANAFRANIL (CLOMIPRAMINE HYDROCHLORIDE)", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "HCT HEXAL ( HYDROCHLOROTHIAZIDE)", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "L-THYROXIN (LEVOTHYROXINE SODIUM)", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "METFORMIN (METFORMIN HYDROCHLORIDE)", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ASS (ACETYLSALICYLIC ACID)", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "EPHEDRINE (EPHEDRINE HYDROCHLORIDE)", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "VIGIL (MODAFINIL)", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "PROTAPHANE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Bladder neoplasm", "outcome": null}, {"pt": "Bladder cancer", "outcome": null}], "classifyText": "XYREM XYREM ATENOLOL (ATENOLOL) SIMVASTATIN (SIMVASTATIN) LISIHEXAL ANAFRANIL (CLOMIPRAMINE HYDROCHLORIDE) HCT HEXAL ( HYDROCHLOROTHIAZIDE) L-THYROXIN (LEVOTHYROXINE SODIUM) METFORMIN (METFORMIN HYDROCHLORIDE) ASS (ACETYLSALICYLIC ACID) EPHEDRINE (EPHEDRINE HYDROCHLORIDE) VIGIL (MODAFINIL) HUMALOG MIX75/25 PROTAPHANE SODIUM OXYBATE SODIUM OXYBATE INSULIN LISPRO NARCOLEPSY CATAPLEXY Bladder neoplasm Bladder cancer"}
{"safetyreportid": "10010964", "receiveDate": "20140314", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "58", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "OXYTROL FOR WOMEN", "drugcharacterization": "1", "drugindication": "INCONTINENCE", "manufacturer": "Allergan, Inc.", "genericName": "OXYBUTYNIN", "brandName": "OXYTROL FOR WOMEN", "pharmClass_epc": "Cholinergic Muscarinic Antagonist [EPC]", "route": "TRANSDERMAL"}, {"medicinalproduct": "METHADONE HCL", "drugcharacterization": "2", "drugindication": "PAIN", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": "MENTAL DISORDER", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "FELODIPINE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Glenmark Pharmaceuticals Inc., USA", "genericName": "FELODIPINE", "brandName": "FELODIPINE", "pharmClass_epc": "Dihydropyridine Calcium Channel Blocker [EPC]", "route": "ORAL"}, {"medicinalproduct": "COLACE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Atlantis Consumer Healthcare, Inc.", "genericName": "DOCUSATE SODIUM", "brandName": "COLACE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LIDODERM", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "TPU Pharma, Inc.", "genericName": "LIDOCAINE PATCH 5%", "brandName": "LIDODERM", "pharmClass_epc": "Amide Local Anesthetic [EPC]", "route": "TOPICAL"}, {"medicinalproduct": "IBUPROFEN", "drugcharacterization": "2", "drugindication": "PAIN", "manufacturer": "DOLGENCORP INC", "genericName": "IBUPROFEN", "brandName": "IBUPROFEN", "pharmClass_epc": "Nonsteroidal Anti-inflammatory Drug [EPC]", "route": "ORAL"}, {"medicinalproduct": "ADVAIR", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "GlaxoSmithKline LLC", "genericName": "FLUTICASONE PROPIONATE AND SALMETEROL", "brandName": "ADVAIR DISKUS", "pharmClass_epc": null, "route": "RESPIRATORY (INHALATION)"}, {"medicinalproduct": "SPIRIVA HANDIHALER", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Boehringer Ingelheim Pharmaceuticals, Inc.", "genericName": "TIOTROPIUM BROMIDE", "brandName": "SPIRIVA HANDIHALER", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "PROAIR HFA", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "OXYGEN", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Apria Healthcare LLC", "genericName": "OXYGEN", "brandName": "OXYGEN COMPRESSED U.S.P", "pharmClass_epc": null, "route": "RESPIRATORY (INHALATION)"}, {"medicinalproduct": "SPACER FOR METERED DOSE INHALER", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ATORVASTATIN", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ASPIRIN", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Unifirst First Aid Corporation", "genericName": "ASPIRIN", "brandName": "BAYER GENUINE ASPIRIN", "pharmClass_epc": "Nonsteroidal Anti-inflammatory Drug [EPC]", "route": "ORAL"}, {"medicinalproduct": "OMEPRAZOLE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Amerisource Bergen", "genericName": "OMEPRAZOLE", "brandName": "GOOD NEIGHBOR PHARMACY OMEPRAZOLE", "pharmClass_epc": "Proton Pump Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "VESICARE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Astellas Pharma US, Inc.", "genericName": "SOLIFENACIN SUCCINATE", "brandName": "VESICARE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "PATANOL", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ACIDOPHILUS", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CYANOCOBALAMIN", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Somerset Therapeutics, LLC", "genericName": "CYANOCOBALAMIN", "brandName": "CYANOCOBALAMIN", "pharmClass_epc": "Vitamin B12 [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "FOLIC ACID", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "PureTek Corporation", "genericName": "FOLIC ACID", "brandName": "VENTRIXYL", "pharmClass_epc": "Vitamin C [EPC]", "route": "ORAL"}, {"medicinalproduct": "MAGNESIUM (UNSPECIFIED)", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CHOLECALCIFEROL", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ASCORBIC ACID", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Fresenius Kabi USA, LLC", "genericName": "ASCORBIC ACID", "brandName": "ASCORBIC ACID", "pharmClass_epc": "Vitamin C [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "OMEGA-3 MARINE TRIGLYCERIDES", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "GLYCERIN (+) MENTHOL (+) XYLITOL/XYLITOL", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Pollakiuria", "outcome": "1"}, {"pt": "Drug ineffective", "outcome": "6"}], "classifyText": "OXYTROL FOR WOMEN METHADONE HCL CYMBALTA FELODIPINE COLACE LIDODERM IBUPROFEN ADVAIR DISKUS SPIRIVA HANDIHALER PROAIR HFA OXYGEN COMPRESSED U.S.P SPACER FOR METERED DOSE INHALER ATORVASTATIN BAYER GENUINE ASPIRIN GOOD NEIGHBOR PHARMACY OMEPRAZOLE VESICARE PATANOL ACIDOPHILUS CYANOCOBALAMIN VENTRIXYL MAGNESIUM (UNSPECIFIED) CHOLECALCIFEROL ASCORBIC ACID OMEGA-3 MARINE TRIGLYCERIDES GLYCERIN (+) MENTHOL (+) XYLITOL/XYLITOL OXYBUTYNIN DULOXETINE HYDROCHLORIDE FELODIPINE DOCUSATE SODIUM LIDOCAINE PATCH 5% IBUPROFEN FLUTICASONE PROPIONATE AND SALMETEROL TIOTROPIUM BROMIDE OXYGEN ASPIRIN OMEPRAZOLE SOLIFENACIN SUCCINATE CYANOCOBALAMIN FOLIC ACID ASCORBIC ACID INCONTINENCE PAIN MENTAL DISORDER PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PAIN PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Pollakiuria Drug ineffective"}
{"safetyreportid": "10011024", "receiveDate": "20140312", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": null, "reportType": "1", "patientSex": "2", "patientAge": "51", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "SODIUM VALPROATE (SODIUM VALPROATE)", "drugcharacterization": "1", "drugindication": "DEPRESSION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SERTRALINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Exelan Pharmaceuticals, Inc.", "genericName": "SERTRALINE", "brandName": "SERTRALINE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "OLANZAPINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Hisun Pharmaceuticals USA, Inc.", "genericName": "OLANZAPINE", "brandName": "OLANZAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Stevens-Johnson syndrome", "outcome": null}, {"pt": "Toxic epidermal necrolysis", "outcome": null}, {"pt": "Systemic lupus erythematosus", "outcome": null}], "classifyText": "SODIUM VALPROATE (SODIUM VALPROATE) SERTRALINE OLANZAPINE SERTRALINE OLANZAPINE DEPRESSION Stevens-Johnson syndrome Toxic epidermal necrolysis Systemic lupus erythematosus"}
{"safetyreportid": "10011049", "receiveDate": "20140304", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": null, "reportType": "1", "patientSex": "2", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "SUBOXONE (RECKITT BENCKISER)", "drugcharacterization": "1", "drugindication": "DRUG DEPENDENCE", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CICYCLOMINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Rash", "outcome": null}, {"pt": "Pruritus", "outcome": null}, {"pt": "Feeling abnormal", "outcome": null}], "classifyText": "SUBOXONE (RECKITT BENCKISER) CICYCLOMINE CYMBALTA DULOXETINE HYDROCHLORIDE DRUG DEPENDENCE Rash Pruritus Feeling abnormal"}
{"safetyreportid": "10011330", "receiveDate": "20140314", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "GB", "reportType": "1", "patientSex": "2", "patientAge": "21", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "CIRCADIN", "drugcharacterization": "2", "drugindication": "INSOMNIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "RISPERIDONE.", "drugcharacterization": "1", "drugindication": "AGITATION", "manufacturer": "Amneal Pharmaceuticals LLC", "genericName": "RISPERIDONE", "brandName": "RISPERIDONE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": "ATTENTION DEFICIT/HYPERACTIVITY DISORDER", "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": "ATTENTION DEFICIT/HYPERACTIVITY DISORDER", "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": "ATTENTION DEFICIT/HYPERACTIVITY DISORDER", "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": "ATTENTION DEFICIT/HYPERACTIVITY DISORDER", "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": "ATTENTION DEFICIT/HYPERACTIVITY DISORDER", "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CITALOPRAM", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Chartwell Governmental & Specialty RX, LLC.", "genericName": "CITALOPRAM", "brandName": "CITALOPRAM", "pharmClass_epc": "Serotonin Reuptake Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "SERTRALINE", "drugcharacterization": "2", "drugindication": "AGITATION", "manufacturer": "Exelan Pharmaceuticals, Inc.", "genericName": "SERTRALINE", "brandName": "SERTRALINE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "SERTRALINE", "drugcharacterization": "2", "drugindication": "AGITATION", "manufacturer": "Exelan Pharmaceuticals, Inc.", "genericName": "SERTRALINE", "brandName": "SERTRALINE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "QUETIAPINE.", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Solco Healthcare U.S., LLC", "genericName": "QUETIAPINE", "brandName": "QUETIAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": "ATTENTION DEFICIT/HYPERACTIVITY DISORDER", "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": "ATTENTION DEFICIT/HYPERACTIVITY DISORDER", "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Attention deficit/hyperactivity disorder", "outcome": "3"}, {"pt": "Bipolar I disorder", "outcome": "3"}, {"pt": "Merycism", "outcome": "3"}, {"pt": "Sedation", "outcome": "3"}, {"pt": "Somnolence", "outcome": "3"}, {"pt": "Major depression", "outcome": "3"}, {"pt": "Depression", "outcome": "3"}, {"pt": "Agitation", "outcome": "3"}], "classifyText": "CIRCADIN RISPERIDONE STRATTERA STRATTERA STRATTERA STRATTERA STRATTERA CITALOPRAM SERTRALINE SERTRALINE QUETIAPINE STRATTERA STRATTERA RISPERIDONE ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE CITALOPRAM SERTRALINE SERTRALINE QUETIAPINE ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE INSOMNIA AGITATION ATTENTION DEFICIT/HYPERACTIVITY DISORDER ATTENTION DEFICIT/HYPERACTIVITY DISORDER ATTENTION DEFICIT/HYPERACTIVITY DISORDER ATTENTION DEFICIT/HYPERACTIVITY DISORDER ATTENTION DEFICIT/HYPERACTIVITY DISORDER PRODUCT USED FOR UNKNOWN INDICATION AGITATION AGITATION PRODUCT USED FOR UNKNOWN INDICATION ATTENTION DEFICIT/HYPERACTIVITY DISORDER ATTENTION DEFICIT/HYPERACTIVITY DISORDER Attention deficit/hyperactivity disorder Bipolar I disorder Merycism Sedation Somnolence Major depression Depression Agitation"}
{"safetyreportid": "10011470", "receiveDate": "20140314", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "56", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "LANTUS", "drugcharacterization": "2", "drugindication": "TYPE 2 DIABETES MELLITUS", "manufacturer": "sanofi-aventis U.S. LLC", "genericName": "INSULIN GLARGINE", "brandName": "LANTUS", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "VICTOZA", "drugcharacterization": "1", "drugindication": "TYPE 2 DIABETES MELLITUS", "manufacturer": "Novo Nordisk", "genericName": "LIRAGLUTIDE", "brandName": "VICTOZA", "pharmClass_epc": "GLP-1 Receptor Agonist [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "2", "drugindication": "TYPE 2 DIABETES MELLITUS", "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "BYETTA", "drugcharacterization": "1", "drugindication": "TYPE 2 DIABETES MELLITUS", "manufacturer": "AstraZeneca Pharmaceuticals LP", "genericName": "EXENATIDE", "brandName": "BYETTA", "pharmClass_epc": "GLP-1 Receptor Agonist [EPC]", "route": "SUBCUTANEOUS"}], "reactions": [{"pt": "Pancreatic carcinoma", "outcome": "3"}, {"pt": "Pancreatitis", "outcome": "1"}], "classifyText": "LANTUS VICTOZA HUMALOG MIX75/25 BYETTA INSULIN GLARGINE LIRAGLUTIDE INSULIN LISPRO EXENATIDE TYPE 2 DIABETES MELLITUS TYPE 2 DIABETES MELLITUS TYPE 2 DIABETES MELLITUS TYPE 2 DIABETES MELLITUS Pancreatic carcinoma Pancreatitis"}
{"safetyreportid": "10011528", "receiveDate": "20140314", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "PL", "reportType": "1", "patientSex": "1", "patientAge": "26", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "VENLAFAXINE", "drugcharacterization": "1", "drugindication": "DEPRESSION", "manufacturer": "Zydus Lifesciences Limited", "genericName": "VENLAFAXINE", "brandName": "VENLAFAXINE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "PAROXETINE", "drugcharacterization": "1", "drugindication": "DEPRESSION", "manufacturer": "Rhodes Pharmaceuticals L.P.", "genericName": "PAROXETINE HYDROCHLORIDE HEMIHYDRATE", "brandName": "PAROXETINE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "SERTRALINE", "drugcharacterization": "1", "drugindication": "DEPRESSION", "manufacturer": "Exelan Pharmaceuticals, Inc.", "genericName": "SERTRALINE", "brandName": "SERTRALINE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "MIRTAZAPINE", "drugcharacterization": "1", "drugindication": "DEPRESSION", "manufacturer": "Aurolife Pharma LLC", "genericName": "MIRTAZAPINE", "brandName": "MIRTAZAPINE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "AGOMELATINE", "drugcharacterization": "1", "drugindication": "DEPRESSION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "VALPROIC ACID", "drugcharacterization": "1", "drugindication": "PERSONALITY DISORDER", "manufacturer": "Bionpharma Inc.", "genericName": "VALPROIC ACID", "brandName": "VALPROIC ACID", "pharmClass_epc": "Anti-epileptic Agent [EPC]", "route": "ORAL"}, {"medicinalproduct": "OLANZAPINE", "drugcharacterization": "1", "drugindication": "PERSONALITY DISORDER", "manufacturer": "Hisun Pharmaceuticals USA, Inc.", "genericName": "OLANZAPINE", "brandName": "OLANZAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "ARIPIPRAZOLE", "drugcharacterization": "1", "drugindication": "PERSONALITY DISORDER", "manufacturer": "Dr. Reddy's Laboratories Inc", "genericName": "ARIPIPRAZOLE ORALLY DISINTEGRATING", "brandName": "ARIPIPRAZOLE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Drug ineffective", "outcome": "3"}], "classifyText": "VENLAFAXINE PAROXETINE SERTRALINE MIRTAZAPINE AGOMELATINE VALPROIC ACID OLANZAPINE ARIPIPRAZOLE VENLAFAXINE PAROXETINE HYDROCHLORIDE HEMIHYDRATE SERTRALINE MIRTAZAPINE VALPROIC ACID OLANZAPINE ARIPIPRAZOLE ORALLY DISINTEGRATING DEPRESSION DEPRESSION DEPRESSION DEPRESSION DEPRESSION PERSONALITY DISORDER PERSONALITY DISORDER PERSONALITY DISORDER Drug ineffective"}
{"safetyreportid": "10011531", "receiveDate": "20140314", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "2", "patientSex": "1", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "ERLOTINIB TABLET", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ERLOTINIB TABLET", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "FLECAINIDE /00627102/", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "GAS-X", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Haleon US Holdings LLC", "genericName": "CALCIUM CARBONATE, SIMETHICONE", "brandName": "GAS-X TOTAL RELIEF MAXIMUM STRENGTH", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "MAALOX /07357001/", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "DIGOXIN", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Sun Pharmaceutical Industries, Inc.", "genericName": "DIGOXIN", "brandName": "DIGOXIN", "pharmClass_epc": "Cardiac Glycoside [EPC]", "route": "ORAL"}, {"medicinalproduct": "SEROQUEL", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "AstraZeneca Pharmaceuticals LP", "genericName": "QUETIAPINE", "brandName": "SEROQUEL XR", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LEUKINE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Partner Therapeutics, Inc.", "genericName": "SARGRAMOSTIM", "brandName": "LEUKINE", "pharmClass_epc": "Leukocyte Growth Factor [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "FOLIC ACID", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "PureTek Corporation", "genericName": "FOLIC ACID", "brandName": "VENTRIXYL", "pharmClass_epc": "Vitamin C [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Atrial fibrillation", "outcome": "6"}, {"pt": "Eructation", "outcome": "6"}, {"pt": "Flatulence", "outcome": "6"}, {"pt": "Abdominal discomfort", "outcome": "6"}, {"pt": "Hyperchlorhydria", "outcome": "6"}], "classifyText": "ERLOTINIB TABLET ERLOTINIB TABLET CYMBALTA FLECAINIDE /00627102/ GAS-X TOTAL RELIEF MAXIMUM STRENGTH MAALOX /07357001/ DIGOXIN SEROQUEL XR LEUKINE VENTRIXYL DULOXETINE HYDROCHLORIDE CALCIUM CARBONATE, SIMETHICONE DIGOXIN QUETIAPINE SARGRAMOSTIM FOLIC ACID PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Atrial fibrillation Eructation Flatulence Abdominal discomfort Hyperchlorhydria"}
{"safetyreportid": "10011631", "receiveDate": "20140314", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "60", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "CETIRIZINE 10 MG", "drugcharacterization": "1", "drugindication": "HYPERSENSITIVITY", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "VALSARTAN/HYDROCHLOROTHIAZIDE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "GLUCOSAMINE/CHONDROITIN", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CRANBERRY", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Memory impairment", "outcome": "1"}], "classifyText": "CETIRIZINE 10 MG CYMBALTA VALSARTAN/HYDROCHLOROTHIAZIDE GLUCOSAMINE/CHONDROITIN CRANBERRY DULOXETINE HYDROCHLORIDE HYPERSENSITIVITY PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Memory impairment"}
{"safetyreportid": "10011747", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": null, "reportType": "1", "patientSex": "2", "patientAge": "73", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "LEVEMIR INSULIN", "drugcharacterization": "1", "drugindication": "TYPE 2 DIABETES MELLITUS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "HUMALOG KWIKPEN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG KWIKPEN", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "CLINDAMYCIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Sagent Pharmaceuticals", "genericName": "CLINDAMYCIN PHOSPHATE", "brandName": "CLINDAMYCIN", "pharmClass_epc": null, "route": "INTRAMUSCULAR"}, {"medicinalproduct": "CLOBETASOL OINTMENT 0.05%", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Rash maculo-papular", "outcome": null}, {"pt": "Rash", "outcome": null}], "classifyText": "LEVEMIR INSULIN HUMALOG KWIKPEN CLINDAMYCIN CLOBETASOL OINTMENT 0.05% INSULIN LISPRO CLINDAMYCIN PHOSPHATE TYPE 2 DIABETES MELLITUS Rash maculo-papular Rash"}
{"safetyreportid": "10011809", "receiveDate": "20140314", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "GB", "reportType": "1", "patientSex": "1", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "CLOZAPINE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Aurobindo Pharma Limited", "genericName": "CLOZAPINE", "brandName": "CLOZAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "OLANZAPINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Hisun Pharmaceuticals USA, Inc.", "genericName": "OLANZAPINE", "brandName": "OLANZAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Oesophageal carcinoma", "outcome": "3"}, {"pt": "Ileus paralytic", "outcome": "6"}, {"pt": "Large intestinal obstruction", "outcome": "6"}, {"pt": "Dysphagia", "outcome": "6"}, {"pt": "Mental impairment", "outcome": "3"}], "classifyText": "CLOZAPINE OLANZAPINE CLOZAPINE OLANZAPINE Oesophageal carcinoma Ileus paralytic Large intestinal obstruction Dysphagia Mental impairment"}
{"safetyreportid": "10011855", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": null, "reportType": "1", "patientSex": "2", "patientAge": "95", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "FORTEO", "drugcharacterization": "1", "drugindication": "SENILE OSTEOPOROSIS", "manufacturer": "Eli Lilly and Company", "genericName": "TERIPARATIDE", "brandName": "FORTEO", "pharmClass_epc": "Parathyroid Hormone Analog [EPC]", "route": "SUBCUTANEOUS"}], "reactions": [{"pt": "Pruritus", "outcome": null}, {"pt": "Rash", "outcome": null}], "classifyText": "FORTEO TERIPARATIDE SENILE OSTEOPOROSIS Pruritus Rash"}
{"safetyreportid": "10011858", "receiveDate": "20140314", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "GB", "reportType": "1", "patientSex": "2", "patientAge": "21", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "CITALOPRAM", "drugcharacterization": "1", "drugindication": "DEPRESSION", "manufacturer": "Chartwell Governmental & Specialty RX, LLC.", "genericName": "CITALOPRAM", "brandName": "CITALOPRAM", "pharmClass_epc": "Serotonin Reuptake Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "CITALOPRAM", "drugcharacterization": "1", "drugindication": "OBSESSIVE-COMPULSIVE DISORDER", "manufacturer": "Chartwell Governmental & Specialty RX, LLC.", "genericName": "CITALOPRAM", "brandName": "CITALOPRAM", "pharmClass_epc": "Serotonin Reuptake Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "QUETIAPINE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Solco Healthcare U.S., LLC", "genericName": "QUETIAPINE", "brandName": "QUETIAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "RISPERIDONE", "drugcharacterization": "1", "drugindication": "AGITATION", "manufacturer": "Amneal Pharmaceuticals LLC", "genericName": "RISPERIDONE", "brandName": "RISPERIDONE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CIRCADIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SERTRALINE", "drugcharacterization": "2", "drugindication": "AGITATION", "manufacturer": "Exelan Pharmaceuticals, Inc.", "genericName": "SERTRALINE", "brandName": "SERTRALINE", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Somnolence", "outcome": "3"}, {"pt": "Depression", "outcome": "3"}, {"pt": "Merycism", "outcome": "3"}, {"pt": "Major depression", "outcome": "3"}, {"pt": "Agitation", "outcome": "3"}, {"pt": "Sedation", "outcome": "3"}, {"pt": "Bipolar I disorder", "outcome": "3"}, {"pt": "Attention deficit/hyperactivity disorder", "outcome": "3"}], "classifyText": "CITALOPRAM CITALOPRAM QUETIAPINE RISPERIDONE STRATTERA STRATTERA STRATTERA STRATTERA STRATTERA STRATTERA STRATTERA CIRCADIN SERTRALINE CITALOPRAM CITALOPRAM QUETIAPINE RISPERIDONE ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE SERTRALINE DEPRESSION OBSESSIVE-COMPULSIVE DISORDER AGITATION AGITATION Somnolence Depression Merycism Major depression Agitation Sedation Bipolar I disorder Attention deficit/hyperactivity disorder"}
{"safetyreportid": "10011862", "receiveDate": "20140314", "serious": 1, "seriousnessdeath": 1, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "IT", "reportType": "1", "patientSex": "2", "patientAge": "58", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "FUROSEMIDE", "drugcharacterization": "1", "drugindication": "OEDEMA PERIPHERAL", "manufacturer": "Ipca Laboratories Limited", "genericName": "FUROSEMIDE", "brandName": "FUROSEMIDE", "pharmClass_epc": "Loop Diuretic [EPC]", "route": "ORAL"}, {"medicinalproduct": "INSULIN LISPRO", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Sanofi-Aventis U.S. LLC", "genericName": "INSULIN LISPRO", "brandName": "ADMELOG", "pharmClass_epc": "Insulin Analog [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "INSULIN GLULISINE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "sanofi-aventis U.S. LLC", "genericName": "INSULIN GLULISINE", "brandName": "APIDRA", "pharmClass_epc": "Insulin Analog [EPC]", "route": "INTRAVENOUS"}], "reactions": [{"pt": "Arthralgia", "outcome": "5"}, {"pt": "Dyspnoea", "outcome": "5"}, {"pt": "Nausea", "outcome": "5"}, {"pt": "Renal failure", "outcome": "5"}, {"pt": "Vomiting", "outcome": "5"}], "classifyText": "FUROSEMIDE ADMELOG APIDRA FUROSEMIDE INSULIN LISPRO INSULIN GLULISINE OEDEMA PERIPHERAL PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Arthralgia Dyspnoea Nausea Renal failure Vomiting"}
{"safetyreportid": "10011918", "receiveDate": "20140314", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "JP", "reportType": "1", "patientSex": "2", "patientAge": "40", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "CYMBALTA", "drugcharacterization": "1", "drugindication": "DEPRESSION", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "FERO GRADUMET", "drugcharacterization": "2", "drugindication": "ANAEMIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Maternal exposure during pregnancy", "outcome": "1"}], "classifyText": "CYMBALTA FERO GRADUMET DULOXETINE HYDROCHLORIDE DEPRESSION ANAEMIA Maternal exposure during pregnancy"}
{"safetyreportid": "10011920", "receiveDate": "20140314", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "SK", "reportType": "1", "patientSex": "1", "patientAge": "72", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "CYMBALTA", "drugcharacterization": "1", "drugindication": "DEPRESSION", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "FUROSEMID /00032601/", "drugcharacterization": "2", "drugindication": "MYOCARDIAL ISCHAEMIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CORDARONE", "drugcharacterization": "2", "drugindication": "MYOCARDIAL ISCHAEMIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ACETYLSALICYLIC ACID", "drugcharacterization": "2", "drugindication": "MYOCARDIAL ISCHAEMIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "THIOGAMMA", "drugcharacterization": "2", "drugindication": "RENAL FAILURE CHRONIC", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CARVEDIGAMMA", "drugcharacterization": "2", "drugindication": "MYOCARDIAL ISCHAEMIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "NOLPAZA", "drugcharacterization": "2", "drugindication": "DUODENAL ULCER", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "MILURIT", "drugcharacterization": "2", "drugindication": "RENAL FAILURE CHRONIC", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CALCIUM", "drugcharacterization": "2", "drugindication": "RENAL FAILURE CHRONIC", "manufacturer": "Apexel Co., Ltd", "genericName": "CALCIUM", "brandName": "7030 CALCIUM PREMIUM", "pharmClass_epc": "Calcium [EPC]", "route": "ORAL"}, {"medicinalproduct": "AMINO ACIDS", "drugcharacterization": "2", "drugindication": "RENAL FAILURE CHRONIC", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Electrocardiogram QT prolonged", "outcome": "1"}], "classifyText": "CYMBALTA FUROSEMID /00032601/ CORDARONE ACETYLSALICYLIC ACID THIOGAMMA CARVEDIGAMMA NOLPAZA MILURIT 7030 CALCIUM PREMIUM AMINO ACIDS DULOXETINE HYDROCHLORIDE CALCIUM DEPRESSION MYOCARDIAL ISCHAEMIA MYOCARDIAL ISCHAEMIA MYOCARDIAL ISCHAEMIA RENAL FAILURE CHRONIC MYOCARDIAL ISCHAEMIA DUODENAL ULCER RENAL FAILURE CHRONIC RENAL FAILURE CHRONIC RENAL FAILURE CHRONIC Electrocardiogram QT prolonged"}
{"safetyreportid": "10011922", "receiveDate": "20140314", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "DE", "reportType": "1", "patientSex": "1", "patientAge": "80", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "CYMBALTA", "drugcharacterization": "1", "drugindication": "ADJUSTMENT DISORDER WITH DEPRESSED MOOD", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "MIRTAZAPINE", "drugcharacterization": "1", "drugindication": "ADJUSTMENT DISORDER WITH DEPRESSED MOOD", "manufacturer": "Aurolife Pharma LLC", "genericName": "MIRTAZAPINE", "brandName": "MIRTAZAPINE", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Alanine aminotransferase increased", "outcome": "3"}, {"pt": "Gamma-glutamyltransferase increased", "outcome": "3"}], "classifyText": "CYMBALTA MIRTAZAPINE DULOXETINE HYDROCHLORIDE MIRTAZAPINE ADJUSTMENT DISORDER WITH DEPRESSED MOOD ADJUSTMENT DISORDER WITH DEPRESSED MOOD Alanine aminotransferase increased Gamma-glutamyltransferase increased"}
{"safetyreportid": "10011925", "receiveDate": "20140314", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "2", "patientSex": "2", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "DULOXETINE HYDROCHLORIDE", "drugcharacterization": "1", "drugindication": "DEPRESSION", "manufacturer": "MARKSANS PHARMA LIMITED", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "DULOXETINE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "DULOXETINE HYDROCHLORIDE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "MARKSANS PHARMA LIMITED", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "DULOXETINE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "SEROQUEL", "drugcharacterization": "2", "drugindication": "ANXIETY", "manufacturer": "AstraZeneca Pharmaceuticals LP", "genericName": "QUETIAPINE", "brandName": "SEROQUEL XR", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "SYNTHROID", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "AbbVie Inc.", "genericName": "LEVOTHYROXINE SODIUM", "brandName": "SYNTHROID", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Suicidal ideation", "outcome": "6"}, {"pt": "Constipation", "outcome": "6"}, {"pt": "Depressed mood", "outcome": "6"}, {"pt": "Drug withdrawal syndrome", "outcome": "6"}, {"pt": "Intentional drug misuse", "outcome": "6"}, {"pt": "Wrong technique in drug usage process", "outcome": "6"}, {"pt": "Crying", "outcome": "6"}], "classifyText": "DULOXETINE DULOXETINE SEROQUEL XR SYNTHROID DULOXETINE HYDROCHLORIDE DULOXETINE HYDROCHLORIDE QUETIAPINE LEVOTHYROXINE SODIUM DEPRESSION ANXIETY PRODUCT USED FOR UNKNOWN INDICATION Suicidal ideation Constipation Depressed mood Drug withdrawal syndrome Intentional drug misuse Wrong technique in drug usage process Crying"}
{"safetyreportid": "10011927", "receiveDate": "20140314", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "FR", "reportType": "1", "patientSex": "1", "patientAge": "35", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "ZYPREXA", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "OLANZAPINE", "brandName": "ZYPREXA INTRAMUSCULAR", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LAROXYL", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Pulmonary embolism", "outcome": "1"}, {"pt": "Thrombosis", "outcome": "1"}], "classifyText": "ZYPREXA INTRAMUSCULAR CYMBALTA LAROXYL OLANZAPINE DULOXETINE HYDROCHLORIDE PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Pulmonary embolism Thrombosis"}
{"safetyreportid": "10011928", "receiveDate": "20140314", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "GB", "reportType": "1", "patientSex": "2", "patientAge": "61", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "OLANZAPINE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Hisun Pharmaceuticals USA, Inc.", "genericName": "OLANZAPINE", "brandName": "OLANZAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "OLANZAPINE", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Hisun Pharmaceuticals USA, Inc.", "genericName": "OLANZAPINE", "brandName": "OLANZAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "OLANZAPINE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Hisun Pharmaceuticals USA, Inc.", "genericName": "OLANZAPINE", "brandName": "OLANZAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Anxiety", "outcome": "3"}, {"pt": "Insomnia", "outcome": "3"}, {"pt": "Nausea", "outcome": "3"}, {"pt": "Vomiting", "outcome": "3"}, {"pt": "Withdrawal syndrome", "outcome": "3"}], "classifyText": "OLANZAPINE OLANZAPINE OLANZAPINE OLANZAPINE OLANZAPINE OLANZAPINE PRODUCT USED FOR UNKNOWN INDICATION Anxiety Insomnia Nausea Vomiting Withdrawal syndrome"}
{"safetyreportid": "10011929", "receiveDate": "20140314", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "DE", "reportType": "1", "patientSex": "2", "patientAge": "0", "patientAgeUnit": "804", "drugs": [{"medicinalproduct": "ZYPREXA", "drugcharacterization": "1", "drugindication": "SCHIZOPHRENIA", "manufacturer": "Eli Lilly and Company", "genericName": "OLANZAPINE", "brandName": "ZYPREXA INTRAMUSCULAR", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "ZYPREXA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "OLANZAPINE", "brandName": "ZYPREXA INTRAMUSCULAR", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "ABILIFY", "drugcharacterization": "1", "drugindication": "SCHIZOPHRENIA", "manufacturer": "Otsuka America Pharmaceutical, Inc.", "genericName": "ARIPIPRAZOLE", "brandName": "ABILIFY", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Temperature regulation disorder", "outcome": "6"}, {"pt": "Premature baby", "outcome": "6"}, {"pt": "Apgar score low", "outcome": "6"}, {"pt": "Foetal exposure during pregnancy", "outcome": "6"}], "classifyText": "ZYPREXA INTRAMUSCULAR ZYPREXA INTRAMUSCULAR ABILIFY OLANZAPINE OLANZAPINE ARIPIPRAZOLE SCHIZOPHRENIA SCHIZOPHRENIA Temperature regulation disorder Premature baby Apgar score low Foetal exposure during pregnancy"}
{"safetyreportid": "10012136", "receiveDate": "20140314", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "CA", "reportType": "1", "patientSex": "2", "patientAge": "56", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "LAMICTAL", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "GlaxoSmithKline LLC", "genericName": "LAMOTRIGINE", "brandName": "LAMICTAL", "pharmClass_epc": "Anti-epileptic Agent [EPC]", "route": "ORAL"}, {"medicinalproduct": "GLUCOPHAGE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "HUMULIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN HUMAN", "brandName": "HUMULIN R", "pharmClass_epc": "Insulin [EPC]", "route": "PARENTERAL"}], "reactions": [{"pt": "Affect lability", "outcome": "3"}, {"pt": "Anxiety", "outcome": "3"}, {"pt": "Cough", "outcome": "3"}, {"pt": "Crying", "outcome": "3"}, {"pt": "Diarrhoea", "outcome": "3"}, {"pt": "Diplopia", "outcome": "3"}, {"pt": "Dyslexia", "outcome": "3"}, {"pt": "Dyspnoea exertional", "outcome": "3"}, {"pt": "Eye oedema", "outcome": "3"}, {"pt": "Hallucination", "outcome": "3"}, {"pt": "Headache", "outcome": "3"}, {"pt": "Incoherent", "outcome": "3"}, {"pt": "Insomnia", "outcome": "3"}, {"pt": "Irritability", "outcome": "3"}, {"pt": "Mood swings", "outcome": "3"}, {"pt": "Oedema peripheral", "outcome": "3"}, {"pt": "Pain in extremity", "outcome": "3"}, {"pt": "Stress", "outcome": "3"}, {"pt": "Suicidal ideation", "outcome": "3"}, {"pt": "Weight decreased", "outcome": "3"}], "classifyText": "LAMICTAL GLUCOPHAGE HUMALOG MIX75/25 HUMULIN R LAMOTRIGINE INSULIN LISPRO INSULIN HUMAN PRODUCT USED FOR UNKNOWN INDICATION Affect lability Anxiety Cough Crying Diarrhoea Diplopia Dyslexia Dyspnoea exertional Eye oedema Hallucination Headache Incoherent Insomnia Irritability Mood swings Oedema peripheral Pain in extremity Stress Suicidal ideation Weight decreased"}
{"safetyreportid": "10012143", "receiveDate": "20140314", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "1", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "TAMSULOSIN", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "DANTROLENE", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Hikma Pharmaceuticals USA Inc.", "genericName": "DANTROLENE", "brandName": "DANTROLENE", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "BACLOFEN INTRATHECAL", "drugcharacterization": "1", "drugindication": null, "manufacturer": "MAIA Pharmaceuticals, Inc.", "genericName": "BACLOFEN", "brandName": "BACLOFEN (INTRATHECAL)", "pharmClass_epc": "gamma-Aminobutyric Acid-ergic Agonist [EPC]", "route": "INTRATHECAL"}, {"medicinalproduct": "BACLOFEN.", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Northstar RxLLC", "genericName": "BACLOFEN", "brandName": "BACLOFEN", "pharmClass_epc": "gamma-Aminobutyric Acid-ergic Agonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "HYDROMORPHONE", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SEROQUEL", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "AstraZeneca Pharmaceuticals LP", "genericName": "QUETIAPINE", "brandName": "SEROQUEL XR", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "SIMVASTATIN.", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Accord Healthcare, Inc.", "genericName": "SIMVASTATIN", "brandName": "SIMVASTATIN", "pharmClass_epc": "HMG-CoA Reductase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "BACLOFEN INTRATHECAL", "drugcharacterization": "1", "drugindication": "MUSCLE SPASTICITY", "manufacturer": "MAIA Pharmaceuticals, Inc.", "genericName": "BACLOFEN", "brandName": "BACLOFEN (INTRATHECAL)", "pharmClass_epc": "gamma-Aminobutyric Acid-ergic Agonist [EPC]", "route": "INTRATHECAL"}, {"medicinalproduct": "POTASSIUM CHLORIDE.", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Zydus Lifesciences Limited", "genericName": "POTASSIUM CHLORIDE", "brandName": "POTASSIUM CHLORIDE", "pharmClass_epc": "Potassium Salt [EPC]", "route": "ORAL"}, {"medicinalproduct": "BISACODYL.", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Publix Super Markets Inc", "genericName": "BISACODYL", "brandName": "LAXATIVE", "pharmClass_epc": "Stimulant Laxative [EPC]", "route": "ORAL"}, {"medicinalproduct": "BACLOFEN INTRATHECAL", "drugcharacterization": "1", "drugindication": null, "manufacturer": "MAIA Pharmaceuticals, Inc.", "genericName": "BACLOFEN", "brandName": "BACLOFEN (INTRATHECAL)", "pharmClass_epc": "gamma-Aminobutyric Acid-ergic Agonist [EPC]", "route": "INTRATHECAL"}, {"medicinalproduct": "LIORESAL", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "BACLOFEN.", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Northstar RxLLC", "genericName": "BACLOFEN", "brandName": "BACLOFEN", "pharmClass_epc": "gamma-Aminobutyric Acid-ergic Agonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "FUROSEMIDE.", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Ipca Laboratories Limited", "genericName": "FUROSEMIDE", "brandName": "FUROSEMIDE", "pharmClass_epc": "Loop Diuretic [EPC]", "route": "ORAL"}, {"medicinalproduct": "HYDROCHLOROTHIAZIDE.", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Aurobindo Pharma Limited", "genericName": "HYDROCHLOROTHIAZIDE", "brandName": "HYDROCHLOROTHIAZIDE", "pharmClass_epc": "Thiazide Diuretic [EPC]", "route": "ORAL"}, {"medicinalproduct": "BACLOFEN INTRATHECAL", "drugcharacterization": "1", "drugindication": null, "manufacturer": "MAIA Pharmaceuticals, Inc.", "genericName": "BACLOFEN", "brandName": "BACLOFEN (INTRATHECAL)", "pharmClass_epc": "gamma-Aminobutyric Acid-ergic Agonist [EPC]", "route": "INTRATHECAL"}, {"medicinalproduct": "VALIUM", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Roche Laboratories Inc.", "genericName": "DIAZEPAM", "brandName": "VALIUM", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Fall", "outcome": "6"}, {"pt": "Tremor", "outcome": "6"}, {"pt": "Mental status changes", "outcome": "6"}, {"pt": "Muscle tightness", "outcome": "6"}, {"pt": "Respiratory depression", "outcome": "6"}, {"pt": "Pain", "outcome": "6"}, {"pt": "Incorrect dose administered", "outcome": "6"}, {"pt": "Loss of consciousness", "outcome": "6"}, {"pt": "Overdose", "outcome": "6"}, {"pt": "Hypersensitivity", "outcome": "6"}, {"pt": "Lethargy", "outcome": "6"}, {"pt": "Muscle spasms", "outcome": "6"}, {"pt": "Therapeutic response decreased", "outcome": "6"}, {"pt": "Muscle spasticity", "outcome": "6"}], "classifyText": "TAMSULOSIN DANTROLENE BACLOFEN (INTRATHECAL) BACLOFEN HYDROMORPHONE SEROQUEL XR SIMVASTATIN CYMBALTA BACLOFEN (INTRATHECAL) POTASSIUM CHLORIDE LAXATIVE BACLOFEN (INTRATHECAL) LIORESAL BACLOFEN FUROSEMIDE HYDROCHLOROTHIAZIDE BACLOFEN (INTRATHECAL) VALIUM DANTROLENE BACLOFEN BACLOFEN QUETIAPINE SIMVASTATIN DULOXETINE HYDROCHLORIDE BACLOFEN POTASSIUM CHLORIDE BISACODYL BACLOFEN BACLOFEN FUROSEMIDE HYDROCHLOROTHIAZIDE BACLOFEN DIAZEPAM PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION MUSCLE SPASTICITY PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Fall Tremor Mental status changes Muscle tightness Respiratory depression Pain Incorrect dose administered Loss of consciousness Overdose Hypersensitivity Lethargy Muscle spasms Therapeutic response decreased Muscle spasticity"}
{"safetyreportid": "10012195", "receiveDate": "20140314", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "AU", "reportType": "1", "patientSex": "1", "patientAge": "57", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "CIALIS", "drugcharacterization": "1", "drugindication": "ERECTILE DYSFUNCTION", "manufacturer": "Eli Lilly and Company", "genericName": "TADALAFIL", "brandName": "CIALIS", "pharmClass_epc": "Phosphodiesterase 5 Inhibitor [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Astigmatism", "outcome": "6"}, {"pt": "Drug ineffective", "outcome": "6"}], "classifyText": "CIALIS TADALAFIL ERECTILE DYSFUNCTION Astigmatism Drug ineffective"}
{"safetyreportid": "10012199", "receiveDate": "20140314", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "JP", "reportType": "1", "patientSex": "2", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "EVISTA", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "RALOXIFENE HYDROCHLORIDE", "brandName": "EVISTA", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Fracture", "outcome": "6"}], "classifyText": "EVISTA RALOXIFENE HYDROCHLORIDE PRODUCT USED FOR UNKNOWN INDICATION Fracture"}
{"safetyreportid": "10012235", "receiveDate": "20140314", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "GB", "reportType": "1", "patientSex": "2", "patientAge": "60", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "CISPLATIN", "drugcharacterization": "1", "drugindication": "LUNG ADENOCARCINOMA", "manufacturer": "Teva Parenteral Medicines, Inc.", "genericName": "CISPLATIN", "brandName": "CISPLATIN", "pharmClass_epc": "Platinum-based Drug [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "CISPLATIN", "drugcharacterization": "1", "drugindication": "LUNG ADENOCARCINOMA", "manufacturer": "Teva Parenteral Medicines, Inc.", "genericName": "CISPLATIN", "brandName": "CISPLATIN", "pharmClass_epc": "Platinum-based Drug [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "CISPLATIN", "drugcharacterization": "1", "drugindication": "LUNG ADENOCARCINOMA", "manufacturer": "Teva Parenteral Medicines, Inc.", "genericName": "CISPLATIN", "brandName": "CISPLATIN", "pharmClass_epc": "Platinum-based Drug [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "PEMETREXED DISODIUM", "drugcharacterization": "1", "drugindication": "LUNG ADENOCARCINOMA", "manufacturer": "Sagent Pharmaceuticals", "genericName": "PEMETREXED DISODIUM", "brandName": "PEMETREXED", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "PEMETREXED DISODIUM", "drugcharacterization": "1", "drugindication": "LUNG ADENOCARCINOMA", "manufacturer": "Sagent Pharmaceuticals", "genericName": "PEMETREXED DISODIUM", "brandName": "PEMETREXED", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "PEMETREXED DISODIUM", "drugcharacterization": "1", "drugindication": "LUNG ADENOCARCINOMA", "manufacturer": "Sagent Pharmaceuticals", "genericName": "PEMETREXED DISODIUM", "brandName": "PEMETREXED", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "APREPITANT", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Merck Sharp & Dohme LLC", "genericName": "APREPITANT", "brandName": "EMEND", "pharmClass_epc": "Substance P/Neurokinin-1 Receptor Antagonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "CYCLIZINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "DEXAMETHASONE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Zydus Lifesciences Limited", "genericName": "DEXAMETHASONE", "brandName": "DEXAMETHASONE", "pharmClass_epc": "Corticosteroid [EPC]", "route": "ORAL"}, {"medicinalproduct": "ONDANSETRON", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Dr. Reddy's Laboratories Limited", "genericName": "ONDANSETRON HYDROCHLORIDE", "brandName": "ONDANSETRON", "pharmClass_epc": "Serotonin-3 Receptor Antagonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "CYANOCOBALAMIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Somerset Therapeutics, LLC", "genericName": "CYANOCOBALAMIN", "brandName": "CYANOCOBALAMIN", "pharmClass_epc": "Vitamin B12 [EPC]", "route": "INTRAMUSCULAR"}], "reactions": [{"pt": "Swelling face", "outcome": "1"}, {"pt": "Rash", "outcome": "6"}, {"pt": "Rash generalised", "outcome": "1"}, {"pt": "Local swelling", "outcome": "1"}, {"pt": "Vomiting", "outcome": "1"}, {"pt": "Capillary leak syndrome", "outcome": "6"}], "classifyText": "CISPLATIN CISPLATIN CISPLATIN PEMETREXED PEMETREXED PEMETREXED EMEND CYCLIZINE DEXAMETHASONE ONDANSETRON CYANOCOBALAMIN CISPLATIN CISPLATIN CISPLATIN PEMETREXED DISODIUM PEMETREXED DISODIUM PEMETREXED DISODIUM APREPITANT DEXAMETHASONE ONDANSETRON HYDROCHLORIDE CYANOCOBALAMIN LUNG ADENOCARCINOMA LUNG ADENOCARCINOMA LUNG ADENOCARCINOMA LUNG ADENOCARCINOMA LUNG ADENOCARCINOMA LUNG ADENOCARCINOMA Swelling face Rash Rash generalised Local swelling Vomiting Capillary leak syndrome"}
{"safetyreportid": "10012385", "receiveDate": "20140312", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "1", "patientAge": "46", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "PRISTIQ", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.", "genericName": "DESVENLAFAXINE SUCCINATE", "brandName": "PRISTIQ EXTENDED-RELEASE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Drug hypersensitivity", "outcome": "6"}, {"pt": "Hypertension", "outcome": "2"}], "classifyText": "PRISTIQ EXTENDED-RELEASE STRATTERA DESVENLAFAXINE SUCCINATE ATOMOXETINE HYDROCHLORIDE Drug hypersensitivity Hypertension"}
{"safetyreportid": "10012448", "receiveDate": "20140314", "serious": 1, "seriousnessdeath": 1, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "JP", "reportType": "2", "patientSex": "2", "patientAge": "78", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "TRACLEER", "drugcharacterization": "1", "drugindication": "PULMONARY HYPERTENSION", "manufacturer": "Actelion Pharmaceuticals US, Inc.", "genericName": "BOSENTAN", "brandName": "TRACLEER", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "FERROUS CITRATE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ALENDRONATE SODIUM.", "drugcharacterization": "2", "drugindication": null, "manufacturer": "EXELAN PHARMACEUTICALS INC.", "genericName": "ALENDRONATE SODIUM", "brandName": "ALENDRONATE SODIUM", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "OXYGEN.", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Apria Healthcare LLC", "genericName": "OXYGEN", "brandName": "OXYGEN COMPRESSED U.S.P", "pharmClass_epc": null, "route": "RESPIRATORY (INHALATION)"}, {"medicinalproduct": "TRACLEER", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Actelion Pharmaceuticals US, Inc.", "genericName": "BOSENTAN", "brandName": "TRACLEER", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ASPIRIN.", "drugcharacterization": "1", "drugindication": "MYOCARDIAL ISCHAEMIA", "manufacturer": "Unifirst First Aid Corporation", "genericName": "ASPIRIN", "brandName": "BAYER GENUINE ASPIRIN", "pharmClass_epc": "Nonsteroidal Anti-inflammatory Drug [EPC]", "route": "ORAL"}, {"medicinalproduct": "FUROSEMIDE.", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Ipca Laboratories Limited", "genericName": "FUROSEMIDE", "brandName": "FUROSEMIDE", "pharmClass_epc": "Loop Diuretic [EPC]", "route": "ORAL"}, {"medicinalproduct": "POLYCARBOPHIL CALCIUM", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "NIZATIDINE.", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Dr Reddy's Laboratories Limited", "genericName": "NIZATIDINE", "brandName": "NIZATIDINE", "pharmClass_epc": "Histamine-2 Receptor Antagonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "TADALAFIL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "AvKARE", "genericName": "TADALAFIL", "brandName": "TADALAFIL", "pharmClass_epc": "Phosphodiesterase 5 Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "BERAPROST SODIUM", "drugcharacterization": "1", "drugindication": "PULMONARY HYPERTENSION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "BROMHEXINE HYDROCHLORIDE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "BIFIDOBACTERIUM NOS", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SPIRONOLACTONE.", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Amneal Pharmaceuticals LLC", "genericName": "SPIRONOLACTONE", "brandName": "SPIRONOLACTONE", "pharmClass_epc": "Aldosterone Antagonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "PREDNISOLONE.", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Chartwell RX, LLC", "genericName": "PREDNISOLONE", "brandName": "PREDNISOLONE", "pharmClass_epc": "Corticosteroid [EPC]", "route": "ORAL"}, {"medicinalproduct": "LOXOPROFEN SODIUM", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "TRACLEER", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Actelion Pharmaceuticals US, Inc.", "genericName": "BOSENTAN", "brandName": "TRACLEER", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Depressed level of consciousness", "outcome": "5"}, {"pt": "Haematoma", "outcome": "5"}, {"pt": "Subdural haemorrhage", "outcome": "5"}, {"pt": "Craniotomy", "outcome": "6"}, {"pt": "Left ventricular failure", "outcome": "2"}, {"pt": "Speech disorder", "outcome": "5"}], "classifyText": "TRACLEER FERROUS CITRATE ALENDRONATE SODIUM OXYGEN COMPRESSED U.S.P TRACLEER BAYER GENUINE ASPIRIN FUROSEMIDE POLYCARBOPHIL CALCIUM NIZATIDINE TADALAFIL BERAPROST SODIUM BROMHEXINE HYDROCHLORIDE BIFIDOBACTERIUM NOS SPIRONOLACTONE PREDNISOLONE LOXOPROFEN SODIUM TRACLEER BOSENTAN ALENDRONATE SODIUM OXYGEN BOSENTAN ASPIRIN FUROSEMIDE NIZATIDINE TADALAFIL SPIRONOLACTONE PREDNISOLONE BOSENTAN PULMONARY HYPERTENSION MYOCARDIAL ISCHAEMIA PULMONARY HYPERTENSION Depressed level of consciousness Haematoma Subdural haemorrhage Craniotomy Left ventricular failure Speech disorder"}
{"safetyreportid": "10012527", "receiveDate": "20140312", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "1", "patientAge": "13", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "CORTEF", "drugcharacterization": "1", "drugindication": "ADDISON^S DISEASE", "manufacturer": "Pharmacia & Upjohn Company LLC", "genericName": "HYDROCORTISONE", "brandName": "CORTEF", "pharmClass_epc": "Corticosteroid [EPC]", "route": "ORAL"}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "2", "drugindication": "DIABETES MELLITUS", "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}], "reactions": [{"pt": "Nausea", "outcome": "6"}, {"pt": "Vomiting", "outcome": "6"}, {"pt": "Blood glucose decreased", "outcome": "6"}, {"pt": "Drug screen negative", "outcome": "6"}], "classifyText": "CORTEF HUMALOG MIX75/25 HYDROCORTISONE INSULIN LISPRO ADDISON^S DISEASE DIABETES MELLITUS Nausea Vomiting Blood glucose decreased Drug screen negative"}
{"safetyreportid": "10012530", "receiveDate": "20140312", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "0", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "LYRICA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Parke-Davis Div of Pfizer Inc", "genericName": "PREGABALIN", "brandName": "LYRICA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "SAVELLA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Allergan, Inc.", "genericName": "MILNACIPRAN HYDROCHLORIDE", "brandName": "SAVELLA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "AMITRIPTYLINE", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "MARIJUANA", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Drug ineffective", "outcome": "6"}], "classifyText": "LYRICA CYMBALTA SAVELLA AMITRIPTYLINE MARIJUANA PREGABALIN DULOXETINE HYDROCHLORIDE MILNACIPRAN HYDROCHLORIDE Drug ineffective"}
{"safetyreportid": "10012538", "receiveDate": "20140314", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "2", "patientSex": "2", "patientAge": "14", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "VX-770 FDC", "drugcharacterization": "1", "drugindication": "CYSTIC FIBROSIS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "VX-809 FDC OR PLACEBO", "drugcharacterization": "1", "drugindication": "CYSTIC FIBROSIS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "VX-770 FDC OR PLACEBO", "drugcharacterization": "1", "drugindication": "CYSTIC FIBROSIS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "MEPHYTON", "drugcharacterization": "2", "drugindication": "NUTRITIONAL SUPPLEMENTATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "HYPERSAL 7%", "drugcharacterization": "2", "drugindication": "CYSTIC FIBROSIS LUNG", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "MIRALAX", "drugcharacterization": "2", "drugindication": "CONSTIPATION", "manufacturer": "Bayer HealthCare LLC.", "genericName": "POLYETHYLENE GLYCOL 3350", "brandName": "MIRALAX", "pharmClass_epc": "Osmotic Laxative [EPC]", "route": "ORAL"}, {"medicinalproduct": "ADVAIR HFA", "drugcharacterization": "2", "drugindication": "CYSTIC FIBROSIS LUNG", "manufacturer": "GlaxoSmithKline LLC", "genericName": "FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE", "brandName": "ADVAIR HFA", "pharmClass_epc": null, "route": "RESPIRATORY (INHALATION)"}, {"medicinalproduct": "CREON", "drugcharacterization": "2", "drugindication": "MALABSORPTION", "manufacturer": "AbbVie Inc.", "genericName": "PANCRELIPASE", "brandName": "CREON", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "PROVENTIL", "drugcharacterization": "2", "drugindication": "CYSTIC FIBROSIS LUNG", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "PREVACID", "drugcharacterization": "2", "drugindication": "DYSPEPSIA", "manufacturer": "Takeda Pharmaceuticals America, Inc.", "genericName": "LANSOPRAZOLE", "brandName": "PREVACID", "pharmClass_epc": "Proton Pump Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "ZITHROMAX", "drugcharacterization": "2", "drugindication": "CYSTIC FIBROSIS", "manufacturer": "Pfizer Laboratories Div Pfizer Inc", "genericName": "AZITHROMYCIN DIHYDRATE", "brandName": "ZITHROMAX", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "VITAMIN D3", "drugcharacterization": "2", "drugindication": "NUTRITIONAL SUPPLEMENTATION", "manufacturer": "Strides Pharma Science Limited", "genericName": "ERGOCALCIFEROL", "brandName": "VITAMIN D", "pharmClass_epc": "Provitamin D2 Compound [EPC]", "route": "ORAL"}, {"medicinalproduct": "THERAGRAN", "drugcharacterization": "2", "drugindication": "NUTRITIONAL SUPPLEMENTATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "VITAMIN E", "drugcharacterization": "2", "drugindication": "NUTRITIONAL SUPPLEMENTATION", "manufacturer": "Guangzhou Mizi Biotechnology Co., LTD.", "genericName": "VITAMIN E", "brandName": "STYE EYE RELIEF SERUM", "pharmClass_epc": "Vitamin C [EPC]", "route": "TOPICAL"}, {"medicinalproduct": "LEXAPRO", "drugcharacterization": "2", "drugindication": "DEPRESSION", "manufacturer": "Allergan, Inc.", "genericName": "ESCITALOPRAM", "brandName": "LEXAPRO", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "PULMOZYME", "drugcharacterization": "2", "drugindication": "CYSTIC FIBROSIS LUNG", "manufacturer": "Genentech, Inc.", "genericName": "DORNASE ALFA", "brandName": "PULMOZYME", "pharmClass_epc": "Recombinant Human Deoxyribonuclease 1 [EPC]", "route": "RESPIRATORY (INHALATION)"}, {"medicinalproduct": "TOBI", "drugcharacterization": "2", "drugindication": "CYSTIC FIBROSIS LUNG", "manufacturer": "Viatris Specialty LLC", "genericName": "TOBRAMYCIN", "brandName": "TOBI", "pharmClass_epc": "Aminoglycoside Antibacterial [EPC]", "route": "ORAL"}, {"medicinalproduct": "CAYSTON", "drugcharacterization": "2", "drugindication": "CYSTIC FIBROSIS LUNG", "manufacturer": "Gilead Sciences, Inc.", "genericName": "AZTREONAM", "brandName": "CAYSTON", "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LANTUS", "drugcharacterization": "2", "drugindication": "CYSTIC FIBROSIS RELATED DIABETES", "manufacturer": "sanofi-aventis U.S. LLC", "genericName": "INSULIN GLARGINE", "brandName": "LANTUS", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "2", "drugindication": "CYSTIC FIBROSIS RELATED DIABETES", "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "ONDANSETRON", "drugcharacterization": "2", "drugindication": "PROPHYLAXIS OF NAUSEA AND VOMITING", "manufacturer": "Dr. Reddy's Laboratories Limited", "genericName": "ONDANSETRON HYDROCHLORIDE", "brandName": "ONDANSETRON", "pharmClass_epc": "Serotonin-3 Receptor Antagonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "MEROPENEM", "drugcharacterization": "2", "drugindication": "INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS", "manufacturer": "Xellia Pharmaceuticals USA LLC", "genericName": "MEROPENEM", "brandName": "MEROPENEM", "pharmClass_epc": "Penem Antibacterial [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "TOBRAMYCIN", "drugcharacterization": "2", "drugindication": "INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS", "manufacturer": "Slate Run Pharmaceuticals, LLC", "genericName": "TOBRAMYCIN", "brandName": "TOBRAMYCIN", "pharmClass_epc": "Aminoglycoside Antibacterial [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "CEFTAZIDIME", "drugcharacterization": "2", "drugindication": "INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS", "manufacturer": "Hospira, Inc.", "genericName": "CEFTAZIDIME", "brandName": "TAZICEF", "pharmClass_epc": null, "route": "INTRAMUSCULAR"}, {"medicinalproduct": "VX-809 FDC", "drugcharacterization": "1", "drugindication": "CYSTIC FIBROSIS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Infective pulmonary exacerbation of cystic fibrosis", "outcome": "1"}], "classifyText": "VX-770 FDC VX-809 FDC OR PLACEBO VX-770 FDC OR PLACEBO MEPHYTON HYPERSAL 7% MIRALAX ADVAIR HFA CREON PROVENTIL PREVACID ZITHROMAX VITAMIN D THERAGRAN STYE EYE RELIEF SERUM LEXAPRO PULMOZYME TOBI CAYSTON LANTUS HUMALOG MIX75/25 ONDANSETRON MEROPENEM TOBRAMYCIN TAZICEF VX-809 FDC POLYETHYLENE GLYCOL 3350 FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE PANCRELIPASE LANSOPRAZOLE AZITHROMYCIN DIHYDRATE ERGOCALCIFEROL VITAMIN E ESCITALOPRAM DORNASE ALFA TOBRAMYCIN AZTREONAM INSULIN GLARGINE INSULIN LISPRO ONDANSETRON HYDROCHLORIDE MEROPENEM TOBRAMYCIN CEFTAZIDIME CYSTIC FIBROSIS CYSTIC FIBROSIS CYSTIC FIBROSIS NUTRITIONAL SUPPLEMENTATION CYSTIC FIBROSIS LUNG CONSTIPATION CYSTIC FIBROSIS LUNG MALABSORPTION CYSTIC FIBROSIS LUNG DYSPEPSIA CYSTIC FIBROSIS NUTRITIONAL SUPPLEMENTATION NUTRITIONAL SUPPLEMENTATION NUTRITIONAL SUPPLEMENTATION DEPRESSION CYSTIC FIBROSIS LUNG CYSTIC FIBROSIS LUNG CYSTIC FIBROSIS LUNG CYSTIC FIBROSIS RELATED DIABETES CYSTIC FIBROSIS RELATED DIABETES PROPHYLAXIS OF NAUSEA AND VOMITING INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS CYSTIC FIBROSIS Infective pulmonary exacerbation of cystic fibrosis"}
{"safetyreportid": "10012598", "receiveDate": "20140314", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "2", "patientSex": "2", "patientAge": "64", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "XARELTO", "drugcharacterization": "1", "drugindication": "DEEP VEIN THROMBOSIS", "manufacturer": "Janssen Pharmaceuticals, Inc.", "genericName": "RIVAROXABAN", "brandName": "XARELTO", "pharmClass_epc": "Factor Xa Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "XARELTO", "drugcharacterization": "1", "drugindication": "DEEP VEIN THROMBOSIS", "manufacturer": "Janssen Pharmaceuticals, Inc.", "genericName": "RIVAROXABAN", "brandName": "XARELTO", "pharmClass_epc": "Factor Xa Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "XARELTO", "drugcharacterization": "1", "drugindication": "PULMONARY EMBOLISM", "manufacturer": "Janssen Pharmaceuticals, Inc.", "genericName": "RIVAROXABAN", "brandName": "XARELTO", "pharmClass_epc": "Factor Xa Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "XARELTO", "drugcharacterization": "1", "drugindication": "PULMONARY EMBOLISM", "manufacturer": "Janssen Pharmaceuticals, Inc.", "genericName": "RIVAROXABAN", "brandName": "XARELTO", "pharmClass_epc": "Factor Xa Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "FORTEO", "drugcharacterization": "2", "drugindication": "OSTEOPOROSIS", "manufacturer": "Eli Lilly and Company", "genericName": "TERIPARATIDE", "brandName": "FORTEO", "pharmClass_epc": "Parathyroid Hormone Analog [EPC]", "route": "SUBCUTANEOUS"}], "reactions": [{"pt": "Deep vein thrombosis", "outcome": "6"}, {"pt": "Heart rate increased", "outcome": "6"}, {"pt": "Chest pain", "outcome": "3"}, {"pt": "Feeling abnormal", "outcome": "3"}], "classifyText": "XARELTO XARELTO XARELTO XARELTO FORTEO RIVAROXABAN RIVAROXABAN RIVAROXABAN RIVAROXABAN TERIPARATIDE DEEP VEIN THROMBOSIS DEEP VEIN THROMBOSIS PULMONARY EMBOLISM PULMONARY EMBOLISM OSTEOPOROSIS Deep vein thrombosis Heart rate increased Chest pain Feeling abnormal"}
{"safetyreportid": "10012675", "receiveDate": "20140314", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 1, "occurcountry": "FR", "reportType": "1", "patientSex": "2", "patientAge": "53", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "RAMIPRIL.", "drugcharacterization": "2", "drugindication": "ATRIAL FIBRILLATION", "manufacturer": "Lupin Pharmaceuticals, Inc.", "genericName": "RAMIPRIL", "brandName": "RAMIPRIL", "pharmClass_epc": "Angiotensin Converting Enzyme Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "SOTALEX", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "FUROSEMIDE.", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Ipca Laboratories Limited", "genericName": "FUROSEMIDE", "brandName": "FUROSEMIDE", "pharmClass_epc": "Loop Diuretic [EPC]", "route": "ORAL"}, {"medicinalproduct": "TEMERIT", "drugcharacterization": "2", "drugindication": "ATRIAL FIBRILLATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LEVOTHYROX", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ZYLORIC", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "TEGRETOL", "drugcharacterization": "1", "drugindication": "BIPOLAR DISORDER", "manufacturer": "Novartis Pharmaceuticals Corporation", "genericName": "CARBAMAZEPINE", "brandName": "TEGRETOL", "pharmClass_epc": "Mood Stabilizer [EPC]", "route": "ORAL"}, {"medicinalproduct": "XARELTO", "drugcharacterization": "3", "drugindication": "ATRIAL FIBRILLATION", "manufacturer": "Janssen Pharmaceuticals, Inc.", "genericName": "RIVAROXABAN", "brandName": "XARELTO", "pharmClass_epc": "Factor Xa Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "FLECAINE", "drugcharacterization": "2", "drugindication": "ATRIAL FIBRILLATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Drug interaction", "outcome": "6"}, {"pt": "Ischaemic stroke", "outcome": "1"}], "classifyText": "RAMIPRIL SOTALEX FUROSEMIDE TEMERIT LEVOTHYROX CYMBALTA ZYLORIC TEGRETOL XARELTO FLECAINE RAMIPRIL FUROSEMIDE DULOXETINE HYDROCHLORIDE CARBAMAZEPINE RIVAROXABAN ATRIAL FIBRILLATION ATRIAL FIBRILLATION BIPOLAR DISORDER ATRIAL FIBRILLATION ATRIAL FIBRILLATION Drug interaction Ischaemic stroke"}
{"safetyreportid": "10012760", "receiveDate": "20140314", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "DE", "reportType": "2", "patientSex": "2", "patientAge": "76", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "RESTEX", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "PREDNISOLON", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "AMPHO-MORONAL", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "EVISTA", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "RALOXIFENE HYDROCHLORIDE", "brandName": "EVISTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "L-THYROXINE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "NITRAZEPAM", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "PANTOZOL", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ABRAXANE", "drugcharacterization": "1", "drugindication": "BREAST CANCER", "manufacturer": "Abraxis BioScience, LLC", "genericName": "PACLITAXEL", "brandName": "ABRAXANE", "pharmClass_epc": "Microtubule Inhibitor [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "CYCLOPHOSPHAMIDE.", "drugcharacterization": "1", "drugindication": "BREAST CANCER", "manufacturer": "Slate Run Pharmaceuticals, LLC", "genericName": "CYCLOPHOSPHAMIDE FOR INJECTION", "brandName": "CYCLOPHOSPHAMIDE", "pharmClass_epc": "Alkylating Drug [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "TOREM", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "PREDNISOLON", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "RAMIPRIL.", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Lupin Pharmaceuticals, Inc.", "genericName": "RAMIPRIL", "brandName": "RAMIPRIL", "pharmClass_epc": "Angiotensin Converting Enzyme Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "ABRAXANE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Abraxis BioScience, LLC", "genericName": "PACLITAXEL", "brandName": "ABRAXANE", "pharmClass_epc": "Microtubule Inhibitor [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "EPIRUBICIN", "drugcharacterization": "1", "drugindication": "BREAST CANCER", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Capillary leak syndrome", "outcome": "1"}, {"pt": "Pleural effusion", "outcome": "1"}], "classifyText": "RESTEX PREDNISOLON AMPHO-MORONAL EVISTA L-THYROXINE NITRAZEPAM PANTOZOL ABRAXANE CYCLOPHOSPHAMIDE TOREM PREDNISOLON RAMIPRIL ABRAXANE EPIRUBICIN RALOXIFENE HYDROCHLORIDE PACLITAXEL CYCLOPHOSPHAMIDE FOR INJECTION RAMIPRIL PACLITAXEL PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION BREAST CANCER BREAST CANCER PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION BREAST CANCER Capillary leak syndrome Pleural effusion"}
{"safetyreportid": "10012896", "receiveDate": "20140314", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "JP", "reportType": "2", "patientSex": "2", "patientAge": "65", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "PIOGLITAZONE", "drugcharacterization": "1", "drugindication": "TYPE 2 DIABETES MELLITUS", "manufacturer": "NorthStar RxLLC", "genericName": "PIOGLITAZONE", "brandName": "PIOGLITAZONE", "pharmClass_epc": "Peroxisome Proliferator Receptor alpha Agonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "BLOPRESS TABLETS 4", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "2", "drugindication": "TYPE 2 DIABETES MELLITUS", "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "LANTUS", "drugcharacterization": "2", "drugindication": "TYPE 2 DIABETES MELLITUS", "manufacturer": "sanofi-aventis U.S. LLC", "genericName": "INSULIN GLARGINE", "brandName": "LANTUS", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "LANTUS", "drugcharacterization": "2", "drugindication": null, "manufacturer": "sanofi-aventis U.S. LLC", "genericName": "INSULIN GLARGINE", "brandName": "LANTUS", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "METGLUCO", "drugcharacterization": "2", "drugindication": "TYPE 2 DIABETES MELLITUS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "DIART", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LIPITOR", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Viatris Specialty LLC", "genericName": "ATORVASTATIN CALCIUM", "brandName": "LIPITOR", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "AMLODIPINE OD /00972402/", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Foot fracture", "outcome": "1"}, {"pt": "Fall", "outcome": "1"}], "classifyText": "PIOGLITAZONE BLOPRESS TABLETS 4 HUMALOG MIX75/25 HUMALOG MIX75/25 HUMALOG MIX75/25 HUMALOG MIX75/25 LANTUS LANTUS METGLUCO DIART LIPITOR AMLODIPINE OD /00972402/ PIOGLITAZONE INSULIN LISPRO INSULIN LISPRO INSULIN LISPRO INSULIN LISPRO INSULIN GLARGINE INSULIN GLARGINE ATORVASTATIN CALCIUM TYPE 2 DIABETES MELLITUS TYPE 2 DIABETES MELLITUS TYPE 2 DIABETES MELLITUS TYPE 2 DIABETES MELLITUS Foot fracture Fall"}
{"safetyreportid": "10012914", "receiveDate": "20140314", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "IT", "reportType": "1", "patientSex": "1", "patientAge": "25", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "CITALOPRAM (UNKNOWN)", "drugcharacterization": "1", "drugindication": "INTENTIONAL SELF-INJURY", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "1", "drugindication": "INTENTIONAL SELF-INJURY", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Drug abuse", "outcome": "1"}, {"pt": "Sopor", "outcome": "1"}], "classifyText": "CITALOPRAM (UNKNOWN) CYMBALTA DULOXETINE HYDROCHLORIDE INTENTIONAL SELF-INJURY INTENTIONAL SELF-INJURY Drug abuse Sopor"}
{"safetyreportid": "10012933", "receiveDate": "20140314", "serious": 1, "seriousnessdeath": 1, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "GB", "reportType": "1", "patientSex": "1", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "AMITRIPTYLINE", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "DIAZEPAM", "drugcharacterization": "3", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Hospira, Inc.", "genericName": "DIAZEPAM", "brandName": "DIAZEPAM", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "MORPHINE", "drugcharacterization": "3", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Edenbridge Pharmaceuticals, LLC", "genericName": "MORPHINE", "brandName": "OPIUM TINCTURE DEODORIZED", "pharmClass_epc": "Opioid Agonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "OLANZAPINE", "drugcharacterization": "3", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Hisun Pharmaceuticals USA, Inc.", "genericName": "OLANZAPINE", "brandName": "OLANZAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "VENLAFAXINE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Zydus Lifesciences Limited", "genericName": "VENLAFAXINE", "brandName": "VENLAFAXINE", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Toxicity to various agents", "outcome": "5"}, {"pt": "Drug screen positive", "outcome": "6"}, {"pt": "Drug interaction", "outcome": "6"}], "classifyText": "AMITRIPTYLINE DIAZEPAM OPIUM TINCTURE DEODORIZED OLANZAPINE VENLAFAXINE DIAZEPAM MORPHINE OLANZAPINE VENLAFAXINE PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Toxicity to various agents Drug screen positive Drug interaction"}
{"safetyreportid": "10013010", "receiveDate": "20140314", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "FR", "reportType": "1", "patientSex": "1", "patientAge": "50", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "OMNIPAQUE", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "GE Healthcare", "genericName": "IOHEXOL", "brandName": "OMNIPAQUE", "pharmClass_epc": "Radiographic Contrast Agent [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "OMNIPAQUE", "drugcharacterization": "1", "drugindication": "DIAGNOSTIC PROCEDURE", "manufacturer": "GE Healthcare", "genericName": "IOHEXOL", "brandName": "OMNIPAQUE", "pharmClass_epc": "Radiographic Contrast Agent [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "CISPLATINE", "drugcharacterization": "1", "drugindication": "LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CISPLATINE", "drugcharacterization": "1", "drugindication": "DIAGNOSTIC PROCEDURE", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "AUGMENTIN", "drugcharacterization": "1", "drugindication": "LUNG DISORDER", "manufacturer": "Allegis Holdings, LLC", "genericName": "AMOXICILLIN AND CLAVULANATE POTASSIUM", "brandName": "AUGMENTIN", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "FLAGYL /00012501/", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ALIMTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "PEMETREXED DISODIUM", "brandName": "ALIMTA", "pharmClass_epc": null, "route": "INTRAVENOUS"}], "reactions": [{"pt": "Kidney infection", "outcome": "1"}, {"pt": "Condition aggravated", "outcome": "1"}], "classifyText": "OMNIPAQUE OMNIPAQUE CISPLATINE CISPLATINE AUGMENTIN FLAGYL /00012501/ ALIMTA IOHEXOL IOHEXOL AMOXICILLIN AND CLAVULANATE POTASSIUM PEMETREXED DISODIUM PRODUCT USED FOR UNKNOWN INDICATION DIAGNOSTIC PROCEDURE LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV DIAGNOSTIC PROCEDURE LUNG DISORDER Kidney infection Condition aggravated"}
{"safetyreportid": "10013084", "receiveDate": "20140314", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "47", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "PREMARIN", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.", "genericName": "CONJUGATED ESTROGENS", "brandName": "PREMARIN VAGINAL", "pharmClass_epc": "Estrogen [EPC]", "route": "VAGINAL"}, {"medicinalproduct": "METHOTREXATE SODIUM", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Fresenius Kabi USA, LLC", "genericName": "METHOTREXATE SODIUM", "brandName": "METHOTREXATE", "pharmClass_epc": null, "route": "INTRA-ARTERIAL"}, {"medicinalproduct": "PERCOCET", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Endo USA, Inc.", "genericName": "OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN", "brandName": "PERCOCET", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "MORPHINE SULFATE ER", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "TEGRETOL", "drugcharacterization": "2", "drugindication": "MIGRAINE", "manufacturer": "Novartis Pharmaceuticals Corporation", "genericName": "CARBAMAZEPINE", "brandName": "TEGRETOL", "pharmClass_epc": "Mood Stabilizer [EPC]", "route": "ORAL"}, {"medicinalproduct": "NEXIUM", "drugcharacterization": "2", "drugindication": null, "manufacturer": "AstraZeneca Pharmaceuticals LP", "genericName": "ESOMEPRAZOLE MAGNESIUM", "brandName": "NEXIUM", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "FOLIC ACID", "drugcharacterization": "2", "drugindication": null, "manufacturer": "PureTek Corporation", "genericName": "FOLIC ACID", "brandName": "VENTRIXYL", "pharmClass_epc": "Vitamin C [EPC]", "route": "ORAL"}, {"medicinalproduct": "DOXYCYCLINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Lupin Pharmaceuticals, Inc.", "genericName": "DOXYCYCLINE", "brandName": "DOXYCYCLINE", "pharmClass_epc": "Tetracycline-class Drug [EPC]", "route": "ORAL"}, {"medicinalproduct": "ASPIRIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Unifirst First Aid Corporation", "genericName": "ASPIRIN", "brandName": "BAYER GENUINE ASPIRIN", "pharmClass_epc": "Nonsteroidal Anti-inflammatory Drug [EPC]", "route": "ORAL"}, {"medicinalproduct": "LIDODERM", "drugcharacterization": "2", "drugindication": null, "manufacturer": "TPU Pharma, Inc.", "genericName": "LIDOCAINE PATCH 5%", "brandName": "LIDODERM", "pharmClass_epc": "Amide Local Anesthetic [EPC]", "route": "TOPICAL"}, {"medicinalproduct": "DICYCLOMINE", "drugcharacterization": "2", "drugindication": "ABDOMINAL PAIN UPPER", "manufacturer": "Hikma Pharmaceuticals USA Inc.", "genericName": "DICYCLOMINE HYDROCHLORIDE", "brandName": "DICYCLOMINE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "DICYCLOMINE", "drugcharacterization": "2", "drugindication": "ABDOMINAL PAIN UPPER", "manufacturer": "Hikma Pharmaceuticals USA Inc.", "genericName": "DICYCLOMINE HYDROCHLORIDE", "brandName": "DICYCLOMINE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ONDANSETRON", "drugcharacterization": "2", "drugindication": "NAUSEA", "manufacturer": "Dr. Reddy's Laboratories Limited", "genericName": "ONDANSETRON HYDROCHLORIDE", "brandName": "ONDANSETRON", "pharmClass_epc": "Serotonin-3 Receptor Antagonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "ONDANSETRON", "drugcharacterization": "2", "drugindication": "MOTION SICKNESS", "manufacturer": "Dr. Reddy's Laboratories Limited", "genericName": "ONDANSETRON HYDROCHLORIDE", "brandName": "ONDANSETRON", "pharmClass_epc": "Serotonin-3 Receptor Antagonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": "NERVE INJURY", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "KLONOPIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "H2-Pharma, LLC", "genericName": "CLONAZEPAM", "brandName": "KLONOPIN", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Liver disorder", "outcome": "1"}, {"pt": "Liver function test abnormal", "outcome": "1"}], "classifyText": "PREMARIN VAGINAL METHOTREXATE PERCOCET MORPHINE SULFATE ER TEGRETOL NEXIUM VENTRIXYL DOXYCYCLINE BAYER GENUINE ASPIRIN LIDODERM DICYCLOMINE DICYCLOMINE ONDANSETRON ONDANSETRON CYMBALTA KLONOPIN CONJUGATED ESTROGENS METHOTREXATE SODIUM OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN CARBAMAZEPINE ESOMEPRAZOLE MAGNESIUM FOLIC ACID DOXYCYCLINE ASPIRIN LIDOCAINE PATCH 5% DICYCLOMINE HYDROCHLORIDE DICYCLOMINE HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE DULOXETINE HYDROCHLORIDE CLONAZEPAM MIGRAINE ABDOMINAL PAIN UPPER ABDOMINAL PAIN UPPER NAUSEA MOTION SICKNESS NERVE INJURY Liver disorder Liver function test abnormal"}
{"safetyreportid": "10013087", "receiveDate": "20140314", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "1", "patientAge": "49", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "VIAGRA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Viatris Specialty LLC", "genericName": "SILDENAFIL CITRATE", "brandName": "VIAGRA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CIALIS", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "TADALAFIL", "brandName": "CIALIS", "pharmClass_epc": "Phosphodiesterase 5 Inhibitor [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Headache", "outcome": "6"}], "classifyText": "VIAGRA CIALIS SILDENAFIL CITRATE TADALAFIL Headache"}
{"safetyreportid": "10013329", "receiveDate": "20140314", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "1", "patientAge": "49", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "LYRICA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Parke-Davis Div of Pfizer Inc", "genericName": "PREGABALIN", "brandName": "LYRICA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "MELOXICAM", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Zydus Pharmaceuticals USA Inc.", "genericName": "MELOXICAM", "brandName": "MELOXICAM", "pharmClass_epc": "Nonsteroidal Anti-inflammatory Drug [EPC]", "route": "ORAL"}, {"medicinalproduct": "LEVOTHYROXINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "AMLODIPINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Pangea Pharmaceuticals, LLC", "genericName": "AMLODIPINE", "brandName": "SDAMLO", "pharmClass_epc": "Dihydropyridine Calcium Channel Blocker [EPC]", "route": "ORAL"}, {"medicinalproduct": "HYDROCHLOROTHIAZIDE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Aurobindo Pharma Limited", "genericName": "HYDROCHLOROTHIAZIDE", "brandName": "HYDROCHLOROTHIAZIDE", "pharmClass_epc": "Thiazide Diuretic [EPC]", "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "METOPROLOL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Baxter Healthcare Corporation", "genericName": "METOPROLOL TARTRATE", "brandName": "METOPROLOL", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "SIMVASTATIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Accord Healthcare, Inc.", "genericName": "SIMVASTATIN", "brandName": "SIMVASTATIN", "pharmClass_epc": "HMG-CoA Reductase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "RANITIDINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Dr. Reddy's Laboratories Limited", "genericName": "RANITIDINE", "brandName": "RANITIDINE", "pharmClass_epc": "Histamine-2 Receptor Antagonist [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Pain", "outcome": "3"}, {"pt": "Irritability", "outcome": "3"}, {"pt": "Paraesthesia", "outcome": "3"}, {"pt": "Movement disorder", "outcome": "3"}], "classifyText": "LYRICA MELOXICAM LEVOTHYROXINE SDAMLO HYDROCHLOROTHIAZIDE CYMBALTA METOPROLOL SIMVASTATIN RANITIDINE PREGABALIN MELOXICAM AMLODIPINE HYDROCHLOROTHIAZIDE DULOXETINE HYDROCHLORIDE METOPROLOL TARTRATE SIMVASTATIN RANITIDINE Pain Irritability Paraesthesia Movement disorder"}
{"safetyreportid": "10013343", "receiveDate": "20140314", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "71", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "PAXIL", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Apotex Corp", "genericName": "PAROXETINE HYDROCHLORIDE", "brandName": "PAXIL CR", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "AMRIX", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Cephalon, LLC", "genericName": "CYCLOBENZAPRINE HYDROCHLORIDE", "brandName": "AMRIX", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LEXAPRO", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Allergan, Inc.", "genericName": "ESCITALOPRAM", "brandName": "LEXAPRO", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "EFFEXOR", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Viatris Specialty LLC", "genericName": "VENLAFAXINE HYDROCHLORIDE", "brandName": "EFFEXOR XR", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "METHOCARBAMOL.", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Somerset Therapeutics, LLC", "genericName": "METHOCARBAMOL", "brandName": "METHOCARBAMOL", "pharmClass_epc": "Muscle Relaxant [EPC]", "route": "INTRAMUSCULAR"}], "reactions": [{"pt": "Drug hypersensitivity", "outcome": "6"}], "classifyText": "PAXIL CR AMRIX LEXAPRO EFFEXOR XR CYMBALTA METHOCARBAMOL PAROXETINE HYDROCHLORIDE CYCLOBENZAPRINE HYDROCHLORIDE ESCITALOPRAM VENLAFAXINE HYDROCHLORIDE DULOXETINE HYDROCHLORIDE METHOCARBAMOL Drug hypersensitivity"}
{"safetyreportid": "10013476", "receiveDate": "20140314", "serious": 1, "seriousnessdeath": 1, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "GB", "reportType": "1", "patientSex": "1", "patientAge": "63", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "SPIRIVA", "drugcharacterization": "1", "drugindication": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "manufacturer": "Boehringer Ingelheim Pharmaceuticals, Inc.", "genericName": "TIOTROPIUM BROMIDE", "brandName": "SPIRIVA HANDIHALER", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ACETAMINOPHEN", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Amazon.com Services LLC", "genericName": "ACETAMINOPHEN", "brandName": "AMAZON BASIC CARE ACETAMINOPHEN", "pharmClass_epc": "Nonsteroidal Anti-inflammatory Drug [EPC]", "route": "ORAL"}, {"medicinalproduct": "ALBUTEROL", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Nivagen Pharmaceuticals Inc", "genericName": "ALBUTEROL SULFATE", "brandName": "ALBUTEROL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "BUMETANIDE", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Advagen Pharma Limited", "genericName": "BUMETANIDE", "brandName": "BUMETANIDE", "pharmClass_epc": "Loop Diuretic [EPC]", "route": "ORAL"}, {"medicinalproduct": "FOSAMAX", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Organon LLC", "genericName": "ALENDRONATE SODIUM", "brandName": "FOSAMAX", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "HUMULIN", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN HUMAN", "brandName": "HUMULIN R", "pharmClass_epc": "Insulin [EPC]", "route": "PARENTERAL"}, {"medicinalproduct": "LISINOPRIL", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Chartwell RX, LLC", "genericName": "LISINOPRIL", "brandName": "LISINOPRIL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "NYSTATIN", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Pharmaceutical Associates, Inc.", "genericName": "NYSTATIN", "brandName": "NYSTATIN", "pharmClass_epc": "Polyene Antifungal [EPC]", "route": "ORAL"}, {"medicinalproduct": "SERETIDE", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SINGULAIR", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Organon LLC", "genericName": "MONTELUKAST SODIUM", "brandName": "SINGULAIR", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "TRAMADOL HYDROCHLORIDE", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Amneal Pharmaceuticals NY LLC", "genericName": "TRAMADOL HYDROCHLORIDE", "brandName": "TRAMADOL HYDROCHLORIDE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "INSULIN HUMAN", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN HUMAN", "brandName": "HUMULIN R", "pharmClass_epc": "Insulin [EPC]", "route": "PARENTERAL"}, {"medicinalproduct": "INSULIN ISOPHANE BIPHASIC", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "INSUMAN COMB", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Lobar pneumonia", "outcome": "5"}], "classifyText": "SPIRIVA HANDIHALER AMAZON BASIC CARE ACETAMINOPHEN ALBUTEROL BUMETANIDE FOSAMAX HUMALOG MIX75/25 HUMULIN R LISINOPRIL NYSTATIN SERETIDE SINGULAIR TRAMADOL HYDROCHLORIDE HUMULIN R INSULIN ISOPHANE BIPHASIC INSUMAN COMB TIOTROPIUM BROMIDE ACETAMINOPHEN ALBUTEROL SULFATE BUMETANIDE ALENDRONATE SODIUM INSULIN LISPRO INSULIN HUMAN LISINOPRIL NYSTATIN MONTELUKAST SODIUM TRAMADOL HYDROCHLORIDE INSULIN HUMAN CHRONIC OBSTRUCTIVE PULMONARY DISEASE PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Lobar pneumonia"}
{"safetyreportid": "10013792", "receiveDate": "20140316", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "37", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "MIRENA", "drugcharacterization": "1", "drugindication": "CONTRACEPTION", "manufacturer": "Bayer HealthCare Pharmaceuticals Inc.", "genericName": "LEVONORGESTREL", "brandName": "MIRENA", "pharmClass_epc": "Progestin [EPC]", "route": "INTRAUTERINE"}, {"medicinalproduct": "FLEXERIL", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "VOLTAREN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Haleon US Holdings LLC", "genericName": "DICLOFENAC SODIUM", "brandName": "VOLTAREN ARTHRITIS PAIN", "pharmClass_epc": null, "route": "TOPICAL"}, {"medicinalproduct": "DIAZEPAM", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Hospira, Inc.", "genericName": "DIAZEPAM", "brandName": "DIAZEPAM", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "PERCOCET", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Endo USA, Inc.", "genericName": "OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN", "brandName": "PERCOCET", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "TRAZODONE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ALLEGRA", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ALBUTEROL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Nivagen Pharmaceuticals Inc", "genericName": "ALBUTEROL SULFATE", "brandName": "ALBUTEROL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CRYSELLE-28", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Uterine perforation", "outcome": null}, {"pt": "Injury", "outcome": null}, {"pt": "Pain", "outcome": null}, {"pt": "Emotional distress", "outcome": null}], "classifyText": "MIRENA FLEXERIL VOLTAREN ARTHRITIS PAIN DIAZEPAM PERCOCET TRAZODONE CYMBALTA ALLEGRA ALBUTEROL CRYSELLE-28 LEVONORGESTREL DICLOFENAC SODIUM DIAZEPAM OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN DULOXETINE HYDROCHLORIDE ALBUTEROL SULFATE CONTRACEPTION Uterine perforation Injury Pain Emotional distress"}
{"safetyreportid": "10013875", "receiveDate": "20140316", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "IT", "reportType": "3", "patientSex": null, "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "FUROSEMIDE.", "drugcharacterization": "1", "drugindication": "OEDEMA PERIPHERAL", "manufacturer": "Ipca Laboratories Limited", "genericName": "FUROSEMIDE", "brandName": "FUROSEMIDE", "pharmClass_epc": "Loop Diuretic [EPC]", "route": "ORAL"}, {"medicinalproduct": "INSULIN GLULISINE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "sanofi-aventis U.S. LLC", "genericName": "INSULIN GLULISINE", "brandName": "APIDRA", "pharmClass_epc": "Insulin Analog [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "INSULIN LISPRO", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Sanofi-Aventis U.S. LLC", "genericName": "INSULIN LISPRO", "brandName": "ADMELOG", "pharmClass_epc": "Insulin Analog [EPC]", "route": "INTRAVENOUS"}], "reactions": [{"pt": "Dyspnoea", "outcome": "1"}, {"pt": "Nausea", "outcome": "1"}, {"pt": "Arthralgia", "outcome": "1"}, {"pt": "Renal failure", "outcome": "1"}, {"pt": "Vomiting", "outcome": "1"}, {"pt": "Dehydration", "outcome": "1"}], "classifyText": "FUROSEMIDE APIDRA ADMELOG FUROSEMIDE INSULIN GLULISINE INSULIN LISPRO OEDEMA PERIPHERAL PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Dyspnoea Nausea Arthralgia Renal failure Vomiting Dehydration"}
{"safetyreportid": "10013877", "receiveDate": "20140316", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "GB", "reportType": "1", "patientSex": "0", "patientAge": "1", "patientAgeUnit": "805", "drugs": [{"medicinalproduct": "QUETIAPINE", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Solco Healthcare U.S., LLC", "genericName": "QUETIAPINE", "brandName": "QUETIAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "ZOPICLONE", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ARIPIPRAZOLE", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Dr. Reddy's Laboratories Inc", "genericName": "ARIPIPRAZOLE ORALLY DISINTEGRATING", "brandName": "ARIPIPRAZOLE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "DULOXETINE HYDROCHLORIDE", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "MARKSANS PHARMA LIMITED", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "DULOXETINE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ZYPREXA", "drugcharacterization": "1", "drugindication": "SCHIZOAFFECTIVE DISORDER", "manufacturer": "Eli Lilly and Company", "genericName": "OLANZAPINE", "brandName": "ZYPREXA INTRAMUSCULAR", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "ZYPREXA", "drugcharacterization": "1", "drugindication": "SCHIZOAFFECTIVE DISORDER", "manufacturer": "Eli Lilly and Company", "genericName": "OLANZAPINE", "brandName": "ZYPREXA INTRAMUSCULAR", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "INTRAMUSCULAR"}], "reactions": [{"pt": "Cleft palate", "outcome": "6"}, {"pt": "High arched palate", "outcome": "6"}, {"pt": "Feeding disorder neonatal", "outcome": "1"}, {"pt": "Exposure during breast feeding", "outcome": "6"}, {"pt": "Foetal exposure during pregnancy", "outcome": "6"}], "classifyText": "QUETIAPINE ZOPICLONE ARIPIPRAZOLE DULOXETINE ZYPREXA INTRAMUSCULAR ZYPREXA INTRAMUSCULAR QUETIAPINE ARIPIPRAZOLE ORALLY DISINTEGRATING DULOXETINE HYDROCHLORIDE OLANZAPINE OLANZAPINE PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION SCHIZOAFFECTIVE DISORDER SCHIZOAFFECTIVE DISORDER Cleft palate High arched palate Feeding disorder neonatal Exposure during breast feeding Foetal exposure during pregnancy"}
{"safetyreportid": "10013919", "receiveDate": "20140316", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "REBIF", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "EMD Serono, Inc.", "genericName": "INTERFERON BETA-1A", "brandName": "REBIF", "pharmClass_epc": "Interferon beta [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "BACLOFEN", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Northstar RxLLC", "genericName": "BACLOFEN", "brandName": "BACLOFEN", "pharmClass_epc": "gamma-Aminobutyric Acid-ergic Agonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "DIAZEPAM", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Hospira, Inc.", "genericName": "DIAZEPAM", "brandName": "DIAZEPAM", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "DICYCLOMINE /00068601/", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "FISH OIL", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Fresenius Kabi USA, LLC", "genericName": "FISH OIL", "brandName": "OMEGAVEN", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "METFORMIN /00082702/", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "OMEPRAZOLE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Amerisource Bergen", "genericName": "OMEPRAZOLE", "brandName": "GOOD NEIGHBOR PHARMACY OMEPRAZOLE", "pharmClass_epc": "Proton Pump Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "SINGULAIR /01362601/", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SUMATRIPTAN", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Rising Pharma Holdings, Inc.", "genericName": "SUMATRIPTAN", "brandName": "SUMATRIPTAN", "pharmClass_epc": "Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "TOPIRAMATE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Camber Pharmaceuticals, Inc.", "genericName": "TOPIRAMATE", "brandName": "TOPIRAMATE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "VITAMIN B12 /00056201/", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "VITAMIN C /00008001/", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ZYRTEC /00884302/", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Injection site dryness", "outcome": "3"}, {"pt": "Injection site exfoliation", "outcome": "3"}, {"pt": "Influenza like illness", "outcome": "3"}, {"pt": "Injection site erythema", "outcome": "3"}], "classifyText": "REBIF BACLOFEN CYMBALTA DIAZEPAM DICYCLOMINE /00068601/ OMEGAVEN METFORMIN /00082702/ GOOD NEIGHBOR PHARMACY OMEPRAZOLE SINGULAIR /01362601/ SUMATRIPTAN TOPIRAMATE VITAMIN B12 /00056201/ VITAMIN C /00008001/ ZYRTEC /00884302/ INTERFERON BETA-1A BACLOFEN DULOXETINE HYDROCHLORIDE DIAZEPAM FISH OIL OMEPRAZOLE SUMATRIPTAN TOPIRAMATE PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Injection site dryness Injection site exfoliation Influenza like illness Injection site erythema"}
{"safetyreportid": "10013930", "receiveDate": "20140316", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "46", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "ONFI", "drugcharacterization": "1", "drugindication": "CONVULSION", "manufacturer": "Lundbeck Pharmaceuticals LLC", "genericName": "CLOBAZAM", "brandName": "ONFI", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "ORAL"}, {"medicinalproduct": "ONFI", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Lundbeck Pharmaceuticals LLC", "genericName": "CLOBAZAM", "brandName": "ONFI", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "ORAL"}, {"medicinalproduct": "ONFI", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Lundbeck Pharmaceuticals LLC", "genericName": "CLOBAZAM", "brandName": "ONFI", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "ORAL"}, {"medicinalproduct": "ONFI", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Lundbeck Pharmaceuticals LLC", "genericName": "CLOBAZAM", "brandName": "ONFI", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "ORAL"}, {"medicinalproduct": "ONFI", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Lundbeck Pharmaceuticals LLC", "genericName": "CLOBAZAM", "brandName": "ONFI", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "ORAL"}, {"medicinalproduct": "ONFI", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Lundbeck Pharmaceuticals LLC", "genericName": "CLOBAZAM", "brandName": "ONFI", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "ORAL"}, {"medicinalproduct": "LAMICTAL", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "GlaxoSmithKline LLC", "genericName": "LAMOTRIGINE", "brandName": "LAMICTAL", "pharmClass_epc": "Anti-epileptic Agent [EPC]", "route": "ORAL"}, {"medicinalproduct": "LAMICTAL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "GlaxoSmithKline LLC", "genericName": "LAMOTRIGINE", "brandName": "LAMICTAL", "pharmClass_epc": "Anti-epileptic Agent [EPC]", "route": "ORAL"}, {"medicinalproduct": "CARBAMAZEPINE ER", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Epic Pharma, LLC", "genericName": "CARBAMAZEPINE", "brandName": "CARBAMAZEPINE ER", "pharmClass_epc": "Mood Stabilizer [EPC]", "route": "ORAL"}, {"medicinalproduct": "CARBAMAZEPINE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Torrent Pharmaceuticals Limited", "genericName": "CARBAMAZEPINE", "brandName": "CARBAMAZEPINE", "pharmClass_epc": "Mood Stabilizer [EPC]", "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "SUMATRIPTAN", "drugcharacterization": "2", "drugindication": "MIGRAINE", "manufacturer": "Rising Pharma Holdings, Inc.", "genericName": "SUMATRIPTAN", "brandName": "SUMATRIPTAN", "pharmClass_epc": "Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "CALCIUM WITH VITAMIN D", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CALCIUM WITH VITAMIN D", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Status epilepticus", "outcome": "6"}, {"pt": "Drug withdrawal convulsions", "outcome": "4"}, {"pt": "Convulsion", "outcome": "6"}, {"pt": "Fall", "outcome": "6"}, {"pt": "Dysstasia", "outcome": "6"}, {"pt": "Gait disturbance", "outcome": "3"}, {"pt": "Drug ineffective", "outcome": "6"}, {"pt": "Somnolence", "outcome": "6"}], "classifyText": "ONFI ONFI ONFI ONFI ONFI ONFI LAMICTAL LAMICTAL CARBAMAZEPINE ER CARBAMAZEPINE CYMBALTA CYMBALTA SUMATRIPTAN CALCIUM WITH VITAMIN D CALCIUM WITH VITAMIN D CLOBAZAM CLOBAZAM CLOBAZAM CLOBAZAM CLOBAZAM CLOBAZAM LAMOTRIGINE LAMOTRIGINE CARBAMAZEPINE CARBAMAZEPINE DULOXETINE HYDROCHLORIDE DULOXETINE HYDROCHLORIDE SUMATRIPTAN CONVULSION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION MIGRAINE PRODUCT USED FOR UNKNOWN INDICATION Status epilepticus Drug withdrawal convulsions Convulsion Fall Dysstasia Gait disturbance Drug ineffective Somnolence"}
{"safetyreportid": "10013963", "receiveDate": "20140316", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "GB", "reportType": "1", "patientSex": "1", "patientAge": "0", "patientAgeUnit": "804", "drugs": [{"medicinalproduct": "ZOPICLONE", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ARIPIPRAZOLE.", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Dr. Reddy's Laboratories Inc", "genericName": "ARIPIPRAZOLE ORALLY DISINTEGRATING", "brandName": "ARIPIPRAZOLE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "DULOXETINE HCL", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ZYPREXA", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "OLANZAPINE", "brandName": "ZYPREXA INTRAMUSCULAR", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "ZYPREXA", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "OLANZAPINE", "brandName": "ZYPREXA INTRAMUSCULAR", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "ARIPIPRAZOLE.", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Dr. Reddy's Laboratories Inc", "genericName": "ARIPIPRAZOLE ORALLY DISINTEGRATING", "brandName": "ARIPIPRAZOLE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "QUETIAPINE.", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Solco Healthcare U.S., LLC", "genericName": "QUETIAPINE", "brandName": "QUETIAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Cleft palate", "outcome": "6"}, {"pt": "Foetal exposure during pregnancy", "outcome": "6"}, {"pt": "High arched palate", "outcome": "6"}, {"pt": "Exposure during breast feeding", "outcome": "6"}, {"pt": "Selective eating disorder", "outcome": "1"}], "classifyText": "ZOPICLONE ARIPIPRAZOLE DULOXETINE HCL ZYPREXA INTRAMUSCULAR ZYPREXA INTRAMUSCULAR ARIPIPRAZOLE QUETIAPINE ARIPIPRAZOLE ORALLY DISINTEGRATING OLANZAPINE OLANZAPINE ARIPIPRAZOLE ORALLY DISINTEGRATING QUETIAPINE PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Cleft palate Foetal exposure during pregnancy High arched palate Exposure during breast feeding Selective eating disorder"}
{"safetyreportid": "10014022", "receiveDate": "20140317", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "ES", "reportType": "2", "patientSex": "1", "patientAge": "66", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "PEG-INTERFERON ALFA 2A", "drugcharacterization": "1", "drugindication": "HEPATITIS C", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "RIBAVIRIN", "drugcharacterization": "1", "drugindication": "HEPATITIS C", "manufacturer": "Bausch Health US, LLC", "genericName": "RIBAVIRIN", "brandName": "VIRAZOLE", "pharmClass_epc": "Nucleoside Analog Antiviral [EPC]", "route": "RESPIRATORY (INHALATION)"}, {"medicinalproduct": "MK-3034", "drugcharacterization": "1", "drugindication": "HEPATITIS C", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "METFORMIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Mylan Pharmaceuticals Inc.", "genericName": "METFORMIN", "brandName": "METFORMIN HYDROCHLORIDE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CAPTOPRIL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "AiPing Pharmaceutical, Inc.", "genericName": "CAPTOPRIL", "brandName": "CAPTOPRIL", "pharmClass_epc": "Angiotensin Converting Enzyme Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}], "reactions": [{"pt": "Toxic skin eruption", "outcome": "1"}], "classifyText": "PEG-INTERFERON ALFA 2A VIRAZOLE MK-3034 METFORMIN HYDROCHLORIDE CAPTOPRIL HUMALOG MIX75/25 RIBAVIRIN METFORMIN CAPTOPRIL INSULIN LISPRO HEPATITIS C HEPATITIS C HEPATITIS C Toxic skin eruption"}
{"safetyreportid": "10014043", "receiveDate": "20140317", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "IS", "reportType": "1", "patientSex": "1", "patientAge": "71", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "LEPONEX", "drugcharacterization": "1", "drugindication": "SCHIZOPHRENIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LEPONEX", "drugcharacterization": "1", "drugindication": "BIPOLAR DISORDER", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LEPONEX", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "OLANZAPINE", "drugcharacterization": "1", "drugindication": "SCHIZOPHRENIA", "manufacturer": "Hisun Pharmaceuticals USA, Inc.", "genericName": "OLANZAPINE", "brandName": "OLANZAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "OLANZAPINE", "drugcharacterization": "1", "drugindication": "BIPOLAR DISORDER", "manufacturer": "Hisun Pharmaceuticals USA, Inc.", "genericName": "OLANZAPINE", "brandName": "OLANZAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "CHLORPROMAZINE", "drugcharacterization": "1", "drugindication": "SCHIZOPHRENIA", "manufacturer": "Sun Pharmaceutical Industries Inc", "genericName": "CHLORPROMAZINE", "brandName": "CHLORPROMAZINE HYDROCHLORIDE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "RISPERIDONE", "drugcharacterization": "1", "drugindication": "SCHIZOPHRENIA", "manufacturer": "Amneal Pharmaceuticals LLC", "genericName": "RISPERIDONE", "brandName": "RISPERIDONE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "PROMETHAZINE", "drugcharacterization": "1", "drugindication": "SCHIZOPHRENIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LAMOTRIGINE", "drugcharacterization": "2", "drugindication": "SCHIZOPHRENIA", "manufacturer": "Actavis Pharma, Inc.", "genericName": "LAMOTRIGINE", "brandName": "LAMOTRIGINE", "pharmClass_epc": "Anti-epileptic Agent [EPC]", "route": "ORAL"}, {"medicinalproduct": "LAMOTRIGINE", "drugcharacterization": "2", "drugindication": "BIPOLAR DISORDER", "manufacturer": "Actavis Pharma, Inc.", "genericName": "LAMOTRIGINE", "brandName": "LAMOTRIGINE", "pharmClass_epc": "Anti-epileptic Agent [EPC]", "route": "ORAL"}, {"medicinalproduct": "ZOPICLONE", "drugcharacterization": "2", "drugindication": "SCHIZOPHRENIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ZOPICLONE", "drugcharacterization": "2", "drugindication": "BIPOLAR DISORDER", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Leukopenia", "outcome": "1"}, {"pt": "Neutropenia", "outcome": "1"}, {"pt": "Pneumonia", "outcome": "1"}, {"pt": "Pyrexia", "outcome": "1"}, {"pt": "Therapeutic response decreased", "outcome": "6"}], "classifyText": "LEPONEX LEPONEX LEPONEX OLANZAPINE OLANZAPINE CHLORPROMAZINE HYDROCHLORIDE RISPERIDONE PROMETHAZINE LAMOTRIGINE LAMOTRIGINE ZOPICLONE ZOPICLONE OLANZAPINE OLANZAPINE CHLORPROMAZINE RISPERIDONE LAMOTRIGINE LAMOTRIGINE SCHIZOPHRENIA BIPOLAR DISORDER SCHIZOPHRENIA BIPOLAR DISORDER SCHIZOPHRENIA SCHIZOPHRENIA SCHIZOPHRENIA SCHIZOPHRENIA BIPOLAR DISORDER SCHIZOPHRENIA BIPOLAR DISORDER Leukopenia Neutropenia Pneumonia Pyrexia Therapeutic response decreased"}
{"safetyreportid": "10014320", "receiveDate": "20140317", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "57", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "TECFIDERA", "drugcharacterization": "1", "drugindication": "MULTIPLE SCLEROSIS", "manufacturer": "Biogen Inc.", "genericName": "DIMETHYL FUMARATE", "brandName": "TECFIDERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "TECFIDERA", "drugcharacterization": "1", "drugindication": "MULTIPLE SCLEROSIS", "manufacturer": "Biogen Inc.", "genericName": "DIMETHYL FUMARATE", "brandName": "TECFIDERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "TECFIDERA", "drugcharacterization": "1", "drugindication": "MULTIPLE SCLEROSIS", "manufacturer": "Biogen Inc.", "genericName": "DIMETHYL FUMARATE", "brandName": "TECFIDERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "GABAPENTIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Rising Pharma Holdings, Inc.", "genericName": "GABAPENTIN", "brandName": "GABAPENTIN", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "BUPROPION XL 300MG TABLET", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CELEBREX 200MG CAPSULE", "drugcharacterization": "2", "drugindication": "ARTHRALGIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Malaise", "outcome": "1"}, {"pt": "Weight decreased", "outcome": "1"}, {"pt": "Feeling abnormal", "outcome": "3"}, {"pt": "Wrong technique in drug usage process", "outcome": "3"}, {"pt": "Intentional drug misuse", "outcome": "3"}, {"pt": "Abdominal pain upper", "outcome": "1"}, {"pt": "Diarrhoea", "outcome": "1"}], "classifyText": "TECFIDERA TECFIDERA TECFIDERA GABAPENTIN BUPROPION XL 300MG TABLET CELEBREX 200MG CAPSULE CYMBALTA DIMETHYL FUMARATE DIMETHYL FUMARATE DIMETHYL FUMARATE GABAPENTIN DULOXETINE HYDROCHLORIDE MULTIPLE SCLEROSIS MULTIPLE SCLEROSIS MULTIPLE SCLEROSIS ARTHRALGIA Malaise Weight decreased Feeling abnormal Wrong technique in drug usage process Intentional drug misuse Abdominal pain upper Diarrhoea"}
{"safetyreportid": "10014432", "receiveDate": "20140317", "serious": 1, "seriousnessdeath": 2, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 2, "occurcountry": "CA", "reportType": "1", "patientSex": "2", "patientAge": "64", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "MOMETASONE FUROATE", "drugcharacterization": "1", "drugindication": "Product used for unknown indication", "manufacturer": "Rugby Laboratories", "genericName": "MOMETASONE FUROATE", "brandName": "RUGBY MOMETASONE FUROATE NASAL", "pharmClass_epc": "Corticosteroid [EPC]", "route": "NASAL"}, {"medicinalproduct": "ALENDRONATE SODIUM", "drugcharacterization": "1", "drugindication": "Product used for unknown indication", "manufacturer": "EXELAN PHARMACEUTICALS INC.", "genericName": "ALENDRONATE SODIUM", "brandName": "ALENDRONATE SODIUM", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ALENDRONATE SODIUM", "drugcharacterization": "1", "drugindication": null, "manufacturer": "EXELAN PHARMACEUTICALS INC.", "genericName": "ALENDRONATE SODIUM", "brandName": "ALENDRONATE SODIUM", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LORATADINE", "drugcharacterization": "1", "drugindication": "Product used for unknown indication", "manufacturer": "Bionpharma Inc.", "genericName": "LORATADINE", "brandName": "LORATADINE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LORATADINE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Bionpharma Inc.", "genericName": "LORATADINE", "brandName": "LORATADINE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LORATADINE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Bionpharma Inc.", "genericName": "LORATADINE", "brandName": "LORATADINE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LORATADINE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Bionpharma Inc.", "genericName": "LORATADINE", "brandName": "LORATADINE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LORATADINE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Bionpharma Inc.", "genericName": "LORATADINE", "brandName": "LORATADINE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "NAPROXEN SODIUM", "drugcharacterization": "1", "drugindication": "Product used for unknown indication", "manufacturer": "CVS", "genericName": "NAPROXEN SODIUM", "brandName": "NAPROXEN SODIUM", "pharmClass_epc": "Nonsteroidal Anti-inflammatory Drug [EPC]", "route": "ORAL"}, {"medicinalproduct": "THYMOCYTE IMMUNE GLOBULIN NOS", "drugcharacterization": "1", "drugindication": "Product used for unknown indication", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ATIVAN", "drugcharacterization": "1", "drugindication": "Product used for unknown indication", "manufacturer": "Bausch Health US LLC", "genericName": "LORAZEPAM", "brandName": "ATIVAN", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "ORAL"}, {"medicinalproduct": "BACLOFEN", "drugcharacterization": "1", "drugindication": "Product used for unknown indication", "manufacturer": "Northstar RxLLC", "genericName": "BACLOFEN", "brandName": "BACLOFEN", "pharmClass_epc": "gamma-Aminobutyric Acid-ergic Agonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "BACLOFEN", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Northstar RxLLC", "genericName": "BACLOFEN", "brandName": "BACLOFEN", "pharmClass_epc": "gamma-Aminobutyric Acid-ergic Agonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "CALCIUM", "drugcharacterization": "1", "drugindication": "Product used for unknown indication", "manufacturer": "Apexel Co., Ltd", "genericName": "CALCIUM", "brandName": "7030 CALCIUM PREMIUM", "pharmClass_epc": "Calcium [EPC]", "route": "ORAL"}, {"medicinalproduct": "CALCIUM CARBONATE", "drugcharacterization": "1", "drugindication": "Product used for unknown indication", "manufacturer": "WINCO FOODS, LLC", "genericName": "CALCIUM CARBONATE", "brandName": "WINCO FOODS ANTACID ULTRA STRENGTH", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CREATINE", "drugcharacterization": "1", "drugindication": "Product used for unknown indication", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "1", "drugindication": "Pain", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "DOCUSATE SODIUM", "drugcharacterization": "1", "drugindication": "Product used for unknown indication", "manufacturer": "Humanwell PuraCap Pharmaceutical (Wuhan), Ltd.", "genericName": "DOCUSATE SODIUM", "brandName": "DOCUSATE SODIUM 100MG TWO-TONE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "DULOXETINE HYDROCHLORIDE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "MARKSANS PHARMA LIMITED", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "DULOXETINE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ERGOCALCIFEROL", "drugcharacterization": "1", "drugindication": "Product used for unknown indication", "manufacturer": "Chartwell RX, LLC", "genericName": "ERGOCALCIFEROL", "brandName": "ERGOCALCIFEROL", "pharmClass_epc": "Provitamin D2 Compound [EPC]", "route": "ORAL"}, {"medicinalproduct": "FOLIC ACID", "drugcharacterization": "1", "drugindication": "Product used for unknown indication", "manufacturer": "PureTek Corporation", "genericName": "FOLIC ACID", "brandName": "VENTRIXYL", "pharmClass_epc": "Vitamin C [EPC]", "route": "ORAL"}, {"medicinalproduct": "FOLIC ACID", "drugcharacterization": "1", "drugindication": null, "manufacturer": "PureTek Corporation", "genericName": "FOLIC ACID", "brandName": "VENTRIXYL", "pharmClass_epc": "Vitamin C [EPC]", "route": "ORAL"}, {"medicinalproduct": "FUROSEMIDE", "drugcharacterization": "1", "drugindication": "Product used for unknown indication", "manufacturer": "Ipca Laboratories Limited", "genericName": "FUROSEMIDE", "brandName": "FUROSEMIDE", "pharmClass_epc": "Loop Diuretic [EPC]", "route": "ORAL"}, {"medicinalproduct": "GLICLAZIDE", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "HORSE CHESTNUT", "drugcharacterization": "1", "drugindication": "Product used for unknown indication", "manufacturer": "Boiron", "genericName": "HORSE CHESTNUT", "brandName": "AESCULUS HIPPOCASTANUM", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "HYDROMORPHONE", "drugcharacterization": "1", "drugindication": "Product used for unknown indication", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "HYDROMORPHONE", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "IMODIUM", "drugcharacterization": "1", "drugindication": "Product used for unknown indication", "manufacturer": "Kenvue Brands LLC", "genericName": "LOPERAMIDE HYDROCHLORIDE", "brandName": "IMODIUM A-D", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "IMODIUM", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Kenvue Brands LLC", "genericName": "LOPERAMIDE HYDROCHLORIDE", "brandName": "IMODIUM A-D", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LACTOBACILLUS ACIDOPHILUS", "drugcharacterization": "1", "drugindication": "Product used for unknown indication", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LYRICA", "drugcharacterization": "1", "drugindication": "Product used for unknown indication", "manufacturer": "Parke-Davis Div of Pfizer Inc", "genericName": "PREGABALIN", "brandName": "LYRICA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "MELATONIN", "drugcharacterization": "1", "drugindication": "Product used for unknown indication", "manufacturer": "BioActive Nutritional, Inc.", "genericName": "MELATONIN", "brandName": "MELATONIN", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "MYCOPHENOLATE MOFETIL", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Endo USA, Inc.", "genericName": "MYCOPHENOLATE MOFETIL", "brandName": "MYCOPHENOLATE MOFETIL", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "NORTRIPTYLINE HYDROCHLORIDE", "drugcharacterization": "1", "drugindication": "Product used for unknown indication", "manufacturer": "Zydus Lifesciences Limited", "genericName": "NORTRIPTYLINE HYDROCHLORIDE", "brandName": "NORTRIPTYLINE HYDROCHLORIDE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "HYDROCHLOROTHIAZIDE", "drugcharacterization": "1", "drugindication": "Product used for unknown indication", "manufacturer": "Aurobindo Pharma Limited", "genericName": "HYDROCHLOROTHIAZIDE", "brandName": "HYDROCHLOROTHIAZIDE", "pharmClass_epc": "Thiazide Diuretic [EPC]", "route": "ORAL"}, {"medicinalproduct": "HYDROCHLOROTHIAZIDE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Aurobindo Pharma Limited", "genericName": "HYDROCHLOROTHIAZIDE", "brandName": "HYDROCHLOROTHIAZIDE", "pharmClass_epc": "Thiazide Diuretic [EPC]", "route": "ORAL"}, {"medicinalproduct": "OMEGA-3 FATTY ACIDS", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "OMEGA-3 FATTY ACIDS", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "OMEGA-3 FATTY ACIDS", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "POTASSIUM CHLORIDE", "drugcharacterization": "1", "drugindication": "Product used for unknown indication", "manufacturer": "Zydus Lifesciences Limited", "genericName": "POTASSIUM CHLORIDE", "brandName": "POTASSIUM CHLORIDE", "pharmClass_epc": "Potassium Salt [EPC]", "route": "ORAL"}, {"medicinalproduct": "POTASSIUM CHLORIDE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Zydus Lifesciences Limited", "genericName": "POTASSIUM CHLORIDE", "brandName": "POTASSIUM CHLORIDE", "pharmClass_epc": "Potassium Salt [EPC]", "route": "ORAL"}, {"medicinalproduct": "POTASSIUM CHLORIDE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Zydus Lifesciences Limited", "genericName": "POTASSIUM CHLORIDE", "brandName": "POTASSIUM CHLORIDE", "pharmClass_epc": "Potassium Salt [EPC]", "route": "ORAL"}, {"medicinalproduct": "POTASSIUM CHLORIDE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Zydus Lifesciences Limited", "genericName": "POTASSIUM CHLORIDE", "brandName": "POTASSIUM CHLORIDE", "pharmClass_epc": "Potassium Salt [EPC]", "route": "ORAL"}, {"medicinalproduct": "PREDNISONE", "drugcharacterization": "1", "drugindication": "Product used for unknown indication", "manufacturer": "ANI Pharmaceuticals, Inc.", "genericName": "PREDNISONE", "brandName": "PREDNISONE", "pharmClass_epc": "Corticosteroid [EPC]", "route": "ORAL"}, {"medicinalproduct": "PYRIDOXINE HYDROCHLORIDE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Fresenius Kabi USA, LLC", "genericName": "PYRIDOXINE HYDROCHLORIDE", "brandName": "PYRIDOXINE HYDROCHLORIDE", "pharmClass_epc": null, "route": "INTRAMUSCULAR"}, {"medicinalproduct": "RANITIDINE HYDROCHLORIDE", "drugcharacterization": "1", "drugindication": "Product used for unknown indication", "manufacturer": "Dr. Reddy's Laboratories Limited", "genericName": "RANITIDINE HYDROCHLORIDE", "brandName": "RANITIDINE HYDROCHLORIDE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "FISH OIL", "drugcharacterization": "1", "drugindication": "Product used for unknown indication", "manufacturer": "Fresenius Kabi USA, LLC", "genericName": "FISH OIL", "brandName": "OMEGAVEN", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "SENNA LEAF", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Boiron", "genericName": "SENNA LEAF", "brandName": "SENNA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "SENNOSIDES", "drugcharacterization": "1", "drugindication": null, "manufacturer": "TOPCO ASSOCIATES LLC", "genericName": "SENNOSIDES", "brandName": "LAXATIVE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "SULFADIAZINE\\TRIMETHOPRIM", "drugcharacterization": "1", "drugindication": "Product used for unknown indication", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SULFADIAZINE\\TRIMETHOPRIM", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SULFADIAZINE\\TRIMETHOPRIM", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SULFADIAZINE\\TRIMETHOPRIM", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SULFADIAZINE\\TRIMETHOPRIM", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SULFADIAZINE\\TRIMETHOPRIM", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SULFADIAZINE\\TRIMETHOPRIM", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "TIZANIDINE HYDROCHLORIDE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Zydus Lifesciences Limited", "genericName": "TIZANIDINE HYDROCHLORIDE", "brandName": "TIZANIDINE HYDROCHLORIDE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "RETINOL", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "VITAMIN B COMPLEX", "drugcharacterization": "1", "drugindication": "Product used for unknown indication", "manufacturer": "Mylan Institutional LLC", "genericName": "THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE", "brandName": "VITAMIN B COMPLEX", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "WARFARIN", "drugcharacterization": "1", "drugindication": "Product used for unknown indication", "manufacturer": "Exelan Pharmaceuticals Inc.", "genericName": "WARFARIN", "brandName": "WARFARIN SODIUM", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ZANTAC", "drugcharacterization": "1", "drugindication": "Product used for unknown indication", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ZOPICLONE", "drugcharacterization": "1", "drugindication": "Product used for unknown indication", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ZOPICLONE", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "BACLOFEN", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Northstar RxLLC", "genericName": "BACLOFEN", "brandName": "BACLOFEN", "pharmClass_epc": "gamma-Aminobutyric Acid-ergic Agonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "DIETARY SUPPLEMENT\\PROBIOTICS", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "BIFIDOBACTERIUM ANIMALIS LACTIS\\LACTOBACILLUS ACIDOPHILUS", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "BIFIDOBACTERIUM BIFIDUM", "drugcharacterization": "1", "drugindication": "Product used for unknown indication", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "PROBIOTICS NOS", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "BROMHEXINE HYDROCHLORIDE", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LORATADINE\\PSEUDOEPHEDRINE SULFATE", "drugcharacterization": "1", "drugindication": "Product used for unknown indication", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CLORPRENALINE HYDROCHLORIDE", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CYANOCOBALAMIN", "drugcharacterization": "1", "drugindication": "Product used for unknown indication", "manufacturer": "Somerset Therapeutics, LLC", "genericName": "CYANOCOBALAMIN", "brandName": "CYANOCOBALAMIN", "pharmClass_epc": "Vitamin B12 [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "CYANOCOBALAMIN", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Somerset Therapeutics, LLC", "genericName": "CYANOCOBALAMIN", "brandName": "CYANOCOBALAMIN", "pharmClass_epc": "Vitamin B12 [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "MINERALS\\VITAMINS", "drugcharacterization": "1", "drugindication": "Product used for unknown indication", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "DEXPANTHENOL", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Laboratorios Quimica Son's, S.A. de C.V", "genericName": "DEXPANTHENOL", "brandName": "BABYSONS", "pharmClass_epc": null, "route": "TOPICAL"}, {"medicinalproduct": "DOCONEXENT\\ICOSAPENT", "drugcharacterization": "1", "drugindication": "Product used for unknown indication", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "HUMAN IMMUNOGLOBULIN G", "drugcharacterization": "1", "drugindication": null, "manufacturer": "ADMA Biologics, Inc.", "genericName": "HUMAN IMMUNOGLOBULIN G", "brandName": "ASCENIV", "pharmClass_epc": "Human Immunoglobulin G [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "MYCOPHENOLIC ACID", "drugcharacterization": "1", "drugindication": "Product used for unknown indication", "manufacturer": "CONCORD BIOTECH LIMITED", "genericName": "MYCOPHENOLIC ACID", "brandName": "MYCOPHENOLIC ACID", "pharmClass_epc": "Antimetabolite Immunosuppressant [EPC]", "route": "ORAL"}, {"medicinalproduct": "NASONEX", "drugcharacterization": "1", "drugindication": null, "manufacturer": "L. Perrigo Company", "genericName": "MOMETASONE FUROATE", "brandName": "NASONEX", "pharmClass_epc": null, "route": "NASAL"}, {"medicinalproduct": "NIACINAMIDE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "NOKSIBCHO cosmetic Co., Ltd.", "genericName": "NIACINAMIDE", "brandName": "THE SKINHOUSE ALOE SOOTHING VITAMIN", "pharmClass_epc": "Adenosine Receptor Agonist [EPC]", "route": "TOPICAL"}, {"medicinalproduct": "SULFAMETHOXAZOLE", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SENOKOT", "drugcharacterization": "1", "drugindication": "Product used for unknown indication", "manufacturer": "Atlantis Consumer Healthcare, Inc.", "genericName": "STANDARDIZED SENNA CONCENTRATE", "brandName": "SENOKOT", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "SULFAMETHOXAZOLE\\TRIMETHOPRIM", "drugcharacterization": "1", "drugindication": "Product used for unknown indication", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SULFAMETHOXAZOLE\\TRIMETHOPRIM", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "DULOXETINE", "drugcharacterization": "1", "drugindication": "Product used for unknown indication", "manufacturer": "MARKSANS PHARMA LIMITED", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "DULOXETINE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "DULOXETINE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "MARKSANS PHARMA LIMITED", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "DULOXETINE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "TIZANIDINE", "drugcharacterization": "1", "drugindication": "Product used for unknown indication", "manufacturer": "Sun Pharmaceutical Industries, Inc.", "genericName": "TIZANIDINE", "brandName": "TIZANIDINE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "TIZANIDINE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Sun Pharmaceutical Industries, Inc.", "genericName": "TIZANIDINE", "brandName": "TIZANIDINE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "TRIAMTERENE", "drugcharacterization": "1", "drugindication": "Product used for unknown indication", "manufacturer": "TRUPHARMA LLC", "genericName": "TRIAMTERENE CAPSULES", "brandName": "TRIAMTERENE", "pharmClass_epc": "Potassium-sparing Diuretic [EPC]", "route": "ORAL"}, {"medicinalproduct": "TRIMIPRAMINE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Breckenridge Pharmaceutical, Inc.", "genericName": "TRIMIPRAMINE", "brandName": "TRIMIPRAMINE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "VITAMIN A", "drugcharacterization": "1", "drugindication": "Product used for unknown indication", "manufacturer": "CAUSE FOR CHANGE LLC", "genericName": "VITAMIN A", "brandName": "SKINEEZ", "pharmClass_epc": "Vitamin A [EPC]", "route": "TOPICAL"}, {"medicinalproduct": "VITAMIN A", "drugcharacterization": "1", "drugindication": null, "manufacturer": "CAUSE FOR CHANGE LLC", "genericName": "VITAMIN A", "brandName": "SKINEEZ", "pharmClass_epc": "Vitamin A [EPC]", "route": "TOPICAL"}, {"medicinalproduct": "VITAMIN A", "drugcharacterization": "1", "drugindication": null, "manufacturer": "CAUSE FOR CHANGE LLC", "genericName": "VITAMIN A", "brandName": "SKINEEZ", "pharmClass_epc": "Vitamin A [EPC]", "route": "TOPICAL"}, {"medicinalproduct": "VITAMIN A", "drugcharacterization": "1", "drugindication": null, "manufacturer": "CAUSE FOR CHANGE LLC", "genericName": "VITAMIN A", "brandName": "SKINEEZ", "pharmClass_epc": "Vitamin A [EPC]", "route": "TOPICAL"}, {"medicinalproduct": "VITAMIN A", "drugcharacterization": "1", "drugindication": null, "manufacturer": "CAUSE FOR CHANGE LLC", "genericName": "VITAMIN A", "brandName": "SKINEEZ", "pharmClass_epc": "Vitamin A [EPC]", "route": "TOPICAL"}, {"medicinalproduct": "VITAMIN B12", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "VITAMIN C", "drugcharacterization": "1", "drugindication": "Product used for unknown indication", "manufacturer": "FlexiGo Inc", "genericName": "VITAMIN C", "brandName": "VITAMIN C SERUM", "pharmClass_epc": "Vitamin C [EPC]", "route": "TOPICAL"}, {"medicinalproduct": "CHOLECALCIFEROL", "drugcharacterization": "1", "drugindication": "Product used for unknown indication", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": ".ALPHA.-TOCOPHEROL", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Coma", "outcome": "1"}, {"pt": "Gastrooesophageal reflux disease", "outcome": "1"}, {"pt": "Pneumonia aspiration", "outcome": "1"}, {"pt": "Somnolence", "outcome": "1"}, {"pt": "Underdose", "outcome": "6"}], "classifyText": "RUGBY MOMETASONE FUROATE NASAL ALENDRONATE SODIUM ALENDRONATE SODIUM LORATADINE LORATADINE LORATADINE LORATADINE LORATADINE NAPROXEN SODIUM THYMOCYTE IMMUNE GLOBULIN NOS ATIVAN BACLOFEN BACLOFEN 7030 CALCIUM PREMIUM WINCO FOODS ANTACID ULTRA STRENGTH CREATINE CYMBALTA CYMBALTA DOCUSATE SODIUM 100MG TWO-TONE DULOXETINE ERGOCALCIFEROL VENTRIXYL VENTRIXYL FUROSEMIDE GLICLAZIDE AESCULUS HIPPOCASTANUM HYDROMORPHONE HYDROMORPHONE IMODIUM A-D IMODIUM A-D LACTOBACILLUS ACIDOPHILUS LYRICA MELATONIN MYCOPHENOLATE MOFETIL NORTRIPTYLINE HYDROCHLORIDE HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDE OMEGA-3 FATTY ACIDS OMEGA-3 FATTY ACIDS OMEGA-3 FATTY ACIDS POTASSIUM CHLORIDE POTASSIUM CHLORIDE POTASSIUM CHLORIDE POTASSIUM CHLORIDE PREDNISONE PYRIDOXINE HYDROCHLORIDE RANITIDINE HYDROCHLORIDE OMEGAVEN SENNA LAXATIVE SULFADIAZINE\\TRIMETHOPRIM SULFADIAZINE\\TRIMETHOPRIM SULFADIAZINE\\TRIMETHOPRIM SULFADIAZINE\\TRIMETHOPRIM SULFADIAZINE\\TRIMETHOPRIM SULFADIAZINE\\TRIMETHOPRIM SULFADIAZINE\\TRIMETHOPRIM TIZANIDINE HYDROCHLORIDE RETINOL VITAMIN B COMPLEX WARFARIN SODIUM ZANTAC ZOPICLONE ZOPICLONE BACLOFEN DIETARY SUPPLEMENT\\PROBIOTICS BIFIDOBACTERIUM ANIMALIS LACTIS\\LACTOBACILLUS ACIDOPHILUS BIFIDOBACTERIUM BIFIDUM PROBIOTICS NOS BROMHEXINE HYDROCHLORIDE LORATADINE\\PSEUDOEPHEDRINE SULFATE CLORPRENALINE HYDROCHLORIDE CYANOCOBALAMIN CYANOCOBALAMIN MINERALS\\VITAMINS BABYSONS DOCONEXENT\\ICOSAPENT ASCENIV MYCOPHENOLIC ACID NASONEX THE SKINHOUSE ALOE SOOTHING VITAMIN SULFAMETHOXAZOLE SENOKOT SULFAMETHOXAZOLE\\TRIMETHOPRIM SULFAMETHOXAZOLE\\TRIMETHOPRIM DULOXETINE DULOXETINE TIZANIDINE TIZANIDINE TRIAMTERENE TRIMIPRAMINE SKINEEZ SKINEEZ SKINEEZ SKINEEZ SKINEEZ VITAMIN B12 VITAMIN C SERUM CHOLECALCIFEROL .ALPHA.-TOCOPHEROL MOMETASONE FUROATE ALENDRONATE SODIUM ALENDRONATE SODIUM LORATADINE LORATADINE LORATADINE LORATADINE LORATADINE NAPROXEN SODIUM LORAZEPAM BACLOFEN BACLOFEN CALCIUM CALCIUM CARBONATE DULOXETINE HYDROCHLORIDE DULOXETINE HYDROCHLORIDE DOCUSATE SODIUM DULOXETINE HYDROCHLORIDE ERGOCALCIFEROL FOLIC ACID FOLIC ACID FUROSEMIDE HORSE CHESTNUT LOPERAMIDE HYDROCHLORIDE LOPERAMIDE HYDROCHLORIDE PREGABALIN MELATONIN MYCOPHENOLATE MOFETIL NORTRIPTYLINE HYDROCHLORIDE HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDE POTASSIUM CHLORIDE POTASSIUM CHLORIDE POTASSIUM CHLORIDE POTASSIUM CHLORIDE PREDNISONE PYRIDOXINE HYDROCHLORIDE RANITIDINE HYDROCHLORIDE FISH OIL SENNA LEAF SENNOSIDES TIZANIDINE HYDROCHLORIDE THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE WARFARIN BACLOFEN CYANOCOBALAMIN CYANOCOBALAMIN DEXPANTHENOL HUMAN IMMUNOGLOBULIN G MYCOPHENOLIC ACID MOMETASONE FUROATE NIACINAMIDE STANDARDIZED SENNA CONCENTRATE DULOXETINE HYDROCHLORIDE DULOXETINE HYDROCHLORIDE TIZANIDINE TIZANIDINE TRIAMTERENE CAPSULES TRIMIPRAMINE VITAMIN A VITAMIN A VITAMIN A VITAMIN A VITAMIN A VITAMIN C Product used for unknown indication Product used for unknown indication Product used for unknown indication Product used for unknown indication Product used for unknown indication Product used for unknown indication Product used for unknown indication Product used for unknown indication Product used for unknown indication Product used for unknown indication Pain Product used for unknown indication Product used for unknown indication Product used for unknown indication Product used for unknown indication Product used for unknown indication Product used for unknown indication Product used for unknown indication Product used for unknown indication Product used for unknown indication Product used for unknown indication Product used for unknown indication Product used for unknown indication Product used for unknown indication Product used for unknown indication Product used for unknown indication Product used for unknown indication Product used for unknown indication Product used for unknown indication Product used for unknown indication Product used for unknown indication Product used for unknown indication Product used for unknown indication Product used for unknown indication Product used for unknown indication Product used for unknown indication Product used for unknown indication Product used for unknown indication Product used for unknown indication Product used for unknown indication Product used for unknown indication Product used for unknown indication Product used for unknown indication Product used for unknown indication Product used for unknown indication Product used for unknown indication Coma Gastrooesophageal reflux disease Pneumonia aspiration Somnolence Underdose"}
{"safetyreportid": "10014475", "receiveDate": "20140317", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "0", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "VYVANSE", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Takeda Pharmaceuticals America, Inc.", "genericName": "LISDEXAMFETAMINE DIMESYLATE", "brandName": "VYVANSE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Serotonin syndrome", "outcome": "6"}, {"pt": "Drug interaction", "outcome": "6"}], "classifyText": "VYVANSE CYMBALTA LISDEXAMFETAMINE DIMESYLATE DULOXETINE HYDROCHLORIDE PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Serotonin syndrome Drug interaction"}
{"safetyreportid": "10014479", "receiveDate": "20140317", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "1", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "LEVITRA", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "VIAGRA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Viatris Specialty LLC", "genericName": "SILDENAFIL CITRATE", "brandName": "VIAGRA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CIALIS", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "TADALAFIL", "brandName": "CIALIS", "pharmClass_epc": "Phosphodiesterase 5 Inhibitor [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Knee arthroplasty", "outcome": null}], "classifyText": "LEVITRA VIAGRA CIALIS SILDENAFIL CITRATE TADALAFIL Knee arthroplasty"}
{"safetyreportid": "10014522", "receiveDate": "20140317", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "MX", "reportType": "2", "patientSex": "2", "patientAge": "63", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "ERLOTINIB TABLET", "drugcharacterization": "1", "drugindication": "NON-SMALL CELL LUNG CANCER", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "AVASTIN /01555201/", "drugcharacterization": "1", "drugindication": "NON-SMALL CELL LUNG CANCER", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "PEMETREXED DISODIUM", "drugcharacterization": "2", "drugindication": "NON-SMALL CELL LUNG CANCER", "manufacturer": "Sagent Pharmaceuticals", "genericName": "PEMETREXED DISODIUM", "brandName": "PEMETREXED", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "CISPLATIN", "drugcharacterization": "2", "drugindication": "NON-SMALL CELL LUNG CANCER", "manufacturer": "Teva Parenteral Medicines, Inc.", "genericName": "CISPLATIN", "brandName": "CISPLATIN", "pharmClass_epc": "Platinum-based Drug [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "NAVELBINE", "drugcharacterization": "2", "drugindication": "NON-SMALL CELL LUNG CANCER", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Pain", "outcome": "6"}, {"pt": "Hypertension", "outcome": "6"}, {"pt": "Investigation", "outcome": "6"}, {"pt": "Vomiting", "outcome": "6"}, {"pt": "Diarrhoea", "outcome": "6"}, {"pt": "Malignant neoplasm progression", "outcome": "6"}], "classifyText": "ERLOTINIB TABLET AVASTIN /01555201/ PEMETREXED CISPLATIN NAVELBINE PEMETREXED DISODIUM CISPLATIN NON-SMALL CELL LUNG CANCER NON-SMALL CELL LUNG CANCER NON-SMALL CELL LUNG CANCER NON-SMALL CELL LUNG CANCER NON-SMALL CELL LUNG CANCER Pain Hypertension Investigation Vomiting Diarrhoea Malignant neoplasm progression"}
{"safetyreportid": "10014596", "receiveDate": "20140317", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "GB", "reportType": "1", "patientSex": "2", "patientAge": "40", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "ZYPREXA", "drugcharacterization": "1", "drugindication": "PSYCHOTIC DISORDER", "manufacturer": "Eli Lilly and Company", "genericName": "OLANZAPINE", "brandName": "ZYPREXA INTRAMUSCULAR", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "INTRAMUSCULAR"}], "reactions": [{"pt": "Neutrophil count decreased", "outcome": "6"}], "classifyText": "ZYPREXA INTRAMUSCULAR OLANZAPINE PSYCHOTIC DISORDER Neutrophil count decreased"}
{"safetyreportid": "10014597", "receiveDate": "20140317", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 1, "occurcountry": "NL", "reportType": "1", "patientSex": "1", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "CYMBALTA", "drugcharacterization": "1", "drugindication": "ANXIETY", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "1", "drugindication": "PANIC ATTACK", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "NEXIUM /01479302/", "drugcharacterization": "2", "drugindication": "BARRETT^S OESOPHAGUS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Oesophageal compression", "outcome": "6"}, {"pt": "Haemoptysis", "outcome": "6"}, {"pt": "Blood iron decreased", "outcome": "6"}, {"pt": "Drug hypersensitivity", "outcome": "6"}], "classifyText": "CYMBALTA CYMBALTA NEXIUM /01479302/ DULOXETINE HYDROCHLORIDE DULOXETINE HYDROCHLORIDE ANXIETY PANIC ATTACK BARRETT^S OESOPHAGUS Oesophageal compression Haemoptysis Blood iron decreased Drug hypersensitivity"}
{"safetyreportid": "10014601", "receiveDate": "20140317", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "KR", "reportType": "1", "patientSex": "2", "patientAge": "31", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "OLANZAPINE", "drugcharacterization": "1", "drugindication": "BIPOLAR DISORDER", "manufacturer": "Hisun Pharmaceuticals USA, Inc.", "genericName": "OLANZAPINE", "brandName": "OLANZAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "OLANZAPINE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Hisun Pharmaceuticals USA, Inc.", "genericName": "OLANZAPINE", "brandName": "OLANZAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "OLANZAPINE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Hisun Pharmaceuticals USA, Inc.", "genericName": "OLANZAPINE", "brandName": "OLANZAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "VALPROIC ACID", "drugcharacterization": "2", "drugindication": "BIPOLAR DISORDER", "manufacturer": "Bionpharma Inc.", "genericName": "VALPROIC ACID", "brandName": "VALPROIC ACID", "pharmClass_epc": "Anti-epileptic Agent [EPC]", "route": "ORAL"}, {"medicinalproduct": "QUETIAPINE", "drugcharacterization": "2", "drugindication": "AFFECTIVE DISORDER", "manufacturer": "Solco Healthcare U.S., LLC", "genericName": "QUETIAPINE", "brandName": "QUETIAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "QUETIAPINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Solco Healthcare U.S., LLC", "genericName": "QUETIAPINE", "brandName": "QUETIAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "CLONAZEPAM", "drugcharacterization": "2", "drugindication": "AFFECTIVE DISORDER", "manufacturer": "Advagen Pharma Ltd", "genericName": "CLONAZEPAM", "brandName": "CLONAZEPAM", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Mania", "outcome": "1"}, {"pt": "Delusion", "outcome": "1"}, {"pt": "Oligohydramnios", "outcome": "6"}, {"pt": "Exposure during pregnancy", "outcome": "1"}, {"pt": "Irritability", "outcome": "1"}, {"pt": "Abnormal behaviour", "outcome": "1"}], "classifyText": "OLANZAPINE OLANZAPINE OLANZAPINE VALPROIC ACID QUETIAPINE QUETIAPINE CLONAZEPAM OLANZAPINE OLANZAPINE OLANZAPINE VALPROIC ACID QUETIAPINE QUETIAPINE CLONAZEPAM BIPOLAR DISORDER BIPOLAR DISORDER AFFECTIVE DISORDER AFFECTIVE DISORDER Mania Delusion Oligohydramnios Exposure during pregnancy Irritability Abnormal behaviour"}
{"safetyreportid": "10014602", "receiveDate": "20140317", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 1, "occurcountry": "JP", "reportType": "1", "patientSex": "2", "patientAge": "63", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "ZYPREXA", "drugcharacterization": "1", "drugindication": "SCHIZOPHRENIA", "manufacturer": "Eli Lilly and Company", "genericName": "OLANZAPINE", "brandName": "ZYPREXA INTRAMUSCULAR", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "DEPAKENE", "drugcharacterization": "2", "drugindication": "SCHIZOPHRENIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ROHYPNOL", "drugcharacterization": "2", "drugindication": "SCHIZOPHRENIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Hypothermia", "outcome": "1"}, {"pt": "Neuroleptic malignant syndrome", "outcome": "1"}, {"pt": "Pancreatitis acute", "outcome": "1"}, {"pt": "Pneumonia aspiration", "outcome": "1"}, {"pt": "Chills", "outcome": "6"}, {"pt": "Decreased appetite", "outcome": "6"}, {"pt": "Blood potassium decreased", "outcome": "6"}], "classifyText": "ZYPREXA INTRAMUSCULAR DEPAKENE ROHYPNOL OLANZAPINE SCHIZOPHRENIA SCHIZOPHRENIA SCHIZOPHRENIA Hypothermia Neuroleptic malignant syndrome Pancreatitis acute Pneumonia aspiration Chills Decreased appetite Blood potassium decreased"}
{"safetyreportid": "10014603", "receiveDate": "20140317", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "JP", "reportType": "1", "patientSex": "2", "patientAge": "35", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "ZYPREXA", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "OLANZAPINE", "brandName": "ZYPREXA INTRAMUSCULAR", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "ZYPREXA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "OLANZAPINE", "brandName": "ZYPREXA INTRAMUSCULAR", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "ETIZOLAM", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "BROTIZOLAM", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ESTAZOLAM", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Actavis Pharma, Inc.", "genericName": "ESTAZOLAM", "brandName": "ESTAZOLAM", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Neuroleptic malignant syndrome", "outcome": "6"}, {"pt": "Pneumonia aspiration", "outcome": "6"}, {"pt": "Melaena", "outcome": "6"}], "classifyText": "ZYPREXA INTRAMUSCULAR ZYPREXA INTRAMUSCULAR ETIZOLAM BROTIZOLAM ESTAZOLAM OLANZAPINE OLANZAPINE ESTAZOLAM PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Neuroleptic malignant syndrome Pneumonia aspiration Melaena"}
{"safetyreportid": "10014679", "receiveDate": "20140317", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "54", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "HIZENTRA", "drugcharacterization": "1", "drugindication": "HYPOGLOBULINAEMIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "HIZENTRA", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "HIZENTRA", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "HIZENTRA", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "HIZENTRA", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "HIZENTRA", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "HIZENTRA", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "HIZENTRA", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CEFUROXIME AXETIL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Aurobindo Pharma Limited", "genericName": "CEFUROXIME AXETIL", "brandName": "CEFUROXIME AXETIL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ASTEPRO", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "GEODON", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Viatris Specialty LLC", "genericName": "ZIPRASIDONE", "brandName": "GEODON", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "CETIRIZINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "GERI-CARE PHARMACEUTICAL CORP", "genericName": "CETIRIZINE", "brandName": "CETIRIZINE HCL", "pharmClass_epc": "Histamine-1 Receptor Antagonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "HYDROXYZINE HCL", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "OMEPRAZOLE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Amerisource Bergen", "genericName": "OMEPRAZOLE", "brandName": "GOOD NEIGHBOR PHARMACY OMEPRAZOLE", "pharmClass_epc": "Proton Pump Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "BENZONATATE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "TAGI Pharma, Inc.", "genericName": "BENZONATATE", "brandName": "BENZONATATE", "pharmClass_epc": "Non-narcotic Antitussive [EPC]", "route": "ORAL"}, {"medicinalproduct": "THEOPHYLLINE ER", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CALCIUM+D", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "XOPENEX", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "DIPHENHYDRAMINE", "drugcharacterization": "2", "drugindication": "PREMEDICATION", "manufacturer": "Velocity Pharma", "genericName": "DIPHENHYDRAMINE", "brandName": "NIGHTIME SLEEP AID", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LIDOCAINE/PRILOCAINE", "drugcharacterization": "2", "drugindication": "PREMEDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "EPI-PEN", "drugcharacterization": "2", "drugindication": "PREMEDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SINGULAIR", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Organon LLC", "genericName": "MONTELUKAST SODIUM", "brandName": "SINGULAIR", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "FLUTICASONE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "PATADAY", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LORATADINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Bionpharma Inc.", "genericName": "LORATADINE", "brandName": "LORATADINE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "TRAMADOL", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SIMVASTATIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Accord Healthcare, Inc.", "genericName": "SIMVASTATIN", "brandName": "SIMVASTATIN", "pharmClass_epc": "HMG-CoA Reductase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "VENTOLIN HFA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "GlaxoSmithKline LLC", "genericName": "ALBUTEROL SULFATE", "brandName": "VENTOLIN HFA", "pharmClass_epc": null, "route": "RESPIRATORY (INHALATION)"}, {"medicinalproduct": "VITAMIN D", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Strides Pharma Science Limited", "genericName": "ERGOCALCIFEROL", "brandName": "VITAMIN D", "pharmClass_epc": "Provitamin D2 Compound [EPC]", "route": "ORAL"}, {"medicinalproduct": "SYMBICORT", "drugcharacterization": "2", "drugindication": null, "manufacturer": "AstraZeneca Pharmaceuticals LP", "genericName": "BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE", "brandName": "SYMBICORT", "pharmClass_epc": "Corticosteroid [EPC]", "route": "RESPIRATORY (INHALATION)"}, {"medicinalproduct": "IPRATROPIUM BROMIDE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "NORTHSTAR RX LLC", "genericName": "IPRATROPIUM BROMIDE", "brandName": "IPRATROPIUM BROMIDE", "pharmClass_epc": null, "route": "NASAL"}, {"medicinalproduct": "SPIRIVA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Boehringer Ingelheim Pharmaceuticals, Inc.", "genericName": "TIOTROPIUM BROMIDE", "brandName": "SPIRIVA HANDIHALER", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "AMOX TR-K CLV", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "PREDNISONE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "ANI Pharmaceuticals, Inc.", "genericName": "PREDNISONE", "brandName": "PREDNISONE", "pharmClass_epc": "Corticosteroid [EPC]", "route": "ORAL"}, {"medicinalproduct": "CEPHALEXIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "AMELLA PHARMA, LLC", "genericName": "CEPHALEXIN", "brandName": "CEPHALEXIN", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Syncope", "outcome": "6"}, {"pt": "Infusion site mass", "outcome": "6"}, {"pt": "Infusion site haemorrhage", "outcome": "6"}, {"pt": "Chills", "outcome": "1"}], "classifyText": "HIZENTRA HIZENTRA HIZENTRA HIZENTRA HIZENTRA HIZENTRA HIZENTRA HIZENTRA CEFUROXIME AXETIL CYMBALTA ASTEPRO GEODON CETIRIZINE HCL HYDROXYZINE HCL GOOD NEIGHBOR PHARMACY OMEPRAZOLE BENZONATATE THEOPHYLLINE ER CALCIUM+D XOPENEX NIGHTIME SLEEP AID LIDOCAINE/PRILOCAINE EPI-PEN SINGULAIR FLUTICASONE PATADAY LORATADINE TRAMADOL SIMVASTATIN VENTOLIN HFA VITAMIN D SYMBICORT IPRATROPIUM BROMIDE SPIRIVA HANDIHALER AMOX TR-K CLV PREDNISONE CEPHALEXIN CEFUROXIME AXETIL DULOXETINE HYDROCHLORIDE ZIPRASIDONE CETIRIZINE OMEPRAZOLE BENZONATATE DIPHENHYDRAMINE MONTELUKAST SODIUM LORATADINE SIMVASTATIN ALBUTEROL SULFATE ERGOCALCIFEROL BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE IPRATROPIUM BROMIDE TIOTROPIUM BROMIDE PREDNISONE CEPHALEXIN HYPOGLOBULINAEMIA PREMEDICATION PREMEDICATION PREMEDICATION Syncope Infusion site mass Infusion site haemorrhage Chills"}
{"safetyreportid": "10014813", "receiveDate": "20140317", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "CA", "reportType": "1", "patientSex": "1", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "CIALIS", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "TADALAFIL", "brandName": "CIALIS", "pharmClass_epc": "Phosphodiesterase 5 Inhibitor [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Arterial occlusive disease", "outcome": "2"}, {"pt": "Chest pain", "outcome": "6"}, {"pt": "Off label use", "outcome": "6"}], "classifyText": "CIALIS TADALAFIL PRODUCT USED FOR UNKNOWN INDICATION Arterial occlusive disease Chest pain Off label use"}
{"safetyreportid": "10014818", "receiveDate": "20140317", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 1, "occurcountry": "JP", "reportType": "1", "patientSex": "1", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "DEPAS", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "GLIMICRON", "drugcharacterization": "2", "drugindication": "TYPE 2 DIABETES MELLITUS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "PANVITAN", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CARBOPLATIN.", "drugcharacterization": "1", "drugindication": "LUNG ADENOCARCINOMA STAGE III", "manufacturer": "Apotex Corp.", "genericName": "CARBOPLATIN", "brandName": "CARBOPLATIN", "pharmClass_epc": "Platinum-based Drug [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "JANUVIA", "drugcharacterization": "2", "drugindication": "TYPE 2 DIABETES MELLITUS", "manufacturer": "Merck Sharp & Dohme LLC", "genericName": "SITAGLIPTIN", "brandName": "JANUVIA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "METHYCOBAL", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ALIMTA", "drugcharacterization": "1", "drugindication": "LUNG ADENOCARCINOMA STAGE III", "manufacturer": "Eli Lilly and Company", "genericName": "PEMETREXED DISODIUM", "brandName": "ALIMTA", "pharmClass_epc": null, "route": "INTRAVENOUS"}], "reactions": [{"pt": "Duodenal perforation", "outcome": "3"}, {"pt": "Jejunal perforation", "outcome": "3"}, {"pt": "Malignant neoplasm progression", "outcome": "6"}], "classifyText": "DEPAS GLIMICRON PANVITAN CARBOPLATIN JANUVIA METHYCOBAL ALIMTA CARBOPLATIN SITAGLIPTIN PEMETREXED DISODIUM TYPE 2 DIABETES MELLITUS LUNG ADENOCARCINOMA STAGE III TYPE 2 DIABETES MELLITUS LUNG ADENOCARCINOMA STAGE III Duodenal perforation Jejunal perforation Malignant neoplasm progression"}
{"safetyreportid": "10014820", "receiveDate": "20140317", "serious": 1, "seriousnessdeath": 1, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "JP", "reportType": "1", "patientSex": "1", "patientAge": "49", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "ALIMTA", "drugcharacterization": "1", "drugindication": "EPITHELIOID MESOTHELIOMA", "manufacturer": "Eli Lilly and Company", "genericName": "PEMETREXED DISODIUM", "brandName": "ALIMTA", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "PANVITAN", "drugcharacterization": "2", "drugindication": "PROPHYLAXIS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ALIMTA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "PEMETREXED DISODIUM", "brandName": "ALIMTA", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "CISPLATIN.", "drugcharacterization": "2", "drugindication": "EPITHELIOID MESOTHELIOMA", "manufacturer": "Teva Parenteral Medicines, Inc.", "genericName": "CISPLATIN", "brandName": "CISPLATIN", "pharmClass_epc": "Platinum-based Drug [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "FRESMIN S", "drugcharacterization": "2", "drugindication": "PROPHYLAXIS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CARBOPLATIN.", "drugcharacterization": "2", "drugindication": "EPITHELIOID MESOTHELIOMA", "manufacturer": "Apotex Corp.", "genericName": "CARBOPLATIN", "brandName": "CARBOPLATIN", "pharmClass_epc": "Platinum-based Drug [EPC]", "route": "INTRAVENOUS"}], "reactions": [{"pt": "Nephrotic syndrome", "outcome": "1"}, {"pt": "Malignant neoplasm progression", "outcome": "5"}], "classifyText": "ALIMTA PANVITAN ALIMTA CISPLATIN FRESMIN S CARBOPLATIN PEMETREXED DISODIUM PEMETREXED DISODIUM CISPLATIN CARBOPLATIN EPITHELIOID MESOTHELIOMA PROPHYLAXIS EPITHELIOID MESOTHELIOMA PROPHYLAXIS EPITHELIOID MESOTHELIOMA Nephrotic syndrome Malignant neoplasm progression"}
{"safetyreportid": "10014823", "receiveDate": "20140317", "serious": 1, "seriousnessdeath": 1, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "DE", "reportType": "1", "patientSex": "2", "patientAge": "53", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "ALIMTA", "drugcharacterization": "1", "drugindication": "NON-SMALL CELL LUNG CANCER", "manufacturer": "Eli Lilly and Company", "genericName": "PEMETREXED DISODIUM", "brandName": "ALIMTA", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "CARBOPLATIN", "drugcharacterization": "2", "drugindication": "NON-SMALL CELL LUNG CANCER", "manufacturer": "Apotex Corp.", "genericName": "CARBOPLATIN", "brandName": "CARBOPLATIN", "pharmClass_epc": "Platinum-based Drug [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "FOLIC ACID", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "PureTek Corporation", "genericName": "FOLIC ACID", "brandName": "VENTRIXYL", "pharmClass_epc": "Vitamin C [EPC]", "route": "ORAL"}, {"medicinalproduct": "VITAMIN B12 /00056201/", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "DEXAMETHASON /00016001/", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Pancytopenia", "outcome": "5"}, {"pt": "Mucosal inflammation", "outcome": "5"}, {"pt": "Off label use", "outcome": "6"}], "classifyText": "ALIMTA CARBOPLATIN VENTRIXYL VITAMIN B12 /00056201/ DEXAMETHASON /00016001/ PEMETREXED DISODIUM CARBOPLATIN FOLIC ACID NON-SMALL CELL LUNG CANCER NON-SMALL CELL LUNG CANCER PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Pancytopenia Mucosal inflammation Off label use"}
{"safetyreportid": "10014824", "receiveDate": "20140317", "serious": 1, "seriousnessdeath": 1, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "FR", "reportType": "1", "patientSex": "1", "patientAge": "71", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "ALIMTA", "drugcharacterization": "1", "drugindication": "BRONCHIAL CARCINOMA", "manufacturer": "Eli Lilly and Company", "genericName": "PEMETREXED DISODIUM", "brandName": "ALIMTA", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "ALIMTA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "PEMETREXED DISODIUM", "brandName": "ALIMTA", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "ALIMTA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "PEMETREXED DISODIUM", "brandName": "ALIMTA", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "ALIMTA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "PEMETREXED DISODIUM", "brandName": "ALIMTA", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "CISPLATINE", "drugcharacterization": "2", "drugindication": "BRONCHIAL CARCINOMA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "VINORELBINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Sagent Pharmaceuticals", "genericName": "VINORELBINE", "brandName": "VINORELBINE", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "CARBOPLATINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Pulmonary fibrosis", "outcome": "5"}, {"pt": "Pyrexia", "outcome": "6"}, {"pt": "Haemophilus infection", "outcome": "6"}, {"pt": "Deep vein thrombosis", "outcome": "6"}, {"pt": "Pulmonary embolism", "outcome": "6"}, {"pt": "Metastases to bone", "outcome": "6"}, {"pt": "Metastases to liver", "outcome": "6"}, {"pt": "Pneumocystis test positive", "outcome": "6"}, {"pt": "Simplex virus test positive", "outcome": "6"}], "classifyText": "ALIMTA ALIMTA ALIMTA ALIMTA CISPLATINE VINORELBINE CARBOPLATINE PEMETREXED DISODIUM PEMETREXED DISODIUM PEMETREXED DISODIUM PEMETREXED DISODIUM VINORELBINE BRONCHIAL CARCINOMA BRONCHIAL CARCINOMA Pulmonary fibrosis Pyrexia Haemophilus infection Deep vein thrombosis Pulmonary embolism Metastases to bone Metastases to liver Pneumocystis test positive Simplex virus test positive"}
{"safetyreportid": "10014913", "receiveDate": "20140317", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "GB", "reportType": "1", "patientSex": "1", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "SERTRALINE HCL", "drugcharacterization": "1", "drugindication": "DEPRESSION", "manufacturer": "Biocon Pharma Inc.", "genericName": "SERTRALINE HYDROCHLORIDE", "brandName": "SERTRALINE HCL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "SERTRALINE HCL", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Biocon Pharma Inc.", "genericName": "SERTRALINE HYDROCHLORIDE", "brandName": "SERTRALINE HCL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "OLANZAPINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Hisun Pharmaceuticals USA, Inc.", "genericName": "OLANZAPINE", "brandName": "OLANZAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "PROMETHAZINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Drug ineffective", "outcome": "3"}, {"pt": "Suicidal ideation", "outcome": "3"}, {"pt": "Obsessive thoughts", "outcome": "3"}, {"pt": "Restlessness", "outcome": "3"}, {"pt": "Ageusia", "outcome": "3"}, {"pt": "Insomnia", "outcome": "3"}, {"pt": "Decreased appetite", "outcome": "3"}, {"pt": "Myalgia", "outcome": "3"}, {"pt": "Hypoaesthesia", "outcome": "3"}], "classifyText": "SERTRALINE HCL SERTRALINE HCL OLANZAPINE PROMETHAZINE SERTRALINE HYDROCHLORIDE SERTRALINE HYDROCHLORIDE OLANZAPINE DEPRESSION Drug ineffective Suicidal ideation Obsessive thoughts Restlessness Ageusia Insomnia Decreased appetite Myalgia Hypoaesthesia"}
{"safetyreportid": "10014936", "receiveDate": "20140317", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "1", "patientAge": "60", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "REVLIMID", "drugcharacterization": "1", "drugindication": "PLASMA CELL MYELOMA", "manufacturer": "Celgene Corporation", "genericName": "LENALIDOMIDE", "brandName": "REVLIMID", "pharmClass_epc": "Thalidomide Analog [EPC]", "route": "ORAL"}, {"medicinalproduct": "REVLIMID", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Celgene Corporation", "genericName": "LENALIDOMIDE", "brandName": "REVLIMID", "pharmClass_epc": "Thalidomide Analog [EPC]", "route": "ORAL"}, {"medicinalproduct": "REVLIMID", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Celgene Corporation", "genericName": "LENALIDOMIDE", "brandName": "REVLIMID", "pharmClass_epc": "Thalidomide Analog [EPC]", "route": "ORAL"}, {"medicinalproduct": "REVLIMID", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Celgene Corporation", "genericName": "LENALIDOMIDE", "brandName": "REVLIMID", "pharmClass_epc": "Thalidomide Analog [EPC]", "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "TAMIFLU", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Genentech, Inc.", "genericName": "OSELTAMIVIR PHOSPHATE", "brandName": "TAMIFLU", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LYRICA", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Parke-Davis Div of Pfizer Inc", "genericName": "PREGABALIN", "brandName": "LYRICA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ZOMETA", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "OMEPRAZOLE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Amerisource Bergen", "genericName": "OMEPRAZOLE", "brandName": "GOOD NEIGHBOR PHARMACY OMEPRAZOLE", "pharmClass_epc": "Proton Pump Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "GLIMEPIRIDE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Carlsbad Technology, Inc.", "genericName": "GLIMEPIRIDE", "brandName": "GLIMEPIRIDE", "pharmClass_epc": "Sulfonylurea [EPC]", "route": "ORAL"}, {"medicinalproduct": "ACYCLOVIR", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Zydus Pharmaceuticals (USA) Inc.", "genericName": "ACYCLOVIR", "brandName": "ACYCLOVIR", "pharmClass_epc": "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "MAGNESIUM GLUCONATE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "AMITRIPTYLINE HCL", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Diabetes mellitus", "outcome": "1"}, {"pt": "Pneumonia", "outcome": "1"}, {"pt": "Influenza", "outcome": "1"}], "classifyText": "REVLIMID REVLIMID REVLIMID REVLIMID CYMBALTA TAMIFLU LYRICA ZOMETA GOOD NEIGHBOR PHARMACY OMEPRAZOLE GLIMEPIRIDE ACYCLOVIR MAGNESIUM GLUCONATE AMITRIPTYLINE HCL LENALIDOMIDE LENALIDOMIDE LENALIDOMIDE LENALIDOMIDE DULOXETINE HYDROCHLORIDE OSELTAMIVIR PHOSPHATE PREGABALIN OMEPRAZOLE GLIMEPIRIDE ACYCLOVIR PLASMA CELL MYELOMA PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Diabetes mellitus Pneumonia Influenza"}
{"safetyreportid": "10014943", "receiveDate": "20140317", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "MX", "reportType": "1", "patientSex": "2", "patientAge": "48", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "CYMBALTA", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Angioedema", "outcome": "2"}, {"pt": "Dry skin", "outcome": "2"}], "classifyText": "CYMBALTA DULOXETINE HYDROCHLORIDE PRODUCT USED FOR UNKNOWN INDICATION Angioedema Dry skin"}
{"safetyreportid": "10015029", "receiveDate": "20140317", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "BR", "reportType": "1", "patientSex": "2", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "HUMULIN R", "drugcharacterization": "1", "drugindication": "DIABETES MELLITUS", "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN HUMAN", "brandName": "HUMULIN R", "pharmClass_epc": "Insulin [EPC]", "route": "PARENTERAL"}, {"medicinalproduct": "HUMULIN N", "drugcharacterization": "1", "drugindication": "DIABETES MELLITUS", "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN HUMAN", "brandName": "HUMULIN N", "pharmClass_epc": "Insulin [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "OMEPRAZOLE", "drugcharacterization": "2", "drugindication": "HYPERTENSION", "manufacturer": "Amerisource Bergen", "genericName": "OMEPRAZOLE", "brandName": "GOOD NEIGHBOR PHARMACY OMEPRAZOLE", "pharmClass_epc": "Proton Pump Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "ATENSINA", "drugcharacterization": "2", "drugindication": "HYPERTENSION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CAPTOPRIL", "drugcharacterization": "2", "drugindication": "HYPERTENSION", "manufacturer": "AiPing Pharmaceutical, Inc.", "genericName": "CAPTOPRIL", "brandName": "CAPTOPRIL", "pharmClass_epc": "Angiotensin Converting Enzyme Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "AMLODIPIN /00972401/", "drugcharacterization": "2", "drugindication": "HYPERTENSION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "FOLIC ACID", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "PureTek Corporation", "genericName": "FOLIC ACID", "brandName": "VENTRIXYL", "pharmClass_epc": "Vitamin C [EPC]", "route": "ORAL"}, {"medicinalproduct": "COMPLEX B /00653501/", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Renal failure", "outcome": "3"}, {"pt": "Blindness", "outcome": "3"}, {"pt": "Diabetic complication", "outcome": "6"}], "classifyText": "HUMULIN R HUMULIN N GOOD NEIGHBOR PHARMACY OMEPRAZOLE ATENSINA CAPTOPRIL AMLODIPIN /00972401/ VENTRIXYL COMPLEX B /00653501/ INSULIN HUMAN INSULIN HUMAN OMEPRAZOLE CAPTOPRIL FOLIC ACID DIABETES MELLITUS DIABETES MELLITUS HYPERTENSION HYPERTENSION HYPERTENSION HYPERTENSION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Renal failure Blindness Diabetic complication"}
{"safetyreportid": "10015038", "receiveDate": "20140317", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "JP", "reportType": "1", "patientSex": "1", "patientAge": "77", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "FORTEO", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "TERIPARATIDE", "brandName": "FORTEO", "pharmClass_epc": "Parathyroid Hormone Analog [EPC]", "route": "SUBCUTANEOUS"}], "reactions": [{"pt": "Spinal deformity", "outcome": "6"}, {"pt": "Neuralgia", "outcome": "6"}], "classifyText": "FORTEO TERIPARATIDE PRODUCT USED FOR UNKNOWN INDICATION Spinal deformity Neuralgia"}
{"safetyreportid": "10015055", "receiveDate": "20140317", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "1", "patientAge": "62", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "OLANZAPINE", "drugcharacterization": "1", "drugindication": "FEELING ABNORMAL", "manufacturer": "Hisun Pharmaceuticals USA, Inc.", "genericName": "OLANZAPINE", "brandName": "OLANZAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "WELLBUTRIN", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Bausch Health US LLC", "genericName": "BUPROPION HYDROCHLORIDE", "brandName": "WELLBUTRIN XL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "REMERON", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Organon LLC", "genericName": "MIRTAZAPINE", "brandName": "REMERON", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CARVEDILOL", "drugcharacterization": "2", "drugindication": "HYPERTENSION", "manufacturer": "Advagen Pharma Limited", "genericName": "CARVEDILOL", "brandName": "CARVEDILOL", "pharmClass_epc": "alpha-Adrenergic Blocker [EPC]", "route": "ORAL"}, {"medicinalproduct": "AMLODIPINE BESYLATE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Zydus Pharmaceuticals USA Inc.", "genericName": "AMLODIPINE BESYLATE", "brandName": "AMLODIPINE BESYLATE", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Hepatic failure", "outcome": "3"}, {"pt": "Ammonia increased", "outcome": "6"}, {"pt": "Confusional state", "outcome": "6"}], "classifyText": "OLANZAPINE WELLBUTRIN XL REMERON CARVEDILOL AMLODIPINE BESYLATE OLANZAPINE BUPROPION HYDROCHLORIDE MIRTAZAPINE CARVEDILOL AMLODIPINE BESYLATE FEELING ABNORMAL HYPERTENSION Hepatic failure Ammonia increased Confusional state"}
{"safetyreportid": "10015245", "receiveDate": "20140317", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "57", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "PRISTIQ", "drugcharacterization": "1", "drugindication": "DEPRESSION", "manufacturer": "Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.", "genericName": "DESVENLAFAXINE SUCCINATE", "brandName": "PRISTIQ EXTENDED-RELEASE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LYRICA", "drugcharacterization": "2", "drugindication": "FIBROMYALGIA", "manufacturer": "Parke-Davis Div of Pfizer Inc", "genericName": "PREGABALIN", "brandName": "LYRICA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ABILIFY", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Otsuka America Pharmaceutical, Inc.", "genericName": "ARIPIPRAZOLE", "brandName": "ABILIFY", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "ASPIRIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Unifirst First Aid Corporation", "genericName": "ASPIRIN", "brandName": "BAYER GENUINE ASPIRIN", "pharmClass_epc": "Nonsteroidal Anti-inflammatory Drug [EPC]", "route": "ORAL"}, {"medicinalproduct": "ATENOLOL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Almatica Pharma LLC", "genericName": "ATENOLOL", "brandName": "TENORMIN", "pharmClass_epc": "beta-Adrenergic Blocker [EPC]", "route": "ORAL"}, {"medicinalproduct": "AZELASTINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Amneal Pharmaceuticals NY LLC", "genericName": "AZELASTINE", "brandName": "AZELASTINE HCL", "pharmClass_epc": null, "route": "NASAL"}, {"medicinalproduct": "CITRUCEL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Haleon US Holdings LLC", "genericName": "METHYLCELLULOSE", "brandName": "CITRUCEL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CLARITIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Bayer Healthcare LLC.", "genericName": "LORATADINE", "brandName": "CLARITIN REDITABS", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "FEXOFENADINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "FUROSEMIDE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Ipca Laboratories Limited", "genericName": "FUROSEMIDE", "brandName": "FUROSEMIDE", "pharmClass_epc": "Loop Diuretic [EPC]", "route": "ORAL"}, {"medicinalproduct": "IBUPROFEN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "DOLGENCORP INC", "genericName": "IBUPROFEN", "brandName": "IBUPROFEN", "pharmClass_epc": "Nonsteroidal Anti-inflammatory Drug [EPC]", "route": "ORAL"}, {"medicinalproduct": "KLONOPIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "H2-Pharma, LLC", "genericName": "CLONAZEPAM", "brandName": "KLONOPIN", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "ORAL"}, {"medicinalproduct": "LASIX", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Validus Pharmaceuticals LLC", "genericName": "FUROSEMIDE", "brandName": "LASIX", "pharmClass_epc": "Loop Diuretic [EPC]", "route": "ORAL"}, {"medicinalproduct": "LEVOTHYROXINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LORTAB", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "NASONEX", "drugcharacterization": "2", "drugindication": null, "manufacturer": "L. Perrigo Company", "genericName": "MOMETASONE FUROATE", "brandName": "NASONEX", "pharmClass_epc": null, "route": "NASAL"}, {"medicinalproduct": "SIMVASTATIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Accord Healthcare, Inc.", "genericName": "SIMVASTATIN", "brandName": "SIMVASTATIN", "pharmClass_epc": "HMG-CoA Reductase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "TOPAMAX", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Janssen Pharmaceuticals, Inc.", "genericName": "TOPIRAMATE", "brandName": "TOPAMAX", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "TOPIRAMATE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Camber Pharmaceuticals, Inc.", "genericName": "TOPIRAMATE", "brandName": "TOPIRAMATE", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Malaise", "outcome": "3"}], "classifyText": "PRISTIQ EXTENDED-RELEASE LYRICA ABILIFY BAYER GENUINE ASPIRIN TENORMIN AZELASTINE HCL CITRUCEL CLARITIN REDITABS CYMBALTA FEXOFENADINE FUROSEMIDE IBUPROFEN KLONOPIN LASIX LEVOTHYROXINE LORTAB NASONEX SIMVASTATIN TOPAMAX TOPIRAMATE DESVENLAFAXINE SUCCINATE PREGABALIN ARIPIPRAZOLE ASPIRIN ATENOLOL AZELASTINE METHYLCELLULOSE LORATADINE DULOXETINE HYDROCHLORIDE FUROSEMIDE IBUPROFEN CLONAZEPAM FUROSEMIDE MOMETASONE FUROATE SIMVASTATIN TOPIRAMATE TOPIRAMATE DEPRESSION FIBROMYALGIA Malaise"}
{"safetyreportid": "10015415", "receiveDate": "20140317", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "GB", "reportType": "1", "patientSex": "2", "patientAge": "37", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "OLANZAPINE", "drugcharacterization": "1", "drugindication": "SCHIZOPHRENIA", "manufacturer": "Hisun Pharmaceuticals USA, Inc.", "genericName": "OLANZAPINE", "brandName": "OLANZAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "VALPROIC ACID", "drugcharacterization": "1", "drugindication": "AFFECTIVE DISORDER", "manufacturer": "Bionpharma Inc.", "genericName": "VALPROIC ACID", "brandName": "VALPROIC ACID", "pharmClass_epc": "Anti-epileptic Agent [EPC]", "route": "ORAL"}, {"medicinalproduct": "CLOZARIL", "drugcharacterization": "1", "drugindication": null, "manufacturer": "HLS Therapeutics (USA), Inc.", "genericName": "CLOZAPINE", "brandName": "CLOZARIL", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Alopecia", "outcome": "3"}, {"pt": "Anxiety", "outcome": "2"}], "classifyText": "OLANZAPINE VALPROIC ACID CLOZARIL OLANZAPINE VALPROIC ACID CLOZAPINE SCHIZOPHRENIA AFFECTIVE DISORDER Alopecia Anxiety"}
{"safetyreportid": "10015422", "receiveDate": "20140317", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "2", "patientSex": "2", "patientAge": "72", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "GAMMAGARD LIQUID", "drugcharacterization": "1", "drugindication": "SELECTIVE IGG SUBCLASS DEFICIENCY", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "GAMMAGARD LIQUID", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "GAMMAGARD LIQUID", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "GAMMAGARD LIQUID", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SYNTHROID", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "AbbVie Inc.", "genericName": "LEVOTHYROXINE SODIUM", "brandName": "SYNTHROID", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CRESTOR", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "AstraZeneca Pharmaceuticals LP", "genericName": "ROSUVASTATIN", "brandName": "CRESTOR", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ASA", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Erythema", "outcome": "3"}, {"pt": "Pain in extremity", "outcome": "3"}, {"pt": "Muscular weakness", "outcome": "3"}, {"pt": "Pain", "outcome": "3"}, {"pt": "Muscular weakness", "outcome": "3"}, {"pt": "Vision blurred", "outcome": "1"}, {"pt": "Headache", "outcome": "1"}, {"pt": "Musculoskeletal discomfort", "outcome": "1"}], "classifyText": "GAMMAGARD LIQUID GAMMAGARD LIQUID GAMMAGARD LIQUID GAMMAGARD LIQUID SYNTHROID CYMBALTA CRESTOR ASA LEVOTHYROXINE SODIUM DULOXETINE HYDROCHLORIDE ROSUVASTATIN SELECTIVE IGG SUBCLASS DEFICIENCY PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Erythema Pain in extremity Muscular weakness Pain Muscular weakness Vision blurred Headache Musculoskeletal discomfort"}
{"safetyreportid": "10015496", "receiveDate": "20140317", "serious": 1, "seriousnessdeath": 2, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 2, "occurcountry": "FR", "reportType": "1", "patientSex": "1", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "CARBAMAZEPINE", "drugcharacterization": "3", "drugindication": "Epilepsy", "manufacturer": "Torrent Pharmaceuticals Limited", "genericName": "CARBAMAZEPINE", "brandName": "CARBAMAZEPINE", "pharmClass_epc": "Mood Stabilizer [EPC]", "route": "ORAL"}, {"medicinalproduct": "OLANZAPINE", "drugcharacterization": "3", "drugindication": "Psychotic disorder", "manufacturer": "Hisun Pharmaceuticals USA, Inc.", "genericName": "OLANZAPINE", "brandName": "OLANZAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "PIPERACILLIN", "drugcharacterization": "2", "drugindication": "Brain abscess", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CYAMEMAZINE", "drugcharacterization": "2", "drugindication": "Psychotic disorder", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CEFOTAXIME", "drugcharacterization": "2", "drugindication": "Brain abscess", "manufacturer": "Hikma Pharmaceuticals USA Inc.", "genericName": "CEFOTAXIME", "brandName": "CEFOTAXIME", "pharmClass_epc": null, "route": "INTRAMUSCULAR"}, {"medicinalproduct": "FOSFOMYCIN", "drugcharacterization": "2", "drugindication": "Brain abscess", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "RIFAMPIN", "drugcharacterization": "2", "drugindication": "Brain abscess", "manufacturer": "Hikma Pharmaceuticals USA Inc.", "genericName": "RIFAMPIN", "brandName": "RIFAMPIN", "pharmClass_epc": "Rifamycin Antibacterial [EPC]", "route": "INTRAVENOUS"}], "reactions": [{"pt": "Drug reaction with eosinophilia and systemic symptoms", "outcome": "1"}, {"pt": "Rash maculo-papular", "outcome": "1"}, {"pt": "Pyrexia", "outcome": "1"}, {"pt": "Hepatic cytolysis", "outcome": "1"}, {"pt": "Alanine aminotransferase increased", "outcome": "1"}, {"pt": "Leukocytosis", "outcome": "1"}, {"pt": "Gamma-glutamyltransferase increased", "outcome": "1"}, {"pt": "Blood alkaline phosphatase increased", "outcome": "1"}, {"pt": "Lymphadenopathy", "outcome": "1"}, {"pt": "Cholestasis", "outcome": "1"}, {"pt": "Cross sensitivity reaction", "outcome": "6"}, {"pt": "Drug interaction", "outcome": "6"}], "classifyText": "CARBAMAZEPINE OLANZAPINE PIPERACILLIN CYAMEMAZINE CEFOTAXIME FOSFOMYCIN RIFAMPIN CARBAMAZEPINE OLANZAPINE CEFOTAXIME RIFAMPIN Epilepsy Psychotic disorder Brain abscess Psychotic disorder Brain abscess Brain abscess Brain abscess Drug reaction with eosinophilia and systemic symptoms Rash maculo-papular Pyrexia Hepatic cytolysis Alanine aminotransferase increased Leukocytosis Gamma-glutamyltransferase increased Blood alkaline phosphatase increased Lymphadenopathy Cholestasis Cross sensitivity reaction Drug interaction"}
{"safetyreportid": "10015556", "receiveDate": "20140317", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "1", "patientAge": "86", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "CYMBALTA", "drugcharacterization": "1", "drugindication": "DEPRESSION", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "1", "drugindication": "BACK PAIN", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Cardiac disorder", "outcome": "6"}, {"pt": "Crying", "outcome": "3"}, {"pt": "Feeling abnormal", "outcome": "3"}, {"pt": "Abnormal behaviour", "outcome": "1"}, {"pt": "Abnormal behaviour", "outcome": "3"}, {"pt": "Fear of death", "outcome": "3"}, {"pt": "Drug dose omission", "outcome": "1"}, {"pt": "Drug withdrawal syndrome", "outcome": "1"}, {"pt": "Somnolence", "outcome": "6"}, {"pt": "Asthenia", "outcome": "6"}, {"pt": "Drug withdrawal syndrome", "outcome": "3"}], "classifyText": "CYMBALTA CYMBALTA CYMBALTA DULOXETINE HYDROCHLORIDE DULOXETINE HYDROCHLORIDE DULOXETINE HYDROCHLORIDE DEPRESSION BACK PAIN Cardiac disorder Crying Feeling abnormal Abnormal behaviour Abnormal behaviour Fear of death Drug dose omission Drug withdrawal syndrome Somnolence Asthenia Drug withdrawal syndrome"}
{"safetyreportid": "10015559", "receiveDate": "20140317", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "FR", "reportType": "1", "patientSex": "2", "patientAge": "81", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "DULOXETINE HYDROCHLORIDE.", "drugcharacterization": "1", "drugindication": "NEURALGIA", "manufacturer": "MARKSANS PHARMA LIMITED", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "DULOXETINE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "DULOXETINE HYDROCHLORIDE.", "drugcharacterization": "1", "drugindication": null, "manufacturer": "MARKSANS PHARMA LIMITED", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "DULOXETINE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "DIFFU K", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LASILIX /00032601/", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "RITUXIMAB.", "drugcharacterization": "2", "drugindication": "NEUROPATHY PERIPHERAL", "manufacturer": "Genentech, Inc.", "genericName": "RITUXIMAB", "brandName": "RITUXAN", "pharmClass_epc": "CD20-directed Cytolytic Antibody [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "KARDEGIC", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "TANGANIL", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LECTIL", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "MOPRAL", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "RIVOTRIL", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "General physical health deterioration", "outcome": "1"}, {"pt": "Weight decreased", "outcome": "1"}, {"pt": "Off label use", "outcome": "6"}, {"pt": "Colitis microscopic", "outcome": "1"}], "classifyText": "DULOXETINE DULOXETINE DIFFU K LASILIX /00032601/ RITUXAN KARDEGIC TANGANIL LECTIL MOPRAL RIVOTRIL DULOXETINE HYDROCHLORIDE DULOXETINE HYDROCHLORIDE RITUXIMAB NEURALGIA NEUROPATHY PERIPHERAL General physical health deterioration Weight decreased Off label use Colitis microscopic"}
{"safetyreportid": "10015563", "receiveDate": "20140317", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "GB", "reportType": "1", "patientSex": "2", "patientAge": "37", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "OLANZAPINE", "drugcharacterization": "1", "drugindication": "SCHIZOPHRENIA", "manufacturer": "Hisun Pharmaceuticals USA, Inc.", "genericName": "OLANZAPINE", "brandName": "OLANZAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "CLOZARIL", "drugcharacterization": "1", "drugindication": "SCHIZOPHRENIA", "manufacturer": "HLS Therapeutics (USA), Inc.", "genericName": "CLOZAPINE", "brandName": "CLOZARIL", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "VALPROATE SODIUM", "drugcharacterization": "1", "drugindication": "AFFECTIVE DISORDER", "manufacturer": "Hikma Pharmaceuticals USA Inc.", "genericName": "VALPROATE SODIUM", "brandName": "VALPROATE SODIUM", "pharmClass_epc": null, "route": "INTRAVENOUS"}], "reactions": [{"pt": "Emotional distress", "outcome": "2"}], "classifyText": "OLANZAPINE CLOZARIL VALPROATE SODIUM OLANZAPINE CLOZAPINE VALPROATE SODIUM SCHIZOPHRENIA SCHIZOPHRENIA AFFECTIVE DISORDER Emotional distress"}
{"safetyreportid": "10015566", "receiveDate": "20140317", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "JP", "reportType": "1", "patientSex": "1", "patientAge": "30", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "CYMBALTA", "drugcharacterization": "1", "drugindication": "AFFECTIVE DISORDER", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Hepatic function abnormal", "outcome": "1"}, {"pt": "Off label use", "outcome": "6"}], "classifyText": "CYMBALTA DULOXETINE HYDROCHLORIDE AFFECTIVE DISORDER Hepatic function abnormal Off label use"}
{"safetyreportid": "10015611", "receiveDate": "20140317", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "JP", "reportType": "2", "patientSex": "2", "patientAge": "76", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "OXYCODONE HCL PR TABLET", "drugcharacterization": "1", "drugindication": "BACK PAIN", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "OXYCODONE HCL PR TABLET", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": "POST LAMINECTOMY SYNDROME", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "OPALMON", "drugcharacterization": "2", "drugindication": "PERIPHERAL VASCULAR DISORDER", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LYRICA", "drugcharacterization": "2", "drugindication": "POST LAMINECTOMY SYNDROME", "manufacturer": "Parke-Davis Div of Pfizer Inc", "genericName": "PREGABALIN", "brandName": "LYRICA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LUNESTA", "drugcharacterization": "2", "drugindication": "INSOMNIA", "manufacturer": "Waylis Therapeutics LLC", "genericName": "ESZOPICLONE", "brandName": "LUNESTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "TOKISHAKUYAKUSAN", "drugcharacterization": "2", "drugindication": "POST LAMINECTOMY SYNDROME", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "GOSHAJINKIGAN", "drugcharacterization": "2", "drugindication": "POST LAMINECTOMY SYNDROME", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "PURSENNID /00142207/", "drugcharacterization": "2", "drugindication": "CONSTIPATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "NOVAMIN /00013301/", "drugcharacterization": "2", "drugindication": "PROPHYLAXIS OF NAUSEA AND VOMITING", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "BESACOLIN", "drugcharacterization": "2", "drugindication": "NEUROGENIC BLADDER", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "MAGMITT", "drugcharacterization": "2", "drugindication": "CONSTIPATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LAXOBERON", "drugcharacterization": "2", "drugindication": "CONSTIPATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "MS ONSHIPPU", "drugcharacterization": "2", "drugindication": "POST LAMINECTOMY SYNDROME", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Septic shock", "outcome": "1"}], "classifyText": "OXYCODONE HCL PR TABLET OXYCODONE HCL PR TABLET CYMBALTA OPALMON LYRICA LUNESTA TOKISHAKUYAKUSAN GOSHAJINKIGAN PURSENNID /00142207/ NOVAMIN /00013301/ BESACOLIN MAGMITT LAXOBERON MS ONSHIPPU DULOXETINE HYDROCHLORIDE PREGABALIN ESZOPICLONE BACK PAIN POST LAMINECTOMY SYNDROME PERIPHERAL VASCULAR DISORDER POST LAMINECTOMY SYNDROME INSOMNIA POST LAMINECTOMY SYNDROME POST LAMINECTOMY SYNDROME CONSTIPATION PROPHYLAXIS OF NAUSEA AND VOMITING NEUROGENIC BLADDER CONSTIPATION CONSTIPATION POST LAMINECTOMY SYNDROME Septic shock"}
{"safetyreportid": "10015740", "receiveDate": "20140317", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "GB", "reportType": "1", "patientSex": "2", "patientAge": "21", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "CITALOPRAM", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Chartwell Governmental & Specialty RX, LLC.", "genericName": "CITALOPRAM", "brandName": "CITALOPRAM", "pharmClass_epc": "Serotonin Reuptake Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "QUETIAPINE", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Solco Healthcare U.S., LLC", "genericName": "QUETIAPINE", "brandName": "QUETIAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "RISPERIDONE", "drugcharacterization": "1", "drugindication": "AGITATION", "manufacturer": "Amneal Pharmaceuticals LLC", "genericName": "RISPERIDONE", "brandName": "RISPERIDONE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": "ATTENTION DEFICIT/HYPERACTIVITY DISORDER", "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": "ATTENTION DEFICIT/HYPERACTIVITY DISORDER", "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": "ATTENTION DEFICIT/HYPERACTIVITY DISORDER", "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": "ATTENTION DEFICIT/HYPERACTIVITY DISORDER", "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": "ATTENTION DEFICIT/HYPERACTIVITY DISORDER", "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": "ATTENTION DEFICIT/HYPERACTIVITY DISORDER", "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": "ATTENTION DEFICIT/HYPERACTIVITY DISORDER", "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CIRCADIN", "drugcharacterization": "2", "drugindication": "INSOMNIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SERTRALINE", "drugcharacterization": "2", "drugindication": "AGITATION", "manufacturer": "Exelan Pharmaceuticals, Inc.", "genericName": "SERTRALINE", "brandName": "SERTRALINE", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Bipolar I disorder", "outcome": "3"}, {"pt": "Depression", "outcome": "3"}, {"pt": "Merycism", "outcome": "3"}, {"pt": "Major depression", "outcome": "3"}, {"pt": "Attention deficit/hyperactivity disorder", "outcome": "3"}, {"pt": "Somnolence", "outcome": "3"}, {"pt": "Sedation", "outcome": "3"}, {"pt": "Agitation", "outcome": "3"}], "classifyText": "CITALOPRAM QUETIAPINE RISPERIDONE STRATTERA STRATTERA STRATTERA STRATTERA STRATTERA STRATTERA STRATTERA CIRCADIN SERTRALINE CITALOPRAM QUETIAPINE RISPERIDONE ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE SERTRALINE PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION AGITATION ATTENTION DEFICIT/HYPERACTIVITY DISORDER ATTENTION DEFICIT/HYPERACTIVITY DISORDER ATTENTION DEFICIT/HYPERACTIVITY DISORDER ATTENTION DEFICIT/HYPERACTIVITY DISORDER ATTENTION DEFICIT/HYPERACTIVITY DISORDER ATTENTION DEFICIT/HYPERACTIVITY DISORDER ATTENTION DEFICIT/HYPERACTIVITY DISORDER INSOMNIA AGITATION Bipolar I disorder Depression Merycism Major depression Attention deficit/hyperactivity disorder Somnolence Sedation Agitation"}
{"safetyreportid": "10015748", "receiveDate": "20140317", "serious": 1, "seriousnessdeath": 1, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "AU", "reportType": "1", "patientSex": "1", "patientAge": "43", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "CONJUGATED ESTROGENS", "drugcharacterization": "1", "drugindication": "GENDER IDENTITY DISORDER", "manufacturer": "Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.", "genericName": "CONJUGATED ESTROGENS", "brandName": "PREMARIN VAGINAL", "pharmClass_epc": "Estrogen [EPC]", "route": "VAGINAL"}, {"medicinalproduct": "CYPROTERONE", "drugcharacterization": "1", "drugindication": "GENDER IDENTITY DISORDER", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CYPROTERONE", "drugcharacterization": "1", "drugindication": "OFF LABEL USE", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ESTRADIOL VALERATE", "drugcharacterization": "1", "drugindication": "GENDER IDENTITY DISORDER", "manufacturer": "Xiromed, LLC", "genericName": "ESTRADIOL VALERATE", "brandName": "ESTRADIOL VALERATE", "pharmClass_epc": null, "route": "INTRAMUSCULAR"}, {"medicinalproduct": "SPIRONOLACTONE", "drugcharacterization": "1", "drugindication": "GENDER IDENTITY DISORDER", "manufacturer": "Amneal Pharmaceuticals LLC", "genericName": "SPIRONOLACTONE", "brandName": "SPIRONOLACTONE", "pharmClass_epc": "Aldosterone Antagonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "SPIRONOLACTONE", "drugcharacterization": "1", "drugindication": "OFF LABEL USE", "manufacturer": "Amneal Pharmaceuticals LLC", "genericName": "SPIRONOLACTONE", "brandName": "SPIRONOLACTONE", "pharmClass_epc": "Aldosterone Antagonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "RISPERIDONE", "drugcharacterization": "1", "drugindication": "MAJOR DEPRESSION", "manufacturer": "Amneal Pharmaceuticals LLC", "genericName": "RISPERIDONE", "brandName": "RISPERIDONE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "RISPERIDONE", "drugcharacterization": "1", "drugindication": "OFF LABEL USE", "manufacturer": "Amneal Pharmaceuticals LLC", "genericName": "RISPERIDONE", "brandName": "RISPERIDONE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "OLANZAPINE", "drugcharacterization": "1", "drugindication": "MAJOR DEPRESSION", "manufacturer": "Hisun Pharmaceuticals USA, Inc.", "genericName": "OLANZAPINE", "brandName": "OLANZAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "OLANZAPINE", "drugcharacterization": "1", "drugindication": "OFF LABEL USE", "manufacturer": "Hisun Pharmaceuticals USA, Inc.", "genericName": "OLANZAPINE", "brandName": "OLANZAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "QUETIAPINE", "drugcharacterization": "1", "drugindication": "MAJOR DEPRESSION", "manufacturer": "Solco Healthcare U.S., LLC", "genericName": "QUETIAPINE", "brandName": "QUETIAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "DOXEPIN", "drugcharacterization": "1", "drugindication": "MAJOR DEPRESSION", "manufacturer": "North Star Rx LLC", "genericName": "DOXEPIN", "brandName": "DOXEPIN", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "DOXEPIN", "drugcharacterization": "1", "drugindication": "OVERDOSE", "manufacturer": "North Star Rx LLC", "genericName": "DOXEPIN", "brandName": "DOXEPIN", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CLONAZEPAM", "drugcharacterization": "1", "drugindication": "MAJOR DEPRESSION", "manufacturer": "Advagen Pharma Ltd", "genericName": "CLONAZEPAM", "brandName": "CLONAZEPAM", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "ORAL"}, {"medicinalproduct": "CLONAZEPAM", "drugcharacterization": "1", "drugindication": "OFF LABEL USE", "manufacturer": "Advagen Pharma Ltd", "genericName": "CLONAZEPAM", "brandName": "CLONAZEPAM", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "ORAL"}, {"medicinalproduct": "LEVOMEPROMAZINE", "drugcharacterization": "1", "drugindication": "MAJOR DEPRESSION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "FLUOXETINE", "drugcharacterization": "1", "drugindication": "MAJOR DEPRESSION", "manufacturer": "QUALLENT PHARMACEUTICALS HEALTH LLC", "genericName": "FLUOXETINE HYDROCHLORIDE", "brandName": "FLUOXETINE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "AMISULPRIDE", "drugcharacterization": "1", "drugindication": "MAJOR DEPRESSION", "manufacturer": "Acacia Pharma Ltd", "genericName": "AMISULPRIDE", "brandName": "BARHEMSYS", "pharmClass_epc": "Dopamine-2 Receptor Antagonist [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "AMISULPRIDE", "drugcharacterization": "1", "drugindication": "OVERDOSE", "manufacturer": "Acacia Pharma Ltd", "genericName": "AMISULPRIDE", "brandName": "BARHEMSYS", "pharmClass_epc": "Dopamine-2 Receptor Antagonist [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "ZOPICLONE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "DOXORUBICIN", "drugcharacterization": "2", "drugindication": "INVASIVE DUCTAL BREAST CARCINOMA", "manufacturer": "Amneal Pharmaceuticals LLC", "genericName": "DOXORUBICIN", "brandName": "DOXORUBICIN HYDROCHLORIDE", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "CYCLOPHOSPHAMIDE", "drugcharacterization": "2", "drugindication": "INVASIVE DUCTAL BREAST CARCINOMA", "manufacturer": "Slate Run Pharmaceuticals, LLC", "genericName": "CYCLOPHOSPHAMIDE FOR INJECTION", "brandName": "CYCLOPHOSPHAMIDE", "pharmClass_epc": "Alkylating Drug [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "PACLITAXEL", "drugcharacterization": "2", "drugindication": "INVASIVE DUCTAL BREAST CARCINOMA", "manufacturer": "Abraxis BioScience, LLC", "genericName": "PACLITAXEL", "brandName": "ABRAXANE", "pharmClass_epc": "Microtubule Inhibitor [EPC]", "route": "INTRAVENOUS"}], "reactions": [{"pt": "Overdose", "outcome": "5"}, {"pt": "Overdose", "outcome": "6"}, {"pt": "Invasive ductal breast carcinoma", "outcome": "2"}, {"pt": "Hyperprolactinaemia", "outcome": "6"}, {"pt": "Metastases to bone", "outcome": "3"}, {"pt": "Metastases to liver", "outcome": "3"}, {"pt": "Depression", "outcome": "6"}], "classifyText": "PREMARIN VAGINAL CYPROTERONE CYPROTERONE ESTRADIOL VALERATE SPIRONOLACTONE SPIRONOLACTONE RISPERIDONE RISPERIDONE OLANZAPINE OLANZAPINE QUETIAPINE DOXEPIN DOXEPIN CLONAZEPAM CLONAZEPAM LEVOMEPROMAZINE FLUOXETINE BARHEMSYS BARHEMSYS ZOPICLONE DOXORUBICIN HYDROCHLORIDE CYCLOPHOSPHAMIDE ABRAXANE CONJUGATED ESTROGENS ESTRADIOL VALERATE SPIRONOLACTONE SPIRONOLACTONE RISPERIDONE RISPERIDONE OLANZAPINE OLANZAPINE QUETIAPINE DOXEPIN DOXEPIN CLONAZEPAM CLONAZEPAM FLUOXETINE HYDROCHLORIDE AMISULPRIDE AMISULPRIDE DOXORUBICIN CYCLOPHOSPHAMIDE FOR INJECTION PACLITAXEL GENDER IDENTITY DISORDER GENDER IDENTITY DISORDER OFF LABEL USE GENDER IDENTITY DISORDER GENDER IDENTITY DISORDER OFF LABEL USE MAJOR DEPRESSION OFF LABEL USE MAJOR DEPRESSION OFF LABEL USE MAJOR DEPRESSION MAJOR DEPRESSION OVERDOSE MAJOR DEPRESSION OFF LABEL USE MAJOR DEPRESSION MAJOR DEPRESSION MAJOR DEPRESSION OVERDOSE INVASIVE DUCTAL BREAST CARCINOMA INVASIVE DUCTAL BREAST CARCINOMA INVASIVE DUCTAL BREAST CARCINOMA Overdose Overdose Invasive ductal breast carcinoma Hyperprolactinaemia Metastases to bone Metastases to liver Depression"}
{"safetyreportid": "10015764", "receiveDate": "20140317", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "IT", "reportType": "1", "patientSex": "1", "patientAge": "20", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "LOPERAMIDE HYDROCHLORIDE 2 MG 224", "drugcharacterization": "1", "drugindication": "ABDOMINAL PAIN", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LOPERAMIDE HYDROCHLORIDE 2 MG 224", "drugcharacterization": "1", "drugindication": "DIARRHOEA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LOPERAMIDE HYDROCHLORIDE 2 MG 224", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "OLANZAPINE", "drugcharacterization": "1", "drugindication": "STUPOR", "manufacturer": "Hisun Pharmaceuticals USA, Inc.", "genericName": "OLANZAPINE", "brandName": "OLANZAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "OLANZAPINE", "drugcharacterization": "1", "drugindication": "MUTISM", "manufacturer": "Hisun Pharmaceuticals USA, Inc.", "genericName": "OLANZAPINE", "brandName": "OLANZAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "OLANZAPINE", "drugcharacterization": "1", "drugindication": "HYPOKINESIA", "manufacturer": "Hisun Pharmaceuticals USA, Inc.", "genericName": "OLANZAPINE", "brandName": "OLANZAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "OLANZAPINE", "drugcharacterization": "1", "drugindication": "NEGATIVISM", "manufacturer": "Hisun Pharmaceuticals USA, Inc.", "genericName": "OLANZAPINE", "brandName": "OLANZAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "OLANZAPINE", "drugcharacterization": "1", "drugindication": "CONSTIPATION", "manufacturer": "Hisun Pharmaceuticals USA, Inc.", "genericName": "OLANZAPINE", "brandName": "OLANZAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "OLANZAPINE", "drugcharacterization": "1", "drugindication": "DYSURIA", "manufacturer": "Hisun Pharmaceuticals USA, Inc.", "genericName": "OLANZAPINE", "brandName": "OLANZAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Overdose", "outcome": "1"}, {"pt": "Catatonia", "outcome": "1"}, {"pt": "Delirium", "outcome": "1"}, {"pt": "Confusional state", "outcome": "1"}, {"pt": "Urinary retention", "outcome": "1"}, {"pt": "Hyperhidrosis", "outcome": "1"}, {"pt": "Hypertonia", "outcome": "1"}, {"pt": "Waxy flexibility", "outcome": "1"}, {"pt": "Psychomotor retardation", "outcome": "1"}, {"pt": "Stupor", "outcome": "1"}, {"pt": "Immobile", "outcome": "1"}, {"pt": "Fatigue", "outcome": "1"}, {"pt": "Mutism", "outcome": "1"}, {"pt": "Decreased appetite", "outcome": "1"}, {"pt": "Impaired self-care", "outcome": "1"}, {"pt": "Feeling abnormal", "outcome": "1"}, {"pt": "Constipation", "outcome": "1"}, {"pt": "Negativism", "outcome": "1"}, {"pt": "Somnolence", "outcome": "1"}], "classifyText": "LOPERAMIDE HYDROCHLORIDE 2 MG 224 LOPERAMIDE HYDROCHLORIDE 2 MG 224 LOPERAMIDE HYDROCHLORIDE 2 MG 224 OLANZAPINE OLANZAPINE OLANZAPINE OLANZAPINE OLANZAPINE OLANZAPINE OLANZAPINE OLANZAPINE OLANZAPINE OLANZAPINE OLANZAPINE OLANZAPINE ABDOMINAL PAIN DIARRHOEA STUPOR MUTISM HYPOKINESIA NEGATIVISM CONSTIPATION DYSURIA Overdose Catatonia Delirium Confusional state Urinary retention Hyperhidrosis Hypertonia Waxy flexibility Psychomotor retardation Stupor Immobile Fatigue Mutism Decreased appetite Impaired self-care Feeling abnormal Constipation Negativism Somnolence"}
{"safetyreportid": "10015829", "receiveDate": "20140317", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "53", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "MIRALAX", "drugcharacterization": "1", "drugindication": "CONSTIPATION", "manufacturer": "Bayer HealthCare LLC.", "genericName": "POLYETHYLENE GLYCOL 3350", "brandName": "MIRALAX", "pharmClass_epc": "Osmotic Laxative [EPC]", "route": "ORAL"}, {"medicinalproduct": "MIRALAX", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Bayer HealthCare LLC.", "genericName": "POLYETHYLENE GLYCOL 3350", "brandName": "MIRALAX", "pharmClass_epc": "Osmotic Laxative [EPC]", "route": "ORAL"}, {"medicinalproduct": "INSULIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Professional Complementary Health Formulas", "genericName": "INSULIN", "brandName": "INSULIN 1556", "pharmClass_epc": "Insulin Analog [EPC]", "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LISINOPRIL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Chartwell RX, LLC", "genericName": "LISINOPRIL", "brandName": "LISINOPRIL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "SIMVASTATIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Accord Healthcare, Inc.", "genericName": "SIMVASTATIN", "brandName": "SIMVASTATIN", "pharmClass_epc": "HMG-CoA Reductase Inhibitor [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Abdominal pain upper", "outcome": "3"}, {"pt": "Pain", "outcome": "3"}, {"pt": "Abdominal pain upper", "outcome": "3"}, {"pt": "Abdominal distension", "outcome": "3"}, {"pt": "Abdominal distension", "outcome": "3"}], "classifyText": "MIRALAX MIRALAX INSULIN 1556 CYMBALTA LISINOPRIL SIMVASTATIN POLYETHYLENE GLYCOL 3350 POLYETHYLENE GLYCOL 3350 INSULIN DULOXETINE HYDROCHLORIDE LISINOPRIL SIMVASTATIN CONSTIPATION Abdominal pain upper Pain Abdominal pain upper Abdominal distension Abdominal distension"}
{"safetyreportid": "10015867", "receiveDate": "20140317", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "FOSAMAX", "drugcharacterization": "1", "drugindication": "OSTEOPOROSIS", "manufacturer": "Organon LLC", "genericName": "ALENDRONATE SODIUM", "brandName": "FOSAMAX", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "FOSAMAX", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Organon LLC", "genericName": "ALENDRONATE SODIUM", "brandName": "FOSAMAX", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "FORTEO", "drugcharacterization": "1", "drugindication": "OSTEOPOROSIS", "manufacturer": "Eli Lilly and Company", "genericName": "TERIPARATIDE", "brandName": "FORTEO", "pharmClass_epc": "Parathyroid Hormone Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "ACTONEL", "drugcharacterization": "1", "drugindication": "OSTEOPOROSIS", "manufacturer": "Allergan, Inc.", "genericName": "RISEDRONATE SODIUM", "brandName": "ACTONEL", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Knee arthroplasty", "outcome": "6"}, {"pt": "Fall", "outcome": "6"}, {"pt": "Femur fracture", "outcome": "6"}, {"pt": "Blood cholesterol increased", "outcome": "3"}, {"pt": "Intramedullary rod insertion", "outcome": "6"}, {"pt": "Vitamin D deficiency", "outcome": "6"}, {"pt": "Tooth extraction", "outcome": "6"}, {"pt": "Femur fracture", "outcome": "6"}], "classifyText": "FOSAMAX FOSAMAX FORTEO ACTONEL ALENDRONATE SODIUM ALENDRONATE SODIUM TERIPARATIDE RISEDRONATE SODIUM OSTEOPOROSIS OSTEOPOROSIS OSTEOPOROSIS Knee arthroplasty Fall Femur fracture Blood cholesterol increased Intramedullary rod insertion Vitamin D deficiency Tooth extraction Femur fracture"}
{"safetyreportid": "10016013", "receiveDate": "20140317", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "GB", "reportType": "1", "patientSex": "2", "patientAge": "21", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "CITALOPRAM", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Chartwell Governmental & Specialty RX, LLC.", "genericName": "CITALOPRAM", "brandName": "CITALOPRAM", "pharmClass_epc": "Serotonin Reuptake Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "QUETIAPINE", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Solco Healthcare U.S., LLC", "genericName": "QUETIAPINE", "brandName": "QUETIAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "RISPERIDONE", "drugcharacterization": "1", "drugindication": "AGITATION", "manufacturer": "Amneal Pharmaceuticals LLC", "genericName": "RISPERIDONE", "brandName": "RISPERIDONE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": "ATTENTION DEFICIT/HYPERACTIVITY DISORDER", "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CIRCADIN", "drugcharacterization": "2", "drugindication": "INSOMNIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SERTRALINE", "drugcharacterization": "2", "drugindication": "AGITATION", "manufacturer": "Exelan Pharmaceuticals, Inc.", "genericName": "SERTRALINE", "brandName": "SERTRALINE", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Bipolar I disorder", "outcome": "3"}, {"pt": "Major depression", "outcome": "3"}, {"pt": "Depression", "outcome": "3"}, {"pt": "Merycism", "outcome": "3"}, {"pt": "Attention deficit/hyperactivity disorder", "outcome": "3"}, {"pt": "Somnolence", "outcome": "3"}, {"pt": "Sedation", "outcome": "3"}, {"pt": "Agitation", "outcome": "3"}], "classifyText": "CITALOPRAM QUETIAPINE RISPERIDONE STRATTERA STRATTERA STRATTERA STRATTERA STRATTERA STRATTERA STRATTERA CIRCADIN SERTRALINE CITALOPRAM QUETIAPINE RISPERIDONE ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE SERTRALINE PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION AGITATION ATTENTION DEFICIT/HYPERACTIVITY DISORDER INSOMNIA AGITATION Bipolar I disorder Major depression Depression Merycism Attention deficit/hyperactivity disorder Somnolence Sedation Agitation"}
{"safetyreportid": "10016159", "receiveDate": "20140317", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "GB", "reportType": "1", "patientSex": "1", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "LEVETIRACETAM.", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Granules Pharmaceuticals Inc.", "genericName": "LEVETIRACETAM", "brandName": "LEVETIRACETAM", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LEVETIRACETAM ACTAVIS", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "KEPPRA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "UCB, Inc.", "genericName": "LEVETIRACETAM", "brandName": "KEPPRA", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "BECLOMETASONE", "drugcharacterization": "2", "drugindication": "HEADACHE", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CUPLEX /00797901/", "drugcharacterization": "2", "drugindication": "SKIN PAPILLOMA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "PARACETAMOL", "drugcharacterization": "2", "drugindication": "PAIN", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "RANITIDINE HYDROCHLORIDE.", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Dr. Reddy's Laboratories Limited", "genericName": "RANITIDINE HYDROCHLORIDE", "brandName": "RANITIDINE HYDROCHLORIDE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "SODIUM VALPROATE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "KEPPRA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "UCB, Inc.", "genericName": "LEVETIRACETAM", "brandName": "KEPPRA", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "KEPPRA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "UCB, Inc.", "genericName": "LEVETIRACETAM", "brandName": "KEPPRA", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "AZELASTINE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Amneal Pharmaceuticals NY LLC", "genericName": "AZELASTINE", "brandName": "AZELASTINE HCL", "pharmClass_epc": null, "route": "NASAL"}, {"medicinalproduct": "FLUTICASONE FUROATE", "drugcharacterization": "2", "drugindication": "SINUS CONGESTION", "manufacturer": "Haleon US Holdings LLC", "genericName": "FLUTICASONE FUROATE", "brandName": "FLONASE SENSIMIST ALLERGY RELIEF", "pharmClass_epc": null, "route": "NASAL"}, {"medicinalproduct": "MIRTAZAPINE.", "drugcharacterization": "2", "drugindication": "DEPRESSION", "manufacturer": "Aurolife Pharma LLC", "genericName": "MIRTAZAPINE", "brandName": "MIRTAZAPINE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "OLANZAPINE.", "drugcharacterization": "2", "drugindication": "DEPRESSION", "manufacturer": "Hisun Pharmaceuticals USA, Inc.", "genericName": "OLANZAPINE", "brandName": "OLANZAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "OPTIVE", "drugcharacterization": "2", "drugindication": "DRY EYE", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SODIUM VALPROATE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "KEPPRA", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "UCB, Inc.", "genericName": "LEVETIRACETAM", "brandName": "KEPPRA", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "KEPPRA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "UCB, Inc.", "genericName": "LEVETIRACETAM", "brandName": "KEPPRA", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "CLINITAS HYDRATE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "EPILIM", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "HYPROMELLOSE", "drugcharacterization": "2", "drugindication": "DRY EYE", "manufacturer": "LABORATORIOS SOPHIA, S.A. DE C.V.", "genericName": "HYPROMELLOSE", "brandName": "SPLASH TEARS", "pharmClass_epc": null, "route": "OPHTHALMIC"}, {"medicinalproduct": "LANSOPRAZOLE.", "drugcharacterization": "2", "drugindication": "GASTROOESOPHAGEAL REFLUX DISEASE", "manufacturer": "Medcore LLC", "genericName": "LANSOPRAZOLE", "brandName": "LANSOPRAZOLE", "pharmClass_epc": "Proton Pump Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "PROPRANOLOL HYDROCHLORIDE.", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Amneal Pharmaceuticals NY LLC", "genericName": "PROPRANOLOL HYDROCHLORIDE", "brandName": "PROPRANOLOL HYDROCHLORIDE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "QUETIAPINE.", "drugcharacterization": "2", "drugindication": "DEPRESSION", "manufacturer": "Solco Healthcare U.S., LLC", "genericName": "QUETIAPINE", "brandName": "QUETIAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "CHLORAMPHENICOL", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "IBUPROFEN.", "drugcharacterization": "2", "drugindication": "BACK PAIN", "manufacturer": "DOLGENCORP INC", "genericName": "IBUPROFEN", "brandName": "IBUPROFEN", "pharmClass_epc": "Nonsteroidal Anti-inflammatory Drug [EPC]", "route": "ORAL"}, {"medicinalproduct": "AMOXICILLIN.", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Hikma Pharmaceuticals USA Inc.", "genericName": "AMOXICILLIN", "brandName": "AMOXICILLIN", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "FLUCLOXACILLIN", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "PIROXICAM.", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Teva Pharmaceuticals USA, Inc.", "genericName": "PIROXICAM", "brandName": "PIROXICAM", "pharmClass_epc": "Nonsteroidal Anti-inflammatory Drug [EPC]", "route": "ORAL"}, {"medicinalproduct": "KEPPRA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "UCB, Inc.", "genericName": "LEVETIRACETAM", "brandName": "KEPPRA", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "PSEUDOEPHEDRINE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LIQUIFILM TEARS", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "KEPPRA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "UCB, Inc.", "genericName": "LEVETIRACETAM", "brandName": "KEPPRA", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "BECONASE AQ", "drugcharacterization": "2", "drugindication": "OROPHARYNGEAL PAIN", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "DOXYCYCLINE HYDROCHLORIDE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Anger", "outcome": "6"}, {"pt": "Confusional state", "outcome": "6"}, {"pt": "Hypoaesthesia", "outcome": "6"}, {"pt": "Localised infection", "outcome": "2"}, {"pt": "Malaise", "outcome": "6"}, {"pt": "Testicular pain", "outcome": "6"}, {"pt": "Feeling of body temperature change", "outcome": "6"}, {"pt": "Stress", "outcome": "6"}, {"pt": "Vomiting", "outcome": "6"}, {"pt": "Seizure", "outcome": "2"}, {"pt": "Anxiety", "outcome": "6"}, {"pt": "Complex partial seizures", "outcome": "6"}, {"pt": "Pain in extremity", "outcome": "6"}, {"pt": "Viral infection", "outcome": "6"}, {"pt": "Nasopharyngitis", "outcome": "6"}, {"pt": "Petit mal epilepsy", "outcome": "6"}, {"pt": "Learning disability", "outcome": "6"}, {"pt": "Pharyngitis", "outcome": "6"}, {"pt": "Dry eye", "outcome": "6"}, {"pt": "Paranoia", "outcome": "2"}, {"pt": "Feeling abnormal", "outcome": "6"}, {"pt": "Memory impairment", "outcome": "6"}, {"pt": "Temporomandibular joint syndrome", "outcome": "6"}, {"pt": "Head injury", "outcome": "6"}, {"pt": "Generalised tonic-clonic seizure", "outcome": "6"}, {"pt": "Agitation", "outcome": "6"}, {"pt": "Vision blurred", "outcome": "6"}, {"pt": "Somnolence", "outcome": "6"}, {"pt": "Nervousness", "outcome": "2"}, {"pt": "Depression", "outcome": "6"}, {"pt": "Aggression", "outcome": "6"}, {"pt": "Therapeutic response unexpected", "outcome": "6"}], "classifyText": "LEVETIRACETAM LEVETIRACETAM ACTAVIS KEPPRA BECLOMETASONE CUPLEX /00797901/ PARACETAMOL RANITIDINE HYDROCHLORIDE SODIUM VALPROATE KEPPRA KEPPRA AZELASTINE HCL FLONASE SENSIMIST ALLERGY RELIEF MIRTAZAPINE OLANZAPINE OPTIVE SODIUM VALPROATE KEPPRA KEPPRA CLINITAS HYDRATE EPILIM SPLASH TEARS LANSOPRAZOLE PROPRANOLOL HYDROCHLORIDE QUETIAPINE CHLORAMPHENICOL IBUPROFEN AMOXICILLIN FLUCLOXACILLIN PIROXICAM KEPPRA PSEUDOEPHEDRINE LIQUIFILM TEARS KEPPRA BECONASE AQ DOXYCYCLINE HYDROCHLORIDE LEVETIRACETAM LEVETIRACETAM RANITIDINE HYDROCHLORIDE LEVETIRACETAM LEVETIRACETAM AZELASTINE FLUTICASONE FUROATE MIRTAZAPINE OLANZAPINE LEVETIRACETAM LEVETIRACETAM HYPROMELLOSE LANSOPRAZOLE PROPRANOLOL HYDROCHLORIDE QUETIAPINE IBUPROFEN AMOXICILLIN PIROXICAM LEVETIRACETAM LEVETIRACETAM PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION HEADACHE SKIN PAPILLOMA PAIN PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION SINUS CONGESTION DEPRESSION DEPRESSION DRY EYE PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION DRY EYE GASTROOESOPHAGEAL REFLUX DISEASE PRODUCT USED FOR UNKNOWN INDICATION DEPRESSION PRODUCT USED FOR UNKNOWN INDICATION BACK PAIN PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION OROPHARYNGEAL PAIN PRODUCT USED FOR UNKNOWN INDICATION Anger Confusional state Hypoaesthesia Localised infection Malaise Testicular pain Feeling of body temperature change Stress Vomiting Seizure Anxiety Complex partial seizures Pain in extremity Viral infection Nasopharyngitis Petit mal epilepsy Learning disability Pharyngitis Dry eye Paranoia Feeling abnormal Memory impairment Temporomandibular joint syndrome Head injury Generalised tonic-clonic seizure Agitation Vision blurred Somnolence Nervousness Depression Aggression Therapeutic response unexpected"}
{"safetyreportid": "10016349", "receiveDate": "20140317", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "55", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "LYRICA", "drugcharacterization": "1", "drugindication": "HEADACHE", "manufacturer": "Parke-Davis Div of Pfizer Inc", "genericName": "PREGABALIN", "brandName": "LYRICA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LYRICA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Parke-Davis Div of Pfizer Inc", "genericName": "PREGABALIN", "brandName": "LYRICA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LYRICA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Parke-Davis Div of Pfizer Inc", "genericName": "PREGABALIN", "brandName": "LYRICA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LYRICA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Parke-Davis Div of Pfizer Inc", "genericName": "PREGABALIN", "brandName": "LYRICA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "TORADOL", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "INDOMETHACIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Chartwell RX, LLC", "genericName": "INDOMETHACIN", "brandName": "INDOMETHACIN", "pharmClass_epc": "Nonsteroidal Anti-inflammatory Drug [EPC]", "route": "ORAL"}, {"medicinalproduct": "FROVATRIPTAN SUCCINATE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Ingenus Pharmaceuticals, LLC", "genericName": "FROVATRIPTAN SUCCINATE", "brandName": "FROVATRIPTAN", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "TOPAMAX", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Janssen Pharmaceuticals, Inc.", "genericName": "TOPIRAMATE", "brandName": "TOPAMAX", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "PHENOBARBITAL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Strides Pharma Science Limited", "genericName": "PHENOBARBITAL", "brandName": "PHENOBARBITAL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ONDANSETRON HYDROCHLORIDE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Dr. Reddy's Laboratories Limited", "genericName": "ONDANSETRON HYDROCHLORIDE", "brandName": "ONDANSETRON", "pharmClass_epc": "Serotonin-3 Receptor Antagonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "FLEXERIL", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "XYZAL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Chattem, Inc.", "genericName": "LEVOCETIRIZINE DIHYDROCHLORIDE", "brandName": "XYZAL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "PREMPRO", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.", "genericName": "CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE", "brandName": "PREMPRO", "pharmClass_epc": "Estrogen [EPC]", "route": "ORAL"}, {"medicinalproduct": "PHENERGAN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Hikma Pharmaceuticals USA Inc.", "genericName": "PROMETHAZINE HYDROCHLORIDE", "brandName": "PHENERGAN", "pharmClass_epc": null, "route": "INTRAMUSCULAR"}, {"medicinalproduct": "PERCOCET", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Endo USA, Inc.", "genericName": "OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN", "brandName": "PERCOCET", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "FIORICET", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Actavis Pharma, Inc.", "genericName": "BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE", "brandName": "FIORICET", "pharmClass_epc": "Barbiturate [EPC]", "route": "ORAL"}, {"medicinalproduct": "AMBIEN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Cosette Pharmaceuticals, Inc.", "genericName": "ZOLPIDEM TARTRATE", "brandName": "AMBIEN", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ALBUTEROL SULFATE HFA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Prasco Laboratories", "genericName": "ALBUTEROL SULFATE", "brandName": "ALBUTEROL SULFATE HFA", "pharmClass_epc": null, "route": "RESPIRATORY (INHALATION)"}, {"medicinalproduct": "VITAMIN D", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Strides Pharma Science Limited", "genericName": "ERGOCALCIFEROL", "brandName": "VITAMIN D", "pharmClass_epc": "Provitamin D2 Compound [EPC]", "route": "ORAL"}, {"medicinalproduct": "LIDOCAINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Guangzhou Liuquanmiao Import & Export Trade Co., Ltd.", "genericName": "LIDOCAINE", "brandName": "LIDOCAINE PAIN RELIEF GEL-PATCH", "pharmClass_epc": "Amide Local Anesthetic [EPC]", "route": "TOPICAL"}, {"medicinalproduct": "MONTELUKAST SODIUM", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Camber Pharmaceuticals, Inc.", "genericName": "MONTELUKAST SODIUM", "brandName": "MONTELUKAST SODIUM", "pharmClass_epc": "Leukotriene Receptor Antagonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "NASONEX", "drugcharacterization": "2", "drugindication": null, "manufacturer": "L. Perrigo Company", "genericName": "MOMETASONE FUROATE", "brandName": "NASONEX", "pharmClass_epc": null, "route": "NASAL"}], "reactions": [{"pt": "Off label use", "outcome": "6"}, {"pt": "Muscle spasms", "outcome": "2"}, {"pt": "Musculoskeletal stiffness", "outcome": "2"}], "classifyText": "LYRICA LYRICA LYRICA LYRICA TORADOL INDOMETHACIN FROVATRIPTAN TOPAMAX PHENOBARBITAL ONDANSETRON CYMBALTA FLEXERIL XYZAL PREMPRO PHENERGAN PERCOCET FIORICET AMBIEN ALBUTEROL SULFATE HFA VITAMIN D LIDOCAINE PAIN RELIEF GEL-PATCH MONTELUKAST SODIUM NASONEX PREGABALIN PREGABALIN PREGABALIN PREGABALIN INDOMETHACIN FROVATRIPTAN SUCCINATE TOPIRAMATE PHENOBARBITAL ONDANSETRON HYDROCHLORIDE DULOXETINE HYDROCHLORIDE LEVOCETIRIZINE DIHYDROCHLORIDE CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE PROMETHAZINE HYDROCHLORIDE OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE ZOLPIDEM TARTRATE ALBUTEROL SULFATE ERGOCALCIFEROL LIDOCAINE MONTELUKAST SODIUM MOMETASONE FUROATE HEADACHE Off label use Muscle spasms Musculoskeletal stiffness"}
{"safetyreportid": "10016356", "receiveDate": "20140317", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "SE", "reportType": "1", "patientSex": "1", "patientAge": "74", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "TEGRETOL", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Novartis Pharmaceuticals Corporation", "genericName": "CARBAMAZEPINE", "brandName": "TEGRETOL", "pharmClass_epc": "Mood Stabilizer [EPC]", "route": "ORAL"}, {"medicinalproduct": "PROPAVAN", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "KALCIDON", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "FELODIPINE.", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Glenmark Pharmaceuticals Inc., USA", "genericName": "FELODIPINE", "brandName": "FELODIPINE", "pharmClass_epc": "Dihydropyridine Calcium Channel Blocker [EPC]", "route": "ORAL"}, {"medicinalproduct": "OLANZAPINE.", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Hisun Pharmaceuticals USA, Inc.", "genericName": "OLANZAPINE", "brandName": "OLANZAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "LITAREX//LITHIUM CITRATE", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "METOPROLOL", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Baxter Healthcare Corporation", "genericName": "METOPROLOL TARTRATE", "brandName": "METOPROLOL", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "ZOPICLONE", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ETALPHA", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Akathisia", "outcome": "1"}, {"pt": "Toxicity to various agents", "outcome": "1"}, {"pt": "Metabolic acidosis", "outcome": "1"}], "classifyText": "TEGRETOL PROPAVAN KALCIDON FELODIPINE OLANZAPINE LITAREX//LITHIUM CITRATE METOPROLOL ZOPICLONE ETALPHA CARBAMAZEPINE FELODIPINE OLANZAPINE METOPROLOL TARTRATE PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Akathisia Toxicity to various agents Metabolic acidosis"}
{"safetyreportid": "10016402", "receiveDate": "20140317", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "IT", "reportType": "3", "patientSex": "2", "patientAge": "53", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "FAMPYRA", "drugcharacterization": "1", "drugindication": "ASTHENIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LAMICTAL", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "GlaxoSmithKline LLC", "genericName": "LAMOTRIGINE", "brandName": "LAMICTAL", "pharmClass_epc": "Anti-epileptic Agent [EPC]", "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Aphasia", "outcome": "1"}, {"pt": "Confusional state", "outcome": "1"}, {"pt": "Tremor", "outcome": "1"}, {"pt": "Vertigo", "outcome": "1"}], "classifyText": "FAMPYRA LAMICTAL CYMBALTA LAMOTRIGINE DULOXETINE HYDROCHLORIDE ASTHENIA PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Aphasia Confusional state Tremor Vertigo"}
{"safetyreportid": "10016410", "receiveDate": "20140317", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "1", "patientAge": "57", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "LYRICA", "drugcharacterization": "1", "drugindication": "DIABETIC NEUROPATHY", "manufacturer": "Parke-Davis Div of Pfizer Inc", "genericName": "PREGABALIN", "brandName": "LYRICA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "2", "drugindication": "DIABETES MELLITUS", "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "LANTUS", "drugcharacterization": "2", "drugindication": "DIABETES MELLITUS", "manufacturer": "sanofi-aventis U.S. LLC", "genericName": "INSULIN GLARGINE", "brandName": "LANTUS", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}], "reactions": [{"pt": "Neuropathy peripheral", "outcome": "6"}, {"pt": "Pain", "outcome": "6"}, {"pt": "Burning sensation", "outcome": "6"}], "classifyText": "LYRICA HUMALOG MIX75/25 LANTUS PREGABALIN INSULIN LISPRO INSULIN GLARGINE DIABETIC NEUROPATHY DIABETES MELLITUS DIABETES MELLITUS Neuropathy peripheral Pain Burning sensation"}
{"safetyreportid": "10016427", "receiveDate": "20140317", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "GB", "reportType": "1", "patientSex": "2", "patientAge": "21", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "QUETIAPINE (UNKNOWN)", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "SERTRALINE", "drugcharacterization": "2", "drugindication": "AGITATION", "manufacturer": "Exelan Pharmaceuticals, Inc.", "genericName": "SERTRALINE", "brandName": "SERTRALINE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CITALOPRAM", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Chartwell Governmental & Specialty RX, LLC.", "genericName": "CITALOPRAM", "brandName": "CITALOPRAM", "pharmClass_epc": "Serotonin Reuptake Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": "ATTENTION DEFICIT/HYPERACTIVITY DISORDER", "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "RISPERIDONE (UNKNOWN)", "drugcharacterization": "1", "drugindication": "AGITATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CIRCADIN", "drugcharacterization": "2", "drugindication": "INSOMNIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Depression", "outcome": "3"}, {"pt": "Somnolence", "outcome": "3"}, {"pt": "Bipolar I disorder", "outcome": "3"}, {"pt": "Sedation", "outcome": "3"}, {"pt": "Agitation", "outcome": "3"}, {"pt": "Major depression", "outcome": "3"}, {"pt": "Merycism", "outcome": "3"}, {"pt": "Attention deficit/hyperactivity disorder", "outcome": "3"}], "classifyText": "QUETIAPINE (UNKNOWN) STRATTERA STRATTERA STRATTERA SERTRALINE STRATTERA CITALOPRAM STRATTERA STRATTERA RISPERIDONE (UNKNOWN) STRATTERA CIRCADIN ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE SERTRALINE ATOMOXETINE HYDROCHLORIDE CITALOPRAM ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE PRODUCT USED FOR UNKNOWN INDICATION AGITATION PRODUCT USED FOR UNKNOWN INDICATION ATTENTION DEFICIT/HYPERACTIVITY DISORDER AGITATION INSOMNIA Depression Somnolence Bipolar I disorder Sedation Agitation Major depression Merycism Attention deficit/hyperactivity disorder"}
{"safetyreportid": "10016430", "receiveDate": "20140317", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "GB", "reportType": "1", "patientSex": "2", "patientAge": "21", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "CITALOPRAM (UNKNOWN)", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "QUETIAPINE (UNKNOWN)", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "RISPERIDONE (UNKNOWN)", "drugcharacterization": "1", "drugindication": "AGITATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CIRCADIN", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SERTRALINE", "drugcharacterization": "2", "drugindication": "AGITATION", "manufacturer": "Exelan Pharmaceuticals, Inc.", "genericName": "SERTRALINE", "brandName": "SERTRALINE", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Bipolar I disorder", "outcome": "3"}, {"pt": "Depression", "outcome": "3"}, {"pt": "Merycism", "outcome": "3"}, {"pt": "Major depression", "outcome": "3"}, {"pt": "Attention deficit/hyperactivity disorder", "outcome": "3"}, {"pt": "Somnolence", "outcome": "3"}, {"pt": "Sedation", "outcome": "3"}, {"pt": "Agitation", "outcome": "3"}], "classifyText": "CITALOPRAM (UNKNOWN) QUETIAPINE (UNKNOWN) RISPERIDONE (UNKNOWN) STRATTERA STRATTERA STRATTERA STRATTERA STRATTERA STRATTERA STRATTERA CIRCADIN SERTRALINE ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE SERTRALINE PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION AGITATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION AGITATION Bipolar I disorder Depression Merycism Major depression Attention deficit/hyperactivity disorder Somnolence Sedation Agitation"}
{"safetyreportid": "10016451", "receiveDate": "20140317", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "SYNTHROID", "drugcharacterization": "1", "drugindication": "HYPOTHYROIDISM", "manufacturer": "AbbVie Inc.", "genericName": "LEVOTHYROXINE SODIUM", "brandName": "SYNTHROID", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "SYNTHROID", "drugcharacterization": "1", "drugindication": null, "manufacturer": "AbbVie Inc.", "genericName": "LEVOTHYROXINE SODIUM", "brandName": "SYNTHROID", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "SYNTHROID", "drugcharacterization": "1", "drugindication": null, "manufacturer": "AbbVie Inc.", "genericName": "LEVOTHYROXINE SODIUM", "brandName": "SYNTHROID", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "GLUCOPHAGE", "drugcharacterization": "1", "drugindication": "DIABETES MELLITUS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "GLIPIZIDE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Roerig", "genericName": "GLIPIZIDE", "brandName": "GLUCOTROL XL", "pharmClass_epc": "Sulfonylurea [EPC]", "route": "ORAL"}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "METHOTREXATE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Chartwell RX, LLC", "genericName": "METHOTREXATE", "brandName": "METHOTREXATE", "pharmClass_epc": "Folate Analog Metabolic Inhibitor [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Hip fracture", "outcome": "1"}, {"pt": "Muscle spasms", "outcome": "3"}, {"pt": "Tremor", "outcome": "3"}, {"pt": "Swelling", "outcome": "3"}, {"pt": "Pain", "outcome": "3"}, {"pt": "Fall", "outcome": "1"}, {"pt": "Inflammation", "outcome": "3"}, {"pt": "Movement disorder", "outcome": "1"}], "classifyText": "SYNTHROID SYNTHROID SYNTHROID GLUCOPHAGE GLUCOTROL XL HUMALOG MIX75/25 METHOTREXATE LEVOTHYROXINE SODIUM LEVOTHYROXINE SODIUM LEVOTHYROXINE SODIUM GLIPIZIDE INSULIN LISPRO METHOTREXATE HYPOTHYROIDISM DIABETES MELLITUS PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Hip fracture Muscle spasms Tremor Swelling Pain Fall Inflammation Movement disorder"}
{"safetyreportid": "10016481", "receiveDate": "20140317", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "1", "patientAge": "6", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "HYDROCHLOROTHIAZIDE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Aurobindo Pharma Limited", "genericName": "HYDROCHLOROTHIAZIDE", "brandName": "HYDROCHLOROTHIAZIDE", "pharmClass_epc": "Thiazide Diuretic [EPC]", "route": "ORAL"}, {"medicinalproduct": "VORICONAZOLE", "drugcharacterization": "1", "drugindication": "ANTIFUNGAL PROPHYLAXIS", "manufacturer": "Eugia US LLC", "genericName": "VORICONAZOLE", "brandName": "VORICONAZOLE", "pharmClass_epc": "Azole Antifungal [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "CICLOSPORIN", "drugcharacterization": "1", "drugindication": "GRAFT VERSUS HOST DISEASE", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "THYROXINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "NIFEDIPINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Oceanside Pharmaceuticals", "genericName": "NIFEDIPINE", "brandName": "NIFEDIPINE", "pharmClass_epc": "Dihydropyridine Calcium Channel Blocker [EPC]", "route": "ORAL"}, {"medicinalproduct": "OLANZAPINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Hisun Pharmaceuticals USA, Inc.", "genericName": "OLANZAPINE", "brandName": "OLANZAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "LOSARTAN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Granules Pharmaceuticals Inc.", "genericName": "LOSARTAN", "brandName": "LOSARTAN POTASSIUM", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "MEGESTROL", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "METHADONE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "VistaPharm, LLC", "genericName": "METHADONE", "brandName": "METHADONE HYDROCHLORIDE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "HYDROCORTISONE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "TRIFECTA PHARMACEUTICALS USA LLC", "genericName": "HYDROCORTISONE", "brandName": "HYDROCORTISONE", "pharmClass_epc": "Corticosteroid [EPC]", "route": "TOPICAL"}, {"medicinalproduct": "THIOTEPA", "drugcharacterization": "2", "drugindication": "GRAFT VERSUS HOST DISEASE", "manufacturer": "Meitheal Pharmaceuticals Inc", "genericName": "THIOTEPA", "brandName": "THIOTEPA", "pharmClass_epc": "Alkylating Drug [EPC]", "route": "INTRACAVITARY"}], "reactions": [{"pt": "Photosensitivity reaction", "outcome": "2"}, {"pt": "Rash erythematous", "outcome": "2"}, {"pt": "Rash papular", "outcome": "2"}, {"pt": "Ephelides", "outcome": "2"}, {"pt": "Graft versus host disease in skin", "outcome": "6"}], "classifyText": "HYDROCHLOROTHIAZIDE VORICONAZOLE CICLOSPORIN THYROXINE NIFEDIPINE OLANZAPINE LOSARTAN POTASSIUM MEGESTROL METHADONE HYDROCHLORIDE HYDROCORTISONE THIOTEPA HYDROCHLOROTHIAZIDE VORICONAZOLE NIFEDIPINE OLANZAPINE LOSARTAN METHADONE HYDROCORTISONE THIOTEPA ANTIFUNGAL PROPHYLAXIS GRAFT VERSUS HOST DISEASE GRAFT VERSUS HOST DISEASE Photosensitivity reaction Rash erythematous Rash papular Ephelides Graft versus host disease in skin"}
{"safetyreportid": "10016668", "receiveDate": "20140317", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "1", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "LANSOPRAZOLE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Medcore LLC", "genericName": "LANSOPRAZOLE", "brandName": "LANSOPRAZOLE", "pharmClass_epc": "Proton Pump Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "PEGINTRON", "drugcharacterization": "1", "drugindication": "HEPATITIS C", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "REBETOL", "drugcharacterization": "1", "drugindication": "HEPATITIS C", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SOVALDI", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Gilead Sciences, Inc.", "genericName": "SOFOSBUVIR", "brandName": "SOVALDI", "pharmClass_epc": "Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "SUBOXONE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "INDIVIOR INC.", "genericName": "BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE", "brandName": "SUBOXONE", "pharmClass_epc": null, "route": "BUCCAL"}, {"medicinalproduct": "COZAAR", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Organon LLC", "genericName": "LOSARTAN POTASSIUM", "brandName": "COZAAR", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "OMEPRAZOLE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Amerisource Bergen", "genericName": "OMEPRAZOLE", "brandName": "GOOD NEIGHBOR PHARMACY OMEPRAZOLE", "pharmClass_epc": "Proton Pump Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "HYDROCHLOROTHIAZIDE (+) LOSARTAN POTASSIUM", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Sciatica", "outcome": "6"}, {"pt": "Flank pain", "outcome": "6"}, {"pt": "Retinal infarction", "outcome": "1"}, {"pt": "Mood swings", "outcome": "6"}, {"pt": "Hypoaesthesia", "outcome": "6"}, {"pt": "Appetite disorder", "outcome": "6"}, {"pt": "Parosmia", "outcome": "6"}, {"pt": "Rash", "outcome": "6"}, {"pt": "Influenza like illness", "outcome": "6"}, {"pt": "Nausea", "outcome": "6"}], "classifyText": "LANSOPRAZOLE PEGINTRON REBETOL SOVALDI SUBOXONE COZAAR GOOD NEIGHBOR PHARMACY OMEPRAZOLE CYMBALTA HYDROCHLOROTHIAZIDE (+) LOSARTAN POTASSIUM LANSOPRAZOLE SOFOSBUVIR BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE LOSARTAN POTASSIUM OMEPRAZOLE DULOXETINE HYDROCHLORIDE HEPATITIS C HEPATITIS C Sciatica Flank pain Retinal infarction Mood swings Hypoaesthesia Appetite disorder Parosmia Rash Influenza like illness Nausea"}
{"safetyreportid": "10016771", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 1, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "BR", "reportType": "2", "patientSex": "2", "patientAge": "91", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "EXELON PATCH", "drugcharacterization": "1", "drugindication": "DEMENTIA ALZHEIMER^S TYPE", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "FUROSEMIDE", "drugcharacterization": "2", "drugindication": "DEPRESSION", "manufacturer": "Ipca Laboratories Limited", "genericName": "FUROSEMIDE", "brandName": "FUROSEMIDE", "pharmClass_epc": "Loop Diuretic [EPC]", "route": "ORAL"}, {"medicinalproduct": "ENALAPRIL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Amneal Pharmaceuticals NY LLC", "genericName": "ENALAPRIL", "brandName": "ENALAPRIL MALEATE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "DAFORIN", "drugcharacterization": "2", "drugindication": "DEPRESSION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "GABAPENTIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Rising Pharma Holdings, Inc.", "genericName": "GABAPENTIN", "brandName": "GABAPENTIN", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Renal failure", "outcome": "5"}, {"pt": "Gastric ulcer haemorrhage", "outcome": "5"}, {"pt": "Pulmonary sepsis", "outcome": "5"}, {"pt": "Memory impairment", "outcome": "3"}], "classifyText": "EXELON PATCH FUROSEMIDE ENALAPRIL MALEATE DAFORIN CYMBALTA GABAPENTIN FUROSEMIDE ENALAPRIL DULOXETINE HYDROCHLORIDE GABAPENTIN DEMENTIA ALZHEIMER^S TYPE DEPRESSION DEPRESSION Renal failure Gastric ulcer haemorrhage Pulmonary sepsis Memory impairment"}
{"safetyreportid": "10016803", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "DE", "reportType": "3", "patientSex": "2", "patientAge": "90", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "PRAMIPEXOLE", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Camber Pharmaceuticals, Inc.", "genericName": "PRAMIPEXOLE", "brandName": "PRAMIPEXOLE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "RISPERDAL", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Janssen Pharmaceuticals, Inc.", "genericName": "RISPERIDONE", "brandName": "RISPERDAL", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "ZYPREXA", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "OLANZAPINE", "brandName": "ZYPREXA INTRAMUSCULAR", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "VALDOXAN", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "DIAZEPAM", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Hospira, Inc.", "genericName": "DIAZEPAM", "brandName": "DIAZEPAM", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "LEVODOPA", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Merz Pharmaceuticals, LLC", "genericName": "LEVODOPA", "brandName": "INBRIJA", "pharmClass_epc": "Aromatic Amino Acid [EPC]", "route": "RESPIRATORY (INHALATION)"}], "reactions": [{"pt": "Fall", "outcome": "6"}, {"pt": "Movement disorder", "outcome": "6"}, {"pt": "Speech disorder", "outcome": "6"}, {"pt": "Eating disorder", "outcome": "6"}, {"pt": "Salivary hypersecretion", "outcome": "6"}, {"pt": "Sedation", "outcome": "6"}], "classifyText": "PRAMIPEXOLE RISPERDAL ZYPREXA INTRAMUSCULAR VALDOXAN DIAZEPAM INBRIJA PRAMIPEXOLE RISPERIDONE OLANZAPINE DIAZEPAM LEVODOPA PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Fall Movement disorder Speech disorder Eating disorder Salivary hypersecretion Sedation"}
{"safetyreportid": "10017086", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "1", "patientAge": "43", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "TECFIDERA", "drugcharacterization": "1", "drugindication": "MULTIPLE SCLEROSIS", "manufacturer": "Biogen Inc.", "genericName": "DIMETHYL FUMARATE", "brandName": "TECFIDERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CLONAZEPAM", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Advagen Pharma Ltd", "genericName": "CLONAZEPAM", "brandName": "CLONAZEPAM", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "DIGOXIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Sun Pharmaceutical Industries, Inc.", "genericName": "DIGOXIN", "brandName": "DIGOXIN", "pharmClass_epc": "Cardiac Glycoside [EPC]", "route": "ORAL"}, {"medicinalproduct": "MENS MULTI VITAMIN AND MINERAL", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "RISPERIDONE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Amneal Pharmaceuticals LLC", "genericName": "RISPERIDONE", "brandName": "RISPERIDONE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "RITALIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Novartis Pharmaceuticals Corporation", "genericName": "METHYLPHENIDATE HYDROCHLORIDE", "brandName": "RITALIN", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "TIZANIDINE HCI", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "TOPAMAX", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Janssen Pharmaceuticals, Inc.", "genericName": "TOPIRAMATE", "brandName": "TOPAMAX", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Meniscus injury", "outcome": "3"}, {"pt": "Pain", "outcome": "3"}, {"pt": "Fatigue", "outcome": "3"}, {"pt": "Dizziness", "outcome": "3"}, {"pt": "Local swelling", "outcome": "6"}], "classifyText": "TECFIDERA CLONAZEPAM CYMBALTA DIGOXIN MENS MULTI VITAMIN AND MINERAL RISPERIDONE RITALIN TIZANIDINE HCI TOPAMAX DIMETHYL FUMARATE CLONAZEPAM DULOXETINE HYDROCHLORIDE DIGOXIN RISPERIDONE METHYLPHENIDATE HYDROCHLORIDE TOPIRAMATE MULTIPLE SCLEROSIS Meniscus injury Pain Fatigue Dizziness Local swelling"}
{"safetyreportid": "10017087", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "47", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "TECFIDERA", "drugcharacterization": "1", "drugindication": "MULTIPLE SCLEROSIS", "manufacturer": "Biogen Inc.", "genericName": "DIMETHYL FUMARATE", "brandName": "TECFIDERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "BACLOFEN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Northstar RxLLC", "genericName": "BACLOFEN", "brandName": "BACLOFEN", "pharmClass_epc": "gamma-Aminobutyric Acid-ergic Agonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "BENADRYL ALLERGY", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Kenvue Brands LLC", "genericName": "DIPHENHYDRAMINE HYDROCHLORIDE", "brandName": "BENADRYL ALLERGY", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "HYDROCORTISONE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "TRIFECTA PHARMACEUTICALS USA LLC", "genericName": "HYDROCORTISONE", "brandName": "HYDROCORTISONE", "pharmClass_epc": "Corticosteroid [EPC]", "route": "TOPICAL"}, {"medicinalproduct": "LAMOTRIGINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Actavis Pharma, Inc.", "genericName": "LAMOTRIGINE", "brandName": "LAMOTRIGINE", "pharmClass_epc": "Anti-epileptic Agent [EPC]", "route": "ORAL"}, {"medicinalproduct": "LIOTHYRONINE SODIUM", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Zydus Lifesciences Limited", "genericName": "LIOTHYRONINE SODIUM", "brandName": "LIOTHYRONINE SODIUM", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LYRICA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Parke-Davis Div of Pfizer Inc", "genericName": "PREGABALIN", "brandName": "LYRICA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "NAPROXEN SODIUM", "drugcharacterization": "2", "drugindication": null, "manufacturer": "CVS", "genericName": "NAPROXEN SODIUM", "brandName": "NAPROXEN SODIUM", "pharmClass_epc": "Nonsteroidal Anti-inflammatory Drug [EPC]", "route": "ORAL"}, {"medicinalproduct": "PRILOSEC", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Covis Pharma US, Inc", "genericName": "OMEPRAZOLE MAGNESIUM", "brandName": "PRILOSEC", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "SUDAFED 12 HOUR", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SYNTHROID", "drugcharacterization": "2", "drugindication": null, "manufacturer": "AbbVie Inc.", "genericName": "LEVOTHYROXINE SODIUM", "brandName": "SYNTHROID", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "TRAZODONE HCI", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "VITAMIN D-3", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Surgery", "outcome": "3"}], "classifyText": "TECFIDERA BACLOFEN BENADRYL ALLERGY CYMBALTA HYDROCORTISONE LAMOTRIGINE LIOTHYRONINE SODIUM LYRICA NAPROXEN SODIUM PRILOSEC SUDAFED 12 HOUR SYNTHROID TRAZODONE HCI VITAMIN D-3 DIMETHYL FUMARATE BACLOFEN DIPHENHYDRAMINE HYDROCHLORIDE DULOXETINE HYDROCHLORIDE HYDROCORTISONE LAMOTRIGINE LIOTHYRONINE SODIUM PREGABALIN NAPROXEN SODIUM OMEPRAZOLE MAGNESIUM LEVOTHYROXINE SODIUM MULTIPLE SCLEROSIS Surgery"}
{"safetyreportid": "10017088", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "1", "patientAge": "52", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "TECFIDERA", "drugcharacterization": "1", "drugindication": "MULTIPLE SCLEROSIS", "manufacturer": "Biogen Inc.", "genericName": "DIMETHYL FUMARATE", "brandName": "TECFIDERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ACYCLOVIR", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Zydus Pharmaceuticals (USA) Inc.", "genericName": "ACYCLOVIR", "brandName": "ACYCLOVIR", "pharmClass_epc": "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "BACLOFEN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Northstar RxLLC", "genericName": "BACLOFEN", "brandName": "BACLOFEN", "pharmClass_epc": "gamma-Aminobutyric Acid-ergic Agonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "BENADRYL ALLERGY", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Kenvue Brands LLC", "genericName": "DIPHENHYDRAMINE HYDROCHLORIDE", "brandName": "BENADRYL ALLERGY", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CEFUROXIME AXETIL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Aurobindo Pharma Limited", "genericName": "CEFUROXIME AXETIL", "brandName": "CEFUROXIME AXETIL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CLONAZEPAM", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Advagen Pharma Ltd", "genericName": "CLONAZEPAM", "brandName": "CLONAZEPAM", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "IBUPROFEN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "DOLGENCORP INC", "genericName": "IBUPROFEN", "brandName": "IBUPROFEN", "pharmClass_epc": "Nonsteroidal Anti-inflammatory Drug [EPC]", "route": "ORAL"}, {"medicinalproduct": "METHYLPHENIDATE HCL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Patrin Pharma, Inc.", "genericName": "METHYLPHENIDATE HCL", "brandName": "METHYLPHENIDATE HCL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "METOPROLOL TARTRATE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Almaject, Inc.", "genericName": "METOPROLOL TARTRATE", "brandName": "METOPROLOL TARTRATE", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "NUEDEXTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Otsuka America Pharmaceutical, Inc", "genericName": "DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE", "brandName": "NUEDEXTA", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Hip fracture", "outcome": "6"}, {"pt": "Osteoporosis", "outcome": "6"}], "classifyText": "TECFIDERA ACYCLOVIR BACLOFEN BENADRYL ALLERGY CEFUROXIME AXETIL CLONAZEPAM CYMBALTA IBUPROFEN METHYLPHENIDATE HCL METOPROLOL TARTRATE NUEDEXTA DIMETHYL FUMARATE ACYCLOVIR BACLOFEN DIPHENHYDRAMINE HYDROCHLORIDE CEFUROXIME AXETIL CLONAZEPAM DULOXETINE HYDROCHLORIDE IBUPROFEN METHYLPHENIDATE HCL METOPROLOL TARTRATE DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE MULTIPLE SCLEROSIS Hip fracture Osteoporosis"}
{"safetyreportid": "10017121", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "AU", "reportType": "1", "patientSex": "2", "patientAge": "35", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "DIAZEPAM", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Hospira, Inc.", "genericName": "DIAZEPAM", "brandName": "DIAZEPAM", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "VALDOXAN", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "OLANZAPINE", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Hisun Pharmaceuticals USA, Inc.", "genericName": "OLANZAPINE", "brandName": "OLANZAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Deep vein thrombosis", "outcome": "2"}], "classifyText": "DIAZEPAM VALDOXAN OLANZAPINE DIAZEPAM OLANZAPINE PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Deep vein thrombosis"}
{"safetyreportid": "10017141", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "BE", "reportType": "1", "patientSex": "2", "patientAge": "87", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "PROLIA", "drugcharacterization": "1", "drugindication": "OSTEOPOROSIS POSTMENOPAUSAL", "manufacturer": "Amgen, Inc", "genericName": "DENOSUMAB", "brandName": "PROLIA", "pharmClass_epc": "RANK Ligand Inhibitor [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "TRAZOLAN", "drugcharacterization": "2", "drugindication": "SLEEP DISORDER", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SEDACID /00661201/", "drugcharacterization": "2", "drugindication": "PROPHYLAXIS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "FERRICURE /00023548/", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": "ANXIETY DISORDER", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "MEDROL /00049601/", "drugcharacterization": "2", "drugindication": "POLYMYALGIA RHEUMATICA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "MICARDIS", "drugcharacterization": "2", "drugindication": "HYPERTENSION", "manufacturer": "Boehringer Ingelheim Pharmaceuticals, Inc.", "genericName": "TELMISARTAN", "brandName": "MICARDIS", "pharmClass_epc": "Angiotensin 2 Receptor Blocker [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Dyspnoea", "outcome": "1"}, {"pt": "Malaise", "outcome": "1"}, {"pt": "Chest pain", "outcome": "1"}, {"pt": "Pulmonary hypertension", "outcome": "1"}], "classifyText": "PROLIA TRAZOLAN SEDACID /00661201/ FERRICURE /00023548/ CYMBALTA MEDROL /00049601/ MICARDIS DENOSUMAB DULOXETINE HYDROCHLORIDE TELMISARTAN OSTEOPOROSIS POSTMENOPAUSAL SLEEP DISORDER PROPHYLAXIS ANXIETY DISORDER POLYMYALGIA RHEUMATICA HYPERTENSION Dyspnoea Malaise Chest pain Pulmonary hypertension"}
{"safetyreportid": "10017150", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "GB", "reportType": "1", "patientSex": "2", "patientAge": "21", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "CITALOPRAM", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Chartwell Governmental & Specialty RX, LLC.", "genericName": "CITALOPRAM", "brandName": "CITALOPRAM", "pharmClass_epc": "Serotonin Reuptake Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "QUETIAPINE", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Solco Healthcare U.S., LLC", "genericName": "QUETIAPINE", "brandName": "QUETIAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "RISPERIDONE", "drugcharacterization": "1", "drugindication": "AGITATION", "manufacturer": "Amneal Pharmaceuticals LLC", "genericName": "RISPERIDONE", "brandName": "RISPERIDONE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": "ATTENTION DEFICIT/HYPERACTIVITY DISORDER", "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CIRCADIN", "drugcharacterization": "2", "drugindication": "INSOMNIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SERTRALINE", "drugcharacterization": "2", "drugindication": "AGITATION", "manufacturer": "Exelan Pharmaceuticals, Inc.", "genericName": "SERTRALINE", "brandName": "SERTRALINE", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Bipolar I disorder", "outcome": "3"}, {"pt": "Depression", "outcome": "3"}, {"pt": "Merycism", "outcome": "3"}, {"pt": "Major depression", "outcome": "3"}, {"pt": "Attention deficit/hyperactivity disorder", "outcome": "3"}, {"pt": "Somnolence", "outcome": "3"}, {"pt": "Sedation", "outcome": "3"}, {"pt": "Agitation", "outcome": "3"}], "classifyText": "CITALOPRAM QUETIAPINE RISPERIDONE STRATTERA STRATTERA STRATTERA STRATTERA STRATTERA STRATTERA STRATTERA CIRCADIN SERTRALINE CITALOPRAM QUETIAPINE RISPERIDONE ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE SERTRALINE PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION AGITATION ATTENTION DEFICIT/HYPERACTIVITY DISORDER INSOMNIA AGITATION Bipolar I disorder Depression Merycism Major depression Attention deficit/hyperactivity disorder Somnolence Sedation Agitation"}
{"safetyreportid": "10017179", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "2", "patientSex": "2", "patientAge": "49", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": "FIBROMYALGIA", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "HYDROXYCHLOROQUINE", "drugcharacterization": "2", "drugindication": "RHEUMATOID ARTHRITIS", "manufacturer": "Chartwell RX, LLC", "genericName": "HYDROXYCHLOROQUINE", "brandName": "HYDROXYCHLOROQUINE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "PROAIR HFA", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "MONTELUKAST", "drugcharacterization": "2", "drugindication": "HYPERSENSITIVITY", "manufacturer": "Amneal Pharmaceuticals LLC", "genericName": "MONTELUKAST", "brandName": "MONTELUKAST SODIUM", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ISOSORBIDE DINITRATE.", "drugcharacterization": "2", "drugindication": null, "manufacturer": "BluePoint Laboratories", "genericName": "ISOSORBIDE DINITRATE", "brandName": "ISOSORBIDE DINITRATE", "pharmClass_epc": "Nitrate Vasodilator [EPC]", "route": "ORAL"}, {"medicinalproduct": "FOLIC ACID.", "drugcharacterization": "2", "drugindication": "FIBROMYALGIA", "manufacturer": "PureTek Corporation", "genericName": "FOLIC ACID", "brandName": "VENTRIXYL", "pharmClass_epc": "Vitamin C [EPC]", "route": "ORAL"}, {"medicinalproduct": "HYOSCYAMINE SULFATE.", "drugcharacterization": "2", "drugindication": "ABDOMINAL PAIN UPPER", "manufacturer": "Chartwell RX, LLC", "genericName": "HYOSCYAMINE SULFATE", "brandName": "HYOSCYAMINE SULFATE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "TRAMADOL HCL", "drugcharacterization": "2", "drugindication": "PAIN", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "FISH OIL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Fresenius Kabi USA, LLC", "genericName": "FISH OIL", "brandName": "OMEGAVEN", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "FOLIC ACID.", "drugcharacterization": "2", "drugindication": "FATIGUE", "manufacturer": "PureTek Corporation", "genericName": "FOLIC ACID", "brandName": "VENTRIXYL", "pharmClass_epc": "Vitamin C [EPC]", "route": "ORAL"}, {"medicinalproduct": "ACTEMRA", "drugcharacterization": "1", "drugindication": "RHEUMATOID ARTHRITIS", "manufacturer": "Genentech, Inc.", "genericName": "TOCILIZUMAB", "brandName": "ACTEMRA", "pharmClass_epc": "Interleukin-6 Receptor Antagonist [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "ACTEMRA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Genentech, Inc.", "genericName": "TOCILIZUMAB", "brandName": "ACTEMRA", "pharmClass_epc": "Interleukin-6 Receptor Antagonist [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "OMEPRAZOLE.", "drugcharacterization": "2", "drugindication": "GASTROOESOPHAGEAL REFLUX DISEASE", "manufacturer": "Amerisource Bergen", "genericName": "OMEPRAZOLE", "brandName": "GOOD NEIGHBOR PHARMACY OMEPRAZOLE", "pharmClass_epc": "Proton Pump Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "ACTEMRA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Genentech, Inc.", "genericName": "TOCILIZUMAB", "brandName": "ACTEMRA", "pharmClass_epc": "Interleukin-6 Receptor Antagonist [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": "DEPRESSION", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ACETAMINOPHEN/OXYCODONE", "drugcharacterization": "2", "drugindication": "PAIN", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Peripheral swelling", "outcome": "6"}, {"pt": "Gait disturbance", "outcome": "6"}, {"pt": "Vision blurred", "outcome": "6"}, {"pt": "Fatigue", "outcome": "6"}, {"pt": "Back pain", "outcome": "6"}, {"pt": "Blood potassium decreased", "outcome": "6"}, {"pt": "Oedema peripheral", "outcome": "6"}, {"pt": "Pain in extremity", "outcome": "6"}, {"pt": "Abdominal discomfort", "outcome": "6"}, {"pt": "Thrombosis", "outcome": "2"}, {"pt": "Gastrointestinal inflammation", "outcome": "6"}, {"pt": "Impaired healing", "outcome": "6"}], "classifyText": "CYMBALTA HYDROXYCHLOROQUINE PROAIR HFA MONTELUKAST SODIUM ISOSORBIDE DINITRATE VENTRIXYL HYOSCYAMINE SULFATE TRAMADOL HCL OMEGAVEN VENTRIXYL ACTEMRA ACTEMRA GOOD NEIGHBOR PHARMACY OMEPRAZOLE ACTEMRA CYMBALTA ACETAMINOPHEN/OXYCODONE DULOXETINE HYDROCHLORIDE HYDROXYCHLOROQUINE MONTELUKAST ISOSORBIDE DINITRATE FOLIC ACID HYOSCYAMINE SULFATE FISH OIL FOLIC ACID TOCILIZUMAB TOCILIZUMAB OMEPRAZOLE TOCILIZUMAB DULOXETINE HYDROCHLORIDE FIBROMYALGIA RHEUMATOID ARTHRITIS HYPERSENSITIVITY FIBROMYALGIA ABDOMINAL PAIN UPPER PAIN FATIGUE RHEUMATOID ARTHRITIS GASTROOESOPHAGEAL REFLUX DISEASE DEPRESSION PAIN Peripheral swelling Gait disturbance Vision blurred Fatigue Back pain Blood potassium decreased Oedema peripheral Pain in extremity Abdominal discomfort Thrombosis Gastrointestinal inflammation Impaired healing"}
{"safetyreportid": "10017192", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 1, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "1", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "GADOLINIUM (UNSPECIFIED)", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "GADOLINIUM (UNSPECIFIED)", "drugcharacterization": "1", "drugindication": "CELLULITIS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "GADOLINIUM (UNSPECIFIED)", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "GADOLINIUM (UNSPECIFIED)", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "RENAGEL", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "FUROSEMIDE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Ipca Laboratories Limited", "genericName": "FUROSEMIDE", "brandName": "FUROSEMIDE", "pharmClass_epc": "Loop Diuretic [EPC]", "route": "ORAL"}, {"medicinalproduct": "LANTUS", "drugcharacterization": "2", "drugindication": null, "manufacturer": "sanofi-aventis U.S. LLC", "genericName": "INSULIN GLARGINE", "brandName": "LANTUS", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "NEUROTIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "EPOGEN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Amgen, Inc", "genericName": "EPOETIN ALFA", "brandName": "EPOGEN", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "REQUIP", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "COUMADIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "PROCRIT", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Janssen Products, LP", "genericName": "ERYTHROPOIETIN", "brandName": "PROCRIT", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "FOSRENOL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Takeda Pharmaceuticals America, Inc.", "genericName": "LANTHANUM CARBONATE", "brandName": "FOSRENOL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ARANESP", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Amgen, Inc", "genericName": "DARBEPOETIN ALFA", "brandName": "ARANESP", "pharmClass_epc": "Erythropoiesis-stimulating Agent [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "PHOSLO", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "METHAMPHETAMINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "METOPROLOL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Baxter Healthcare Corporation", "genericName": "METOPROLOL TARTRATE", "brandName": "METOPROLOL", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "CLONIDINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Mylan Pharmaceuticals Inc.", "genericName": "CLONIDINE", "brandName": "CLONIDINE", "pharmClass_epc": "Central alpha-2 Adrenergic Agonist [EPC]", "route": "TRANSDERMAL"}, {"medicinalproduct": "AMLOPDIPINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "BENAZEPRIL", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "NITROGLYCERIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Aurobindo Pharma Limited", "genericName": "NITROGLYCERIN", "brandName": "NITROGLYCERIN", "pharmClass_epc": "Nitrate Vasodilator [EPC]", "route": "SUBLINGUAL"}], "reactions": [{"pt": "Nephrogenic systemic fibrosis", "outcome": "5"}], "classifyText": "GADOLINIUM (UNSPECIFIED) GADOLINIUM (UNSPECIFIED) GADOLINIUM (UNSPECIFIED) GADOLINIUM (UNSPECIFIED) RENAGEL FUROSEMIDE LANTUS HUMALOG MIX75/25 NEUROTIN EPOGEN REQUIP COUMADIN PROCRIT FOSRENOL ARANESP PHOSLO METHAMPHETAMINE METOPROLOL CLONIDINE AMLOPDIPINE BENAZEPRIL NITROGLYCERIN FUROSEMIDE INSULIN GLARGINE INSULIN LISPRO EPOETIN ALFA ERYTHROPOIETIN LANTHANUM CARBONATE DARBEPOETIN ALFA METOPROLOL TARTRATE CLONIDINE NITROGLYCERIN PRODUCT USED FOR UNKNOWN INDICATION CELLULITIS PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Nephrogenic systemic fibrosis"}
{"safetyreportid": "10017342", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "JP", "reportType": "1", "patientSex": "1", "patientAge": "55", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "XEPLION", "drugcharacterization": "1", "drugindication": "SCHIZOPHRENIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "XEPLION", "drugcharacterization": "1", "drugindication": "SCHIZOPHRENIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "XEPLION", "drugcharacterization": "1", "drugindication": "SCHIZOPHRENIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "XEPLION", "drugcharacterization": "1", "drugindication": "SCHIZOPHRENIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "NON-PYRINE COLD PREPARATION", "drugcharacterization": "2", "drugindication": "NASOPHARYNGITIS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "AKINETON", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CARBAMAZEPINE", "drugcharacterization": "2", "drugindication": "SCHIZOPHRENIA", "manufacturer": "Torrent Pharmaceuticals Limited", "genericName": "CARBAMAZEPINE", "brandName": "CARBAMAZEPINE", "pharmClass_epc": "Mood Stabilizer [EPC]", "route": "ORAL"}, {"medicinalproduct": "LENDORMIN", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ROHYPNOL", "drugcharacterization": "2", "drugindication": "SCHIZOPHRENIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LEVOTOMIN", "drugcharacterization": "2", "drugindication": "SCHIZOPHRENIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "GASTER", "drugcharacterization": "2", "drugindication": "GASTRODUODENAL ULCER", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ZYPREXA", "drugcharacterization": "2", "drugindication": "SCHIZOPHRENIA", "manufacturer": "Eli Lilly and Company", "genericName": "OLANZAPINE", "brandName": "ZYPREXA INTRAMUSCULAR", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "QUETIAPINE", "drugcharacterization": "2", "drugindication": "SCHIZOPHRENIA", "manufacturer": "Solco Healthcare U.S., LLC", "genericName": "QUETIAPINE", "brandName": "QUETIAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "BIPERIDEN HYDROCHLORIDE", "drugcharacterization": "2", "drugindication": "SCHIZOPHRENIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "BROTIZOLAM", "drugcharacterization": "2", "drugindication": "SCHIZOPHRENIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "DALMATE", "drugcharacterization": "2", "drugindication": "SCHIZOPHRENIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "VEGETAMIN-B", "drugcharacterization": "2", "drugindication": "SCHIZOPHRENIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "MOHRUS TAPE L", "drugcharacterization": "2", "drugindication": "INTERVERTEBRAL DISC PROTRUSION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "PL COMBINATION", "drugcharacterization": "2", "drugindication": "NASOPHARYNGITIS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "TSUMARA SHAKUYAKUKANZOTO", "drugcharacterization": "2", "drugindication": "SCHIZOPHRENIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Water intoxication", "outcome": "2"}, {"pt": "Status epilepticus", "outcome": "1"}], "classifyText": "XEPLION XEPLION XEPLION XEPLION NON-PYRINE COLD PREPARATION AKINETON CARBAMAZEPINE LENDORMIN ROHYPNOL LEVOTOMIN GASTER ZYPREXA INTRAMUSCULAR QUETIAPINE BIPERIDEN HYDROCHLORIDE BROTIZOLAM DALMATE VEGETAMIN-B MOHRUS TAPE L PL COMBINATION TSUMARA SHAKUYAKUKANZOTO CARBAMAZEPINE OLANZAPINE QUETIAPINE SCHIZOPHRENIA SCHIZOPHRENIA SCHIZOPHRENIA SCHIZOPHRENIA NASOPHARYNGITIS PRODUCT USED FOR UNKNOWN INDICATION SCHIZOPHRENIA PRODUCT USED FOR UNKNOWN INDICATION SCHIZOPHRENIA SCHIZOPHRENIA GASTRODUODENAL ULCER SCHIZOPHRENIA SCHIZOPHRENIA SCHIZOPHRENIA SCHIZOPHRENIA SCHIZOPHRENIA SCHIZOPHRENIA INTERVERTEBRAL DISC PROTRUSION NASOPHARYNGITIS SCHIZOPHRENIA Water intoxication Status epilepticus"}
{"safetyreportid": "10017349", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "IT", "reportType": "1", "patientSex": "2", "patientAge": "41", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "RISPERDAL", "drugcharacterization": "1", "drugindication": "SELF INJURIOUS BEHAVIOUR", "manufacturer": "Janssen Pharmaceuticals, Inc.", "genericName": "RISPERIDONE", "brandName": "RISPERDAL", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "QUETIAPINE", "drugcharacterization": "1", "drugindication": "SELF INJURIOUS BEHAVIOUR", "manufacturer": "Solco Healthcare U.S., LLC", "genericName": "QUETIAPINE", "brandName": "QUETIAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "1", "drugindication": "SELF INJURIOUS BEHAVIOUR", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LORAZEPAM", "drugcharacterization": "1", "drugindication": "SELF INJURIOUS BEHAVIOUR", "manufacturer": "International Medication Systems, Limited", "genericName": "LORAZEPAM", "brandName": "LORAZEPAM", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "ABILIFY", "drugcharacterization": "1", "drugindication": "SELF INJURIOUS BEHAVIOUR", "manufacturer": "Otsuka America Pharmaceutical, Inc.", "genericName": "ARIPIPRAZOLE", "brandName": "ABILIFY", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "DEPAKIN", "drugcharacterization": "1", "drugindication": "SELF INJURIOUS BEHAVIOUR", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Intentional self-injury", "outcome": "6"}, {"pt": "Intentional drug misuse", "outcome": "6"}, {"pt": "Hypotension", "outcome": "6"}, {"pt": "Tachycardia", "outcome": "6"}], "classifyText": "RISPERDAL QUETIAPINE CYMBALTA LORAZEPAM ABILIFY DEPAKIN RISPERIDONE QUETIAPINE DULOXETINE HYDROCHLORIDE LORAZEPAM ARIPIPRAZOLE SELF INJURIOUS BEHAVIOUR SELF INJURIOUS BEHAVIOUR SELF INJURIOUS BEHAVIOUR SELF INJURIOUS BEHAVIOUR SELF INJURIOUS BEHAVIOUR SELF INJURIOUS BEHAVIOUR Intentional self-injury Intentional drug misuse Hypotension Tachycardia"}
{"safetyreportid": "10017431", "receiveDate": "20140318", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "LYRICA", "drugcharacterization": "1", "drugindication": "FIBROMYALGIA", "manufacturer": "Parke-Davis Div of Pfizer Inc", "genericName": "PREGABALIN", "brandName": "LYRICA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "1", "drugindication": "FIBROMYALGIA", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Drug ineffective", "outcome": "6"}], "classifyText": "LYRICA CYMBALTA PREGABALIN DULOXETINE HYDROCHLORIDE FIBROMYALGIA FIBROMYALGIA Drug ineffective"}
{"safetyreportid": "10017457", "receiveDate": "20140318", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "56", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "LYRICA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Parke-Davis Div of Pfizer Inc", "genericName": "PREGABALIN", "brandName": "LYRICA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LYRICA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Parke-Davis Div of Pfizer Inc", "genericName": "PREGABALIN", "brandName": "LYRICA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "MEDROL", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Pharmacia & Upjohn Company LLC", "genericName": "METHYLPREDNISOLONE", "brandName": "MEDROL", "pharmClass_epc": "Corticosteroid [EPC]", "route": "ORAL"}, {"medicinalproduct": "AVINZA", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "AVINZA", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "AZITHROMYCIN", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Lupin Pharmaceuticals, Inc.", "genericName": "AZITHROMYCIN", "brandName": "AZITHROMYCIN", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LISINOPRIL", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Chartwell RX, LLC", "genericName": "LISINOPRIL", "brandName": "LISINOPRIL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "VITAMIN D", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Strides Pharma Science Limited", "genericName": "ERGOCALCIFEROL", "brandName": "VITAMIN D", "pharmClass_epc": "Provitamin D2 Compound [EPC]", "route": "ORAL"}, {"medicinalproduct": "VICODIN ES", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "KLONOPIN", "drugcharacterization": "1", "drugindication": null, "manufacturer": "H2-Pharma, LLC", "genericName": "CLONAZEPAM", "brandName": "KLONOPIN", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "ORAL"}, {"medicinalproduct": "ACTONEL", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Allergan, Inc.", "genericName": "RISEDRONATE SODIUM", "brandName": "ACTONEL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "VENTOLIN", "drugcharacterization": "1", "drugindication": null, "manufacturer": "GlaxoSmithKline LLC", "genericName": "ALBUTEROL SULFATE", "brandName": "VENTOLIN HFA", "pharmClass_epc": null, "route": "RESPIRATORY (INHALATION)"}, {"medicinalproduct": "ABILIFY", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Otsuka America Pharmaceutical, Inc.", "genericName": "ARIPIPRAZOLE", "brandName": "ABILIFY", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "FLEXERIL", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ADVAIR", "drugcharacterization": "1", "drugindication": null, "manufacturer": "GlaxoSmithKline LLC", "genericName": "FLUTICASONE PROPIONATE AND SALMETEROL", "brandName": "ADVAIR DISKUS", "pharmClass_epc": null, "route": "RESPIRATORY (INHALATION)"}, {"medicinalproduct": "NUVIGIL", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Cephalon, LLC", "genericName": "ARMODAFINIL", "brandName": "NUVIGIL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CALCIUM", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Apexel Co., Ltd", "genericName": "CALCIUM", "brandName": "7030 CALCIUM PREMIUM", "pharmClass_epc": "Calcium [EPC]", "route": "ORAL"}, {"medicinalproduct": "ANTIVERT", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ZYRTEC", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Kenvue Brands LLC", "genericName": "CETIRIZINE HYDROCHLORIDE", "brandName": "ZYRTEC", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Diarrhoea", "outcome": "6"}, {"pt": "Vomiting", "outcome": "6"}, {"pt": "Nausea", "outcome": "6"}, {"pt": "Malaise", "outcome": "6"}, {"pt": "Asthenia", "outcome": "6"}, {"pt": "Flushing", "outcome": "6"}, {"pt": "Dizziness", "outcome": "6"}, {"pt": "Activities of daily living impaired", "outcome": "6"}, {"pt": "Abdominal discomfort", "outcome": "6"}, {"pt": "Depressed mood", "outcome": "6"}], "classifyText": "LYRICA LYRICA MEDROL AVINZA AVINZA AZITHROMYCIN LISINOPRIL VITAMIN D VICODIN ES KLONOPIN ACTONEL CYMBALTA VENTOLIN HFA ABILIFY FLEXERIL ADVAIR DISKUS NUVIGIL 7030 CALCIUM PREMIUM ANTIVERT ZYRTEC PREGABALIN PREGABALIN METHYLPREDNISOLONE AZITHROMYCIN LISINOPRIL ERGOCALCIFEROL CLONAZEPAM RISEDRONATE SODIUM DULOXETINE HYDROCHLORIDE ALBUTEROL SULFATE ARIPIPRAZOLE FLUTICASONE PROPIONATE AND SALMETEROL ARMODAFINIL CALCIUM CETIRIZINE HYDROCHLORIDE Diarrhoea Vomiting Nausea Malaise Asthenia Flushing Dizziness Activities of daily living impaired Abdominal discomfort Depressed mood"}
{"safetyreportid": "10017478", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": null, "reportType": "1", "patientSex": "0", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "LIDODERM PATCH", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CIALIS", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "TADALAFIL", "brandName": "CIALIS", "pharmClass_epc": "Phosphodiesterase 5 Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "ASPIRIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Unifirst First Aid Corporation", "genericName": "ASPIRIN", "brandName": "BAYER GENUINE ASPIRIN", "pharmClass_epc": "Nonsteroidal Anti-inflammatory Drug [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Drug ineffective", "outcome": null}, {"pt": "Product substitution issue", "outcome": null}, {"pt": "Product adhesion issue", "outcome": null}, {"pt": "Product physical issue", "outcome": null}], "classifyText": "LIDODERM PATCH CIALIS BAYER GENUINE ASPIRIN TADALAFIL ASPIRIN Drug ineffective Product substitution issue Product adhesion issue Product physical issue"}
{"safetyreportid": "10017808", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "JP", "reportType": "1", "patientSex": "2", "patientAge": "34", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "PROGRAF", "drugcharacterization": "1", "drugindication": "PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE", "manufacturer": "Astellas Pharma US, Inc.", "genericName": "TACROLIMUS", "brandName": "PROGRAF", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "PROGRAF", "drugcharacterization": "1", "drugindication": "PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE", "manufacturer": "Astellas Pharma US, Inc.", "genericName": "TACROLIMUS", "brandName": "PROGRAF", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "GASTER", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ITRACONAZOLE", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Ascend Laboratories, LLC", "genericName": "ITRACONAZOLE", "brandName": "ITRACONAZOLE", "pharmClass_epc": "Azole Antifungal [EPC]", "route": "ORAL"}, {"medicinalproduct": "COLCHICINE", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Camber Pharmaceuticals, Inc.", "genericName": "COLCHICINE", "brandName": "COLCHICINE", "pharmClass_epc": "Alkaloid [EPC]", "route": "ORAL"}, {"medicinalproduct": "PENTASA", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Takeda Pharmaceuticals America, Inc.", "genericName": "MESALAMINE", "brandName": "PENTASA", "pharmClass_epc": "Aminosalicylate [EPC]", "route": "ORAL"}, {"medicinalproduct": "FINIBAX", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "VANCOMYCIN /00314402/", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CELLCEPT", "drugcharacterization": "2", "drugindication": "PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE", "manufacturer": "Genentech, Inc.", "genericName": "MYCOPHENOLATE MOFETIL", "brandName": "CELLCEPT", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CELLCEPT", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Genentech, Inc.", "genericName": "MYCOPHENOLATE MOFETIL", "brandName": "CELLCEPT", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CELLCEPT", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Genentech, Inc.", "genericName": "MYCOPHENOLATE MOFETIL", "brandName": "CELLCEPT", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "FLUDARA", "drugcharacterization": "2", "drugindication": "PREMEDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "FLUDARA", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "BUSULFAN", "drugcharacterization": "2", "drugindication": "PREMEDICATION", "manufacturer": "Meitheal Pharmaceuticals Inc.", "genericName": "BUSULFAN", "brandName": "BUSULFAN", "pharmClass_epc": "Alkylating Drug [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "CICLOSPORIN", "drugcharacterization": "2", "drugindication": "PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CICLOSPORIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ENDOXAN", "drugcharacterization": "2", "drugindication": "PREMEDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ENDOXAN", "drugcharacterization": "2", "drugindication": "IMMUNOSUPPRESSANT DRUG THERAPY", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "URSO /00465701/", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CINAL", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "BIOFERMIN R", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "PLANOVAR", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "FRANDOL", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "XYLOCAINE /00033401/", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "THROMBIN", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "NERISONA", "drugcharacterization": "2", "drugindication": "PRURITUS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "NERISONA", "drugcharacterization": "2", "drugindication": "ECZEMA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "NERISONA", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "HYALEIN", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "HIRUDOID /00723701/", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "BRONUCK", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LIDOMEX", "drugcharacterization": "2", "drugindication": "PRURITUS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ACICLOVIN", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ACICLOVIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ACICLOVIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ACICLOVIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ACICLOVIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ACICLOVIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ACICLOVIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ATARAX-P /00058402/", "drugcharacterization": "2", "drugindication": "NAUSEA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ATARAX-P /00058402/", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ADONA /00056903/", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "AMBISOME", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Astellas Pharma US, Inc.", "genericName": "AMPHOTERICIN B", "brandName": "AMBISOME", "pharmClass_epc": "Lipid-based Polyene Antifungal [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "ALBUMINAR", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "OMEPRAL /00661201/", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CANCIDAS", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Merck Sharp & Dohme LLC", "genericName": "CASPOFUNGIN ACETATE", "brandName": "CANCIDAS", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "CUBICIN", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CUBICIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ZYVOX", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Hp Halden Pharma AS", "genericName": "LINEZOLID", "brandName": "ZYVOX", "pharmClass_epc": "Oxazolidinone Antibacterial [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "SANDIMMUN", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SERENACE", "drugcharacterization": "2", "drugindication": "INSOMNIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SERENACE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SERENACE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SOSEGON /00052101/", "drugcharacterization": "2", "drugindication": "PAIN", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SOLU-MEDROL", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Pharmacia & Upjohn Company LLC", "genericName": "METHYLPREDNISOLONE SODIUM SUCCINATE", "brandName": "SOLU-MEDROL", "pharmClass_epc": null, "route": "INTRAMUSCULAR"}, {"medicinalproduct": "TIENAM", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "NICARDIPINE HYDROCHLORIDE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Civica, Inc.", "genericName": "NICARDIPINE HYDROCHLORIDE", "brandName": "NICARDIPINE HYDROCHLORIDE", "pharmClass_epc": "Dihydropyridine Calcium Channel Blocker [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "NEUTROGIN", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "HANP", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "HUMULIN R", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN HUMAN", "brandName": "HUMULIN R", "pharmClass_epc": "Insulin [EPC]", "route": "PARENTERAL"}, {"medicinalproduct": "VFEND", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Roerig", "genericName": "VORICONAZOLE", "brandName": "VFEND", "pharmClass_epc": "Azole Antifungal [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "VFEND", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Roerig", "genericName": "VORICONAZOLE", "brandName": "VFEND", "pharmClass_epc": "Azole Antifungal [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "FENTANYL /00174602/", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "FENTANYL /00174602/", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "POLARAMINE", "drugcharacterization": "2", "drugindication": "PREOPERATIVE CARE", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "VOLVIX", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "MIRACLID", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "MEROPEN /01250501/", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LASIX /00032601/", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LASIX /00032601/", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "RECOMODULIN", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ALBUMIN", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ALBUMIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "HEXIZAC", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "HEXIZAC", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "PROCAINE HYDROCHLORIDE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Thrombotic microangiopathy", "outcome": "6"}, {"pt": "Posterior reversible encephalopathy syndrome", "outcome": "2"}, {"pt": "Drug-induced liver injury", "outcome": "6"}], "classifyText": "PROGRAF PROGRAF GASTER ITRACONAZOLE COLCHICINE PENTASA FINIBAX VANCOMYCIN /00314402/ CELLCEPT CELLCEPT CELLCEPT FLUDARA FLUDARA BUSULFAN CICLOSPORIN CICLOSPORIN ENDOXAN ENDOXAN URSO /00465701/ CINAL BIOFERMIN R PLANOVAR FRANDOL XYLOCAINE /00033401/ THROMBIN NERISONA NERISONA NERISONA HYALEIN HIRUDOID /00723701/ BRONUCK LIDOMEX ACICLOVIN ACICLOVIN ACICLOVIN ACICLOVIN ACICLOVIN ACICLOVIN ACICLOVIN ATARAX-P /00058402/ ATARAX-P /00058402/ ADONA /00056903/ AMBISOME ALBUMINAR OMEPRAL /00661201/ CANCIDAS CUBICIN CUBICIN ZYVOX SANDIMMUN SERENACE SERENACE SERENACE SOSEGON /00052101/ SOLU-MEDROL TIENAM NICARDIPINE HYDROCHLORIDE NEUTROGIN HANP HUMULIN R VFEND VFEND FENTANYL /00174602/ FENTANYL /00174602/ POLARAMINE VOLVIX MIRACLID MEROPEN /01250501/ LASIX /00032601/ LASIX /00032601/ RECOMODULIN ALBUMIN ALBUMIN HEXIZAC HEXIZAC PROCAINE HYDROCHLORIDE TACROLIMUS TACROLIMUS ITRACONAZOLE COLCHICINE MESALAMINE MYCOPHENOLATE MOFETIL MYCOPHENOLATE MOFETIL MYCOPHENOLATE MOFETIL BUSULFAN AMPHOTERICIN B CASPOFUNGIN ACETATE LINEZOLID METHYLPREDNISOLONE SODIUM SUCCINATE NICARDIPINE HYDROCHLORIDE INSULIN HUMAN VORICONAZOLE VORICONAZOLE PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE PREMEDICATION PREMEDICATION PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE PREMEDICATION IMMUNOSUPPRESSANT DRUG THERAPY PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRURITUS ECZEMA PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRURITUS PRODUCT USED FOR UNKNOWN INDICATION NAUSEA PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION INSOMNIA PAIN PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PREOPERATIVE CARE PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Thrombotic microangiopathy Posterior reversible encephalopathy syndrome Drug-induced liver injury"}
{"safetyreportid": "10017840", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "2", "patientSex": "2", "patientAge": "54", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "ERLOTINIB", "drugcharacterization": "1", "drugindication": "NON-SMALL CELL LUNG CANCER", "manufacturer": "Armas Pharmaceuticals Inc.", "genericName": "ERLOTINIB HYDROCHLORIDE", "brandName": "ERLOTINIB", "pharmClass_epc": "Kinase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "AVASTIN /01555201/", "drugcharacterization": "1", "drugindication": "LUNG NEOPLASM MALIGNANT", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "FOLIC ACID", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "PureTek Corporation", "genericName": "FOLIC ACID", "brandName": "VENTRIXYL", "pharmClass_epc": "Vitamin C [EPC]", "route": "ORAL"}, {"medicinalproduct": "CALCIUM", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Apexel Co., Ltd", "genericName": "CALCIUM", "brandName": "7030 CALCIUM PREMIUM", "pharmClass_epc": "Calcium [EPC]", "route": "ORAL"}, {"medicinalproduct": "ACETAMINOPHEN", "drugcharacterization": "2", "drugindication": "PAIN", "manufacturer": "Amazon.com Services LLC", "genericName": "ACETAMINOPHEN", "brandName": "AMAZON BASIC CARE ACETAMINOPHEN", "pharmClass_epc": "Nonsteroidal Anti-inflammatory Drug [EPC]", "route": "ORAL"}, {"medicinalproduct": "ONDASETRON /00955301/", "drugcharacterization": "2", "drugindication": "NAUSEA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "KEPPRA", "drugcharacterization": "2", "drugindication": "CONVULSION", "manufacturer": "UCB, Inc.", "genericName": "LEVETIRACETAM", "brandName": "KEPPRA", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "PROCRIT /00928302/", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "DECADRON /00016001/", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "PANTOPRAZOLE", "drugcharacterization": "2", "drugindication": "GASTROOESOPHAGEAL REFLUX DISEASE", "manufacturer": "XLCare Pharmaceuticals Inc.", "genericName": "PANTOPRAZOLE", "brandName": "PANTOPRAZOLE SODIUM", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ALIMTA", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "PEMETREXED DISODIUM", "brandName": "ALIMTA", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "NEULASTA", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Amgen, Inc", "genericName": "PEGFILGRASTIM", "brandName": "NEULASTA", "pharmClass_epc": "Leukocyte Growth Factor [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "TAXOTERE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CARBOPLATIN", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Apotex Corp.", "genericName": "CARBOPLATIN", "brandName": "CARBOPLATIN", "pharmClass_epc": "Platinum-based Drug [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "AREDIA", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Eye pruritus", "outcome": "1"}, {"pt": "Lacrimation increased", "outcome": "1"}, {"pt": "Facial pain", "outcome": "6"}, {"pt": "Weight fluctuation", "outcome": "6"}, {"pt": "Surgical failure", "outcome": "6"}, {"pt": "Growth of eyelashes", "outcome": "1"}, {"pt": "Hair texture abnormal", "outcome": "1"}, {"pt": "Blister", "outcome": "6"}, {"pt": "Rash", "outcome": "3"}, {"pt": "Dry skin", "outcome": "6"}, {"pt": "Wound", "outcome": "3"}], "classifyText": "ERLOTINIB AVASTIN /01555201/ VENTRIXYL 7030 CALCIUM PREMIUM AMAZON BASIC CARE ACETAMINOPHEN ONDASETRON /00955301/ KEPPRA PROCRIT /00928302/ DECADRON /00016001/ PANTOPRAZOLE SODIUM ALIMTA NEULASTA TAXOTERE CARBOPLATIN AREDIA ERLOTINIB HYDROCHLORIDE FOLIC ACID CALCIUM ACETAMINOPHEN LEVETIRACETAM PANTOPRAZOLE PEMETREXED DISODIUM PEGFILGRASTIM CARBOPLATIN NON-SMALL CELL LUNG CANCER LUNG NEOPLASM MALIGNANT PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PAIN NAUSEA CONVULSION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION GASTROOESOPHAGEAL REFLUX DISEASE PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Eye pruritus Lacrimation increased Facial pain Weight fluctuation Surgical failure Growth of eyelashes Hair texture abnormal Blister Rash Dry skin Wound"}
{"safetyreportid": "10017848", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "43", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "ABILIFY TABS 15 MG", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "EFFEXOR XR", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Viatris Specialty LLC", "genericName": "VENLAFAXINE HYDROCHLORIDE", "brandName": "EFFEXOR XR", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "METFORMIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Mylan Pharmaceuticals Inc.", "genericName": "METFORMIN", "brandName": "METFORMIN HYDROCHLORIDE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LOSARTAN POTASSIUM", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Micro Labs Limited", "genericName": "LOSARTAN POTASSIUM", "brandName": "LOSARTAN POTASSIUM", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Mania", "outcome": "6"}, {"pt": "Depression", "outcome": "6"}, {"pt": "Suicidal ideation", "outcome": "6"}, {"pt": "Fear", "outcome": "6"}], "classifyText": "ABILIFY TABS 15 MG EFFEXOR XR CYMBALTA METFORMIN HYDROCHLORIDE LOSARTAN POTASSIUM VENLAFAXINE HYDROCHLORIDE DULOXETINE HYDROCHLORIDE METFORMIN LOSARTAN POTASSIUM Mania Depression Suicidal ideation Fear"}
{"safetyreportid": "10017915", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "1", "patientAge": "46", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "ERBITUX SOLN FOR INF", "drugcharacterization": "1", "drugindication": "COLON CANCER METASTATIC", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LANTUS", "drugcharacterization": "2", "drugindication": null, "manufacturer": "sanofi-aventis U.S. LLC", "genericName": "INSULIN GLARGINE", "brandName": "LANTUS", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "LIPITOR", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Viatris Specialty LLC", "genericName": "ATORVASTATIN CALCIUM", "brandName": "LIPITOR", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ALOXI", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "EMEND", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Merck Sharp & Dohme LLC", "genericName": "APREPITANT", "brandName": "EMEND", "pharmClass_epc": "Substance P/Neurokinin-1 Receptor Antagonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "FAMOTIDINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "LEADER/ Cardinal Health 110, Inc.", "genericName": "FAMOTIDINE", "brandName": "FAMOTIDINE", "pharmClass_epc": "Histamine-2 Receptor Antagonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "IRINOTECAN", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "FLUOROURACIL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Dr. Reddy's Laboratories Inc.", "genericName": "FLUOROURACIL CREAM, 0.5%", "brandName": "FLUOROURACIL", "pharmClass_epc": "Nucleoside Metabolic Inhibitor [EPC]", "route": "TOPICAL"}], "reactions": [{"pt": "Drug hypersensitivity", "outcome": "1"}], "classifyText": "ERBITUX SOLN FOR INF LANTUS HUMALOG MIX75/25 LIPITOR ALOXI EMEND FAMOTIDINE IRINOTECAN FLUOROURACIL INSULIN GLARGINE INSULIN LISPRO ATORVASTATIN CALCIUM APREPITANT FAMOTIDINE FLUOROURACIL CREAM, 0.5% COLON CANCER METASTATIC Drug hypersensitivity"}
{"safetyreportid": "10018011", "receiveDate": "20140313", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": null, "reportType": "1", "patientSex": "2", "patientAge": "78", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "IMDUR", "drugcharacterization": "1", "drugindication": "HYPERTENSION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "TANOMIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "EVISTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "RALOXIFENE HYDROCHLORIDE", "brandName": "EVISTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ZETIA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Organon LLC", "genericName": "EZETIMIBE", "brandName": "ZETIA", "pharmClass_epc": "Dietary Cholesterol Absorption Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "POTASSIUM MODS", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "VASOTEC", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Bausch Health US LLC", "genericName": "ENALAPRIL MALEATE", "brandName": "VASOTEC", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Headache", "outcome": null}, {"pt": "Neck pain", "outcome": null}, {"pt": "Musculoskeletal pain", "outcome": null}, {"pt": "Head discomfort", "outcome": null}], "classifyText": "IMDUR TANOMIN EVISTA ZETIA POTASSIUM MODS VASOTEC RALOXIFENE HYDROCHLORIDE EZETIMIBE ENALAPRIL MALEATE HYPERTENSION Headache Neck pain Musculoskeletal pain Head discomfort"}
{"safetyreportid": "10018264", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "JP", "reportType": "1", "patientSex": "1", "patientAge": "50", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "MYSLEE", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ABILIFY", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Otsuka America Pharmaceutical, Inc.", "genericName": "ARIPIPRAZOLE", "brandName": "ABILIFY", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "EPERISONE HYDROCHLORIDE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "DEPAS", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "TRIAZOLAM", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Ingenus Pharmaceuticals, LLC", "genericName": "TRIAZOLAM", "brandName": "TRIAZOLAM", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "ORAL"}, {"medicinalproduct": "FAMOTIDINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "LEADER/ Cardinal Health 110, Inc.", "genericName": "FAMOTIDINE", "brandName": "FAMOTIDINE", "pharmClass_epc": "Histamine-2 Receptor Antagonist [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Road traffic accident", "outcome": "6"}], "classifyText": "MYSLEE ABILIFY CYMBALTA EPERISONE HYDROCHLORIDE DEPAS TRIAZOLAM FAMOTIDINE ARIPIPRAZOLE DULOXETINE HYDROCHLORIDE TRIAZOLAM FAMOTIDINE PRODUCT USED FOR UNKNOWN INDICATION Road traffic accident"}
{"safetyreportid": "10018288", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "1", "patientAge": "58", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "ERBITUX", "drugcharacterization": "1", "drugindication": "RECTAL CANCER", "manufacturer": "ImClone LLC", "genericName": "CETUXIMAB", "brandName": "ERBITUX", "pharmClass_epc": "Epidermal Growth Factor Receptor Antagonist [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "BENADRYL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Lil' Drug Store Products, Inc.", "genericName": "DIPHENHYDRAMINE HYDROCHLORIDE", "brandName": "BENADRYL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ATIVAN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Bausch Health US LLC", "genericName": "LORAZEPAM", "brandName": "ATIVAN", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "ORAL"}, {"medicinalproduct": "PREDNISONE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "ANI Pharmaceuticals, Inc.", "genericName": "PREDNISONE", "brandName": "PREDNISONE", "pharmClass_epc": "Corticosteroid [EPC]", "route": "ORAL"}, {"medicinalproduct": "FLOMAX", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LIPITOR", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Viatris Specialty LLC", "genericName": "ATORVASTATIN CALCIUM", "brandName": "LIPITOR", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "OMEGA 3 FATTY ACID", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "BYSTOLIC", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Allergan, Inc.", "genericName": "NEBIVOLOL HYDROCHLORIDE", "brandName": "BYSTOLIC", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ALTACE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ASPIRIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Unifirst First Aid Corporation", "genericName": "ASPIRIN", "brandName": "BAYER GENUINE ASPIRIN", "pharmClass_epc": "Nonsteroidal Anti-inflammatory Drug [EPC]", "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ZANTAC", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "GLUCOPHAGE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "VITAMIN B12", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "FOLIC ACID", "drugcharacterization": "2", "drugindication": null, "manufacturer": "PureTek Corporation", "genericName": "FOLIC ACID", "brandName": "VENTRIXYL", "pharmClass_epc": "Vitamin C [EPC]", "route": "ORAL"}, {"medicinalproduct": "MULTIVITAMIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Oncora Pharma, LLC", "genericName": "MULTIVITAMIN", "brandName": "LUMAVEX", "pharmClass_epc": "Vitamin C [EPC]", "route": "ORAL"}, {"medicinalproduct": "LOMOTIL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Pfizer Laboratories Div Pfizer Inc", "genericName": "DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE", "brandName": "LOMOTIL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "KEFLEX", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "RAMIPRIL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Lupin Pharmaceuticals, Inc.", "genericName": "RAMIPRIL", "brandName": "RAMIPRIL", "pharmClass_epc": "Angiotensin Converting Enzyme Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "METFORMIN HCL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Ascend Laboratories, LLC", "genericName": "METFORMIN HCL", "brandName": "METFORMIN HCL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LOVAZA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Waylis Therapeutics LLC", "genericName": "OMEGA-3-ACID ETHYL ESTERS", "brandName": "LOVAZA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "TAMSULOSIN HCL", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "RANITIDINE HCL", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "METAMUCIL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "The Procter & Gamble Manufacturing Company", "genericName": "PSYLLIUM HUSK", "brandName": "METAMUCIL THERAPY FOR REGULARITY", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Anaphylactic reaction", "outcome": "6"}], "classifyText": "ERBITUX BENADRYL ATIVAN PREDNISONE FLOMAX LIPITOR OMEGA 3 FATTY ACID BYSTOLIC ALTACE BAYER GENUINE ASPIRIN CYMBALTA ZANTAC GLUCOPHAGE HUMALOG MIX75/25 VITAMIN B12 VENTRIXYL LUMAVEX LOMOTIL KEFLEX RAMIPRIL METFORMIN HCL LOVAZA TAMSULOSIN HCL RANITIDINE HCL METAMUCIL THERAPY FOR REGULARITY CETUXIMAB DIPHENHYDRAMINE HYDROCHLORIDE LORAZEPAM PREDNISONE ATORVASTATIN CALCIUM NEBIVOLOL HYDROCHLORIDE ASPIRIN DULOXETINE HYDROCHLORIDE INSULIN LISPRO FOLIC ACID MULTIVITAMIN DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE RAMIPRIL METFORMIN HCL OMEGA-3-ACID ETHYL ESTERS PSYLLIUM HUSK RECTAL CANCER Anaphylactic reaction"}
{"safetyreportid": "10018309", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "1", "patientAge": "58", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "ERBITUX", "drugcharacterization": "1", "drugindication": "HEPATIC CANCER", "manufacturer": "ImClone LLC", "genericName": "CETUXIMAB", "brandName": "ERBITUX", "pharmClass_epc": "Epidermal Growth Factor Receptor Antagonist [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "BENADRYL", "drugcharacterization": "2", "drugindication": "PREMEDICATION", "manufacturer": "Lil' Drug Store Products, Inc.", "genericName": "DIPHENHYDRAMINE HYDROCHLORIDE", "brandName": "BENADRYL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ATIVAN", "drugcharacterization": "2", "drugindication": "PREMEDICATION", "manufacturer": "Bausch Health US LLC", "genericName": "LORAZEPAM", "brandName": "ATIVAN", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "ORAL"}, {"medicinalproduct": "ATIVAN", "drugcharacterization": "2", "drugindication": "PREMEDICATION", "manufacturer": "Bausch Health US LLC", "genericName": "LORAZEPAM", "brandName": "ATIVAN", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "ORAL"}, {"medicinalproduct": "BYSTOLIC", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Allergan, Inc.", "genericName": "NEBIVOLOL HYDROCHLORIDE", "brandName": "BYSTOLIC", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "VITAMIN B12", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "VITAMIN B12", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "FOLIC ACID", "drugcharacterization": "2", "drugindication": null, "manufacturer": "PureTek Corporation", "genericName": "FOLIC ACID", "brandName": "VENTRIXYL", "pharmClass_epc": "Vitamin C [EPC]", "route": "ORAL"}, {"medicinalproduct": "ATORVASTATIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "METFORMIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Mylan Pharmaceuticals Inc.", "genericName": "METFORMIN", "brandName": "METFORMIN HYDROCHLORIDE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "TAMSULOSIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Anaphylactic reaction", "outcome": "1"}, {"pt": "Off label use", "outcome": "6"}], "classifyText": "ERBITUX BENADRYL ATIVAN ATIVAN BYSTOLIC VITAMIN B12 VITAMIN B12 CYMBALTA CYMBALTA VENTRIXYL ATORVASTATIN METFORMIN HYDROCHLORIDE TAMSULOSIN CETUXIMAB DIPHENHYDRAMINE HYDROCHLORIDE LORAZEPAM LORAZEPAM NEBIVOLOL HYDROCHLORIDE DULOXETINE HYDROCHLORIDE DULOXETINE HYDROCHLORIDE FOLIC ACID METFORMIN HEPATIC CANCER PREMEDICATION PREMEDICATION PREMEDICATION Anaphylactic reaction Off label use"}
{"safetyreportid": "10018377", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 1, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 1, "occurcountry": "JP", "reportType": "2", "patientSex": "2", "patientAge": "26", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "THYMOGLOBULINE", "drugcharacterization": "1", "drugindication": "BONE MARROW CONDITIONING REGIMEN", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "OMEPRAL", "drugcharacterization": "2", "drugindication": "PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LASIX", "drugcharacterization": "2", "drugindication": "PROPHYLAXIS", "manufacturer": "Validus Pharmaceuticals LLC", "genericName": "FUROSEMIDE", "brandName": "LASIX", "pharmClass_epc": "Loop Diuretic [EPC]", "route": "ORAL"}, {"medicinalproduct": "ATARAX-P", "drugcharacterization": "2", "drugindication": "INSOMNIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "AMBISOME", "drugcharacterization": "2", "drugindication": "SEPSIS", "manufacturer": "Astellas Pharma US, Inc.", "genericName": "AMPHOTERICIN B", "brandName": "AMBISOME", "pharmClass_epc": "Lipid-based Polyene Antifungal [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "AMBISOME", "drugcharacterization": "2", "drugindication": "CELLULITIS", "manufacturer": "Astellas Pharma US, Inc.", "genericName": "AMPHOTERICIN B", "brandName": "AMBISOME", "pharmClass_epc": "Lipid-based Polyene Antifungal [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "AMBISOME", "drugcharacterization": "2", "drugindication": "PNEUMONIA", "manufacturer": "Astellas Pharma US, Inc.", "genericName": "AMPHOTERICIN B", "brandName": "AMBISOME", "pharmClass_epc": "Lipid-based Polyene Antifungal [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "ANTHROBIN P", "drugcharacterization": "2", "drugindication": "DISSEMINATED INTRAVASCULAR COAGULATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CRAVIT", "drugcharacterization": "2", "drugindication": "SEPSIS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CRAVIT", "drugcharacterization": "2", "drugindication": "CELLULITIS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CRAVIT", "drugcharacterization": "2", "drugindication": "PNEUMONIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SOLU-CORTEF", "drugcharacterization": "2", "drugindication": "PYREXIA", "manufacturer": "Pharmacia & Upjohn Company LLC", "genericName": "HYDROCORTISONE SODIUM SUCCINATE", "brandName": "SOLU-CORTEF", "pharmClass_epc": null, "route": "INTRAMUSCULAR"}, {"medicinalproduct": "BACTRAMIN", "drugcharacterization": "2", "drugindication": "SEPSIS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "BACTRAMIN", "drugcharacterization": "2", "drugindication": "CELLULITIS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "BACTRAMIN", "drugcharacterization": "2", "drugindication": "PNEUMONIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "VICCLOX", "drugcharacterization": "2", "drugindication": "SEPSIS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "VICCLOX", "drugcharacterization": "2", "drugindication": "CELLULITIS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "VICCLOX", "drugcharacterization": "2", "drugindication": "PNEUMONIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "HUMULIN R", "drugcharacterization": "2", "drugindication": "DIABETES MELLITUS", "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN HUMAN", "brandName": "HUMULIN R", "pharmClass_epc": "Insulin [EPC]", "route": "PARENTERAL"}, {"medicinalproduct": "FUNGUARD", "drugcharacterization": "2", "drugindication": "SEPSIS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "FUNGUARD", "drugcharacterization": "2", "drugindication": "CELLULITIS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "FUNGUARD", "drugcharacterization": "2", "drugindication": "PNEUMONIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "FENTANYL", "drugcharacterization": "2", "drugindication": "PAIN", "manufacturer": "Aveva Drug Delivery Systems Inc.", "genericName": "FENTANYL", "brandName": "FENTANYL", "pharmClass_epc": "Opioid Agonist [EPC]", "route": "TRANSDERMAL"}, {"medicinalproduct": "CEFTAZIDIME", "drugcharacterization": "2", "drugindication": "SEPSIS", "manufacturer": "Hospira, Inc.", "genericName": "CEFTAZIDIME", "brandName": "TAZICEF", "pharmClass_epc": null, "route": "INTRAMUSCULAR"}, {"medicinalproduct": "CEFTAZIDIME", "drugcharacterization": "2", "drugindication": "CELLULITIS", "manufacturer": "Hospira, Inc.", "genericName": "CEFTAZIDIME", "brandName": "TAZICEF", "pharmClass_epc": null, "route": "INTRAMUSCULAR"}, {"medicinalproduct": "CEFTAZIDIME", "drugcharacterization": "2", "drugindication": "PNEUMONIA", "manufacturer": "Hospira, Inc.", "genericName": "CEFTAZIDIME", "brandName": "TAZICEF", "pharmClass_epc": null, "route": "INTRAMUSCULAR"}, {"medicinalproduct": "LEVEMIR", "drugcharacterization": "2", "drugindication": "DIABETES MELLITUS", "manufacturer": "Novo Nordisk", "genericName": "INSULIN DETEMIR", "brandName": "LEVEMIR", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "ROPION", "drugcharacterization": "2", "drugindication": "PYREXIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ZYVOX", "drugcharacterization": "2", "drugindication": "SEPSIS", "manufacturer": "Hp Halden Pharma AS", "genericName": "LINEZOLID", "brandName": "ZYVOX", "pharmClass_epc": "Oxazolidinone Antibacterial [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "ZYVOX", "drugcharacterization": "2", "drugindication": "CELLULITIS", "manufacturer": "Hp Halden Pharma AS", "genericName": "LINEZOLID", "brandName": "ZYVOX", "pharmClass_epc": "Oxazolidinone Antibacterial [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "ZYVOX", "drugcharacterization": "2", "drugindication": "PNEUMONIA", "manufacturer": "Hp Halden Pharma AS", "genericName": "LINEZOLID", "brandName": "ZYVOX", "pharmClass_epc": "Oxazolidinone Antibacterial [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "MEROPEN", "drugcharacterization": "2", "drugindication": "SEPSIS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "MEROPEN", "drugcharacterization": "2", "drugindication": "CELLULITIS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "MEROPEN", "drugcharacterization": "2", "drugindication": "PNEUMONIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "BUSCOPAN", "drugcharacterization": "2", "drugindication": "ABDOMINAL PAIN", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ERYTHROCIN", "drugcharacterization": "2", "drugindication": "SEPSIS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ERYTHROCIN", "drugcharacterization": "2", "drugindication": "CELLULITIS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ERYTHROCIN", "drugcharacterization": "2", "drugindication": "PNEUMONIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ALBUMINAR", "drugcharacterization": "2", "drugindication": "HYPOALBUMINAEMIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SILECE", "drugcharacterization": "2", "drugindication": "INSOMNIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "BAKTAR", "drugcharacterization": "2", "drugindication": "SEPSIS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "BAKTAR", "drugcharacterization": "2", "drugindication": "CELLULITIS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "BAKTAR", "drugcharacterization": "2", "drugindication": "PNEUMONIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "BROTIZOLAM", "drugcharacterization": "2", "drugindication": "INSOMNIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ROHYPNOL", "drugcharacterization": "2", "drugindication": "INSOMNIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Venoocclusive liver disease", "outcome": "5"}, {"pt": "Cardiac failure congestive", "outcome": "3"}, {"pt": "Renal impairment", "outcome": "3"}, {"pt": "Pneumonia", "outcome": "3"}], "classifyText": "THYMOGLOBULINE OMEPRAL LASIX ATARAX-P AMBISOME AMBISOME AMBISOME ANTHROBIN P CRAVIT CRAVIT CRAVIT SOLU-CORTEF BACTRAMIN BACTRAMIN BACTRAMIN VICCLOX VICCLOX VICCLOX HUMULIN R FUNGUARD FUNGUARD FUNGUARD FENTANYL TAZICEF TAZICEF TAZICEF LEVEMIR ROPION ZYVOX ZYVOX ZYVOX MEROPEN MEROPEN MEROPEN BUSCOPAN ERYTHROCIN ERYTHROCIN ERYTHROCIN ALBUMINAR SILECE BAKTAR BAKTAR BAKTAR BROTIZOLAM ROHYPNOL FUROSEMIDE AMPHOTERICIN B AMPHOTERICIN B AMPHOTERICIN B HYDROCORTISONE SODIUM SUCCINATE INSULIN HUMAN FENTANYL CEFTAZIDIME CEFTAZIDIME CEFTAZIDIME INSULIN DETEMIR LINEZOLID LINEZOLID LINEZOLID BONE MARROW CONDITIONING REGIMEN PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER PROPHYLAXIS INSOMNIA SEPSIS CELLULITIS PNEUMONIA DISSEMINATED INTRAVASCULAR COAGULATION SEPSIS CELLULITIS PNEUMONIA PYREXIA SEPSIS CELLULITIS PNEUMONIA SEPSIS CELLULITIS PNEUMONIA DIABETES MELLITUS SEPSIS CELLULITIS PNEUMONIA PAIN SEPSIS CELLULITIS PNEUMONIA DIABETES MELLITUS PYREXIA SEPSIS CELLULITIS PNEUMONIA SEPSIS CELLULITIS PNEUMONIA ABDOMINAL PAIN SEPSIS CELLULITIS PNEUMONIA HYPOALBUMINAEMIA INSOMNIA SEPSIS CELLULITIS PNEUMONIA INSOMNIA INSOMNIA Venoocclusive liver disease Cardiac failure congestive Renal impairment Pneumonia"}
{"safetyreportid": "10018382", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "1", "patientAge": "33", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "MORPHINE SULFATE.", "drugcharacterization": "2", "drugindication": "PAIN", "manufacturer": "International Medication Systems, Limited", "genericName": "MORPHINE SULFATE", "brandName": "MORPHINE SULFATE", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "ANTIVERT", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "PEGINTRON", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "PEGINTRON", "drugcharacterization": "1", "drugindication": "HEPATITIS C", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "PEGINTRON", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ZOFRAN", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ZYPREXA", "drugcharacterization": "2", "drugindication": "BIPOLAR II DISORDER", "manufacturer": "Eli Lilly and Company", "genericName": "OLANZAPINE", "brandName": "ZYPREXA INTRAMUSCULAR", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "SOVALDI", "drugcharacterization": "1", "drugindication": "HEPATITIS C", "manufacturer": "Gilead Sciences, Inc.", "genericName": "SOFOSBUVIR", "brandName": "SOVALDI", "pharmClass_epc": "Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "SERAX", "drugcharacterization": "2", "drugindication": "ANXIETY", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "PROZAC", "drugcharacterization": "2", "drugindication": "DEPRESSION", "manufacturer": "Dista Products Company", "genericName": "FLUOXETINE HYDROCHLORIDE", "brandName": "PROZAC", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "RIBASPHERE RIBAPAK", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "REBETOL", "drugcharacterization": "1", "drugindication": "HEPATITIS C", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "TRAZODONE HYDROCHLORIDE.", "drugcharacterization": "2", "drugindication": "SLEEP DISORDER", "manufacturer": "Teva Pharmaceuticals USA, Inc.", "genericName": "TRAZODONE HYDROCHLORIDE", "brandName": "TRAZODONE HYDROCHLORIDE", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Leukopenia", "outcome": "1"}, {"pt": "Injection site rash", "outcome": "1"}, {"pt": "Thrombocytopenia", "outcome": "1"}, {"pt": "Suicidal ideation", "outcome": "1"}, {"pt": "Suicidal ideation", "outcome": "1"}, {"pt": "Depression", "outcome": "1"}, {"pt": "Depression", "outcome": "1"}, {"pt": "Anaemia", "outcome": "1"}, {"pt": "Fatigue", "outcome": "1"}, {"pt": "Nausea", "outcome": "1"}, {"pt": "Injection site pruritus", "outcome": "1"}, {"pt": "Headache", "outcome": "1"}], "classifyText": "MORPHINE SULFATE ANTIVERT PEGINTRON PEGINTRON PEGINTRON ZOFRAN ZYPREXA INTRAMUSCULAR SOVALDI SERAX PROZAC RIBASPHERE RIBAPAK REBETOL TRAZODONE HYDROCHLORIDE MORPHINE SULFATE OLANZAPINE SOFOSBUVIR FLUOXETINE HYDROCHLORIDE TRAZODONE HYDROCHLORIDE PAIN HEPATITIS C BIPOLAR II DISORDER HEPATITIS C ANXIETY DEPRESSION HEPATITIS C SLEEP DISORDER Leukopenia Injection site rash Thrombocytopenia Suicidal ideation Suicidal ideation Depression Depression Anaemia Fatigue Nausea Injection site pruritus Headache"}
{"safetyreportid": "10018402", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "CA", "reportType": "2", "patientSex": "2", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "COPAXONE", "drugcharacterization": "1", "drugindication": "MULTIPLE SCLEROSIS", "manufacturer": "Teva Neuroscience, Inc.", "genericName": "GLATIRAMER ACETATE", "brandName": "COPAXONE", "pharmClass_epc": null, "route": "SUBCUTANEOUS"}, {"medicinalproduct": "VITAMIN D", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Strides Pharma Science Limited", "genericName": "ERGOCALCIFEROL", "brandName": "VITAMIN D", "pharmClass_epc": "Provitamin D2 Compound [EPC]", "route": "ORAL"}, {"medicinalproduct": "VESICARE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Astellas Pharma US, Inc.", "genericName": "SOLIFENACIN SUCCINATE", "brandName": "VESICARE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "AMITRIPTYLINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LYRICA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Parke-Davis Div of Pfizer Inc", "genericName": "PREGABALIN", "brandName": "LYRICA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "NEXIUM", "drugcharacterization": "2", "drugindication": null, "manufacturer": "AstraZeneca Pharmaceuticals LP", "genericName": "ESOMEPRAZOLE MAGNESIUM", "brandName": "NEXIUM", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Multiple sclerosis", "outcome": "3"}, {"pt": "Haemoglobin decreased", "outcome": "6"}, {"pt": "Transfusion", "outcome": "6"}], "classifyText": "COPAXONE VITAMIN D VESICARE AMITRIPTYLINE LYRICA NEXIUM CYMBALTA GLATIRAMER ACETATE ERGOCALCIFEROL SOLIFENACIN SUCCINATE PREGABALIN ESOMEPRAZOLE MAGNESIUM DULOXETINE HYDROCHLORIDE MULTIPLE SCLEROSIS Multiple sclerosis Haemoglobin decreased Transfusion"}
{"safetyreportid": "10018533", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "2", "patientSex": "1", "patientAge": "60", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "TADALAFIL", "drugcharacterization": "1", "drugindication": "PULMONARY HYPERTENSION", "manufacturer": "AvKARE", "genericName": "TADALAFIL", "brandName": "TADALAFIL", "pharmClass_epc": "Phosphodiesterase 5 Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "VENTOLIN /00139501/", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "PROTONIX", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.", "genericName": "PANTOPRAZOLE SODIUM", "brandName": "PROTONIX I.V.", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "TORSEMIDE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Chartwell RX, LLC", "genericName": "TORSEMIDE", "brandName": "TORSEMIDE", "pharmClass_epc": "Loop Diuretic [EPC]", "route": "ORAL"}, {"medicinalproduct": "ADVAIR", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "GlaxoSmithKline LLC", "genericName": "FLUTICASONE PROPIONATE AND SALMETEROL", "brandName": "ADVAIR DISKUS", "pharmClass_epc": null, "route": "RESPIRATORY (INHALATION)"}, {"medicinalproduct": "LIPITOR", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Viatris Specialty LLC", "genericName": "ATORVASTATIN CALCIUM", "brandName": "LIPITOR", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "TOPROL", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ASPIRIN", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Unifirst First Aid Corporation", "genericName": "ASPIRIN", "brandName": "BAYER GENUINE ASPIRIN", "pharmClass_epc": "Nonsteroidal Anti-inflammatory Drug [EPC]", "route": "ORAL"}, {"medicinalproduct": "DOCUSATE SODIUM", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Humanwell PuraCap Pharmaceutical (Wuhan), Ltd.", "genericName": "DOCUSATE SODIUM", "brandName": "DOCUSATE SODIUM 100MG TWO-TONE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LOSARTAN", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Granules Pharmaceuticals Inc.", "genericName": "LOSARTAN", "brandName": "LOSARTAN POTASSIUM", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "POTASSIUM", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SPIRONOLACTONE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Amneal Pharmaceuticals LLC", "genericName": "SPIRONOLACTONE", "brandName": "SPIRONOLACTONE", "pharmClass_epc": "Aldosterone Antagonist [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Cardiac failure chronic", "outcome": "1"}, {"pt": "Chronic obstructive pulmonary disease", "outcome": "1"}, {"pt": "Acute respiratory failure", "outcome": "1"}, {"pt": "Dyspnoea", "outcome": "6"}, {"pt": "Fluid retention", "outcome": "6"}, {"pt": "Nasopharyngitis", "outcome": "1"}], "classifyText": "TADALAFIL VENTOLIN /00139501/ PROTONIX I.V. TORSEMIDE ADVAIR DISKUS LIPITOR TOPROL BAYER GENUINE ASPIRIN DOCUSATE SODIUM 100MG TWO-TONE LOSARTAN POTASSIUM POTASSIUM SPIRONOLACTONE TADALAFIL PANTOPRAZOLE SODIUM TORSEMIDE FLUTICASONE PROPIONATE AND SALMETEROL ATORVASTATIN CALCIUM ASPIRIN DOCUSATE SODIUM LOSARTAN SPIRONOLACTONE PULMONARY HYPERTENSION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Cardiac failure chronic Chronic obstructive pulmonary disease Acute respiratory failure Dyspnoea Fluid retention Nasopharyngitis"}
{"safetyreportid": "10018626", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "GB", "reportType": "1", "patientSex": "1", "patientAge": "0", "patientAgeUnit": "804", "drugs": [{"medicinalproduct": "ARIPIPRAZOLE (UNKNOWN)", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "DULOXETINE HYDROCHLORIDE (AELLC)", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "QUETIAPINE (UNKNOWN)", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ZOPICLONE (UNKNOWN)", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ZYPREXA", "drugcharacterization": "1", "drugindication": "SCHIZOAFFECTIVE DISORDER", "manufacturer": "Eli Lilly and Company", "genericName": "OLANZAPINE", "brandName": "ZYPREXA INTRAMUSCULAR", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "ZYPREXA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "OLANZAPINE", "brandName": "ZYPREXA INTRAMUSCULAR", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "INTRAMUSCULAR"}], "reactions": [{"pt": "Cleft palate", "outcome": "6"}, {"pt": "High arched palate", "outcome": "6"}, {"pt": "Feeding disorder neonatal", "outcome": "1"}, {"pt": "Exposure during breast feeding", "outcome": "6"}, {"pt": "Foetal exposure during pregnancy", "outcome": "6"}], "classifyText": "ARIPIPRAZOLE (UNKNOWN) DULOXETINE HYDROCHLORIDE (AELLC) QUETIAPINE (UNKNOWN) ZOPICLONE (UNKNOWN) ZYPREXA INTRAMUSCULAR ZYPREXA INTRAMUSCULAR OLANZAPINE OLANZAPINE PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION SCHIZOAFFECTIVE DISORDER Cleft palate High arched palate Feeding disorder neonatal Exposure during breast feeding Foetal exposure during pregnancy"}
{"safetyreportid": "10018689", "receiveDate": "20140314", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": null, "reportType": "1", "patientSex": "1", "patientAge": "8", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": "ATTENTION DEFICIT/HYPERACTIVITY DISORDER", "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Aggression", "outcome": null}, {"pt": "Weight increased", "outcome": null}], "classifyText": "STRATTERA ATOMOXETINE HYDROCHLORIDE ATTENTION DEFICIT/HYPERACTIVITY DISORDER Aggression Weight increased"}
{"safetyreportid": "10018861", "receiveDate": "20140318", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "64", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "SPIRIVA", "drugcharacterization": "1", "drugindication": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "manufacturer": "Boehringer Ingelheim Pharmaceuticals, Inc.", "genericName": "TIOTROPIUM BROMIDE", "brandName": "SPIRIVA HANDIHALER", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "TRAZODONE", "drugcharacterization": "2", "drugindication": "DEPRESSION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "MAALOX", "drugcharacterization": "2", "drugindication": "RENAL FAILURE", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "TYLENOL", "drugcharacterization": "2", "drugindication": "ARTHRITIS", "manufacturer": "Kenvue Brands LLC", "genericName": "ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE", "brandName": "TYLENOL COLD PLUS HEAD CONGESTION SEVERE", "pharmClass_epc": "Expectorant [EPC]", "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": "DEPRESSION", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "BAKING SODA", "drugcharacterization": "2", "drugindication": "RENAL FAILURE", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "AMITRIPTYLLINE", "drugcharacterization": "2", "drugindication": "HYPOAESTHESIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "FISH OIL", "drugcharacterization": "2", "drugindication": "ARTHRITIS", "manufacturer": "Fresenius Kabi USA, LLC", "genericName": "FISH OIL", "brandName": "OMEGAVEN", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "ENALOPRIL", "drugcharacterization": "2", "drugindication": "HYPERTENSION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "COLCHICINE", "drugcharacterization": "2", "drugindication": "GOUT", "manufacturer": "Camber Pharmaceuticals, Inc.", "genericName": "COLCHICINE", "brandName": "COLCHICINE", "pharmClass_epc": "Alkaloid [EPC]", "route": "ORAL"}, {"medicinalproduct": "PEPCID", "drugcharacterization": "2", "drugindication": "GASTROOESOPHAGEAL REFLUX DISEASE", "manufacturer": "Bausch Health US LLC", "genericName": "FAMOTIDINE", "brandName": "PEPCID", "pharmClass_epc": "Histamine-2 Receptor Antagonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "ALLOPURINOL", "drugcharacterization": "2", "drugindication": "GOUT", "manufacturer": "Accord Healthcare Inc.", "genericName": "ALLOPURINOL", "brandName": "ALLOPURINOL", "pharmClass_epc": "Xanthine Oxidase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "ALLOPURINOL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Accord Healthcare Inc.", "genericName": "ALLOPURINOL", "brandName": "ALLOPURINOL", "pharmClass_epc": "Xanthine Oxidase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "GLUCOASAMINE AND CHONDROITIN TRIPLE STRENGTH", "drugcharacterization": "2", "drugindication": "ARTHRITIS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LEVOTHYROXINE", "drugcharacterization": "2", "drugindication": "HYPOTHYROIDISM", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LASIX", "drugcharacterization": "2", "drugindication": "RENAL FAILURE", "manufacturer": "Validus Pharmaceuticals LLC", "genericName": "FUROSEMIDE", "brandName": "LASIX", "pharmClass_epc": "Loop Diuretic [EPC]", "route": "ORAL"}, {"medicinalproduct": "LITHIUM CARBONATE", "drugcharacterization": "2", "drugindication": "BIPOLAR DISORDER", "manufacturer": "Boiron", "genericName": "LITHIUM CARBONATE", "brandName": "LITHIUM CARBONICUM", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Urine output decreased", "outcome": "3"}], "classifyText": "SPIRIVA HANDIHALER TRAZODONE MAALOX TYLENOL COLD PLUS HEAD CONGESTION SEVERE CYMBALTA BAKING SODA AMITRIPTYLLINE OMEGAVEN ENALOPRIL COLCHICINE PEPCID ALLOPURINOL ALLOPURINOL GLUCOASAMINE AND CHONDROITIN TRIPLE STRENGTH LEVOTHYROXINE LASIX LITHIUM CARBONICUM TIOTROPIUM BROMIDE ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE DULOXETINE HYDROCHLORIDE FISH OIL COLCHICINE FAMOTIDINE ALLOPURINOL ALLOPURINOL FUROSEMIDE LITHIUM CARBONATE CHRONIC OBSTRUCTIVE PULMONARY DISEASE DEPRESSION RENAL FAILURE ARTHRITIS DEPRESSION RENAL FAILURE HYPOAESTHESIA ARTHRITIS HYPERTENSION GOUT GASTROOESOPHAGEAL REFLUX DISEASE GOUT ARTHRITIS HYPOTHYROIDISM RENAL FAILURE BIPOLAR DISORDER Urine output decreased"}
{"safetyreportid": "10018905", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "2", "patientSex": "2", "patientAge": "58", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "HUMIRA", "drugcharacterization": "1", "drugindication": "CROHN^S DISEASE", "manufacturer": "Cordavis Limited", "genericName": "ADALIMUMAB", "brandName": "HUMIRA", "pharmClass_epc": null, "route": null}, {"medicinalproduct": "HUMIRA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Cordavis Limited", "genericName": "ADALIMUMAB", "brandName": "HUMIRA", "pharmClass_epc": null, "route": null}, {"medicinalproduct": "PREDNISONE", "drugcharacterization": "2", "drugindication": "CROHN^S DISEASE", "manufacturer": "ANI Pharmaceuticals, Inc.", "genericName": "PREDNISONE", "brandName": "PREDNISONE", "pharmClass_epc": "Corticosteroid [EPC]", "route": "ORAL"}, {"medicinalproduct": "PREDNISONE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "ANI Pharmaceuticals, Inc.", "genericName": "PREDNISONE", "brandName": "PREDNISONE", "pharmClass_epc": "Corticosteroid [EPC]", "route": "ORAL"}, {"medicinalproduct": "PREDNISONE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "ANI Pharmaceuticals, Inc.", "genericName": "PREDNISONE", "brandName": "PREDNISONE", "pharmClass_epc": "Corticosteroid [EPC]", "route": "ORAL"}, {"medicinalproduct": "LABETALOL", "drugcharacterization": "2", "drugindication": "HYPERTENSION", "manufacturer": "Marlex Pharmaceuticals Inc", "genericName": "LABETALOL", "brandName": "LABETALOL HYDROCHLORIDE", "pharmClass_epc": "beta-Adrenergic Blocker [EPC]", "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": "DEPRESSION", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": "PAIN", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "FLORASTOR", "drugcharacterization": "2", "drugindication": "PROPHYLAXIS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "PRILOSEC", "drugcharacterization": "2", "drugindication": "DYSPEPSIA", "manufacturer": "Covis Pharma US, Inc", "genericName": "OMEPRAZOLE MAGNESIUM", "brandName": "PRILOSEC", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "FUROSEMIDE", "drugcharacterization": "2", "drugindication": "FLUID RETENTION", "manufacturer": "Ipca Laboratories Limited", "genericName": "FUROSEMIDE", "brandName": "FUROSEMIDE", "pharmClass_epc": "Loop Diuretic [EPC]", "route": "ORAL"}, {"medicinalproduct": "K-DUR", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "KLONOPIN", "drugcharacterization": "2", "drugindication": "ANXIETY", "manufacturer": "H2-Pharma, LLC", "genericName": "CLONAZEPAM", "brandName": "KLONOPIN", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "ORAL"}, {"medicinalproduct": "AMBIEN", "drugcharacterization": "2", "drugindication": "INSOMNIA", "manufacturer": "Cosette Pharmaceuticals, Inc.", "genericName": "ZOLPIDEM TARTRATE", "brandName": "AMBIEN", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "AMLODIPINE", "drugcharacterization": "2", "drugindication": "HYPERTENSION", "manufacturer": "Pangea Pharmaceuticals, LLC", "genericName": "AMLODIPINE", "brandName": "SDAMLO", "pharmClass_epc": "Dihydropyridine Calcium Channel Blocker [EPC]", "route": "ORAL"}, {"medicinalproduct": "VITAMIN B", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "VITAMIN D", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Strides Pharma Science Limited", "genericName": "ERGOCALCIFEROL", "brandName": "VITAMIN D", "pharmClass_epc": "Provitamin D2 Compound [EPC]", "route": "ORAL"}, {"medicinalproduct": "CO Q10", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "OMEGA 3", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ALPRAZOLAM", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Actavis Pharma, Inc.", "genericName": "ALPRAZOLAM", "brandName": "ALPRAZOLAM", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "ORAL"}, {"medicinalproduct": "ULTRAM", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Renal neoplasm", "outcome": "3"}, {"pt": "Procedural haemorrhage", "outcome": "3"}, {"pt": "Abdominal pain", "outcome": "3"}, {"pt": "Drug ineffective", "outcome": "2"}, {"pt": "Abdominal distension", "outcome": "3"}, {"pt": "Haematoma", "outcome": "3"}, {"pt": "Pain", "outcome": "3"}, {"pt": "Waist circumference increased", "outcome": "3"}, {"pt": "Pain", "outcome": "3"}, {"pt": "Gait disturbance", "outcome": "3"}, {"pt": "Injection site haemorrhage", "outcome": "3"}, {"pt": "Scratch", "outcome": "3"}, {"pt": "Skin haemorrhage", "outcome": "3"}], "classifyText": "HUMIRA HUMIRA PREDNISONE PREDNISONE PREDNISONE LABETALOL HYDROCHLORIDE CYMBALTA CYMBALTA FLORASTOR PRILOSEC FUROSEMIDE K-DUR KLONOPIN AMBIEN SDAMLO VITAMIN B VITAMIN D CO Q10 OMEGA 3 ALPRAZOLAM ULTRAM ADALIMUMAB ADALIMUMAB PREDNISONE PREDNISONE PREDNISONE LABETALOL DULOXETINE HYDROCHLORIDE DULOXETINE HYDROCHLORIDE OMEPRAZOLE MAGNESIUM FUROSEMIDE CLONAZEPAM ZOLPIDEM TARTRATE AMLODIPINE ERGOCALCIFEROL ALPRAZOLAM CROHN^S DISEASE CROHN^S DISEASE HYPERTENSION DEPRESSION PAIN PROPHYLAXIS DYSPEPSIA FLUID RETENTION PRODUCT USED FOR UNKNOWN INDICATION ANXIETY INSOMNIA HYPERTENSION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Renal neoplasm Procedural haemorrhage Abdominal pain Drug ineffective Abdominal distension Haematoma Pain Waist circumference increased Pain Gait disturbance Injection site haemorrhage Scratch Skin haemorrhage"}
{"safetyreportid": "10018943", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "55", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "ADVAIR", "drugcharacterization": "1", "drugindication": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "manufacturer": "GlaxoSmithKline LLC", "genericName": "FLUTICASONE PROPIONATE AND SALMETEROL", "brandName": "ADVAIR DISKUS", "pharmClass_epc": null, "route": "RESPIRATORY (INHALATION)"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "BLOOD PRESSURE MEDICATION", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "INHALER", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LISINOPRIL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Chartwell RX, LLC", "genericName": "LISINOPRIL", "brandName": "LISINOPRIL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "NORVASC", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Viatris Specialty LLC", "genericName": "AMLODIPINE BESYLATE", "brandName": "NORVASC", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "VITAMIN A", "drugcharacterization": "2", "drugindication": null, "manufacturer": "CAUSE FOR CHANGE LLC", "genericName": "VITAMIN A", "brandName": "SKINEEZ", "pharmClass_epc": "Vitamin A [EPC]", "route": "TOPICAL"}, {"medicinalproduct": "VITAMIN D", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Strides Pharma Science Limited", "genericName": "ERGOCALCIFEROL", "brandName": "VITAMIN D", "pharmClass_epc": "Provitamin D2 Compound [EPC]", "route": "ORAL"}, {"medicinalproduct": "ACIPHEX", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Waylis Therapeutics LLC", "genericName": "RABEPRAZOLE SODIUM", "brandName": "ACIPHEX", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "POTASSIUM", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "METFORMIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Mylan Pharmaceuticals Inc.", "genericName": "METFORMIN", "brandName": "METFORMIN HYDROCHLORIDE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "KLONOPIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "H2-Pharma, LLC", "genericName": "CLONAZEPAM", "brandName": "KLONOPIN", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "ORAL"}, {"medicinalproduct": "OXYGEN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Apria Healthcare LLC", "genericName": "OXYGEN", "brandName": "OXYGEN COMPRESSED U.S.P", "pharmClass_epc": null, "route": "RESPIRATORY (INHALATION)"}], "reactions": [{"pt": "Type 2 diabetes mellitus", "outcome": "6"}, {"pt": "Patella fracture", "outcome": "6"}, {"pt": "Hyperlipidaemia", "outcome": "6"}, {"pt": "Depression", "outcome": "6"}, {"pt": "Insomnia", "outcome": "6"}, {"pt": "Gastrooesophageal reflux disease", "outcome": "6"}, {"pt": "Hypertension", "outcome": "6"}, {"pt": "Cardiac murmur", "outcome": "6"}, {"pt": "Malaise", "outcome": "1"}, {"pt": "Dyspnoea", "outcome": "1"}, {"pt": "Asthma", "outcome": "1"}], "classifyText": "ADVAIR DISKUS CYMBALTA BLOOD PRESSURE MEDICATION INHALER LISINOPRIL NORVASC SKINEEZ VITAMIN D ACIPHEX POTASSIUM METFORMIN HYDROCHLORIDE KLONOPIN OXYGEN COMPRESSED U.S.P FLUTICASONE PROPIONATE AND SALMETEROL DULOXETINE HYDROCHLORIDE LISINOPRIL AMLODIPINE BESYLATE VITAMIN A ERGOCALCIFEROL RABEPRAZOLE SODIUM METFORMIN CLONAZEPAM OXYGEN CHRONIC OBSTRUCTIVE PULMONARY DISEASE Type 2 diabetes mellitus Patella fracture Hyperlipidaemia Depression Insomnia Gastrooesophageal reflux disease Hypertension Cardiac murmur Malaise Dyspnoea Asthma"}
{"safetyreportid": "10019043", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "2", "patientSex": "0", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "FUROSEMIDE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Ipca Laboratories Limited", "genericName": "FUROSEMIDE", "brandName": "FUROSEMIDE", "pharmClass_epc": "Loop Diuretic [EPC]", "route": "ORAL"}, {"medicinalproduct": "GABAPENTIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Rising Pharma Holdings, Inc.", "genericName": "GABAPENTIN", "brandName": "GABAPENTIN", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "INSULIN DETEMIR", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Novo Nordisk", "genericName": "INSULIN DETEMIR", "brandName": "LEVEMIR", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "INSULIN HUMAN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN HUMAN", "brandName": "HUMULIN R", "pharmClass_epc": "Insulin [EPC]", "route": "PARENTERAL"}, {"medicinalproduct": "LISINOPRIL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Chartwell RX, LLC", "genericName": "LISINOPRIL", "brandName": "LISINOPRIL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "MAGNESIUM OXIDE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Westminster Pharmaceuticals, LLC", "genericName": "MAGNESIUM OXIDE", "brandName": "MAGNESIUM OXIDE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "METOPROLOL TARTRATE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Almaject, Inc.", "genericName": "METOPROLOL TARTRATE", "brandName": "METOPROLOL TARTRATE", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "POTASSIUM CHLORIDE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Zydus Lifesciences Limited", "genericName": "POTASSIUM CHLORIDE", "brandName": "POTASSIUM CHLORIDE", "pharmClass_epc": "Potassium Salt [EPC]", "route": "ORAL"}, {"medicinalproduct": "SIMVASTATIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Accord Healthcare, Inc.", "genericName": "SIMVASTATIN", "brandName": "SIMVASTATIN", "pharmClass_epc": "HMG-CoA Reductase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "VITAMIN B COMPLEX", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Mylan Institutional LLC", "genericName": "THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE", "brandName": "VITAMIN B COMPLEX", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "METOLAZONE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Mylan Pharmaceuticals Inc.", "genericName": "METOLAZONE", "brandName": "METOLAZONE", "pharmClass_epc": "Thiazide-like Diuretic [EPC]", "route": "ORAL"}, {"medicinalproduct": "INSULIN ASPART", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Novo Nordisk", "genericName": "INSULIN ASPART", "brandName": "NOVOLOG", "pharmClass_epc": "Insulin Analog [EPC]", "route": "INTRAVENOUS"}, {"medicinalproduct": "ARIPIPRAZOLE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Dr. Reddy's Laboratories Inc", "genericName": "ARIPIPRAZOLE ORALLY DISINTEGRATING", "brandName": "ARIPIPRAZOLE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "AMLODIPINE BESYLATE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Zydus Pharmaceuticals USA Inc.", "genericName": "AMLODIPINE BESYLATE", "brandName": "AMLODIPINE BESYLATE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ARIPIPRAZOLE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Dr. Reddy's Laboratories Inc", "genericName": "ARIPIPRAZOLE ORALLY DISINTEGRATING", "brandName": "ARIPIPRAZOLE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "ASPIRIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Unifirst First Aid Corporation", "genericName": "ASPIRIN", "brandName": "BAYER GENUINE ASPIRIN", "pharmClass_epc": "Nonsteroidal Anti-inflammatory Drug [EPC]", "route": "ORAL"}, {"medicinalproduct": "CHOLECALCIFEROL", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "FLUOXETINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "QUALLENT PHARMACEUTICALS HEALTH LLC", "genericName": "FLUOXETINE HYDROCHLORIDE", "brandName": "FLUOXETINE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "FOLIC ACID", "drugcharacterization": "2", "drugindication": null, "manufacturer": "PureTek Corporation", "genericName": "FOLIC ACID", "brandName": "VENTRIXYL", "pharmClass_epc": "Vitamin C [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Hyperglycaemia", "outcome": "1"}, {"pt": "Pneumonia", "outcome": "1"}, {"pt": "Oedema", "outcome": "4"}], "classifyText": "FUROSEMIDE GABAPENTIN LEVEMIR HUMULIN R LISINOPRIL MAGNESIUM OXIDE METOPROLOL TARTRATE POTASSIUM CHLORIDE SIMVASTATIN VITAMIN B COMPLEX METOLAZONE NOVOLOG ARIPIPRAZOLE AMLODIPINE BESYLATE ARIPIPRAZOLE BAYER GENUINE ASPIRIN CHOLECALCIFEROL FLUOXETINE VENTRIXYL FUROSEMIDE GABAPENTIN INSULIN DETEMIR INSULIN HUMAN LISINOPRIL MAGNESIUM OXIDE METOPROLOL TARTRATE POTASSIUM CHLORIDE SIMVASTATIN THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE METOLAZONE INSULIN ASPART ARIPIPRAZOLE ORALLY DISINTEGRATING AMLODIPINE BESYLATE ARIPIPRAZOLE ORALLY DISINTEGRATING ASPIRIN FLUOXETINE HYDROCHLORIDE FOLIC ACID Hyperglycaemia Pneumonia Oedema"}
{"safetyreportid": "10019044", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "DE", "reportType": "1", "patientSex": "2", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "ABILIFY", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Otsuka America Pharmaceutical, Inc.", "genericName": "ARIPIPRAZOLE", "brandName": "ABILIFY", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "ZYPREXA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "OLANZAPINE", "brandName": "ZYPREXA INTRAMUSCULAR", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "INTRAMUSCULAR"}], "reactions": [{"pt": "Temperature regulation disorder", "outcome": "6"}, {"pt": "Premature baby", "outcome": "6"}, {"pt": "Foetal exposure during pregnancy", "outcome": "6"}], "classifyText": "ABILIFY ZYPREXA INTRAMUSCULAR ARIPIPRAZOLE OLANZAPINE Temperature regulation disorder Premature baby Foetal exposure during pregnancy"}
{"safetyreportid": "10019045", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "DE", "reportType": "1", "patientSex": "1", "patientAge": "1", "patientAgeUnit": "804", "drugs": [{"medicinalproduct": "ABILIFY", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Otsuka America Pharmaceutical, Inc.", "genericName": "ARIPIPRAZOLE", "brandName": "ABILIFY", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "ZYPREXA", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "OLANZAPINE", "brandName": "ZYPREXA INTRAMUSCULAR", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "INTRAMUSCULAR"}], "reactions": [{"pt": "Neonatal respiratory distress syndrome", "outcome": "1"}, {"pt": "Premature baby", "outcome": "6"}, {"pt": "Temperature regulation disorder", "outcome": "6"}, {"pt": "Ventricular extrasystoles", "outcome": "6"}, {"pt": "Foetal exposure during pregnancy", "outcome": "6"}], "classifyText": "ABILIFY ZYPREXA INTRAMUSCULAR ARIPIPRAZOLE OLANZAPINE PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Neonatal respiratory distress syndrome Premature baby Temperature regulation disorder Ventricular extrasystoles Foetal exposure during pregnancy"}
{"safetyreportid": "10019084", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "GB", "reportType": "2", "patientSex": "2", "patientAge": "68", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "AMBRISENTAN", "drugcharacterization": "1", "drugindication": "PULMONARY ARTERIAL HYPERTENSION", "manufacturer": "Actavis Pharma, Inc.", "genericName": "AMBRISENTAN", "brandName": "AMBRISENTAN", "pharmClass_epc": "Endothelin Receptor Antagonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "PLACEBO", "drugcharacterization": "1", "drugindication": "PULMONARY ARTERIAL HYPERTENSION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "TADALAFIL", "drugcharacterization": "1", "drugindication": "PULMONARY ARTERIAL HYPERTENSION", "manufacturer": "AvKARE", "genericName": "TADALAFIL", "brandName": "TADALAFIL", "pharmClass_epc": "Phosphodiesterase 5 Inhibitor [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Rectal haemorrhage", "outcome": "3"}], "classifyText": "AMBRISENTAN PLACEBO TADALAFIL AMBRISENTAN TADALAFIL PULMONARY ARTERIAL HYPERTENSION PULMONARY ARTERIAL HYPERTENSION PULMONARY ARTERIAL HYPERTENSION Rectal haemorrhage"}
{"safetyreportid": "10019164", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "GB", "reportType": "2", "patientSex": "2", "patientAge": "68", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "AMBRISENTAN", "drugcharacterization": "1", "drugindication": "PULMONARY ARTERIAL HYPERTENSION", "manufacturer": "Actavis Pharma, Inc.", "genericName": "AMBRISENTAN", "brandName": "AMBRISENTAN", "pharmClass_epc": "Endothelin Receptor Antagonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "TADALAFIL", "drugcharacterization": "1", "drugindication": "PULMONARY ARTERIAL HYPERTENSION", "manufacturer": "AvKARE", "genericName": "TADALAFIL", "brandName": "TADALAFIL", "pharmClass_epc": "Phosphodiesterase 5 Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "PLACEBO", "drugcharacterization": "1", "drugindication": "PULMONARY ARTERIAL HYPERTENSION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CLOPIDOGREL", "drugcharacterization": "2", "drugindication": "CORONARY ARTERY DISEASE", "manufacturer": "NorthStar RxLLC", "genericName": "CLOPIDOGREL", "brandName": "CLOPIDOGREL", "pharmClass_epc": "P2Y12 Platelet Inhibitor [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Rectal haemorrhage", "outcome": "1"}], "classifyText": "AMBRISENTAN TADALAFIL PLACEBO CLOPIDOGREL AMBRISENTAN TADALAFIL CLOPIDOGREL PULMONARY ARTERIAL HYPERTENSION PULMONARY ARTERIAL HYPERTENSION PULMONARY ARTERIAL HYPERTENSION CORONARY ARTERY DISEASE Rectal haemorrhage"}
{"safetyreportid": "10019172", "receiveDate": "20140314", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": null, "reportType": "1", "patientSex": "2", "patientAge": "65", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "DULOXETINE", "drugcharacterization": "1", "drugindication": "PRODUCT SUBSTITUTION ISSUE", "manufacturer": "MARKSANS PHARMA LIMITED", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "DULOXETINE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Product substitution issue", "outcome": null}, {"pt": "Depression", "outcome": null}, {"pt": "Feeling abnormal", "outcome": null}, {"pt": "Abnormal dreams", "outcome": null}, {"pt": "Affect lability", "outcome": null}, {"pt": "Impaired work ability", "outcome": null}], "classifyText": "DULOXETINE CYMBALTA DULOXETINE HYDROCHLORIDE DULOXETINE HYDROCHLORIDE PRODUCT SUBSTITUTION ISSUE Product substitution issue Depression Feeling abnormal Abnormal dreams Affect lability Impaired work ability"}
{"safetyreportid": "10019189", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "SE", "reportType": "1", "patientSex": "1", "patientAge": "18", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "STRATTERA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "ATOMOXETINE HYDROCHLORIDE", "brandName": "STRATTERA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "FLUOXETINE HYDROCHLORIDE", "drugcharacterization": "2", "drugindication": "MAJOR DEPRESSION", "manufacturer": "NorthStar Rx LLC", "genericName": "FLUOXETINE HYDROCHLORIDE", "brandName": "FLUOXETINE HYDROCHLORIDE", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Suicidal ideation", "outcome": "1"}, {"pt": "Anxiety", "outcome": "3"}, {"pt": "Hallucination, auditory", "outcome": "6"}, {"pt": "Depression", "outcome": "3"}], "classifyText": "STRATTERA STRATTERA STRATTERA STRATTERA FLUOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE ATOMOXETINE HYDROCHLORIDE FLUOXETINE HYDROCHLORIDE PRODUCT USED FOR UNKNOWN INDICATION MAJOR DEPRESSION Suicidal ideation Anxiety Hallucination, auditory Depression"}
{"safetyreportid": "10019190", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "ES", "reportType": "1", "patientSex": "2", "patientAge": "71", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "CYMBALTA", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Pharyngeal oedema", "outcome": "6"}, {"pt": "Dizziness", "outcome": "6"}, {"pt": "Nausea", "outcome": "6"}, {"pt": "Tremor", "outcome": "6"}, {"pt": "Mydriasis", "outcome": "6"}, {"pt": "Tachycardia", "outcome": "6"}], "classifyText": "CYMBALTA DULOXETINE HYDROCHLORIDE PRODUCT USED FOR UNKNOWN INDICATION Pharyngeal oedema Dizziness Nausea Tremor Mydriasis Tachycardia"}
{"safetyreportid": "10019191", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "SE", "reportType": "1", "patientSex": "1", "patientAge": "66", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "HALDOL", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "OMEPRAZOLE.", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Amerisource Bergen", "genericName": "OMEPRAZOLE", "brandName": "GOOD NEIGHBOR PHARMACY OMEPRAZOLE", "pharmClass_epc": "Proton Pump Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "ENALAPRIL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Amneal Pharmaceuticals NY LLC", "genericName": "ENALAPRIL", "brandName": "ENALAPRIL MALEATE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "DOXAZOSIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Zydus Lifesciences Limited", "genericName": "DOXAZOSIN", "brandName": "DOXAZOSIN", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "FURIX", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ZYPREXA", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "OLANZAPINE", "brandName": "ZYPREXA INTRAMUSCULAR", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "ABILIFY", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Otsuka America Pharmaceutical, Inc.", "genericName": "ARIPIPRAZOLE", "brandName": "ABILIFY", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "AKINETON", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "TROMBYL", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "TEGRETOL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Novartis Pharmaceuticals Corporation", "genericName": "CARBAMAZEPINE", "brandName": "TEGRETOL", "pharmClass_epc": "Mood Stabilizer [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Hypothyroidism", "outcome": "6"}, {"pt": "Urinary retention", "outcome": "6"}, {"pt": "Pleural effusion", "outcome": "6"}, {"pt": "Agitation", "outcome": "6"}, {"pt": "Muscle spasms", "outcome": "6"}, {"pt": "General physical health deterioration", "outcome": "6"}, {"pt": "Erysipelas", "outcome": "6"}, {"pt": "Apathy", "outcome": "6"}, {"pt": "Bradycardia", "outcome": "1"}, {"pt": "Hypothermia", "outcome": "2"}, {"pt": "Anxiety", "outcome": "6"}], "classifyText": "HALDOL GOOD NEIGHBOR PHARMACY OMEPRAZOLE ENALAPRIL MALEATE DOXAZOSIN FURIX ZYPREXA INTRAMUSCULAR ABILIFY AKINETON TROMBYL TEGRETOL OMEPRAZOLE ENALAPRIL DOXAZOSIN OLANZAPINE ARIPIPRAZOLE CARBAMAZEPINE PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Hypothyroidism Urinary retention Pleural effusion Agitation Muscle spasms General physical health deterioration Erysipelas Apathy Bradycardia Hypothermia Anxiety"}
{"safetyreportid": "10019193", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "DE", "reportType": "1", "patientSex": "2", "patientAge": "40", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "CYMBALTA", "drugcharacterization": "1", "drugindication": "DEPRESSION", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CLINOVIR /00115202/", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Depression", "outcome": "6"}, {"pt": "Pain", "outcome": "6"}, {"pt": "Vaginal haemorrhage", "outcome": "1"}], "classifyText": "CYMBALTA CYMBALTA CLINOVIR /00115202/ DULOXETINE HYDROCHLORIDE DULOXETINE HYDROCHLORIDE DEPRESSION PRODUCT USED FOR UNKNOWN INDICATION Depression Pain Vaginal haemorrhage"}
{"safetyreportid": "10019195", "receiveDate": "20140318", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "GR", "reportType": "1", "patientSex": "2", "patientAge": "44", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "CYMBALTA", "drugcharacterization": "1", "drugindication": "DEPRESSION", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Aspartate aminotransferase increased", "outcome": "1"}, {"pt": "Alanine aminotransferase increased", "outcome": "1"}, {"pt": "Blood alkaline phosphatase increased", "outcome": "1"}], "classifyText": "CYMBALTA CYMBALTA DULOXETINE HYDROCHLORIDE DULOXETINE HYDROCHLORIDE DEPRESSION Aspartate aminotransferase increased Alanine aminotransferase increased Blood alkaline phosphatase increased"}
{"safetyreportid": "10019196", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "CH", "reportType": "1", "patientSex": "2", "patientAge": "44", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "CYMBALTA", "drugcharacterization": "1", "drugindication": "DEPRESSION", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LORAZEPAM", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "International Medication Systems, Limited", "genericName": "LORAZEPAM", "brandName": "LORAZEPAM", "pharmClass_epc": "Benzodiazepine [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "WELLBUTRIN", "drugcharacterization": "2", "drugindication": "DEPRESSION", "manufacturer": "Bausch Health US LLC", "genericName": "BUPROPION HYDROCHLORIDE", "brandName": "WELLBUTRIN XL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "TRUXAL", "drugcharacterization": "2", "drugindication": "SLEEP DISORDER", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SEROQUEL XR", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "AstraZeneca Pharmaceuticals LP", "genericName": "QUETIAPINE", "brandName": "SEROQUEL XR", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "PROMAZIN /00033001/", "drugcharacterization": "2", "drugindication": "SLEEP DISORDER", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LAMICTAL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "GlaxoSmithKline LLC", "genericName": "LAMOTRIGINE", "brandName": "LAMICTAL", "pharmClass_epc": "Anti-epileptic Agent [EPC]", "route": "ORAL"}, {"medicinalproduct": "CIPRALEX", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "EFEXOR", "drugcharacterization": "2", "drugindication": "DEPRESSION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "REMERON", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Organon LLC", "genericName": "MIRTAZAPINE", "brandName": "REMERON", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LITHIUM", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Advagen Pharma Ltd", "genericName": "LITHIUM", "brandName": "LITHIUM", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Dyskinesia", "outcome": "3"}, {"pt": "Torticollis", "outcome": "6"}, {"pt": "Chest discomfort", "outcome": "6"}, {"pt": "Sensory disturbance", "outcome": "6"}, {"pt": "Tremor", "outcome": "6"}, {"pt": "Dyskinesia", "outcome": "6"}, {"pt": "Intentional product misuse", "outcome": "6"}], "classifyText": "CYMBALTA CYMBALTA LORAZEPAM WELLBUTRIN XL TRUXAL SEROQUEL XR PROMAZIN /00033001/ LAMICTAL CIPRALEX EFEXOR REMERON LITHIUM DULOXETINE HYDROCHLORIDE DULOXETINE HYDROCHLORIDE LORAZEPAM BUPROPION HYDROCHLORIDE QUETIAPINE LAMOTRIGINE MIRTAZAPINE LITHIUM DEPRESSION PRODUCT USED FOR UNKNOWN INDICATION DEPRESSION SLEEP DISORDER PRODUCT USED FOR UNKNOWN INDICATION SLEEP DISORDER DEPRESSION Dyskinesia Torticollis Chest discomfort Sensory disturbance Tremor Dyskinesia Intentional product misuse"}
{"safetyreportid": "10019198", "receiveDate": "20140318", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "JP", "reportType": "1", "patientSex": "2", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "ZYPREXA", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "OLANZAPINE", "brandName": "ZYPREXA INTRAMUSCULAR", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "AMLODIPINE", "drugcharacterization": "1", "drugindication": "HYPERTENSION", "manufacturer": "Pangea Pharmaceuticals, LLC", "genericName": "AMLODIPINE", "brandName": "SDAMLO", "pharmClass_epc": "Dihydropyridine Calcium Channel Blocker [EPC]", "route": "ORAL"}, {"medicinalproduct": "TOLEDOMIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Gingival bleeding", "outcome": "6"}], "classifyText": "ZYPREXA INTRAMUSCULAR SDAMLO TOLEDOMIN OLANZAPINE AMLODIPINE PRODUCT USED FOR UNKNOWN INDICATION HYPERTENSION Gingival bleeding"}
{"safetyreportid": "10019228", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 1, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "83", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "REVLIMID", "drugcharacterization": "1", "drugindication": "PLASMA CELL MYELOMA", "manufacturer": "Celgene Corporation", "genericName": "LENALIDOMIDE", "brandName": "REVLIMID", "pharmClass_epc": "Thalidomide Analog [EPC]", "route": "ORAL"}, {"medicinalproduct": "MEGACE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "AUGMENTIN", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Allegis Holdings, LLC", "genericName": "AMOXICILLIN AND CLAVULANATE POTASSIUM", "brandName": "AUGMENTIN", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "AMITRIPTYLINE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LIPITOR", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Viatris Specialty LLC", "genericName": "ATORVASTATIN CALCIUM", "brandName": "LIPITOR", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LEVOTHYROXINE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "FIBERCON", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Foundation Consumer Brands", "genericName": "CALCIUM POLYCARBOPHIL", "brandName": "FIBERCON", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Death", "outcome": "5"}], "classifyText": "REVLIMID MEGACE AUGMENTIN HUMALOG MIX75/25 AMITRIPTYLINE LIPITOR LEVOTHYROXINE FIBERCON LENALIDOMIDE AMOXICILLIN AND CLAVULANATE POTASSIUM INSULIN LISPRO ATORVASTATIN CALCIUM CALCIUM POLYCARBOPHIL PLASMA CELL MYELOMA PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Death"}
{"safetyreportid": "10019262", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "FR", "reportType": "1", "patientSex": "2", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "EFFEXOR", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Viatris Specialty LLC", "genericName": "VENLAFAXINE HYDROCHLORIDE", "brandName": "EFFEXOR XR", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ZYPREXA", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "OLANZAPINE", "brandName": "ZYPREXA INTRAMUSCULAR", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "LEVOTHYROX", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "INSULIN", "drugcharacterization": "2", "drugindication": "GESTATIONAL DIABETES", "manufacturer": "Professional Complementary Health Formulas", "genericName": "INSULIN", "brandName": "INSULIN 1556", "pharmClass_epc": "Insulin Analog [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Foetal exposure during pregnancy", "outcome": "3"}, {"pt": "Multiple congenital abnormalities", "outcome": "3"}], "classifyText": "EFFEXOR XR ZYPREXA INTRAMUSCULAR LEVOTHYROX INSULIN 1556 VENLAFAXINE HYDROCHLORIDE OLANZAPINE INSULIN GESTATIONAL DIABETES Foetal exposure during pregnancy Multiple congenital abnormalities"}
{"safetyreportid": "10019278", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "JP", "reportType": "1", "patientSex": "2", "patientAge": "64", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "LYRICA", "drugcharacterization": "1", "drugindication": "SPINAL COLUMN STENOSIS", "manufacturer": "Parke-Davis Div of Pfizer Inc", "genericName": "PREGABALIN", "brandName": "LYRICA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "DORAL", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ZYPREXA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "OLANZAPINE", "brandName": "ZYPREXA INTRAMUSCULAR", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "NITRAZEPAM", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SEROQUEL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "AstraZeneca Pharmaceuticals LP", "genericName": "QUETIAPINE", "brandName": "SEROQUEL XR", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Dystonia", "outcome": "1"}, {"pt": "Dysstasia", "outcome": "1"}], "classifyText": "LYRICA DORAL ZYPREXA INTRAMUSCULAR NITRAZEPAM SEROQUEL XR PREGABALIN OLANZAPINE QUETIAPINE SPINAL COLUMN STENOSIS Dystonia Dysstasia"}
{"safetyreportid": "10019300", "receiveDate": "20140318", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "JP", "reportType": "1", "patientSex": "1", "patientAge": "45", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "ZYPREXA", "drugcharacterization": "1", "drugindication": "SCHIZOPHRENIA", "manufacturer": "Eli Lilly and Company", "genericName": "OLANZAPINE", "brandName": "ZYPREXA INTRAMUSCULAR", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "INTRAMUSCULAR"}], "reactions": [{"pt": "White blood cell count decreased", "outcome": "1"}], "classifyText": "ZYPREXA INTRAMUSCULAR OLANZAPINE SCHIZOPHRENIA White blood cell count decreased"}
{"safetyreportid": "10019302", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "DE", "reportType": "1", "patientSex": "2", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "OLANZAPINE", "drugcharacterization": "1", "drugindication": "SCHIZOPHRENIA, PARANOID TYPE", "manufacturer": "Hisun Pharmaceuticals USA, Inc.", "genericName": "OLANZAPINE", "brandName": "OLANZAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "ZYPADHERA", "drugcharacterization": "1", "drugindication": "SCHIZOPHRENIA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Oedema peripheral", "outcome": "2"}, {"pt": "Erythema", "outcome": "6"}, {"pt": "Feeling hot", "outcome": "6"}, {"pt": "Fall", "outcome": "6"}, {"pt": "Dizziness", "outcome": "6"}, {"pt": "Oedema peripheral", "outcome": "2"}], "classifyText": "OLANZAPINE ZYPADHERA OLANZAPINE SCHIZOPHRENIA, PARANOID TYPE SCHIZOPHRENIA Oedema peripheral Erythema Feeling hot Fall Dizziness Oedema peripheral"}
{"safetyreportid": "10019303", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 1, "occurcountry": "GB", "reportType": "1", "patientSex": "2", "patientAge": "66", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "OLANZAPINE", "drugcharacterization": "1", "drugindication": "AGITATION", "manufacturer": "Hisun Pharmaceuticals USA, Inc.", "genericName": "OLANZAPINE", "brandName": "OLANZAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "OLANZAPINE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Hisun Pharmaceuticals USA, Inc.", "genericName": "OLANZAPINE", "brandName": "OLANZAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}, {"medicinalproduct": "AMITRIPTYLIN", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ATENOLOL", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Almatica Pharma LLC", "genericName": "ATENOLOL", "brandName": "TENORMIN", "pharmClass_epc": "beta-Adrenergic Blocker [EPC]", "route": "ORAL"}, {"medicinalproduct": "FOLIC ACID", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "PureTek Corporation", "genericName": "FOLIC ACID", "brandName": "VENTRIXYL", "pharmClass_epc": "Vitamin C [EPC]", "route": "ORAL"}, {"medicinalproduct": "LEVOTHYROXINE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SIMVASTATIN", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Accord Healthcare, Inc.", "genericName": "SIMVASTATIN", "brandName": "SIMVASTATIN", "pharmClass_epc": "HMG-CoA Reductase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "ZOPICLONE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "QUETIAPINE", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Solco Healthcare U.S., LLC", "genericName": "QUETIAPINE", "brandName": "QUETIAPINE", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Sepsis", "outcome": "1"}, {"pt": "Hypotension", "outcome": "6"}, {"pt": "Tachycardia", "outcome": "6"}, {"pt": "Neutropenia", "outcome": "2"}, {"pt": "Thrombocytopenia", "outcome": "2"}, {"pt": "Body temperature increased", "outcome": "6"}], "classifyText": "OLANZAPINE OLANZAPINE AMITRIPTYLIN TENORMIN VENTRIXYL LEVOTHYROXINE SIMVASTATIN ZOPICLONE QUETIAPINE OLANZAPINE OLANZAPINE ATENOLOL FOLIC ACID SIMVASTATIN QUETIAPINE AGITATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Sepsis Hypotension Tachycardia Neutropenia Thrombocytopenia Body temperature increased"}
{"safetyreportid": "10019313", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "CH", "reportType": "1", "patientSex": "2", "patientAge": "54", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "LEPONEX ^NOVARTIS^", "drugcharacterization": "3", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LEPONEX ^NOVARTIS^", "drugcharacterization": "3", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LYRICA", "drugcharacterization": "1", "drugindication": "SCHIZOPHRENIA, PARANOID TYPE", "manufacturer": "Parke-Davis Div of Pfizer Inc", "genericName": "PREGABALIN", "brandName": "LYRICA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LEPONEX ^NOVARTIS^", "drugcharacterization": "3", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LEPONEX ^NOVARTIS^", "drugcharacterization": "3", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ZYPREXA", "drugcharacterization": "3", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "OLANZAPINE", "brandName": "ZYPREXA INTRAMUSCULAR", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "LEPONEX ^NOVARTIS^", "drugcharacterization": "3", "drugindication": "SCHIZOPHRENIA, PARANOID TYPE", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ZYPREXA", "drugcharacterization": "3", "drugindication": "SCHIZOPHRENIA, PARANOID TYPE", "manufacturer": "Eli Lilly and Company", "genericName": "OLANZAPINE", "brandName": "ZYPREXA INTRAMUSCULAR", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "ZYPREXA", "drugcharacterization": "3", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "OLANZAPINE", "brandName": "ZYPREXA INTRAMUSCULAR", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "LEPONEX ^NOVARTIS^", "drugcharacterization": "3", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LEPONEX ^NOVARTIS^", "drugcharacterization": "3", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ZYPREXA", "drugcharacterization": "3", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "OLANZAPINE", "brandName": "ZYPREXA INTRAMUSCULAR", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "ZYPREXA", "drugcharacterization": "3", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "OLANZAPINE", "brandName": "ZYPREXA INTRAMUSCULAR", "pharmClass_epc": "Atypical Antipsychotic [EPC]", "route": "INTRAMUSCULAR"}], "reactions": [{"pt": "Restlessness", "outcome": "6"}, {"pt": "Alanine aminotransferase increased", "outcome": "3"}, {"pt": "Blood alkaline phosphatase increased", "outcome": "3"}, {"pt": "Gamma-glutamyltransferase increased", "outcome": "3"}, {"pt": "Aspartate aminotransferase increased", "outcome": "3"}, {"pt": "Blood creatine phosphokinase increased", "outcome": "3"}, {"pt": "Toxicity to various agents", "outcome": "1"}, {"pt": "Mixed liver injury", "outcome": "3"}, {"pt": "Gait disturbance", "outcome": "6"}, {"pt": "Liver disorder", "outcome": "3"}, {"pt": "Product use issue", "outcome": "6"}, {"pt": "Drug interaction", "outcome": "1"}, {"pt": "Tachycardia", "outcome": "6"}, {"pt": "Asthenia", "outcome": "6"}, {"pt": "Antipsychotic drug level increased", "outcome": "1"}, {"pt": "Pneumonia aspiration", "outcome": "6"}], "classifyText": "LEPONEX ^NOVARTIS^ LEPONEX ^NOVARTIS^ LYRICA LEPONEX ^NOVARTIS^ LEPONEX ^NOVARTIS^ ZYPREXA INTRAMUSCULAR LEPONEX ^NOVARTIS^ ZYPREXA INTRAMUSCULAR ZYPREXA INTRAMUSCULAR LEPONEX ^NOVARTIS^ LEPONEX ^NOVARTIS^ ZYPREXA INTRAMUSCULAR ZYPREXA INTRAMUSCULAR PREGABALIN OLANZAPINE OLANZAPINE OLANZAPINE OLANZAPINE OLANZAPINE SCHIZOPHRENIA, PARANOID TYPE SCHIZOPHRENIA, PARANOID TYPE SCHIZOPHRENIA, PARANOID TYPE Restlessness Alanine aminotransferase increased Blood alkaline phosphatase increased Gamma-glutamyltransferase increased Aspartate aminotransferase increased Blood creatine phosphokinase increased Toxicity to various agents Mixed liver injury Gait disturbance Liver disorder Product use issue Drug interaction Tachycardia Asthenia Antipsychotic drug level increased Pneumonia aspiration"}
{"safetyreportid": "10019361", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 1, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "RU", "reportType": "1", "patientSex": "1", "patientAge": "63", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "ALIMTA", "drugcharacterization": "1", "drugindication": "NON-SMALL CELL LUNG CANCER STAGE IV", "manufacturer": "Eli Lilly and Company", "genericName": "PEMETREXED DISODIUM", "brandName": "ALIMTA", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "CISPLATINUM", "drugcharacterization": "1", "drugindication": "NON-SMALL CELL LUNG CANCER STAGE IV", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CYANOCOBALAMINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "FOLIC ACID", "drugcharacterization": "2", "drugindication": null, "manufacturer": "PureTek Corporation", "genericName": "FOLIC ACID", "brandName": "VENTRIXYL", "pharmClass_epc": "Vitamin C [EPC]", "route": "ORAL"}, {"medicinalproduct": "DEXAMETHASONE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Zydus Lifesciences Limited", "genericName": "DEXAMETHASONE", "brandName": "DEXAMETHASONE", "pharmClass_epc": "Corticosteroid [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Cardiac arrest", "outcome": "5"}, {"pt": "Myocardial infarction", "outcome": "5"}], "classifyText": "ALIMTA CISPLATINUM CYANOCOBALAMINE VENTRIXYL DEXAMETHASONE PEMETREXED DISODIUM FOLIC ACID DEXAMETHASONE NON-SMALL CELL LUNG CANCER STAGE IV NON-SMALL CELL LUNG CANCER STAGE IV Cardiac arrest Myocardial infarction"}
{"safetyreportid": "10019392", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "71", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "JAKAFI", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Incyte Corporation", "genericName": "RUXOLITINIB", "brandName": "JAKAFI", "pharmClass_epc": "Kinase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "AMBIEN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Cosette Pharmaceuticals, Inc.", "genericName": "ZOLPIDEM TARTRATE", "brandName": "AMBIEN", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ZOLOFT", "drugcharacterization": "2", "drugindication": null, "manufacturer": "ROERIG", "genericName": "SERTRALINE HYDROCHLORIDE", "brandName": "ZOLOFT", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LOSARTAN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Granules Pharmaceuticals Inc.", "genericName": "LOSARTAN", "brandName": "LOSARTAN POTASSIUM", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "NORVASC", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Viatris Specialty LLC", "genericName": "AMLODIPINE BESYLATE", "brandName": "NORVASC", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "GEMFIBROZIL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Cadila Pharmaceuticals Limited", "genericName": "GEMFIBROZIL", "brandName": "GEMFIBROZIL", "pharmClass_epc": "Peroxisome Proliferator Receptor alpha Agonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "GABAPENTIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Rising Pharma Holdings, Inc.", "genericName": "GABAPENTIN", "brandName": "GABAPENTIN", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "GLIPIZIDE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Roerig", "genericName": "GLIPIZIDE", "brandName": "GLUCOTROL XL", "pharmClass_epc": "Sulfonylurea [EPC]", "route": "ORAL"}, {"medicinalproduct": "CRESTOR", "drugcharacterization": "2", "drugindication": null, "manufacturer": "AstraZeneca Pharmaceuticals LP", "genericName": "ROSUVASTATIN", "brandName": "CRESTOR", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "METOPROLOL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Baxter Healthcare Corporation", "genericName": "METOPROLOL TARTRATE", "brandName": "METOPROLOL", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "ASPIRIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Unifirst First Aid Corporation", "genericName": "ASPIRIN", "brandName": "BAYER GENUINE ASPIRIN", "pharmClass_epc": "Nonsteroidal Anti-inflammatory Drug [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Hospitalisation", "outcome": "6"}], "classifyText": "JAKAFI CYMBALTA AMBIEN ZOLOFT LOSARTAN POTASSIUM NORVASC GEMFIBROZIL GABAPENTIN GLUCOTROL XL CRESTOR METOPROLOL BAYER GENUINE ASPIRIN RUXOLITINIB DULOXETINE HYDROCHLORIDE ZOLPIDEM TARTRATE SERTRALINE HYDROCHLORIDE LOSARTAN AMLODIPINE BESYLATE GEMFIBROZIL GABAPENTIN GLIPIZIDE ROSUVASTATIN METOPROLOL TARTRATE ASPIRIN Hospitalisation"}
{"safetyreportid": "10019549", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "GB", "reportType": "2", "patientSex": "2", "patientAge": "68", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "AMBRISENTAN", "drugcharacterization": "1", "drugindication": "PULMONARY ARTERIAL HYPERTENSION", "manufacturer": "Actavis Pharma, Inc.", "genericName": "AMBRISENTAN", "brandName": "AMBRISENTAN", "pharmClass_epc": "Endothelin Receptor Antagonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "TADALAFIL", "drugcharacterization": "1", "drugindication": "PULMONARY ARTERIAL HYPERTENSION", "manufacturer": "AvKARE", "genericName": "TADALAFIL", "brandName": "TADALAFIL", "pharmClass_epc": "Phosphodiesterase 5 Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "PLACEBO", "drugcharacterization": "1", "drugindication": "PULMONARY ARTERIAL HYPERTENSION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CLOPIDOGREL", "drugcharacterization": "2", "drugindication": "CARDIAC FAILURE CONGESTIVE", "manufacturer": "NorthStar RxLLC", "genericName": "CLOPIDOGREL", "brandName": "CLOPIDOGREL", "pharmClass_epc": "P2Y12 Platelet Inhibitor [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Rectal haemorrhage", "outcome": "1"}], "classifyText": "AMBRISENTAN TADALAFIL PLACEBO CLOPIDOGREL AMBRISENTAN TADALAFIL CLOPIDOGREL PULMONARY ARTERIAL HYPERTENSION PULMONARY ARTERIAL HYPERTENSION PULMONARY ARTERIAL HYPERTENSION CARDIAC FAILURE CONGESTIVE Rectal haemorrhage"}
{"safetyreportid": "10019568", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "FORTEO", "drugcharacterization": "1", "drugindication": "OSTEOPOROSIS", "manufacturer": "Eli Lilly and Company", "genericName": "TERIPARATIDE", "brandName": "FORTEO", "pharmClass_epc": "Parathyroid Hormone Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "LIPITOR", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Viatris Specialty LLC", "genericName": "ATORVASTATIN CALCIUM", "brandName": "LIPITOR", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Hepatic enzyme increased", "outcome": "6"}], "classifyText": "FORTEO LIPITOR TERIPARATIDE ATORVASTATIN CALCIUM OSTEOPOROSIS PRODUCT USED FOR UNKNOWN INDICATION Hepatic enzyme increased"}
{"safetyreportid": "10019569", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "1", "patientAge": "24", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "HUMALOG LISPRO", "drugcharacterization": "1", "drugindication": "TYPE 1 DIABETES MELLITUS", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "HUMULIN R", "drugcharacterization": "2", "drugindication": "TYPE 1 DIABETES MELLITUS", "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN HUMAN", "brandName": "HUMULIN R", "pharmClass_epc": "Insulin [EPC]", "route": "PARENTERAL"}, {"medicinalproduct": "HYDROCORTISONE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "TRIFECTA PHARMACEUTICALS USA LLC", "genericName": "HYDROCORTISONE", "brandName": "HYDROCORTISONE", "pharmClass_epc": "Corticosteroid [EPC]", "route": "TOPICAL"}], "reactions": [{"pt": "Diabetic ketoacidosis", "outcome": "6"}, {"pt": "Diabetic neuropathy", "outcome": "3"}], "classifyText": "HUMALOG LISPRO HUMULIN R HYDROCORTISONE INSULIN HUMAN HYDROCORTISONE TYPE 1 DIABETES MELLITUS TYPE 1 DIABETES MELLITUS Diabetic ketoacidosis Diabetic neuropathy"}
{"safetyreportid": "10019571", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "1", "patientAge": "22", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "HUMALOG", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}], "reactions": [{"pt": "Glycosylated haemoglobin increased", "outcome": "6"}, {"pt": "Blood ketone body", "outcome": "6"}, {"pt": "Pollakiuria", "outcome": "6"}, {"pt": "Blood glucose increased", "outcome": "1"}, {"pt": "Thirst", "outcome": "6"}, {"pt": "Myalgia", "outcome": "6"}], "classifyText": "HUMALOG MIX75/25 INSULIN LISPRO PRODUCT USED FOR UNKNOWN INDICATION Glycosylated haemoglobin increased Blood ketone body Pollakiuria Blood glucose increased Thirst Myalgia"}
{"safetyreportid": "10019573", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "1", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "FORTEO", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "TERIPARATIDE", "brandName": "FORTEO", "pharmClass_epc": "Parathyroid Hormone Analog [EPC]", "route": "SUBCUTANEOUS"}], "reactions": [{"pt": "Hip fracture", "outcome": "6"}, {"pt": "Fatigue", "outcome": "6"}], "classifyText": "FORTEO TERIPARATIDE PRODUCT USED FOR UNKNOWN INDICATION Hip fracture Fatigue"}
{"safetyreportid": "10019575", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "0", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "FORTEO", "drugcharacterization": "1", "drugindication": "OSTEOPOROSIS", "manufacturer": "Eli Lilly and Company", "genericName": "TERIPARATIDE", "brandName": "FORTEO", "pharmClass_epc": "Parathyroid Hormone Analog [EPC]", "route": "SUBCUTANEOUS"}], "reactions": [{"pt": "Pulmonary embolism", "outcome": "6"}, {"pt": "Pneumonia", "outcome": "6"}], "classifyText": "FORTEO TERIPARATIDE OSTEOPOROSIS Pulmonary embolism Pneumonia"}
{"safetyreportid": "10019576", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 1, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "GB", "reportType": "1", "patientSex": "1", "patientAge": "63", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "HUMALOG", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "HUMULIN", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN HUMAN", "brandName": "HUMULIN R", "pharmClass_epc": "Insulin [EPC]", "route": "PARENTERAL"}, {"medicinalproduct": "HUMULIN", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN HUMAN", "brandName": "HUMULIN R", "pharmClass_epc": "Insulin [EPC]", "route": "PARENTERAL"}, {"medicinalproduct": "FOSAMAX", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Organon LLC", "genericName": "ALENDRONATE SODIUM", "brandName": "FOSAMAX", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "MONTELUKAST SODIUM", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Camber Pharmaceuticals, Inc.", "genericName": "MONTELUKAST SODIUM", "brandName": "MONTELUKAST SODIUM", "pharmClass_epc": "Leukotriene Receptor Antagonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "SPIRIVA", "drugcharacterization": "1", "drugindication": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "manufacturer": "Boehringer Ingelheim Pharmaceuticals, Inc.", "genericName": "TIOTROPIUM BROMIDE", "brandName": "SPIRIVA HANDIHALER", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "BUMETANIDE", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Advagen Pharma Limited", "genericName": "BUMETANIDE", "brandName": "BUMETANIDE", "pharmClass_epc": "Loop Diuretic [EPC]", "route": "ORAL"}, {"medicinalproduct": "LISINOPRIL", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Chartwell RX, LLC", "genericName": "LISINOPRIL", "brandName": "LISINOPRIL", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "NYSTATIN", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Pharmaceutical Associates, Inc.", "genericName": "NYSTATIN", "brandName": "NYSTATIN", "pharmClass_epc": "Polyene Antifungal [EPC]", "route": "ORAL"}, {"medicinalproduct": "PARACETAMOL", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ALBUTEROL /00139501/", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "SERETIDE", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "TRAMADOL", "drugcharacterization": "1", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Lobar pneumonia", "outcome": "5"}], "classifyText": "HUMALOG MIX75/25 HUMULIN R HUMULIN R FOSAMAX MONTELUKAST SODIUM SPIRIVA HANDIHALER BUMETANIDE LISINOPRIL NYSTATIN PARACETAMOL ALBUTEROL /00139501/ SERETIDE TRAMADOL INSULIN LISPRO INSULIN HUMAN INSULIN HUMAN ALENDRONATE SODIUM MONTELUKAST SODIUM TIOTROPIUM BROMIDE BUMETANIDE LISINOPRIL NYSTATIN PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION CHRONIC OBSTRUCTIVE PULMONARY DISEASE PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION PRODUCT USED FOR UNKNOWN INDICATION Lobar pneumonia"}
{"safetyreportid": "10019577", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "BR", "reportType": "2", "patientSex": "2", "patientAge": "58", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "TERIPARATIDE", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Teva Pharmaceuticals USA, Inc.", "genericName": "TERIPARATIDE", "brandName": "TERIPARATIDE", "pharmClass_epc": "Parathyroid Hormone Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "CYCLOBENZAPRINE HYDROCHLORIDE.", "drugcharacterization": "2", "drugindication": null, "manufacturer": "SA3, LLC", "genericName": "CYCLOBENZAPRINE HYDROCHLORIDE", "brandName": "CYCLOBENZAPRINE HYDROCHLORIDE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "TYLENOL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Kenvue Brands LLC", "genericName": "ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE", "brandName": "TYLENOL COLD PLUS HEAD CONGESTION SEVERE", "pharmClass_epc": "Expectorant [EPC]", "route": "ORAL"}, {"medicinalproduct": "LEXOTAN", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LUFTAL /00159501/", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "DOMPERIDONA", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LEXOTAN", "drugcharacterization": "2", "drugindication": "ANXIETY", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LUFTAL /00159501/", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "TERIPARATIDE", "drugcharacterization": "1", "drugindication": "OSTEOPOROSIS", "manufacturer": "Teva Pharmaceuticals USA, Inc.", "genericName": "TERIPARATIDE", "brandName": "TERIPARATIDE", "pharmClass_epc": "Parathyroid Hormone Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "OMEPRAZOLE.", "drugcharacterization": "2", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "manufacturer": "Amerisource Bergen", "genericName": "OMEPRAZOLE", "brandName": "GOOD NEIGHBOR PHARMACY OMEPRAZOLE", "pharmClass_epc": "Proton Pump Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "LEXOTAN", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CYCLOBENZAPRINE HYDROCHLORIDE.", "drugcharacterization": "2", "drugindication": "PAIN", "manufacturer": "SA3, LLC", "genericName": "CYCLOBENZAPRINE HYDROCHLORIDE", "brandName": "CYCLOBENZAPRINE HYDROCHLORIDE", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "OMEPRAZOLE.", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Amerisource Bergen", "genericName": "OMEPRAZOLE", "brandName": "GOOD NEIGHBOR PHARMACY OMEPRAZOLE", "pharmClass_epc": "Proton Pump Inhibitor [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Urinary retention", "outcome": "2"}, {"pt": "Muscle spasms", "outcome": "3"}, {"pt": "Myalgia", "outcome": "3"}, {"pt": "Gait disturbance", "outcome": "3"}, {"pt": "Peripheral swelling", "outcome": "2"}, {"pt": "Intestinal dilatation", "outcome": "3"}, {"pt": "Blood alkaline phosphatase increased", "outcome": "6"}, {"pt": "Spinal compression fracture", "outcome": "3"}, {"pt": "Musculoskeletal chest pain", "outcome": "3"}, {"pt": "Injection site erythema", "outcome": "1"}, {"pt": "Abdominal pain", "outcome": "3"}, {"pt": "Thyroid hormones increased", "outcome": "6"}, {"pt": "Asthenia", "outcome": "6"}, {"pt": "Constipation", "outcome": "3"}, {"pt": "Pain", "outcome": "3"}], "classifyText": "TERIPARATIDE CYCLOBENZAPRINE HYDROCHLORIDE TYLENOL COLD PLUS HEAD CONGESTION SEVERE LEXOTAN LUFTAL /00159501/ DOMPERIDONA LEXOTAN LUFTAL /00159501/ TERIPARATIDE GOOD NEIGHBOR PHARMACY OMEPRAZOLE LEXOTAN CYCLOBENZAPRINE HYDROCHLORIDE GOOD NEIGHBOR PHARMACY OMEPRAZOLE TERIPARATIDE CYCLOBENZAPRINE HYDROCHLORIDE ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE TERIPARATIDE OMEPRAZOLE CYCLOBENZAPRINE HYDROCHLORIDE OMEPRAZOLE PRODUCT USED FOR UNKNOWN INDICATION ANXIETY PRODUCT USED FOR UNKNOWN INDICATION OSTEOPOROSIS PRODUCT USED FOR UNKNOWN INDICATION PAIN Urinary retention Muscle spasms Myalgia Gait disturbance Peripheral swelling Intestinal dilatation Blood alkaline phosphatase increased Spinal compression fracture Musculoskeletal chest pain Injection site erythema Abdominal pain Thyroid hormones increased Asthenia Constipation Pain"}
{"safetyreportid": "10019579", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "JP", "reportType": "1", "patientSex": "2", "patientAge": "81", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "EVISTA", "drugcharacterization": "1", "drugindication": "OSTEOPOROSIS", "manufacturer": "Eli Lilly and Company", "genericName": "RALOXIFENE HYDROCHLORIDE", "brandName": "EVISTA", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Breast cancer", "outcome": "1"}, {"pt": "Compression fracture", "outcome": "6"}], "classifyText": "EVISTA RALOXIFENE HYDROCHLORIDE OSTEOPOROSIS Breast cancer Compression fracture"}
{"safetyreportid": "10019609", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "55", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "TIKOSYN", "drugcharacterization": "1", "drugindication": "ATRIAL FIBRILLATION", "manufacturer": "Pfizer Laboratories Div Pfizer Inc", "genericName": "DOFETILIDE", "brandName": "TIKOSYN", "pharmClass_epc": "Antiarrhythmic [EPC]", "route": "ORAL"}, {"medicinalproduct": "SYNTHROID", "drugcharacterization": "3", "drugindication": null, "manufacturer": "AbbVie Inc.", "genericName": "LEVOTHYROXINE SODIUM", "brandName": "SYNTHROID", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "METOPROLOL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Baxter Healthcare Corporation", "genericName": "METOPROLOL TARTRATE", "brandName": "METOPROLOL", "pharmClass_epc": null, "route": "INTRAVENOUS"}, {"medicinalproduct": "FUROSEMIDE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Ipca Laboratories Limited", "genericName": "FUROSEMIDE", "brandName": "FUROSEMIDE", "pharmClass_epc": "Loop Diuretic [EPC]", "route": "ORAL"}, {"medicinalproduct": "FAMOTIDINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "LEADER/ Cardinal Health 110, Inc.", "genericName": "FAMOTIDINE", "brandName": "FAMOTIDINE", "pharmClass_epc": "Histamine-2 Receptor Antagonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}], "reactions": [{"pt": "Drug interaction", "outcome": "6"}, {"pt": "Drug ineffective", "outcome": "6"}, {"pt": "Atrial fibrillation", "outcome": "2"}, {"pt": "Ventricular tachycardia", "outcome": "6"}], "classifyText": "TIKOSYN SYNTHROID METOPROLOL FUROSEMIDE FAMOTIDINE CYMBALTA DOFETILIDE LEVOTHYROXINE SODIUM METOPROLOL TARTRATE FUROSEMIDE FAMOTIDINE DULOXETINE HYDROCHLORIDE ATRIAL FIBRILLATION Drug interaction Drug ineffective Atrial fibrillation Ventricular tachycardia"}
{"safetyreportid": "10019731", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "58", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "TRACLEER", "drugcharacterization": "1", "drugindication": "PULMONARY HYPERTENSION", "manufacturer": "Actelion Pharmaceuticals US, Inc.", "genericName": "BOSENTAN", "brandName": "TRACLEER", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "LIPITOR", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Viatris Specialty LLC", "genericName": "ATORVASTATIN CALCIUM", "brandName": "LIPITOR", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "OXYGEN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Apria Healthcare LLC", "genericName": "OXYGEN", "brandName": "OXYGEN COMPRESSED U.S.P", "pharmClass_epc": null, "route": "RESPIRATORY (INHALATION)"}, {"medicinalproduct": "LASIX", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Validus Pharmaceuticals LLC", "genericName": "FUROSEMIDE", "brandName": "LASIX", "pharmClass_epc": "Loop Diuretic [EPC]", "route": "ORAL"}, {"medicinalproduct": "ALLOPURINOL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Accord Healthcare Inc.", "genericName": "ALLOPURINOL", "brandName": "ALLOPURINOL", "pharmClass_epc": "Xanthine Oxidase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "METOLAZONE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Mylan Pharmaceuticals Inc.", "genericName": "METOLAZONE", "brandName": "METOLAZONE", "pharmClass_epc": "Thiazide-like Diuretic [EPC]", "route": "ORAL"}, {"medicinalproduct": "EFFIENT", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Cosette Pharmaceuticals, Inc.", "genericName": "PRASUGREL HYDROCHLORIDE", "brandName": "EFFIENT", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ESTRADIOL", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Sandoz Inc", "genericName": "ESTRADIOL", "brandName": "VIVELLE-DOT", "pharmClass_epc": "Estrogen [EPC]", "route": "TRANSDERMAL"}, {"medicinalproduct": "KAPPABI", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "IRON", "drugcharacterization": "2", "drugindication": null, "manufacturer": "True Botanica, LLC", "genericName": "IRON", "brandName": "FERRUM METALLICUM 6X", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "REMERON", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Organon LLC", "genericName": "MIRTAZAPINE", "brandName": "REMERON", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "SPIRONOLACTONE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Amneal Pharmaceuticals LLC", "genericName": "SPIRONOLACTONE", "brandName": "SPIRONOLACTONE", "pharmClass_epc": "Aldosterone Antagonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "POTASSIUM", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "GABAPENTIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Rising Pharma Holdings, Inc.", "genericName": "GABAPENTIN", "brandName": "GABAPENTIN", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "HYDROCORTISONE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "TRIFECTA PHARMACEUTICALS USA LLC", "genericName": "HYDROCORTISONE", "brandName": "HYDROCORTISONE", "pharmClass_epc": "Corticosteroid [EPC]", "route": "TOPICAL"}, {"medicinalproduct": "SYNTHROID", "drugcharacterization": "2", "drugindication": null, "manufacturer": "AbbVie Inc.", "genericName": "LEVOTHYROXINE SODIUM", "brandName": "SYNTHROID", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "MAGNESIUM", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Korea Life Science", "genericName": "MAGNESIUM", "brandName": "BYE ZERO", "pharmClass_epc": null, "route": "TOPICAL"}, {"medicinalproduct": "OMEPRAZOLE", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Amerisource Bergen", "genericName": "OMEPRAZOLE", "brandName": "GOOD NEIGHBOR PHARMACY OMEPRAZOLE", "pharmClass_epc": "Proton Pump Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "COMBIVENT", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "PULMICORT", "drugcharacterization": "2", "drugindication": null, "manufacturer": "H2-Pharma LLC", "genericName": "BUDESONIDE", "brandName": "PULMICORT FLEXHALER", "pharmClass_epc": "Corticosteroid [EPC]", "route": "RESPIRATORY (INHALATION)"}, {"medicinalproduct": "SPIRIVA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Boehringer Ingelheim Pharmaceuticals, Inc.", "genericName": "TIOTROPIUM BROMIDE", "brandName": "SPIRIVA HANDIHALER", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "SEREVENT", "drugcharacterization": "2", "drugindication": null, "manufacturer": "GlaxoSmithKline LLC", "genericName": "SALMETEROL XINAFOATE", "brandName": "SEREVENT DISKUS", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "ROFLUMILAST", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Novadoz Pharmaceuticals LLC", "genericName": "ROFLUMILAST", "brandName": "ROFLUMILAST", "pharmClass_epc": "Phosphodiesterase 4 Inhibitor [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Endotracheal intubation", "outcome": "6"}, {"pt": "Renal haemangioma", "outcome": "6"}, {"pt": "Intervertebral disc protrusion", "outcome": "3"}, {"pt": "Back pain", "outcome": "3"}, {"pt": "Blood potassium decreased", "outcome": "6"}, {"pt": "Urine flow decreased", "outcome": "2"}, {"pt": "Arthralgia", "outcome": "6"}, {"pt": "Muscle spasms", "outcome": "6"}, {"pt": "Abdominal pain", "outcome": "3"}, {"pt": "Musculoskeletal chest pain", "outcome": "2"}, {"pt": "Oedema peripheral", "outcome": "6"}, {"pt": "Fatigue", "outcome": "6"}, {"pt": "Oedema", "outcome": "6"}, {"pt": "Weight increased", "outcome": "6"}], "classifyText": "TRACLEER LIPITOR OXYGEN COMPRESSED U.S.P LASIX ALLOPURINOL METOLAZONE EFFIENT VIVELLE-DOT KAPPABI FERRUM METALLICUM 6X REMERON SPIRONOLACTONE POTASSIUM GABAPENTIN HYDROCORTISONE SYNTHROID BYE ZERO GOOD NEIGHBOR PHARMACY OMEPRAZOLE COMBIVENT PULMICORT FLEXHALER SPIRIVA HANDIHALER SEREVENT DISKUS HUMALOG MIX75/25 ROFLUMILAST BOSENTAN ATORVASTATIN CALCIUM OXYGEN FUROSEMIDE ALLOPURINOL METOLAZONE PRASUGREL HYDROCHLORIDE ESTRADIOL IRON MIRTAZAPINE SPIRONOLACTONE GABAPENTIN HYDROCORTISONE LEVOTHYROXINE SODIUM MAGNESIUM OMEPRAZOLE BUDESONIDE TIOTROPIUM BROMIDE SALMETEROL XINAFOATE INSULIN LISPRO ROFLUMILAST PULMONARY HYPERTENSION Endotracheal intubation Renal haemangioma Intervertebral disc protrusion Back pain Blood potassium decreased Urine flow decreased Arthralgia Muscle spasms Abdominal pain Musculoskeletal chest pain Oedema peripheral Fatigue Oedema Weight increased"}
{"safetyreportid": "10019750", "receiveDate": "20140318", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "2", "patientAge": "57", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "CYMBALTA", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "RAMIPRIL.", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Lupin Pharmaceuticals, Inc.", "genericName": "RAMIPRIL", "brandName": "RAMIPRIL", "pharmClass_epc": "Angiotensin Converting Enzyme Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "CETAPHIL DAILY FACIAL CLEANSER", "drugcharacterization": "2", "drugindication": "THERAPEUTIC SKIN CARE TOPICAL", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ABILINE EYE MAKEUP REMOVER", "drugcharacterization": "2", "drugindication": "THERAPEUTIC SKIN CARE TOPICAL", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "NEURONTIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Parke-Davis Div of Pfizer Inc", "genericName": "GABAPENTIN", "brandName": "NEURONTIN", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "ASPIRIN.", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Unifirst First Aid Corporation", "genericName": "ASPIRIN", "brandName": "BAYER GENUINE ASPIRIN", "pharmClass_epc": "Nonsteroidal Anti-inflammatory Drug [EPC]", "route": "ORAL"}, {"medicinalproduct": "MIRVASO", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Galderma Laboratories, L.P.", "genericName": "BRIMONIDINE TARTRATE", "brandName": "MIRVASO", "pharmClass_epc": null, "route": "TOPICAL"}, {"medicinalproduct": "PHYSICIANS FORMULA MAKEUP", "drugcharacterization": "2", "drugindication": "THERAPEUTIC SKIN CARE TOPICAL", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "OXYCODONE", "drugcharacterization": "2", "drugindication": "BACK PAIN", "manufacturer": "Amneal Pharmaceuticals LLC", "genericName": "OXYCODONE", "brandName": "OXYCODONE HYDROCHLORIDE", "pharmClass_epc": "Opioid Agonist [EPC]", "route": "ORAL"}, {"medicinalproduct": "ROBAXIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Hikma Pharmaceuticals USA Inc.", "genericName": "METHOCARBAMOL", "brandName": "ROBAXIN", "pharmClass_epc": "Muscle Relaxant [EPC]", "route": "INTRAMUSCULAR"}, {"medicinalproduct": "CALCIUM", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Apexel Co., Ltd", "genericName": "CALCIUM", "brandName": "7030 CALCIUM PREMIUM", "pharmClass_epc": "Calcium [EPC]", "route": "ORAL"}, {"medicinalproduct": "MIRVASO", "drugcharacterization": "1", "drugindication": "ROSACEA", "manufacturer": "Galderma Laboratories, L.P.", "genericName": "BRIMONIDINE TARTRATE", "brandName": "MIRVASO", "pharmClass_epc": null, "route": "TOPICAL"}, {"medicinalproduct": "SIMVASTATIN.", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Accord Healthcare, Inc.", "genericName": "SIMVASTATIN", "brandName": "SIMVASTATIN", "pharmClass_epc": "HMG-CoA Reductase Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "BIOTIN", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Guangdong Aimu Biological Technology Co., Ltd", "genericName": "BIOTIN", "brandName": "AVEYA BIOTIN HAIR GROWTH", "pharmClass_epc": "Arteriolar Vasodilator [EPC]", "route": "TOPICAL"}, {"medicinalproduct": "GLUCOSAMINE", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Condition aggravated", "outcome": "1"}, {"pt": "Erythema", "outcome": "1"}], "classifyText": "CYMBALTA RAMIPRIL CETAPHIL DAILY FACIAL CLEANSER ABILINE EYE MAKEUP REMOVER NEURONTIN BAYER GENUINE ASPIRIN MIRVASO PHYSICIANS FORMULA MAKEUP OXYCODONE HYDROCHLORIDE ROBAXIN 7030 CALCIUM PREMIUM MIRVASO SIMVASTATIN AVEYA BIOTIN HAIR GROWTH GLUCOSAMINE DULOXETINE HYDROCHLORIDE RAMIPRIL GABAPENTIN ASPIRIN BRIMONIDINE TARTRATE OXYCODONE METHOCARBAMOL CALCIUM BRIMONIDINE TARTRATE SIMVASTATIN BIOTIN THERAPEUTIC SKIN CARE TOPICAL THERAPEUTIC SKIN CARE TOPICAL THERAPEUTIC SKIN CARE TOPICAL BACK PAIN ROSACEA Condition aggravated Erythema"}
{"safetyreportid": "10019839", "receiveDate": "20140318", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "0", "patientAge": null, "patientAgeUnit": null, "drugs": [{"medicinalproduct": "LYRICA", "drugcharacterization": "1", "drugindication": "FIBROMYALGIA", "manufacturer": "Parke-Davis Div of Pfizer Inc", "genericName": "PREGABALIN", "brandName": "LYRICA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "CYMBALTA", "drugcharacterization": "1", "drugindication": "FIBROMYALGIA", "manufacturer": "Eli Lilly and Company", "genericName": "DULOXETINE HYDROCHLORIDE", "brandName": "CYMBALTA", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "TYLENOL", "drugcharacterization": "1", "drugindication": "FIBROMYALGIA", "manufacturer": "Kenvue Brands LLC", "genericName": "ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE", "brandName": "TYLENOL COLD PLUS HEAD CONGESTION SEVERE", "pharmClass_epc": "Expectorant [EPC]", "route": "ORAL"}], "reactions": [{"pt": "Somnolence", "outcome": "6"}], "classifyText": "LYRICA CYMBALTA TYLENOL COLD PLUS HEAD CONGESTION SEVERE PREGABALIN DULOXETINE HYDROCHLORIDE ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE FIBROMYALGIA FIBROMYALGIA FIBROMYALGIA Somnolence"}
{"safetyreportid": "10019926", "receiveDate": "20140318", "serious": 2, "seriousnessdeath": 0, "seriousnesshospitalization": 0, "seriousnesslifethreatening": 0, "occurcountry": "US", "reportType": "1", "patientSex": "1", "patientAge": "61", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "MIRVASO (BRIMONIDINE) TOPICAL GEL, 0.33%", "drugcharacterization": "1", "drugindication": "ROSACEA", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "MIRVASO (BRIMONIDINE) TOPICAL GEL, 0.33%", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "ORACEA (DOXYCYCLINE, USP) CAPSULES 40 MG", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CETAPHIL GENTLE SKIN CLEANSER", "drugcharacterization": "2", "drugindication": "THERAPEUTIC SKIN CARE TOPICAL", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "CIALIS", "drugcharacterization": "2", "drugindication": "PROSTATOMEGALY", "manufacturer": "Eli Lilly and Company", "genericName": "TADALAFIL", "brandName": "CIALIS", "pharmClass_epc": "Phosphodiesterase 5 Inhibitor [EPC]", "route": "ORAL"}, {"medicinalproduct": "AVEENO CONTINUOUS PROTECTION SPF 100", "drugcharacterization": "2", "drugindication": "PROPHYLAXIS AGAINST SOLAR RADIATION", "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}], "reactions": [{"pt": "Urticaria", "outcome": "1"}, {"pt": "Pharyngeal oedema", "outcome": "1"}, {"pt": "Swollen tongue", "outcome": "1"}, {"pt": "Lip swelling", "outcome": "1"}, {"pt": "Rebound effect", "outcome": "6"}, {"pt": "Condition aggravated", "outcome": "3"}, {"pt": "Rash papular", "outcome": "3"}, {"pt": "Erythema", "outcome": "3"}, {"pt": "Rosacea", "outcome": "3"}, {"pt": "Flushing", "outcome": "6"}, {"pt": "Inappropriate schedule of drug administration", "outcome": "1"}], "classifyText": "MIRVASO (BRIMONIDINE) TOPICAL GEL, 0.33% MIRVASO (BRIMONIDINE) TOPICAL GEL, 0.33% ORACEA (DOXYCYCLINE, USP) CAPSULES 40 MG CETAPHIL GENTLE SKIN CLEANSER CIALIS AVEENO CONTINUOUS PROTECTION SPF 100 TADALAFIL ROSACEA THERAPEUTIC SKIN CARE TOPICAL PROSTATOMEGALY PROPHYLAXIS AGAINST SOLAR RADIATION Urticaria Pharyngeal oedema Swollen tongue Lip swelling Rebound effect Condition aggravated Rash papular Erythema Rosacea Flushing Inappropriate schedule of drug administration"}
{"safetyreportid": "10019952", "receiveDate": "20140318", "serious": 1, "seriousnessdeath": 0, "seriousnesshospitalization": 1, "seriousnesslifethreatening": 0, "occurcountry": "FR", "reportType": "1", "patientSex": "2", "patientAge": "49", "patientAgeUnit": "801", "drugs": [{"medicinalproduct": "ESCITALOPRAM", "drugcharacterization": "1", "drugindication": null, "manufacturer": "Allergan, Inc.", "genericName": "ESCITALOPRAM", "brandName": "LEXAPRO", "pharmClass_epc": null, "route": "ORAL"}, {"medicinalproduct": "TEMESTA", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LEXOMIL ROCHE", "drugcharacterization": "1", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "AVLOCARDYL", "drugcharacterization": "2", "drugindication": null, "manufacturer": null, "genericName": null, "brandName": null, "pharmClass_epc": null, "route": null}, {"medicinalproduct": "LANTUS", "drugcharacterization": "2", "drugindication": null, "manufacturer": "sanofi-aventis U.S. LLC", "genericName": "INSULIN GLARGINE", "brandName": "LANTUS", "pharmClass_epc": "Insulin Analog [EPC]", "route": "SUBCUTANEOUS"}, {"medicinalproduct": "HUMALOG", "drugcharacterization": "2", "drugindication": null, "manufacturer": "Eli Lilly and Company", "genericName": "INSULIN LISPRO", "brandName": "HUMALOG MIX75/25", "
Raw
labels_slim.jsonl
View raw

(Sorry about that, but we can’t show files that are this big right now.)

Sign up for free to join this conversation on GitHub. Already have an account? Sign in to comment